Pipes Feed Preview: BBC News & FOX News : Health & LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events & Health | The Indian Express & Medical News, Health News Latest, Medical News Today - Medical Dialogues | & Healthier, Happy Lives Blog & No Feed provided

1. Plan for GPs to keep millions out of hospital

   Thu, 17 Apr 2025 09:48:37 -0000

   GPs will work more closely with specialists to support patients closer to home, the government says.

2. Disposable vape use falling in UK ahead of ban

   Wed, 16 Apr 2025 06:23:05 -0000

   The number of people vaping in the UK has stalled, while disposable vape usage has fallen, a study suggests.

3. WHO agrees legally binding pandemic treaty

   Wed, 16 Apr 2025 12:40:46 -0000

   The agreement is designed to ensure more cooperation between nations in the event of another pandemic.

4. Doctors in two end-of-life cases can be named

   Wed, 16 Apr 2025 13:22:54 -0000

   Those involved in caring for Isaiah Haastrup and Zainab Abbasi can be named, the Supreme Court rules.

5. North Scotland among highest rates of Huntington's

   Wed, 16 Apr 2025 07:59:26 -0000

   The statistics are five times higher than the world figure, a University of Aberdeen study says.

6. Adult ADHD diagnosis 'tough but totally made sense'

   Tue, 15 Apr 2025 23:00:59 -0000

   Jennifer Cousins says it is "unfair" that there are no commissioned services for ADHD in Northern Ireland.

7. Brazilian butt lift ads banned by UK regulator

   Wed, 16 Apr 2025 00:00:58 -0000

   The ads used time-limited deals to "irresponsibly pressurise" customers into booking, says the Advertising Standards Authority.

8. Why men are so unhealthy - and what can be done

   Sun, 06 Apr 2025 00:40:30 -0000

   Men are more likely to die prematurely than women - and worse at seeking care when they need it.

9. What goes on inside toddlers' brains?

   Thu, 10 Apr 2025 23:13:02 -0000

   A unique study is tracking the development of hundreds of babies whose parents have also been studied since birth.

10. 'My long Covid turned out to be terminal cancer'

    Mon, 07 Apr 2025 10:39:19 -0000

    Olivia Knowles noticed something "wasn't quite correct" while competing in an ironman competition.

11. Woman contacted by stranger on DNA site - and the truth about her birth unravelled

    Sat, 05 Apr 2025 00:20:36 -0000

    An NHS trust has paid compensation after a woman, now in her 70s, discovered she had been swapped at birth.

12. 'I could live 30 years but plan to die': How assisted dying law is dividing Canadians

    Fri, 04 Apr 2025 01:24:38 -0000

    BBC News reports on assisted dying in Canada, where some say it's now easier to choose to die than get support to live

13. Are my braids doing more harm than good?

    Sun, 30 Mar 2025 00:03:42 -0000

    Research suggests the synthetic hair used for braiding could be bad for you - but will that stop women using it?

14. California man invites BBC to witness his death as MPs debate assisted dying

    Thu, 03 Apr 2025 21:10:48 -0000

    Wayne Hawkins believes terminally ill people should be able to die when they choose, but others in the state disagree.

15. 'I fear I'll be dead before I get justice for my son'

    Sat, 29 Mar 2025 09:56:44 -0000

    Tony Summers' son Paul was diagnosed with HIV and Hepatitis C and died in 2008 aged 44.

16. Doctor 'betrayed' over son's death at her hospital

    Thu, 27 Mar 2025 17:31:46 -0000

    Deborah Burns says she is unable to return to work at the hospital after the death of her son, William Hewes.

17. Baby slings unsafe for hands-free feeding, charities warn

    Wed, 26 Mar 2025 16:12:49 -0000

    Parenting charities, including the NCT, have updated their advice saying slings and carriers are unsafe for feeding.

18. Fake £4m Xanax drug gang boss jailed

    Thu, 27 Mar 2025 16:35:28 -0000

    The gang, managed from Thailand, produced 11 million pills in the West Midlands to be sold online.

19. Baby deaths trust claimed £2m 'good care' payments

    Wed, 26 Mar 2025 06:19:57 -0000

    An NHS trust criticised over a baby's death claimed money for providing good care, the BBC can reveal.

20. Fertility patients sold unproven add-ons, HFEA says

    Wed, 26 Mar 2025 10:25:25 -0000

    Despite little proof add-ons help, many IVF clinics offer them, the UK's fertility regulator warns.

21. UK draws up new disease-threat watch list

    Tue, 25 Mar 2025 01:38:56 -0000

    Some are viruses with global pandemic potential - like Covid - others infectious illnesses with no treatments.

22. What are the Pip and universal credit changes and who is affected?

    Wed, 26 Mar 2025 15:03:20 -0000

    The government has set out more details about its proposed cuts to disability benefits.

23. Who are the millions of Britons not working?

    Wed, 26 Mar 2025 15:23:42 -0000

    About a quarter of the working age population - those aged 16 to 64 - do not currently have a job.

24. Who can get an NHS Covid booster this spring?

    Wed, 02 Apr 2025 07:02:46 -0000

    The NHS Covid spring booster campaign is under way, but vaccines are also available privately.

25. Scans in shopping centres and AI - can ideas like these help save the NHS?

    Mon, 24 Mar 2025 06:04:23 -0000

    Government says more NHS funds in England will go to social care as we look at how it can deliver change.

26. First case of bird flu in sheep found on UK farm

    Mon, 24 Mar 2025 14:57:28 -0000

    The UK's chief veterinary officer confirms the case was discovered on a farm in Yorkshire.

27. What is assisted dying and how could the law change?

    Wed, 26 Mar 2025 10:17:24 -0000

    MPs backed a proposal to let terminally ill people in England and Wales choose to end their life.

28. Hancock criticises 'wholly naive' Covid inquiry

    Wed, 19 Mar 2025 17:14:53 -0000

    The former health secretary was giving evidence about medical equipment deals during the pandemic.

29. Mone accuses Covid inquiry of 'cover-up'

    Thu, 13 Mar 2025 19:10:36 -0000

    She says husband Doug Barrowman and her are targets of a "politically motivated witch hunt".

30. Michael Gove denies trying to circumvent Dyson ventilator checks

    Tue, 11 Mar 2025 12:29:20 -0000

    Former cabinet minister says it would be ludicrous to suggest he tried to shortcut safety checks in the pandemic.

31. How does the Covid inquiry work?

    Thu, 16 Jan 2025 09:58:17 -0000

    The inquiry has heard from politicians, civil servants, public health experts and bereaved families.

32. Michelle Mone-linked PPE firm evidence to be heard in private

    Wed, 26 Feb 2025 00:00:16 -0000

    Covid inquiry says hearings into the firm, led by Michelle Mone's husband, must be held in closed session.

33. Large UK-wide pandemic preparedness tests planned this year

    Thu, 16 Jan 2025 16:36:01 -0000

    The stress test will involve thousands of people to help the UK prepare for potential future threats.

34. Families failed by Covid jabs tell inquiry of pain

    Wed, 15 Jan 2025 18:39:40 -0000

    They said there was no support after the death and harm suffered by their loved ones.

35. NHS hours from PPE running out in Covid - Hancock

    Thu, 21 Nov 2024 16:58:34 -0000

    Former health secretary tells inquiry some healthcare settings did run out - "and it was awful".

36. Covid inquiry told Treasury blocked NHS bed request

    Mon, 11 Nov 2024 18:06:48 -0000

    NHS England chief executive Amanda Pritchard says the decision, in July 2020, was very disappointing.

37. Covid inquiry told top NHS doctor was terrified

    Thu, 07 Nov 2024 17:34:34 -0000

    Sir Stephen Powis says points-based tool was drawn up should need to prioritise patients have arisen.

38. How close were hospitals to collapse in Covid?

    Mon, 28 Oct 2024 00:06:04 -0000

    The Covid inquiry restarts its live hearings this week, after senior staff in the NHS revealed just how close some hospitals were to collapse

39. Covid inquiry told of trust do-not-resuscitate rule

    Thu, 10 Oct 2024 16:54:11 -0000

    Patients' families were “horrified but not surprised” when told the blanket policy had been in place.

40. We were not treated as parents, Covid inquiry told

    Mon, 07 Oct 2024 14:11:38 -0000

    Mum of premature twins says rigid restrictions on birthing wards during Covid were traumatic.

41. Covid ambulance crews faced 'crucial PPE delays'

    Tue, 01 Oct 2024 14:39:04 -0000

    Crews say they faced crucial delays trying to save dying patients because of the time it took to put on equipment.

42. Covid was like a daily terror attack, doctor tells inquiry

    Thu, 26 Sep 2024 14:06:37 -0000

    Covid inquiry hears harrowing testimony from ex-adviser in emergency preparedness at NHS England.

43. Covid inquiry rejects clinicians’ anonymity plea

    Thu, 26 Sep 2024 00:11:07 -0000

    The UK Health Security Agency argued naming the junior officials could put them at risk of abuse.

44. Warning tax rises could force care homes to close

    Thu, 31 Oct 2024 13:50:35 -0000

    Social care providers say the sector is in "unprecedented danger" without more funding.

45. High-grade masks evidence weak, Covid inquiry told

    Thu, 19 Sep 2024 11:39:28 -0000

    UKHSA's Prof Susan Hopkins said respirator masks may have worked no better than thin surgical masks.

46. Nurses bore the brunt of Covid, ex-chief nurse says

    Tue, 17 Sep 2024 15:58:13 -0000

    Dame Ruth May tells the Covid inquiry nurses struggled with low staffing levels and difficulties accessing protective equipment.

47. Labour's plan for benefits throws up a bigger dilemma

    Mon, 17 Mar 2025 06:06:29 -0000

    The debate has sparked a wider dilemma about the broader purpose of welfare

48. First place in British Isles set to approve right to die

    Tue, 25 Feb 2025 13:02:21 -0000

    Laws in the Isle of Man to let terminally ill adults end their own lives are in the last stages of debate.

49. Generation K: The disturbing rise of ketamine abuse among young people

    Tue, 25 Feb 2025 06:00:36 -0000

    Increasing numbers of young people are using the drug, experts say. The health impacts can be catastrophic.

50. Assisted dying bill: What is in proposed law?

    Fri, 29 Nov 2024 15:30:26 -0000

    The proposed law would allow some terminally ill adults to end their own lives. But there are requirements.

51. 'My first cervical screening was over before I knew it'

    Sun, 02 Feb 2025 01:06:51 -0000

    The BBC speaks to six people about their first cervical screening, and what they wish they'd known beforehand.

52. How are the vaping rules changing?

    Tue, 05 Nov 2024 17:06:32 -0000

    Marketing rules will be stricter, nicotine vapes will be taxed and disposable vapes will be banned.

53. Is the system letting down people who were harmed by Covid vaccines?

    Wed, 23 Oct 2024 05:48:59 -0000

    People affected by rare blood clots say they feel they have been airbrushed out of the pandemic.

54. How will weight-loss drugs change our relationship with food?

    Sat, 19 Oct 2024 03:10:13 -0000

    The rise of these treatments has major implications for how we think about obesity, says James Gallagher.

55. NHS needs better plan around weight loss jabs, warn experts

    Wed, 16 Oct 2024 07:27:18 -0000

    Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.

56. How many of us will end up being diagnosed with ADHD?

    Sun, 15 Sep 2024 00:36:40 -0000

    Experts suggest that the number of people with ADHD is actually going to remain steady.

57. The junior doctors' strikes may be over. But is trouble ahead?

    Fri, 02 Aug 2024 00:43:02 -0000

    The end of the pay dispute sounded too good to be true. And now some are wondering if it might be.

58. Why we might never know the truth about ultra-processed foods

    Sat, 27 Jul 2024 23:33:23 -0000

    Experts can’t agree how exactly they affect us and it’s not clear that science will give us an answer.

59. Are weight-loss injections the answer to obesity?

    Sun, 19 Mar 2023 00:52:45 -0000

    The appeal is clear - but should we be turning to appetite-suppressing injections?

60. What is assisted dying and how could the law change?

    Wed, 26 Mar 2025 10:17:24 -0000

    MPs backed a proposal to let terminally ill people in England and Wales choose to end their life.

61. Chris Hoy says men should talk about health issues more

    Fri, 13 Dec 2024 09:51:18 -0000

    Six-time Olympic cycling champion Chris Hoy calls for more openness on health matters

62. Paris: Grassroots to Glory

    Mon, 08 Jul 2024 09:43:25 -0000

    The Rugby 7s player has struggled with body image in the past, but says sport has helped

63. Paris: Grassroots to Glory

    Thu, 18 Jul 2024 05:01:00 -0000

    The Paralympic Rowing Cox will compete a year after getting the all clear from cancer.

64. How Dame Deborah James helped save a mum's life

    Mon, 24 Jun 2024 09:06:52 -0000

    A mother-of-three shared her story with Dame Deborah's mother Heather on BBC Breakfast.

65. Can health secretary name NHS trusts performing well?

    Thu, 11 Apr 2024 09:09:11 -0000

    Victoria Atkins is challenged to name some health trusts meeting their targets to cut waiting lists.

66. 'I embrace my alopecia, but I’d love my old hair back’

    Sun, 03 Mar 2024 23:36:30 -0000

    People living with alopecia could have access to treatment on the NHS in Scotland for the first time.

67. Joe Rogan gave up drinking alcohol for this one simple reason

    Fri, 18 Apr 2025 19:13:21 -0000

    Podcaster Joe Rogan recently stopped drinking alcohol, he announced on a recent episode of “The Joe Rogan Experience." Neurosurgeon Dr. Brett Osborn shares the associated health risks.

68. Jennifer Aniston breaks 'extreme' fear of flying with hypnosis: Does it work?

    Fri, 18 Apr 2025 17:32:48 -0000

    Jennifer Aniston recently shared that hypnosis therapy helped address her severe fear of flying. Psychotherapist Jonathan Alpert comments on how to treat flight anxiety.

69. E. coli outbreak went unpublicized by FDA despite affecting 15 states: report

    Fri, 18 Apr 2025 12:39:57 -0000

    The FDA is under fire for not publicly warning about deadly E. coli outbreak linked to romaine lettuce that sickened 89 people across 15 states, raising questions about food safety protocols.

70. New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'

    Fri, 18 Apr 2025 09:00:36 -0000

    A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at least 400 mg of levodopa daily, tavapadon helped reduce motor fluctuations.

71. First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

    Thu, 17 Apr 2025 20:02:56 -0000

    Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

72. Smartphone use could reduce dementia risk in older adults, study finds

    Thu, 17 Apr 2025 18:36:08 -0000

    The risk of dementia could decrease with consistent use of smartphones and other technology among older adults, according to a new study from Baylor University.

73. Rising autism rates now affect 3% of children, says CDC report

    Thu, 17 Apr 2025 09:00:27 -0000

    A new CDC report stated that autism rates are rising in the U.S., as more than 3% of America's kids are being diagnosed. A spokesperson from Autism Speaks reacts to the latest data.

74. Medical test linked to cancer, plus rising strep throat cases

    Wed, 16 Apr 2025 21:56:49 -0000

    The Fox News Health Newsletter brings you trending and important stories about health care, drug developments, mental health issues, real people's triumphs over medical struggles, and more.

75. Fake Ozempic drugs found in US drug supply, FDA warns

    Wed, 16 Apr 2025 21:34:26 -0000

    The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.

76. Texas measles outbreak swells to 561 cases, CDC sends more help

    Wed, 16 Apr 2025 18:13:32 -0000

    Measles have continued to spread in Texas with a total of 561 reported cases. Gaines County, the center of the outbreak, saw an increase of nine cases since mid-April.

77. Dementia risk connected to cannabis-related hospital visits, says study

    Wed, 16 Apr 2025 17:08:56 -0000

    New research found that older individuals who visited the hospital for cannabis-related reasons could be at a higher risk of developing dementia. Canadian researcher Daniel Myran discusses the findings.

78. Common medical test linked to 5% of cancers, study suggests: ‘Use them wisely’

    Wed, 16 Apr 2025 13:03:15 -0000

    CT scans, or CAT scans, are widely used to get internal images of the body and diagnose dangerous medical conditions, but they could pose a hidden risk. Doctors discuss.

79. More babies born to women over 40 than teens for first time in US history

    Tue, 15 Apr 2025 20:22:48 -0000

    New birth data from the CDC reflects a major increase in birth rates among women over 40, as teen pregnancies continue to decline. Fertility specialist Dr. Ashley Wiltshire reacts.

80. Kennedy applauds 'visionary' Indiana governor's MAHA executive orders

    Tue, 15 Apr 2025 18:23:44 -0000

    HHS Sec. Robert F. Kennedy Jr. and CMS administrator Dr. Mehmet Oz joined Indiana Gov. Mike Braun as he announced executive orders aimed at making Hoosiers healthier.

81. Anti-aging benefits linked to one surprising health habit

    Tue, 15 Apr 2025 09:10:33 -0000

    Meditation has been linked to a slowdown in aging and reduction in stress. Biohacker Dave Asprey speaks with Fox News Digital about the health benefits of the practice.

82. Men's multivitamins recalled due to undeclared allergen: FDA

    Tue, 15 Apr 2025 01:01:19 -0000

    A men's multivitamin brand has been recalled because it contains an undeclared allergen that could be fatal to certain consumers.

83. Fluoride exposure linked to ‘detrimental effects’ on health of pregnant women, infants

    Mon, 14 Apr 2025 16:27:31 -0000

    New meta-analysis looks into studies on the impact of fluoride on pregnant women and infants, concluding that fluoride is toxic to early brain development.

84. Woman with Alzheimer's begins 3,000-mile walk to raise awareness

    Mon, 14 Apr 2025 09:00:29 -0000

    A California woman was motivated to embark on a 3,000-mile walk to raise awareness of the power of healthy living. Judy Benjamin, 80, shares her story with Fox News Digital.

85. Artificial intelligence transforms patient care and reduces burnout, physician says

    Sun, 13 Apr 2025 21:10:16 -0000

    Across the country, thousands of physicians are using a new form of medical AI called ambient listening. A doctor speaks about the potential benefits for patients and staff.

86. Creatine may not build more muscle after all, study suggests

    Sun, 13 Apr 2025 09:00:05 -0000

    The sports supplement creatine may not be effective in building muscle, according to a new study from the University of New South Wales. Researchers and exercise scientists speak about the findings.

87. ​ 7 smart ways to handle rude people gracefully​

    Sat, 19 Apr 2025 07:34:34 -0000

    We’ve all had to deal with rude people-- either at work, amid traffic, on social media, or even in our own families. Sometimes it can be just about passing comments, other times it's nagging that might get on our nerves. While it’s tempting to snap back or shut down, that usually just feeds into the negativity. But there can be some calm yet smart ways to respond to such people, instead of reacting to them. We might not be able to control how others act, but we can control how we respond. And that makes all the difference. Responding with maturity and emotional intelligence doesn’t mean you’re weak or letting someone walk all over you. It means you’re strong enough not to let their behaviour control your emotions or mood. It’s about choosing your response with intention and not out of frustration.Here are 7 smart and practical ways to deal with rude people that will help you stay calm, confident, and in control even in difficult situations:

88. How can chia seed water reduce belly fat?

    Sat, 12 Apr 2025 03:30:00 -0000

    Chia seed water is gaining traction as a weight management tool, particularly for reducing belly fat. Rich in fiber, protein, and omega-3 fatty acids, these seeds promote fullness, regulate blood sugar, and combat inflammation. Incorporating chia seed water into a balanced diet and exercise routine can support weight loss goals by improving digestion and providing sustained energy.

89. 10 habits of parents that boosts kids' confidence

    Fri, 18 Apr 2025 23:30:00 -0000

    ​Confidence is built slowly, through consistent love, encouragement, and how they’re treated at home. Here are everyday habits that quietly shape confident, emotionally secure kids.​

90. ​​7 foods to improve digestion after a heavy meal​

    Fri, 18 Apr 2025 09:42:00 -0000

    Overeating can leave you feeling bloated and uncomfortable, but natural remedies like ginger, pineapple, peppermint, and fennel can help ease digestion. Foods like papaya, yogurt, and diluted apple cider vinegar also support gut health and help your stomach feel lighter and more at ease.4o

91. Arvind Kejriwal's daughter Harshita marries Sambhav Jain

    Fri, 18 Apr 2025 15:36:44 -0000

    Arvind Kejriwal's daughter, Harshita, married Sambhav Jain on April 18, 2025, at Kapurthala House in Delhi. The wedding was attended by close family and friends, including Punjab CM Bhagwant Mann and Manish Sisodia. Harshita, an IIT Delhi graduate and former BCG consultant, co-founded 'Basil Health' with Sambhav.

92. Sheer sarees make a chic comeback

    Sat, 19 Apr 2025 00:30:00 -0000

    A classic of the 90s, sheer sarees are having a bold, effortless return in the Indian woman's wardrobe. Recall Aishwarya Rai in Mohabbatein - those airy, see-through drapes that floated while she waved her pallu against the setting of snow-topped mountains. Fast forward to now, and this ethereal cloth is being reimagined by designers and adopted by celebrities at events ranging from poojas to parties to destination weddings. Sheer sarees are known for their effortless flow and the ideal combination of old-world silhouettes with modern detailing. Here's how Bollywood fashion icons are putting sheer sarees back in the limelight.

93. 5 signs of an emotionally immature partner

    Fri, 18 Apr 2025 22:30:00 -0000

    Emotional maturity and empathy are the foundation of a healthy relationship. Without it, communication breaks down, conflicts escalate, which can make one partner often feel drained, unheard, and unappreciated. Emotional immaturity isn’t always obvious at first — it can hide behind charm, humour, or even passion. But over time, the cracks start to show. Recognising the signs early can save you from confusion and heartache in the long run in your relationship. Here we list some signs of an emotionally immature partner to look out for, and to deal with them:

94. Royal aide who accused Meghan of bullying, joins Prince William

    Fri, 18 Apr 2025 17:26:58 -0000

    Prince William's Earthshot Prize has appointed Jason Knauf, former aide to the royal family, as its new CEO, succeeding Hannah Jones this summer. Knauf, previously involved with the Prize as a trustee, will now lead the environmental initiative. Notably, Knauf was involved in a past controversy, having accused Meghan Markle of bullying staff during his time as communications secretary.

95. Pakistani actress Anoushey Ashraf's stylish wedding pictures

    Fri, 18 Apr 2025 14:30:00 -0000

    Pakistani TV host Anoushey Ashraf celebrated her destination wedding with Shahab Mirza in Turkey, captivating the internet with dreamy pictures. Anoushey donned a Nomi Ansari lehenga, a spring romance ode with mint green, blush pink hues, and zari embroidery. She paired tradition with a modern low-neck blouse and vintage veil.

96. How to make Castor Oil serum for quick hair growth

    Fri, 18 Apr 2025 17:30:00 -0000

    Discover how to create a potent DIY castor oil serum for enhanced hair growth and scalp health. This natural remedy combines castor, coconut, and argan oils with essential oils like rosemary and lavender. Regular use stimulates follicles, reduces hair fall, and improves texture, offering a chemical-free path to revitalized hair within weeks.

97. Japan begins 4-day workweek: Countries that follow it

    Wed, 16 Apr 2025 06:15:00 -0000

    ​The idea of a permanent three-day weekend has long been a dream for workers around the world and now, it’s slowly becoming a reality. As work culture continues to change over time, especially post-pandemic, the global push for a four-day work week has serious consideration. More and more countries, companies, and employees are starting to rethink what productivity and a healthy work-life balance should look like.​This novel 4-day workweek follows a “100-80-100” model. It means workers get 100% of their pay, 80% of the time, while still getting their work done at 100% efficiency. It is being led by a group called ‘4 Day Week Global’, which started off as a major campaign in Germany in late 2023, and has already seen success in places like Spain, Portugal, and the UK.​Even some of the happiest countries in the world like Iceland, Denmark, and the Netherlands are leading this change. The movement doesn’t just reduce burnout but also improves mental health, increases job satisfaction, and in many cases, even boosts output. With growing evidence pointing to the benefits, the four-day workweek could very Completely change and revamp the future of work. Here are a few countries that have adopted the new 4-day work week regime.​

98. 8 notable books with strong female leads and characters

    Fri, 18 Apr 2025 12:30:00 -0000

    Since time immemorial, women have been in one of the most ‘backward’ sections of society. From real-life to books and literature, they were rarely ever the main leads or the ones to save a distressed man. And so, here are 8 notable books with strong female characters.

99. 6 sly tricks gaslighters commonly use

    Fri, 18 Apr 2025 06:20:26 -0000

    Gaslighting is not always loud and obvious. It often creeps in quietly, masked as love, care, or concern. Over time, it distorts your sense of self and reality. Here we list six sly tactics a gaslighter uses to gain control— subtly step by step. Awareness is your first weapon. Let’s dive into how it happens and what to look out for.

100. Government bans sale and manufacture of 35 cocktail drugs

     Fri, 18 Apr 2025 03:30:00 -0000

     India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, due to safety concerns. These combinations were manufactured and sold without proper evaluation, posing risks to public health. The decision aims to prevent adverse reactions and ensure the scientific validation of drug combinations, urging caution among doctors and patients.

101. 6 ways spirituality improves & benefits health and well-being

     Fri, 18 Apr 2025 04:34:54 -0000

     In today’s world, with stress and anxiety everywhere, spirituality is giving people a chance to find balance. Be it prayers, or meditation, or breathwork, people get the chance to recharge themselves. And here we mention 6 ways spirituality improves and benefits health and well-being.

102. How to grow Mint and Cherry tomatoes in the same pot

     Thu, 17 Apr 2025 11:30:35 -0000

     Have you ever run out of space in your balcony garden and wondered if there were two plants that could be grown in the same pot to save space? If yes, here we mention a step-by-step on how to grow Mint and Cherry tomatoes in one pot and harvest them quickly.

103. How to naturally recover and strengthen your liver (With the right support)

     Fri, 18 Apr 2025 01:30:00 -0000

     Your liver, a resilient organ, can regenerate and heal with proper care. Dr. Chaudhary suggests incorporating liver-supportive foods, regular exercise, sufficient sleep, and stress management techniques. Limiting processed sugar, smoking, and alcohol, along with staying hydrated, further supports liver health. These consistent lifestyle changes enhance the liver's natural ability to cleanse, heal, and protect.

104. 5 benefits of applying glycerine for hair

     Thu, 17 Apr 2025 09:30:00 -0000

     Let's take a look at the five benefits of applying glycerine to hair.

105. Create this homemade natural ginger oil to fill your bald hair patch

     Fri, 18 Apr 2025 02:30:00 -0000

     Understand the potential of ginger oil hair masks and say goodbye to your embarrassing bald hair patch.

106. How to slay one-colour looks without melting

     Fri, 18 Apr 2025 07:37:57 -0000

     Monochrome for summers? Here’s how to slay one-colour looks without melting

107. Here’s how much protein you can get for just Rs 100

     Sat, 19 Apr 2025 06:00:17 -0000

108. 6 ways to improve brain functioning

     Fri, 18 Apr 2025 15:00:13 -0000

109. This is what happens to the body if you take paracetamol ‘like it’s Cadbury Gems,’ as a doctor has claimed Indians do

     Fri, 18 Apr 2025 08:57:13 -0000

110. ‘It started with me discovering…’: Karan Johar reveals secret to sudden weight loss and transformation, dismisses Ozempic rumours

     Fri, 18 Apr 2025 08:00:10 -0000

111. From popping painkillers to shortage of sleep, seven common habits that could be harming your kidneys

     Thu, 17 Apr 2025 18:00:49 -0000

112. A cancer survivor lists ‘toxic’ things one should never use at home after being diagnosed at 35 while pregnant; we verify

     Thu, 17 Apr 2025 09:59:11 -0000

113. Are twins allergic to the same things?

     Wed, 16 Apr 2025 15:00:36 -0000

114. Type 5 diabetes: Find out who is more susceptible to this newly discovered condition

     Wed, 16 Apr 2025 10:55:42 -0000

115. This is what happens to the body if you always wear clothes that are too tight

     Wed, 16 Apr 2025 07:00:06 -0000

116. New study finds no evidence technology causes ‘digital dementia’ in older people

     Tue, 15 Apr 2025 15:00:27 -0000

117. Myth or fact: Those who walk fast are at a lower risk of diabetes

     Tue, 15 Apr 2025 10:58:05 -0000

118. ‘She won’t live more than two years’: Madhubala’s sister Madhur Bhushan reflects on the actor’s final years after heart ailment diagnosis; how it can go undetected

     Tue, 15 Apr 2025 06:02:07 -0000

119. Cancer hijacks your brain, steals your motivation — new research in mice reveals how, offering potential avenues for treatment

     Mon, 14 Apr 2025 17:00:20 -0000

120. Why you must never self-medicate

     Mon, 14 Apr 2025 09:00:06 -0000

121. Samantha Ruth Prabhu reveals reason behind not doing junk food ads: ‘Now, I vet my brands with 3 doctors…’

     Mon, 14 Apr 2025 07:58:12 -0000

122. Twin brothers adopt vegan vs meat diet for 6 months; the results might shock you

     Mon, 14 Apr 2025 06:00:06 -0000

123. How often do you daydream? It may be a cause for concern

     Sun, 13 Apr 2025 15:00:29 -0000

124. What happens if droplets of lemon juice are splashed into your eye while squeezing it?

     Sun, 13 Apr 2025 14:00:52 -0000

125. Being married linked to increased risk of dementia: New study

     Sun, 13 Apr 2025 12:30:19 -0000

126. Tired of washing your hair every day? We have a solution for you (literally)

     Sun, 13 Apr 2025 11:30:11 -0000

127. ‘Full fat, full sugar, full maida:’ Celeb nutritionist Rujuta Diwekar advises against skimping on traditional desserts

     Sun, 13 Apr 2025 10:15:53 -0000

128. ‘Diagnosed with lung cancer at stage zero’: Soha Ali Khan on how Sharmila Tagore’s early diagnosis helped; understand what stage zero cancer means

     Sun, 13 Apr 2025 07:59:50 -0000

129. These common foods and beverages may be ruining the health of your skin and hair, according to an expert

     Sun, 13 Apr 2025 04:00:08 -0000

130. Could changing your diet improve endometriosis pain? Recent study suggests it’s possible

     Sat, 12 Apr 2025 15:00:11 -0000

131. Bed rotting vs bed marinating: Which one helps you rest?

     Sat, 12 Apr 2025 14:00:08 -0000

132. What happens to the body when you have bread every day?

     Sat, 12 Apr 2025 11:57:16 -0000

133. Bhagyashree hails gavar phali as ‘Maharashtrian protein’; expert says it is ‘ideal for gut health’

     Sat, 12 Apr 2025 09:56:16 -0000

134. Night-time sleep improves one’s recall of sequence of events, benefits seen even after a year: Study

     Sat, 12 Apr 2025 09:00:08 -0000

135. Reasons your blood sugar level is high despite quitting refined sugar

     Sat, 12 Apr 2025 07:00:12 -0000

136. ‘No surgery. No exercise. No medication:’ A look at R Madhavan’s 21 day weight loss diet plan

     Sat, 12 Apr 2025 04:00:12 -0000

137. ‘She couldn’t catch her breath’: 17-year-old cheerleader diagnosed with ‘popcorn lung’ after years of vaping; experts explain what it is and whether this condition can be treated

     Fri, 11 Apr 2025 12:59:26 -0000

138. ‘Chakku chhuriyan tez kar lo’: Tahira Kashyap, battling breast cancer again, shares song she listened to in operation theatre; expert explains benefits

     Fri, 11 Apr 2025 07:59:47 -0000

139. Should pregnant women drink orange juice before an ultrasound?

     Thu, 10 Apr 2025 15:00:13 -0000

140. Are you overweight or do you have inflammation? Find out with this test

     Thu, 10 Apr 2025 05:00:07 -0000

141. Anjali Anand recalls sleeping only 3 hours a day for five months, says ‘got punished for it’: ‘Just because I am a different size…’

     Wed, 09 Apr 2025 18:00:22 -0000

142. Vitamin D builds your bones and keeps your gut sealed – but many children are deficient

     Wed, 09 Apr 2025 17:00:14 -0000

143. Fermented vs nonfermented milk: Why women should rethink their dairy choices for heart health

     Wed, 09 Apr 2025 13:00:54 -0000

144. Do you feel the need to poop after every meal?

     Wed, 09 Apr 2025 09:00:54 -0000

145. ‘0.6 kg salt, 2 litres oil, and 3 kg sugar’ for family of 4: Andhra Pradesh Chief Minister N Chandrababu Naidu urges people to cut back on intake to reduce disease burden; expert elucidates

     Wed, 09 Apr 2025 06:00:31 -0000

146. Here’s how much toothpaste you should use while brushing

     Tue, 08 Apr 2025 16:00:11 -0000

147. What exactly are ‘blue balls’ and are they dangerous?

     Tue, 08 Apr 2025 14:00:07 -0000

148. ‘It was a lot of fun’: Milind Soman, who ‘used to drink a lot till my late 20s’, opens up about his relationship with alcohol

     Tue, 08 Apr 2025 10:58:31 -0000

149. Find out what happens to the body if you don’t consume enough magnesium

     Tue, 08 Apr 2025 09:55:31 -0000

150. ‘Round 2 for me…’: Ayushmann Khurana calls wife Tahira Kashyap ‘my hero’ after her cancer relapses; doctor explains the reasons

     Mon, 07 Apr 2025 07:59:50 -0000

151. Influencer claims the time of day you shower can affect how much vitamin D your body absorbs; expert weighs in

     Mon, 07 Apr 2025 05:00:13 -0000

152. This fruit can help boost your performance in the bedroom

     Sun, 06 Apr 2025 15:00:22 -0000

153. These changes in your eyes could indicate a trauma response, learn what they are

     Sun, 06 Apr 2025 14:00:10 -0000

154. Add a healthy twist to your daily meals with these 7 varieties of rotis

     Sun, 06 Apr 2025 09:00:30 -0000

155. 6 powerful superfoods that naturally boost gut health

     Sun, 06 Apr 2025 04:00:02 -0000

156. Protein is being added to yoghurt, bread, coffee – but is it really good for our health?

     Sat, 05 Apr 2025 16:00:26 -0000

157. Catwoman actor Halle Berry spills diet and fitness secrets : ‘That’s how I manage my diabetes’

     Sat, 05 Apr 2025 15:00:22 -0000

158. 3 foods to avoid in hot weather; nutritionist shares better alternatives

     Sat, 05 Apr 2025 09:02:05 -0000

159. Increased screen time found to increase depression risk in teen girls by disrupting sleep, study finds

     Sat, 05 Apr 2025 08:00:02 -0000

160. Here’s what happens to the body when you reduce sitting time by 40 minutes per day

     Sat, 05 Apr 2025 05:00:05 -0000

161. Bill Gates supports weight loss drugs, suggests ways to tackle obesity

     Sat, 05 Apr 2025 04:00:12 -0000

162. Men can also experience the symptoms of a pregnancy!

     Fri, 04 Apr 2025 14:00:18 -0000

163. Expert answers: Is passing gas 10-20 times per day normal?

     Fri, 04 Apr 2025 06:00:11 -0000

164. Bengaluru CEO recalls ‘horrific weekend’, says was rushed to ICU after nose bleed: ‘Then came the real shock – my blood pressure was 230’

     Thu, 03 Apr 2025 10:59:25 -0000

165. General, localised, and others: Some symptoms that can signal the presence of cancer much before diagnosis

     Thu, 03 Apr 2025 08:00:33 -0000

166. Top 7 ways to boost your immune system

     Wed, 02 Apr 2025 14:00:07 -0000

167. The three hormones that have a significant influence on physical and emotional well-being are…

     Wed, 02 Apr 2025 08:00:01 -0000

168. Flip-flops or sliders: Which type of footwear should diabetics ideally wear?

     Wed, 02 Apr 2025 06:00:00 -0000

169. Early-onset Alzheimer’s: New drug shows promise in slowing disease

     Tue, 01 Apr 2025 14:00:47 -0000

170. Zerodha’s Nithin Kamath says his body is almost back to normal 14 months after suffering stroke: ‘My writing hasn’t improved at all’

     Tue, 01 Apr 2025 10:59:21 -0000

171. ‘3 quilts, gloves, topi, mota socks’: Hina Khan recalls shivering and feeling extremely cold during chemotherapy

     Tue, 01 Apr 2025 05:00:18 -0000

172. Can tuberculosis be transmitted through kissing or sexual contact?

     Mon, 31 Mar 2025 07:00:07 -0000

173. Chronic kidney disease often goes undiagnosed, but early detection can prevent severe outcomes

     Sun, 30 Mar 2025 16:00:25 -0000

174. Fake dyed kaali dal from Himachal Pradesh sparks health alarms — what happens if you eat it?

     Sun, 30 Mar 2025 08:59:36 -0000

175. Boys with cancer can face infertility as adults. Can storing their stem cells help?

     Sat, 29 Mar 2025 18:00:12 -0000

176. Masaba Gupta enjoys the ‘greatest post-feed protein treat to exist’; here’s why it is essential for breastfeeding moms

     Sat, 29 Mar 2025 10:00:38 -0000

177. This is what will happen to the body if you abruptly stop taking thyroid medication

     Sat, 29 Mar 2025 04:00:03 -0000

178. Kolkata Knight Riders player Ramandeep Singh shares diet plan during peak IPL season: ‘Four egg whites and one whole egg’

     Sat, 29 Mar 2025 03:00:03 -0000

179. Top 10 vitamin supplements for good health

     Fri, 28 Mar 2025 15:30:26 -0000

180. Hina Khan says migraines lasted ‘for days together’ if her scalp got exposed for more than 20-30 minutes: ‘When I had shaved my hair…’

     Fri, 28 Mar 2025 05:00:39 -0000

181. A look at Bryan Johnson’s ‘very affordable’ and ‘dramatically simplified’ morning routine

     Thu, 27 Mar 2025 15:00:00 -0000

182. Insomnia alert: Psychologist recommends changes that can improve sleep

     Thu, 27 Mar 2025 14:00:50 -0000

183. This mineral is required to activate vitamin D in the kidney and liver; find out if you are consuming enough

     Thu, 27 Mar 2025 09:59:34 -0000

184. ‘Nothing is easy’: When Alia Bhatt addressed claims of ‘unnatural’ weight loss after giving birth to Raha; metabolic changes new mothers face

     Thu, 27 Mar 2025 07:00:01 -0000

185. A much-less talked about sign of diabetes is…

     Thu, 27 Mar 2025 06:00:23 -0000

186. If you drive a manual car for over two hours daily, you may be prone to this painful condition

     Wed, 26 Mar 2025 09:00:03 -0000

187. Answered: Why your gas may be smelly and what it indicates

     Wed, 26 Mar 2025 06:58:50 -0000

188. How many hours of uninterrupted sleep should you get every night?

     Tue, 25 Mar 2025 11:57:49 -0000

189. All about leptin resistance and how it affects your body

     Tue, 25 Mar 2025 04:00:06 -0000

190. Brand making stick-on supplements receives 50 lakhs on Shark Tank India; we find out their effectiveness

     Mon, 24 Mar 2025 16:00:18 -0000

191. Here’s what happens to the body if you use too much nasal spray

     Mon, 24 Mar 2025 13:00:55 -0000

192. As UP man performs surgery on himself after watching YouTube videos, expert expresses caution against such practices

     Mon, 24 Mar 2025 07:00:37 -0000

193. Can sleeping with a tape on your mouth really cure ADHD? We asked an expert

     Sun, 23 Mar 2025 15:00:03 -0000

194. What happens to the body when you include one spoon of raw cocoa powder in your diet everyday?

     Sun, 23 Mar 2025 11:56:48 -0000

195. Do you yawn too much? You could be suffering from an iron deficiency

     Sun, 23 Mar 2025 11:00:27 -0000

196. ‘Petha juice is back’: Masaba Gupta includes ash gourd juice in postpartum diet; should new mothers consume it?

     Sun, 23 Mar 2025 08:00:00 -0000

197. Brief guide to vitamin, mineral supplements — when too much of good thing can become toxic

     Sun, 23 Mar 2025 06:59:43 -0000

198. Walnuts vs Almonds: Which nut triggers your acne?

     Sat, 22 Mar 2025 09:57:22 -0000

199. Amateur MMA fighter Jake Sendler dies at 21 from rare muscle condition linked to intense workouts

     Sat, 22 Mar 2025 06:58:47 -0000

200. Ananya Panday swears by this Ayurvedic ‘jeera paani’ morning drink

     Sat, 22 Mar 2025 05:00:09 -0000

201. The ‘MEDSRX’ formula promises to help boost your immunity: ‘Aapko cancer nahi ho sakta’

     Sat, 22 Mar 2025 04:00:17 -0000

202. Weight loss drug Mounjaro launched in India: Know price, how it works, side-effects, and if it’s more effective than Ozempic

     Fri, 21 Mar 2025 08:58:05 -0000

203. Here’s what will happen to the body if you completely stop having protein

     Fri, 21 Mar 2025 05:00:07 -0000

204. This is the best form of exercise for those with type 1 diabetes, study finds

     Thu, 20 Mar 2025 09:59:37 -0000

205. Here’s what may happen if you travel on flight with a cold

     Thu, 20 Mar 2025 08:00:15 -0000

206. Can a daily nap do more harm than good? Sleep researcher explains

     Wed, 19 Mar 2025 15:00:57 -0000

207. How real is gaming disorder, and what should we keep in mind?

     Wed, 19 Mar 2025 07:00:08 -0000

208. Vikram Bhatt on battling autoimmune condition similar to myositis that Samantha Ruth Prabhu suffers from: ‘When big idols like Deepika Padukone…’

     Wed, 19 Mar 2025 06:00:09 -0000

209. ‘Thoda dimaag lagaao’: Hina Khan shares pic of dry, brittle and discoloured nails, says its the ‘most common side-effect of chemotherapy’

     Wed, 19 Mar 2025 04:00:17 -0000

210. Changes to speech and language can help detect Alzheimer’s early — here are five things to look out for

     Tue, 18 Mar 2025 15:00:59 -0000

211. Sports and energy drinks are not the same; here’s how they affect the body, particularly digestive health

     Tue, 18 Mar 2025 09:00:11 -0000

212. My Son Kept Falling When He Was Playing; 24 Hours Later, He Was In A Coma!

     Tue, 18 Mar 2025 04:41:05 -0000

213. Astronauts Sunita Williams and Barry Wilmore spent 9 months in space instead of 1 week — here’s how it may affect their health

     Mon, 17 Mar 2025 07:01:48 -0000

214. Painkillers aren’t one-size-fits-all: Here’s why they may be less effective for women than men

     Mon, 17 Mar 2025 05:00:19 -0000

215. ‘Whole new ball game for heart transplants’: Australian man survives 100 days with artificial titanium heart

     Sun, 16 Mar 2025 11:18:42 -0000

216. Home births are on the rise, but are they safe for women with diabetes?

     Sun, 16 Mar 2025 05:00:42 -0000

217. Samantha swears by Wim Hof breathing technique: Here’s how it can set the tone for your day

     Sat, 15 Mar 2025 15:00:03 -0000

218. What happens to the body if you go on a 3-day mono diet of grapes?

     Sat, 15 Mar 2025 14:00:45 -0000

219. ‘Sleepmaxxing’: All you need to know about the latest trend promising restful sleep

     Sat, 15 Mar 2025 10:00:43 -0000

220. What is the 1-minute gut health test?

     Sat, 15 Mar 2025 05:00:29 -0000

221. Here’s what happens to the body if you do not sleep for 3 days, like Janhvi Kapoor

     Fri, 14 Mar 2025 07:00:11 -0000

222. Warning signs of kidney fungus you shouldn’t ignore (especially if you’re diabetic)

     Thu, 13 Mar 2025 06:00:22 -0000

223. Sana Makbul opens up about battle with autoimmune hepatitis: ‘Samantha Ruth Prabhu has myositis, a muscle condition. I have it with the liver’

     Thu, 13 Mar 2025 04:58:04 -0000

224. Ice baths popular for exercise recovery, general wellness. But what does science say?

     Wed, 12 Mar 2025 17:00:02 -0000

225. Can crossing your legs instantly relieve constipation?

     Wed, 12 Mar 2025 13:00:01 -0000

226. Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’

     Wed, 12 Mar 2025 11:59:21 -0000

227. Here’s what will happen to the brain if you do not use smartphones for 3 days straight

     Wed, 12 Mar 2025 10:59:32 -0000

228. ‘I was recently clinically diagnosed with ADHD and anxiety’: Alia Bhatt says her body overheats in social situations, here’s why it happens

     Wed, 12 Mar 2025 08:00:10 -0000

229. Why increasing rates of tuberculosis in UK, US should concern everyone

     Tue, 11 Mar 2025 17:00:34 -0000

230. Ginger peel: Find out if you should have it or discard

     Tue, 11 Mar 2025 15:00:41 -0000

231. Bryan Johnson says he ‘started life on the petroleum diet’

     Tue, 11 Mar 2025 14:00:00 -0000

232. How regular bedtime habits are reshaping sleep quality in India

     Tue, 11 Mar 2025 08:59:11 -0000

233. From clear, white, to pink and brown: Know what the colour of your phlegm means

     Tue, 11 Mar 2025 07:00:18 -0000

234. Tanishaa Mukerji shares what happens during egg freezing, why she opted for the medical procedure: ‘You are numb in that area in the stomach’

     Tue, 11 Mar 2025 04:00:10 -0000

235. ‘From that day until now, it’s everyday’: Woman remembers every day of her life in vivid detail

     Mon, 10 Mar 2025 14:00:05 -0000

236. Social media post claims 125-300mg of magnesium per meal can ‘reverse’ depression in just seven days; we ask experts if it is true

     Mon, 10 Mar 2025 07:58:04 -0000

237. Vitamin patches are trending; what are they and how do they work?

     Mon, 10 Mar 2025 03:59:57 -0000

238. Parasitic worms could be hiding in you — how to spot unusual signs

     Sun, 09 Mar 2025 05:59:37 -0000

239. What is lipedema, and why are Indian women more susceptible to it?

     Sun, 09 Mar 2025 05:00:21 -0000

240. Why do diabetics suffer from shoulder pain? This is what an expert has to say

     Sun, 09 Mar 2025 03:56:51 -0000

241. Can melatonin supplements really ‘reverse’ DNA damage caused by lack of sleep?

     Sat, 08 Mar 2025 08:00:02 -0000

242. What is causing the surge in flu cases in Delhi-NCR? Experts explain

     Sat, 08 Mar 2025 06:00:24 -0000

243. Therapeutic laziness: The 2025 sleep trend that embraces doing nothing

     Thu, 06 Mar 2025 16:00:10 -0000

244. Supplements you should avoid taking without consulting an expert

     Thu, 06 Mar 2025 12:00:13 -0000

245. Here’s what happens to the body when you are exposed to EMFs in the environment

     Thu, 06 Mar 2025 08:00:35 -0000

246. What’s the difference between wholemeal and wholegrain bread? Not a whole lot

     Wed, 05 Mar 2025 15:00:37 -0000

247. Here’s how much protein Ivanka Trump consumes per meal: ‘It works… I’ve never been stronger!’

     Wed, 05 Mar 2025 14:00:41 -0000

248. Vitamin B12 strips or tablets: Find out which one you should pick

     Wed, 05 Mar 2025 10:58:32 -0000

249. 10 things a gynaecologist wants you to never do for good vaginal health

     Wed, 05 Mar 2025 09:00:01 -0000

250. This is what happens to the body if you eat an apple a day, like the saying goes

     Wed, 05 Mar 2025 05:00:20 -0000

251. Bryan Johnson injects brain with anti-depressant ketamine: ‘It completely scrambled my…’

     Tue, 04 Mar 2025 14:00:18 -0000

252. Fact check: The brain takes 8 minutes to realise that the stomach is full

     Tue, 04 Mar 2025 09:00:04 -0000

253. This is what happens if you guzzle water after having desserts

     Tue, 04 Mar 2025 07:03:31 -0000

254. Sunaina Roshan reveals how she reversed Grade 3 fatty liver with two simple yet crucial lifestyle changes: ‘Sheer willpower and determination’

     Tue, 04 Mar 2025 06:01:03 -0000

255. Do weight loss drugs like Ozempic directly impact intimacy?

     Tue, 04 Mar 2025 05:00:07 -0000

256. Hina Khan shows radiation burns from cancer treatment, shares a positive note: ‘Scarred not scared’

     Tue, 04 Mar 2025 04:00:30 -0000

257. Intense heat changes our biology, can make us age significantly faster: Study

     Mon, 03 Mar 2025 16:00:54 -0000

258. A neurologist tells us the 3 things they would never do (and why you shouldn’t, too)

     Mon, 03 Mar 2025 14:00:39 -0000

259. Digital creator says ‘age-old remedy’ can help you get rid of spectacles; expert weighs in

     Mon, 03 Mar 2025 09:58:39 -0000

260. Understanding the link between losing muscle mass and diabetes

     Mon, 03 Mar 2025 04:00:04 -0000

261. What happens to the body when you consume excess melatonin?

     Sun, 02 Mar 2025 15:00:03 -0000

262. Lizzo says eating in ‘calorie-deficit and weight training’ her secret to weight loss; expert shares tips on achieving both

     Sun, 02 Mar 2025 13:00:26 -0000

263. Do salads make you feel bloated? Find out why

     Sun, 02 Mar 2025 12:00:56 -0000

264. If you’re on tretinoin, you might not be able to donate blood

     Sun, 02 Mar 2025 07:59:31 -0000

265. Can inserting menstrual cups incorrectly lead to kidney injury? Here’s what you should know

     Sun, 02 Mar 2025 06:00:35 -0000

266. Instead of coffee, these (healthier) drinks can help kids power through the exam season

     Sun, 02 Mar 2025 04:00:39 -0000

267. Eating disorders don’t just affect teen girls. Risk may go up around pregnancy, menopause too

     Sat, 01 Mar 2025 16:00:29 -0000

268. ‘It wasn’t complete torture’: Jacob Elordi on the psychological impact of losing weight as a group activity

     Sat, 01 Mar 2025 15:00:13 -0000

269. Five tips to find what really brings you joy outside of work

     Sat, 01 Mar 2025 09:58:59 -0000

270. Should you drink 2 bottles of water for every cup of coffee? Experts weigh in

     Sat, 01 Mar 2025 06:00:20 -0000

271. What happens to the body if you eat a bowl of guava every day?

     Sat, 01 Mar 2025 04:00:04 -0000

272. ‘My mood is stable all day long… it is beautiful’: Bryan Johnson on avoiding stimulants like coffee and nicotine to achieve steady well-being

     Fri, 28 Feb 2025 19:00:53 -0000

273. Mumbai fire: Here’s what happens to the body when you inhale too much flames and smoke

     Fri, 28 Feb 2025 16:00:22 -0000

274. Content creator shows how late night snacking affects blood glucose levels

     Fri, 28 Feb 2025 06:00:04 -0000

275. Study suggests brain development in childhood could be less flexible in those with schizophrenia

     Thu, 27 Feb 2025 15:00:35 -0000

276. ‘I am taking immunotherapies’: Hina Khan shares cancer treatment update, revealing that her chemotherapy is over

     Thu, 27 Feb 2025 11:59:53 -0000

277. This is what happens to your blood pressure when you add magnesium to your diet

     Thu, 27 Feb 2025 04:59:49 -0000

278. 5 foods and beverages that should be avoided immediately after taking thyroid medication

     Wed, 26 Feb 2025 05:00:19 -0000

279. ‘Darr lag raha hai par fir bhi…’: Shark Tank India contestants pitch Ozempic-like pill to address diabetes and obesity; can it be considered safe yet?

     Tue, 25 Feb 2025 12:00:00 -0000

280. Why your vitamin D levels are low even after taking supplements

     Tue, 25 Feb 2025 04:00:08 -0000

281. After rare surgery in Delhi, this defence scientist now carries five kidneys; a look at the groundbreaking case

     Mon, 24 Feb 2025 17:00:26 -0000

282. Ramzan is almost here. 5 tips to boost your wellbeing and energy levels if you’re fasting

     Mon, 24 Feb 2025 16:00:04 -0000

283. EU declares caffeine ‘harmful to humans if swallowed’: What it means for the brew and other energy drinks

     Mon, 24 Feb 2025 12:00:47 -0000

284. ‘To become a fit and healthy nation,’ PM Modi urges people to reduce edible oil consumption by 10%; appoints ten icons

     Mon, 24 Feb 2025 09:00:17 -0000

285. Myth vs fact: Deep breathing exercises before bed can help prevent a heart attack

     Mon, 24 Feb 2025 08:00:14 -0000

286. ‘Don’t listen to rich boys’: Rujuta Diwekar slams Nikhil Kamath for promoting eating out daily; how frequently should you do it?

     Sun, 23 Feb 2025 08:00:33 -0000

287. Tom Cruise shares BTS video of hanging upside-down from plane for ‘Mission: Impossible – The Final Reckoning’: ‘There were times I’d pass out’

     Sat, 22 Feb 2025 15:00:47 -0000

288. More people are asking generative AI questions about their health. But the wrong answer can be risky

     Sat, 22 Feb 2025 14:00:44 -0000

289. Having x-ray to diagnose knee arthritis might make you more likely to consider potentially unnecessary surgery

     Sat, 22 Feb 2025 07:59:55 -0000

290. Which fruit has the most and least amount of protein? Find out here

     Sat, 22 Feb 2025 06:00:02 -0000

291. What happens to the body when your day starts with health drinks?

     Sat, 22 Feb 2025 03:59:54 -0000

292. Bryan Johnson claims, ‘Men who don’t have nighttime erections are 70 percent more likely to die prematurely’ — can it really predict death?

     Fri, 21 Feb 2025 16:00:25 -0000

293. More adults are wondering if they have autism. Here are tips to seek a diagnosis

     Thu, 20 Feb 2025 15:00:17 -0000

294. Answered: What ‘deep, quality sleep’ really means

     Thu, 20 Feb 2025 10:59:34 -0000

295. How probiotics left a 33-year-old battling abdominal pain, bloating, and unintended weight loss: ‘Magic?…nah…common sense’

     Thu, 20 Feb 2025 08:59:35 -0000

296. Many gluten-free foods are high in calories and sugar, low on fiber and protein, and they cost more

     Wed, 19 Feb 2025 16:00:12 -0000

297. What your feet can tell you about your health

     Wed, 19 Feb 2025 14:00:00 -0000

298. ‘I knew something was wrong, but…’: Hina Khan visits Farah Khan’s house for yakhni with nadru, opens up on ignoring cancer symptoms while shooting

     Wed, 19 Feb 2025 13:00:50 -0000

299. Are those Instagram-viral nose magnets actually safe to use to stop snoring?

     Wed, 19 Feb 2025 11:56:05 -0000

300. ‘Lifting a pencil will feel like a workout’: Sunita Williams, Butch Wilmore to return to Earth; here’s how their bodies may react to gravity

     Wed, 19 Feb 2025 10:58:23 -0000

301. Are you a diabetic? This is how you can manage insulin resistance

     Wed, 19 Feb 2025 06:00:17 -0000

302. How brain can miraculously switch off pain

     Tue, 18 Feb 2025 14:00:49 -0000

303. Blood Donation: Benefits and Myths

     Tue, 18 Feb 2025 10:33:01 -0000

304. ‘Scheduled the itinerary around my breast pumping timings’: New mom Radhika Apte expresses gratitude for support she received at BAFTAs

     Tue, 18 Feb 2025 08:57:08 -0000

305. Diabetics, here’s how to check blood sugar without hurting the tip of your fingers

     Tue, 18 Feb 2025 07:58:24 -0000

306. Here’s how to ensure your body is absorbing vitamin B12 effectively

     Tue, 18 Feb 2025 06:00:09 -0000

307. Who can apply for NEET PG 2025?...

     Sat, 19 Apr 2025 08:04:57 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283592-neet-pg-2025-eligibility.webp' /><p><span style="background-color: rgb(255, 255, 255);">New Delhi- The National Board of Examinations in Medical Sciences (</span><a href="http://medicaldialogues.in/topics/nbems" target="_blank" style="background-color: rgb(255, 255, 255);">NBEMS</a><span style="background-color: rgb(255, 255, 255);">) is conducting the registration process for the National Eligibility and Entrance Test-Postgraduate (</span><a href="https://medicaldialogues.in/topics/neet-pg" target="_blank" style="background-color: rgb(255, 255, 255);">NEET PG</a><span style="background-color: rgb(255, 255, 255);">) exam for the academic year 2025 PG medical admissions. The information bulletin has been released on the official website of NBEMS. All the interested candidates are advised to take note of the eligibility criteria and other important details as mentioned below.</span></p><p><b><u>Eligibility Criteria </u></b></p><p><b>The eligibility criteria For Indian Medical Graduates to appear in NEET-PG 2025 is as follows: </b></p><p><i>Candidates who have completed their MBBS from India must:</i></p><p> Possess MBBS degree or Provisional MBBS Pass Certificate recognized as per the provisions of the NMC Act, 2019 and the Post Graduate Medical Education Regulations, 2023, </p><p style="text-align: center; ">and</p><p> Possess Permanent or Provisional registration certificate of MBBS qualification issued by the NMC/ the erstwhile Medical Council of India or State Medical Council,</p><p style="text-align: center; ">and </p><p> have Completed one year of internship or are likely to complete the internship on or before 31st July 2025, Candidates found to be ineligible at any stage of NEET-PG 2025 will not be permitted to appear in the examination and/or counseling. In an unlikely event of any ineligible candidate appearing and/or being successful in the NEETPG 2025, the results/ candidature of such candidate shall be cancelled and/or are deemed to be cancelled.</p><p>Requests for appearing in NEET-PG 2025 from candidates completing internship after 31st July 2025 or having qualifications that are not recognized as per the NMC Act, 2019 and the repealed IMC Act, 1956 shall be summarily rejected. Candidates are further advised not to canvass for the same.</p><p>The dates indicated by candidates with regard to 12 months Compulsory Rotating Resident Internship in the application form (i.e. internship starting and completion date) shall be treated as final and candidates will be required to submit the original Compulsory Rotating Resident Internship completion certificate at the time of counseling/admission in allotted Medical College/Institute.</p><p>The cut off dates for the recognition of the Medical Colleges, from where the candidates have passed their MBBS Degree Course and completed compulsory rotatory Internship for the year 2025 will be as prescribed by the NMC. The Colleges recognized after the cut- off date prescribed by the NMC will not be considered.</p><p>Registration with the NMC/ the erstwhile Medical Council of India or State Medical Council is necessary and its documentary proof should be furnished by the candidates on the day of examination and at the time of counseling/admission.</p><p>Some of the Universities/Institutions are having regulations that candidates who are already pursuing the PG Course in their University or in another University are not eligible for admission till they complete the course. The candidates who are already pursuing PG Courses either through All India Quota or State Quota and are applying for a seat under All India Quota / State quota seats may confirm the eligibility conditions of that University in this regard. NBEMS / MoHFW / Designated Counseling Authority shall not be responsible if such candidates are refused for admission. Such candidates may opt for the subject and the college at their own risk and cost.</p><p>The definition of NRI for admission to Deemed University shall be as per Hon’ble Supreme Court order dated 22/08/2017 in WP 689/2017. Eligibility of candidates issued admit card for the examination shall be purely provisional. Appearance in NEET-PG 2025 does not confer any automatic rights upon the candidate for admission to MD/MS/PG Diploma courses.</p><p><b><u>ELIGIBILITY CRITERIA FOR FOREIGN MEDICAL GRADUATES: </u></b></p><p>Indian citizens or overseas citizens of India who have obtained their Primary Medical Qualifications from Medical Colleges outside India should have qualified the Foreign Medical Graduate Examination (Screening Test) as per Screening Test Regulations, 2002 which is conducted by National Board of Examinations in Medical Sciences. Further, they should have been registered with the NMC / the erstwhile Medical Council of India or State Medical Council and should have completed their internship or likely to complete their internship on or before 31st July 2025.</p><p><b><u>ELIGIBILITY CRITERIA FOR FOREIGN NATIONALS: </u></b></p><p>Their basic Medical Qualification, equivalent to MBBS, should be recognized by the NMC.</p><p>Foreign Nationals desirous of appearing in NEET-PG and those, who are required to have security clearance as per the Ministry of Home Affairs (MHA) requirements, shall obtain the security clearance from Ministry of Home Affairs, Govt. of India before applying for NEET-PG.The security clearance shall be required to be submitted while applying for NEET-PG.</p><p>The NMC may, on payment of the prescribed fee for registration, grant temporary registration for the duration of the Post Graduate course limited to the medical college/institution to which he/she is admitted for the time being exclusively for pursuing postgraduate studies. Provided further that temporary registration to such foreign national shall be subject to the condition that such person is duly registered with appropriate registering authority in his own country where from he has obtained his Basic Medical qualification, and is duly recognized by the corresponding Medical Council or concerned authority and Permission/No Objection Certificate from the medical council of that country to allow undertaking Post Graduation in India has also been obtained.</p><p>Candidates are advised not to canvass with NBEMS for eligibility in NEETPG or issuance of admit card. Queries, if any, can be submitted through Communication Web Portal only. Canvassing in any form shall invite rejection of the application.&nbsp;</p><p><u><b>SCHEDULE</b></u></p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div dir="ltr"><table><colgroup><col width="54"><col width="362"><col width="208"></colgroup><tbody><tr><td><p dir="ltr">S.NO</p></td><td><p dir="ltr">PROCESSES</p></td><td><p dir="ltr">TIMELINES</p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Online Submission of Application Form.</p></td><td><p dir="ltr">17th April 2025 (03:00 PM Onwards) to 07th May 2025 (Till 11:55 PM).</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City).</p></td><td><p dir="ltr">09th May 2025 to 13th May 2025</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Pre-Final Selective Edit Window to rectify Deficient/Incorrect Images</p><p dir="ltr">-Photograph</p><p dir="ltr">-Signatures</p><p dir="ltr">-Thumb Impression.</p></td><td><p dir="ltr">17th May 2025 to 21st May 2025</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Final Selective Edit Window to rectify Deficient / Incorrect Images Photograph Signatures Thumb Impression (No further opportunity shall be given).</p></td><td><p dir="ltr">24th May 2025 to 26th May 2025</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Informing the Test City to the candidates.</p></td><td><p dir="ltr">02nd June 2025</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Issue of Admit Cards.</p></td><td><p dir="ltr">11th June 2025</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Examination Date.</p></td><td><p dir="ltr">15th June 2025</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Declaration of Result</p></td><td><p dir="ltr">By 15th July 2025</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Cut-off date for completion of internship towards eligibility for NEET-PG 2025.</p></td><td><p dir="ltr">31st July 2025</p></td></tr></tbody></table></div></div><p><u><b>Information for Candidates</b></u></p><p>NEET-PG 2025 is the eligibility-cum-ranking examination for admission to various MD/MS/PG Diploma courses of 2025-26 admission session. Admissions to Post MBBS DNB Courses, Post MBBS Direct 6 year DrNB courses and NBEMS diploma courses are also undertaken through NEETPG.</p><p>NEET-PG 2025 will be conducted by NBEMS. The role of NBEMS is limited to the conduct of NEET-PG, declaration of the result and handing over the result to the designated counseling authority. NBEMS has no role in counseling and allotment of PG seats. Verification of documents and eligibility determination of the candidates shall be undertaken at the time of counseling/admission process by the concerned authority.</p><p>Candidate may kindly note that appearance in NEET-PG does not confer any automatic rights to secure a Post graduate MD/MS/Post Graduate Diploma seat. The selection and admission to Postgraduate seats in any medical institutions recognized for running MD/ MS/Post Graduate Diploma courses as per the National Medical Commission (NMC) Act, 2019 and the Post Graduate Medical Education Regulations, 2023 is subject to fulfilling the admission criteria, eligibility, medical fitness and such criteria as may be prescribed by the respective universities, medical institutions, the NMC, State/Central Government.</p><p>Candidates are advised to read the Information Bulletin carefully and go through the instructions regarding submission of online application form given in the information bulletin as well as on NEET-PG 2025 index page on NBEMS website https://natboard.edu.in before starting online submission process for NEET-PG 2025 .</p><p>Candidates are deemed to have read, agreed and accepted the Information Bulletin and the terms and conditions in the Information Bulletin for NEET-PG 2025 on completing the online submission of application form.</p><p>Candidate should ensure that all the information entered during the online submission of application form is correct and factual. Information provided by the candidates in the online application form shall be treated as correct. The responsibility of correctness of information in the application form shall be of the concerned candidate. The option of editing certain information entered in the application form shall be available to the candidates during the edit window. NBEMS will not entertain, under any circumstances, any request for change in the information provided by the candidates after closure of the edit window. Please refer Chapter on Instructions to fill Application Form for details regarding Edit Window.</p><p>NBEMS itself does not edit /modify/alter any information entered by the candidates at the time of online submission of application form under any circumstances. There is no provision of accessing the application form to make any changes in the information provided in the application form after closure of edit window. Such requests to make any changes shall not be entertained. Candidates, however, shall be able to rectify the deficiencies in their application (if so communicated by NBEMS) regarding images uploaded, by the prescribed cut-off dates.</p><p>Please refer Chapter on Instructions to Fill NEET-PG Application Form. Candidates are advised to review their applications submitted and rectify the deficiencies, if found any, within the window as detailed below. Candidates may note that deficiency in the application form pertaining to images uploaded may be communicated to them by NBEMS, however, it shall be the sole responsibility of the applicant to ensure that the application submitted is complete in all aspects as per the information bulletin. If any deficiency in the application which was not communicated by NBEMS to the applicant before conduct of the examination, is noted at any later stage, this would not create any equity in favour of the candidate and confer any rights on to the candidates for grant of eligibility for the examination.</p><p>Edit Window: Candidates who have successfully submitted their payment for the application during Application Submission window shall only be allowed to edit their applications during 09th May 2025 to 13th May 2025. No new application can be registered or payment can be made during edit window. However, the balance fee required, if any, in case of change in candidate category and/or PwD status can be paid during the edit window. Any information/document can be changed/corrected during the edit window except for Name, Test City, Nationality, Mobile Number and Email ID. Information can be edited any number of times before the closure of the edit window. The last submitted information will be saved in records.</p><p>Final Edit Window: Deficiency related to images uploaded (photograph, Signature, Thumb Impression) shall be intimated to the concerned candidates and same can be corrected during the Pre-Final Selective edit window i.e. 17th May 2025 to 21st May 2025. A list of such applicants who would fail to rectify their images in the application form shall be published on NBEMS website and a FINAL Selective Edit window will be opened from 24th May 2025 to 26th May 2025 for them to enable them to rectify the images as per image upload guidelines. Applications of such candidates who would fail to rectify their images even during this FINAL edit window shall be rejected. No further opportunity shall be given to make corrections.</p><p>Candidates are advised to submit the images in their application as per prescribed image upload guidelines. Failure to submit images as per guidelines and/or failure to rectify the images shall invite rejection of the application.</p><p>Application for NEET-PG 2025 can only be submitted online through NBEMS website.</p><p>There is no other methodology for application submission. Application submitted through any other mode shall be summarily rejected.</p><p>A candidate can submit NEET-PG 2025 application form only once. If a candidate is found to have submitted more than one application form for NEET-PG 2025, NBEMS may issue admit card to the application bearing higher order Application number (application ID) and cancel other application(s) forfeiting the fee for them. In an event any unfair practice is detected by NBEMS at any stage of examination/admission process, NBEMS may cancel the candidature of such candidates and debar them from appearing in any examinations conducted by NBEMS as per provisions of the Unfair Means Guidelines.</p><p>Candidates who fail to submit duly completed applications with requisite documents and/or fail to rectify the deficiencies in their applications by the last date prescribed for rectification shall be declared ineligible. Admit Card shall not be issued to candidates who are declared ineligible before conduct of examination. In such cases, the entire fees will be forfeited.</p><p>Applications of candidates producing false or fabricated information/records will not be considered and such candidates will be further debarred from appearing in the future examinations of NBEMS. Action as deemed appropriate by NBEMS will be taken if false or fabricated records/ information is submitted or any unfair means are used.</p><p>Candidates are advised to ensure that the information provided is factual and supported with documents. Columns marked (*) in the application form are mandatory and can not be left blank. In the event of rejection of the application form, no correspondence/request for re-consideration will be entertained.</p><p>Candidates should ensure before applying for the examination that their MBBS degree is recognized as per provisions of the NMC Act, 2019 and the Post Graduate Medical Education Regulations, 2023. If it is found at any time that MBBS degree is not recognized, the candidature / result of the candidate shall be cancelled/ deemed to be cancelled.</p><p>Candidates should go through this bulletin carefully for eligibility criteria before applying. Queries pertaining to eligibility and other issues will only be entertained if the information requested is not given in the bulletin of information or NBEMS website. No Queries of the Guardians/Parents will be entertained on telephone with regard to the eligibility and disclosure of the results.</p><p>Submission of incomplete online application form not in accordance with prescribed instructions shall invite rejection of the application. In such cases, the examination fee shall not be refunded.</p><p>Candidate found ineligible at any stage of NEET-PG 2025 Examination, will not be permitted to appear in the examination. In an unlikely event of any ineligible candidate appearing and/or passing the NEET-PG 2025 examination, the results/candidature of such candidate shall be cancelled and/or is deemed to be cancelled, even if result has been declared or score card has been issued.</p><p>NBEMS reserves the right to withdraw permission, if any, granted inadvertently to any candidate who is not eligible to appear in the NEET-PG 2025 Examinations even though the admit card/roll number has been issued or name/roll number is displayed on NBEMS website.</p><p>Fee shall neither be carried forward to a future exam nor refunded under any circumstances. Application once submitted can not be withdrawn.</p><p>Candidates’ eligibility is purely provisional &amp; is subjected to the fulfilment of eligibility criteria as prescribed in this Information Bulletin.</p><p>Instructions in the Information Bulletin are liable to change based on decisions taken by the NBEMS / MoHFW / NMC / DGHS from time to time.</p><p>There is no equity or any rights that are / or deemed to be arising in favour of candidate. Candidates are required to refer to the latest bulletin or corrigendum that may be issued to incorporate these changes. Refer NBEMS website in for latest updates or corrigendum.</p><p>The existing schedule, pattern, policy and guidelines are for ready reference only but in no way, they are or are ought to be treated as representative or acknowledgment of fact that NBEMS is bound to follow the same in future.</p><p>NBEMS reserves its absolute right to alter, amend, modify or apply any or some of the instructions/ guidelines contained in this information bulletin.</p><p>In case of any ambiguity in interpretation of any of the instructions / terms / rules / criteria regarding the determination of eligibility/conduct of examinations / registration of candidates/information contained herein, the interpretation of the NBEMS shall be final and binding in nature. In case of any discrepancy in the information contained in English and Hindi version of the bulletin, the information mentioned in English language shall be considered final.</p><p>Request shall not be entertained for change in date/center of examination under any circumstances. Candidates are advised not to canvass for such representation.</p><p>Admit Cards for NEET-PG 2025 can be downloaded at NBEMS website from 11th June 2025 onwards. Candidates found ineligible before conduct of the examination shall not be issued admit cards.</p><p>Result of NEET-PG 2025 shall be published on NBEMS websites</p><p>NEET-PG 2025 shall be conducted by NBEMS at various exam centres engaged for the purpose. Candidates are advised to familiarise themselves with the route and location of the exam centre well in advance to avoid any last minute delay in arrival to the exam centre. Please refer Chapter on details of Test Day Procedures.</p><p>The examination test centre staff on duty is authorized to verify the identity of candidates and may take steps to verify and record the identity of candidates. Candidates are required to extend requisite cooperation.</p><p>Possession/Use of mobile phones/Electronic devices is strictly prohibited in the premises of NBEMS test Centres. Candidates shall be liable for penal action for Possession/ Use of Mobile phones/ Electronic devices. Resorting to use of any unfair practice in NEET-PG 2025 shall be dealt with as per the Unfair Mean Guidelines of NBEMS. Such candidates shall be imposed academic and/or criminal punishments as may be applicable. Please go through guidelines detailed in Chapter on use of unfair means in the examination.</p><p>Demo Test: A demo test shall be available for the benefit of candidates to familiarise themselves with the Computer Based Test format at website Candidates will be able to access the Demo test tentatively from 05th June 2025 onwards.</p><p>The candidates should communicate with NBEMS regarding matters related to NEET-PG 2025 as per prescribed Protocols only, detailed under Chapter on Communication Protocols.</p><p>Candidates are encouraged to communicate for NEET-PG 2025 through “Helpdesk” tab which can be accessed after the applicant login to its application account. The correspondence through post should be addressed to the Executive Director, National Board of Examinations in Medical Sciences, Medical Enclave, Mahatma Gandhi Marg, Ansari Nagar, New Delhi110029. Candidates are requested to superscribe the envelope with the subject matter of the correspondence for expeditious processing.</p><p>The Registration for NEET-PG 2025 at the time of Counseling to be conducted by designated counseling authority will be as per the details of candidates submitted in NBEMS NEET-PG 2025. Hence, candidates are advised to maintain their same Registration details e.g. mobile number, Email ID etc. as provided in the NBEMS NEET-PG 2025 application form.</p><p>The jurisdiction for court cases/disputes shall be at New Delhi only.</p></div>

308. Sanofi secures USFDA approval for Dupixent for chronic spontaneous urticaria

     Sat, 19 Apr 2025 07:45:26 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/11/16/261049-usfda-50-2.webp' /><p>Paris: <a href="https://medicaldialogues.in/topics/sanofi">Sanofi </a>has received approval from the US Food and Drug Administration (FDA) for&nbsp;<a href="https://medicaldialogues.in/topics/Dupixent">Dupixent </a>(<a href="https://medicaldialogues.in/topics/dupilumab">dupilumab</a>)&nbsp;for the treatment of adults and adolescents aged 12 years and older with <a href="https://medicaldialogues.in/topics/chronic-spontaneous-urticaria">chronic spontaneous urticaria</a> (CSU) who remain symptomatic despite histamine-1 (H1) antihistamine treatment.</p><p>Dupixent (dupilumab) is an injection administered under the skin (subcutaneous injection) at different injection sites. In adults with CSU who remain symptomatic despite H1 antihistamine treatment, Dupixent 300 mg is administered every two weeks after an initial loading dose. In patients aged 12 to 17 years with CSU who remain symptomatic despite H1 antihistamine treatment, Dupixent is administered every two weeks based on weight (200 mg for adolescents ≥30 to &lt;60 kg, 300 mg for adolescents ≥60 kg) after an initial loading dose. Dupixent is intended for use under the guidance of a healthcare professional and can be given in a clinic or at home after training by a healthcare professional. In adolescents aged 12 to 17 years, Dupixent should be administered under the supervision of an adult.</p><p>Dupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL4) and interleukin-13 (IL13) pathways and is not an immunosuppressant. The Dupixent development program has shown significant clinical benefit and a decrease in type 2 inflammation in phase 3 studies, establishing that IL4 and IL13 are two of the key and central drivers of the type 2 inflammation that plays a major role in multiple related and often co-morbid diseases.</p><div class="pasted-from-word-wrapper"><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">Kenneth Mendez,&nbsp;President and Chief Executive Officer at the Asthma and Allergy Foundation of America said,&nbsp;“People with chronic spontaneous urticaria experience sudden, unpredictable hives and severe itch that cause a significant, and often overwhelming, burden on their everyday lives. The approval of this treatment offers patients more options and the chance to control their disease.”</p><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">Alyssa Johnsen, M.D., Ph.D.,&nbsp;Global Therapeutic Area Head, Immunology and Oncology Development at Sanofi said,&nbsp;“CSU patients with uncontrolled disease experience highly burdensome itch and hives that can significantly disrupt daily living. This FDA approval provides a new treatment option to help address the underlying drivers of these severe and recurring signs and symptoms. Dupixent has the potential to improve outcomes for CSU patients who previously had limited treatment options.”</p><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">The US approval is based on data from two phase 3 clinical studies, Study A (n=136) and Study C (n=148), which included biologic-naïve patients aged 12 years and older who were symptomatic despite the use of antihistamines and assessed Dupixent as an add-on therapy to standard-of-care antihistamines, compared to antihistamines alone. Both studies met their primary and key secondary endpoints with Dupixent demonstrating reductions in itch severity and urticaria activity (a composite of itch and hives) compared to placebo at 24 weeks. Dupixent also increased the likelihood of well-controlled disease or complete response compared to placebo at 24 weeks. Study B (n=108) provided additional safety data and evaluated Dupixent in patients aged 12 years and older who were inadequate responders or intolerant to anti-IgE therapy and symptomatic despite antihistamine use.</p><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">Safety results from Study A, Study B, and Study C were generally consistent with the known safety profile of Dupixent in its approved indications. In pooled data from all three studies, the most common adverse event (≥2%) more frequently observed in patients on Dupixent compared to placebo was injection site reactions.</p><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">George D. Yancopoulus, M.D., Ph.D.,&nbsp;Board co-Chair, President and Chief Scientific Officer at Regeneron said&nbsp;“Dupixent is the first new targeted treatment for chronic spontaneous urticaria, or CSU, in over ten years, with pivotal trials demonstrating its ability to help patients significantly reduce the hallmark symptoms of intense itch and unpredictable hives associated with this disease. With this FDA decision, Dupixent is now approved for seven chronic, debilitating atopic conditions driven in part by underlying type 2 inflammation, several of which have been shown to co-morbidly occur with CSU, such as atopic dermatitis and asthma – providing patients with one treatment that might help multiple atopy conditions. We look forward to bringing Dupixent to the more than 300,000 CSU patients in the US with inadequately controlled disease on standard-of-care treatment who, until now, had limited treatment options.”</p><p class="MuiTypography-root MuiTypography-body1 css-sqijso-MuiTypography-root">Dupixent is already approved for CSU in Japan, the United Arab Emirates, and Brazil. Submissions are currently under review with other regulatory authorities around the world including in the EU.</p><p>CSU is a chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch. CSU is typically treated with H1 antihistamines, medicines that target H1 receptors on cells to control symptoms of itch and urticaria. However, the disease remains uncontrolled despite antihistamine treatment in many patients, some of whom are left with limited alternative treatment options. These individuals continue to experience symptoms that can be debilitating and significantly impact their quality of life. More than 300,000 people in the US suffer from CSU that is inadequately controlled by antihistamines.</p><p>Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical studies involving more than 10,000 patients with various chronic diseases driven in part by type 2 inflammation.</p></div>

309. Crackdown on Illegal Hospitals: FIR against 50 Quacks in Sambhal

     Sat, 19 Apr 2025 06:45:18 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283655-illegal-hospital.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Sambhal: In a recent crackdown on illegal healthcare establishments, </span><span style="text-align: justify;">Chief Medical Officer, Tarun Kumar Pathak on Friday said that the health department has taken action against 70 </span><a href="https://medicaldialogues.in/topics/illegal-hospital" target="_blank" style="background-color: rgb(249, 249, 249); text-align: justify;">illegal hospitals </a><span style="text-align: justify;">and clinics.&nbsp;</span>Additionally, FIRs have been registered against more than 50 quacks found operating these illegal establishments.</p><p style="text-align: justify;">According to the PTI report, a special campaign was launched in Sambhal, Gunnaur and Chandausi to identify and shut down unregistered healthcare facilities, said Pathak.</p><p style="text-align: justify;">As a result, approximately 70 illegal hospitals and clinics have been closed, he added. &nbsp;&nbsp;</p><p style="text-align: justify; ">Pathak said that FIRs have been filed against more than 50 individuals operating these illegal establishments.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/up-illegal-hospital-sealed-class-12-pass-quack-held-after-pregnant-womans-death-105325"><b>Also Read:UP illegal hospital sealed, Class 12 pass quack held after pregnant woman's death</b></a></p><p style="text-align: justify;">The chief medical officer said that "action was taken against quacks and labs which are running illegally" and "do not have any registration".</p><p style="text-align: justify;">"In the last one week, we have appointed nodal officers in three sectors of the district. 70 hospitals and clinics which are not registered with us have been identified and closed, and FIRs have been filed against 50 people," Pathak told reporters here, news agency PTI reported.</p><p style="text-align: justify;">"Our campaign against quacks and illegal clinics will continue in the coming days," he said.</p><p style="text-align: justify;">Medical Dialogues had earlier reported that the Telangana State Medical Council (TSMC) had taken legal action against 12 individuals for illegally practising medicine. Of these, eight practised in Hyderabad and its surrounding areas, while the remaining four were located in various districts. As part of the crackdown, FIRs have been registered at police stations nearest to the locations of these unauthorized healthcare facilities. The illegal practitioners were found in Vanasthalipuram, Dundigal, Bachupally, Sangareddy, and Banswada.&nbsp;</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/up-illegal-hospital-operates-patients-without-authorized-surgeons-sealed-100653"><b>Also Read:UP: Illegal hospital operates patients without authorized surgeons, sealed</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

310. USFDA issues EIR for Emcure Pharma Pune API facility

     Sat, 19 Apr 2025 06:45:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/03/23/234973-emcure-50.webp' /><p style="text-align: justify; "><b>Pune</b>: In a recent BSE filing,&nbsp;<span style="text-align: justify; background-color: rgb(255, 255, 255);"><a href="https://medicaldialogues.in/topics/emcure-pharma">Emcure Pharma</a> has informed that&nbsp;</span><span style="text-align: justify;">the Company has received the Establishment Inspection Report (EIR) from the United States Food &amp; Drug Administration (“USFDA”) for the API manufacturing facility located at M.I.D.C., Kurkumbh, Taluka - Daund, Pune – 413802, Maharashtra. The USFDA has classified the inspection of the facility as “Voluntary Action Indicated” (VAI).</span></p><p>oluntary action indicated (VAI), means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action&nbsp;</p><p style="text-align: justify; ">A current Good Manufacturing Practices (‘cGMP’) inspection was conducted from February 19, 2025 to February 25, 2025. Following the inspection, the company had initially received two observations in Form 483.</p><p><b style="text-align: justify;"><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/emcure-pharma-pune-facility-gets-2-usfda-observations-143962">Emcure Pharma Pune facility gets 2 USFDA observations</a></i></b></p><p style="text-align: justify; ">Emcure Pharmaceuticals Ltd., established in 1981, is an Indian pharma company headquartered in Pune, India. It is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure is an R&amp;D driven company that develops and manufactures a wide range of differentiated pharmaceutical products. Emcure is present in 70+ countries globally including Europe and Canada.</p><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/emcure-pharma-european-arm-tillomed-buys-strategic-pharma-portfolio-from-manx-for-197-mn-146047">Emcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million pounds</a></i></b></p><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p style="text-align: justify; "><br></p></div><p style="text-align: justify; "><br></p>

311. Gurugram Hospital technician arrested for sexual assault on patient

     Sat, 19 Apr 2025 06:15:08 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/02/10/273457-doctor-arrested.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Gurugram: A 25-year-old technician working at&nbsp;</span><a href="https://medicaldialogues.in/topics/medanta-hospital" target="_blank">Medanta Hospital</a>&nbsp;in Gurugram&nbsp;<span style="text-align: justify;">has been arrested in connection with the alleged&nbsp;</span>sexual assault of a woman patient, police said.&nbsp;</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">The accused has been identified as Deepak (25), a native of Bihar’s Muzaffarpur, who had been living in Gurugram for some time, they said.&nbsp;</p><p style="text-align: justify; ">A senior police officer said that during the interrogation, the accused revealed that he joined Medanta five months ago after completing his bachelor's in Operation Theatre Technology at a private university here, news agency PTI reported.</p><p style="text-align: justify;">Police said they identified the accused after examining CCTV footage, interrogating the hospital staff and investigating various facts.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/sit-formed-to-probe-alleged-sexual-assault-on-patient-at-gurugram-hospital-146835"><b>Also Read:SIT formed to probe alleged sexual assault on patient at Gurugram Hospital</b></a></p><p style="text-align: justify;">"Over 50 employees of the hospital and some doctors were questioned, and footage from 800 CCTV cameras was examined. After multiple analyses, we finally identified the accused and arrested him today. He has confessed to the crime," said Dr Arpit Jain, DCP (headquarters), who led the special investigation team in the case.</p><p style="text-align: justify;">The accused will be produced before the court on Saturday for further proceedings, and the probe is still underway, police added.</p><p>"We have been informed that the police have identified a suspect who has been taken into custody in connection with the ongoing investigation concerning allegations of sexual assault on a patient. On the basis of the information provided to us by the police, at present, we have suspended the suspect employee," the statement issued by the hospital's medical superintendent Dr Sanjay Durani read, reports <a href="https://timesofindia.indiatimes.com/city/gurgaon/icu-technician-arrested-for-sexual-assault-on-flight-attendant-at-hospital/articleshow/120415608.cms" rel="nofollow">TOI</a>.</p><p><span style="text-align: justify;">The incident came to light when the 46-year-old flight attendant lodged a complaint on April 14. She alleged that she was admitted to </span><a href="https://medicaldialogues.in/topics/medanta-hospital" target="_blank" style="text-align: justify; background-color: rgb(249, 249, 249);">Medanta Hospital</a><span style="text-align: justify;"> on April 5 for some treatment. And, on the next day, April 6, a man carried out digital rape on her in the hospital ICU room, where two other nurses were also present who did nothing to stop him.</span><br></p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/rape-allegations-rock-medanta-patient-alleges-sexual-assault-by-hospital-staff-while-on-ventilator-146770"><b>Also Read:Rape allegations rock Medanta: Patient Alleges Sexual Assault by Hospital Staff While on Ventilator</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

312. JB Chemicals gets USFDA nod for hypertension drug Bisoprolol

     Sat, 19 Apr 2025 05:51:27 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/11/278017-hypertension-2.webp' /><p style="text-align: justify; "><b>Mumbai:</b><a href="https://medicaldialogues.in/topics/jb-chemicals-and-pharma">&nbsp;J.B. Chemicals &amp; Pharmaceuticals Limited</a> has announced that&nbsp;<span style="background-color: rgb(255, 255, 255);">the company has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Bisoprolol Tablets USP, 5 mg, and 10 mg.</span></p><p style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);">The product is the generic version of Zebeta (Teva).</span></p><p style="text-align: justify; ">Bisoprolol Tablets<span style="background-color: rgb(255, 255, 255);">&nbsp;are indicated in the management of <a href="https://medicaldialogues.in/topics/hypertension">hypertension</a>.&nbsp;</span></p><p style="text-align: justify; ">Hypertension is a condition where the force of the blood against the artery walls is consistently too high. It's often called a "silent killer" because it usually has no symptoms but can lead to serious health issues.</p><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/jb-chemicals-and-pharma-panoli-facility-concludes-usfda-inspection-no-observations-144928">JB Chemicals and Pharma Panoli facility concludes USFDA inspection no observations</a></i></b></p><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p style="text-align: justify; ">Established in 1976, J.B. Pharma is a pharmaceutical company headquartered in Mumbai, India. Besides India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. The company exports its finished formulations to over 40 countries including the USA. Besides supplying branded generic formulations to several countries, it also manufactures medicated lozenges. It has eight state of the art manufacturing facilities in India including a dedicated manufacturing facility for lozenges. The manufacturing facilities are certified by leading regulators across the world.</p><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/kkr-divests-58-percent-stake-in-jb-chemicals-pharma-for-rs-1460-crore-145801">KKR divests 5.8 percent stake in JB Chemicals &amp; Pharma for Rs 1460 crore</a></i></b></p></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; "><br></p></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; "><br></p></div>

313. HC orders ESIC Hospital Andheri Completion by August 15

     Sat, 19 Apr 2025 05:45:53 -0000

     <img src='https://medicaldialogues.in/h-upload/2022/11/02/189703-bombay-high.webp' /><p style="text-align: justify; "><b>Mumbai:</b> After the massive fire incident in December 2018, the <a href="https://medicaldialogues.in/topics/esic" target="_blank">Employees' State Insurance Corporation </a>(ESIC) Hospital in Andheri East remained non-operational all these years. The <a href="https://medicaldialogues.in/topics/bombay-high-court" target="_blank">Bombay High Court,</a> through a recent judgement, ordered the corporation to finish rebuilding its Model Super Speciality Hospital in Andheri East by August 15, 2025.&nbsp;</p><p style="text-align: justify; ">Disposing of the PIL filed by Rajesh Sharma, former Deputy Mayor of Mumbai, the court has also asked ESIC to make sure the hospital starts functioning by January 31, 2026, which was badly damaged in the fire in December 2018.</p><p style="text-align: justify; ">The order came after a public interest litigation (PIL) filed by Rajesh Sharma, former Deputy Mayor of Mumbai. Sharma, through his lawyers Rahul Kamerkar and Aparajita Jha, urged the court to take action as the hospital had not resumed services even after more than five years.&nbsp;</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/fire-at-esic-hospital-mumbai-6-killed-145-injured-minister-announces-compensation" target="_blank">Fire at ESIC Hospital Mumbai: 6 killed, 145 injured; Minister announces Compensation</a></b></p><p style="text-align: justify; "><a href="https://indianexpress.com/article/cities/mumbai/hc-esic-hospital-andheri-operational-9950328/" rel="nofollow">The&nbsp;Indian Express</a> has reporetd that the PIL stated that the Andheri Model ESIC Hospital used to give various services such as OPD (Out-Patient Department), IPD (In-Patient Department), ICU (Intensive Care Unit) and Super Speciality services.</p><p style="text-align: justify; ">Through his PIL, Sharma raised concerns that ESIC has not taken any steps to restart the said hospital despite over five years having passed since the fire incident. The said hospital is the largest ESIC hospital in the city with a capacity of nearly 350 beds and superspeciality facilities.</p><p style="text-align: justify; ">Medical Dialogues in 2018 reported about an unfortunate fire incident in the 5th storey Employees State Insurance Corporation (ESIC) Hospital in MIDC, Marol, in Andheri that took away six lives and injured more than 145 people. Later, the death toll increased to 11 people.</p><p style="text-align: justify; ">The victims were immediately rushed to the other hospitals: RN Cooper Hospital, Thackeray Trauma Hospital in Jogeshwari, Holy Spirit Hospital and Seven Hills Hospital in Andheri, Hiranandani Hospital in Powai, and Siddharth Hospital in Goregaon.</p><p style="text-align: justify; ">The fire broke out on the fourth floor of ESIC and happened on December 17, 2018, when 20 LPG cylinders were stored under a staircase without proper permission, leading to a tragic accident.</p><p style="text-align: justify; ">In response, advocate Shailesh Pathak for ESIC Director General submitted minutes of the 235th special meeting of its Standing Committee held on January 23, 2025 and stated that the National Building Construction Company (NBCC) has undertaken the work of construction of the hospital and has agreed to hand over the renovated building of the hospital on or before August 15, 2025. Pathak added that ESIC shall make ” all endeavours in right earnest” to commence the functioning of the said hospital on or before January 31, 2026.</p><p style="text-align: justify; ">The bench of Chief Justice Alok Aradhe and Justice Makarand Karnik noted the timeline and disposed of the PIL, instructing ESIC to complete construction and to make the hospital operational within the timeline as promised.&nbsp;</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/state-news/maharashtra/increase-polling-stations-in-future-maharashtra-medical-council-elections-hc-145325" target="_blank">Increase polling stations in future Maharashtra Medical Council Elections: HC</a></b></p>

314. Maithilee Mistry to join Abbott India from Sanofi Consumer Healthcare India as CFO

     Sat, 19 Apr 2025 05:00:14 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283672-maithilee-mistry-50.webp' /><p style="text-align: justify; "><b>Mumbai</b>:&nbsp;<a href="https://medicaldialogues.in/topics/abbott-india">Abbott India</a> has announced the <a href="https://medicaldialogues.in/topics/appointment">appointment</a> of Maithilee Mistry as the Chief Financial Officer of the Company with effect from May 6, 2025.</p><p style="text-align: justify; ">On her appointment as Chief Financial Officer, Mistry shall also be the Key Managerial Personnel of the Company effective the same date.</p><div class="pasted-from-word-wrapper" style="text-align: justify; ">"We hereby inform you that, upon recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors at its Meeting held today i.e., April 18, 2025, approved the appointment of Ms. Maithilee Mistry as the Chief Financial Officer of the Company with effect from May 6, 2025," the Company stated in a BSE filing.</div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Maithilee Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years, having held leadership roles in various Multinational companies.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "> Previously, Maithilee held a role of CFO for S<a href="https://medicaldialogues.in/topics/Sanofi-Consumer-Healthcare-India">anofi Consumer Healthcare India Limited</a>. Prior to that, she worked with Dow chemical in USA as global Funding Director, responsible for all aspects of corporate funding and banking relations. Before relocating to USA, she was Finance Director for Dow Chemical, India subcontinent region. Maithilee has also served as Board member in various companies including a public listed entity and other joint ventures in India. Before Joining Dow, she has also held leadership positions with Omya and Cognis, European multinational companies, leading teams in India and Southwest Asia with responsibilities for Finance, HR, Legal and IT. </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">She is a qualified Chartered Accountant who started her career with Deloitte (India) as a member of statutory audit team.</div><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/abbott-india-names-anushree-kunhambu-as-associate-director-new-product-introduction-and-therapy-area-strategy-146736">Abbott India names Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy</a></i></b></p><p style="text-align: justify; ">Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories The Company offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.</p><p style="text-align: justify; ">Abbott India Limited is part of Abbott's global pharmaceutical business in India.&nbsp;</p>

315. Dr MI Sahadulla bags International Recognition by Royal College of Physicians

     Sat, 19 Apr 2025 04:45:37 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283564-dr-mi-sahadulla.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Thiruvananthapuram: Dr MI Sahadulla, Chairman and Managing Director, <a href="https://medicaldialogues.in/topics/kimshealth" target="_blank">KIMSHEALTH</a>, has been conferred with the prestigious International PACES Champion Award 2024 by the Federation of the Royal Colleges of Physicians of the United Kingdom. &nbsp; &nbsp;</span></p><p style="text-align: justify; ">This recognition highlights Dr. Sahadulla’s exceptional contributions and unwavering commitment to the PACES (Practical Assessment of Clinical Examination Skills) examinations conducted internationally. The award was presented by Dr. Graham Curry, Chair Examiner from the Federation, at an official event held at Hotel Gokulam Grand, Thiruvananthapuram. &nbsp; &nbsp; &nbsp;</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/aig-hospitals-chairman-dr-nageshwar-reddy-honoured-with-legend-of-endoscopy-award-in-tokyo-146724"><b>Also Read:AIG Hospitals Chairman Dr Nageshwar Reddy honoured with Legend of Endoscopy Award in Tokyo</b></a></p><p style="text-align: justify;">The International PACES Champion Award is the highest honour conferred by the Federation on individuals who have significantly contributed to the success and global outreach of the MRCP(UK) examinations. Dr. Sahadulla is one of only ten recipients worldwide this year, and one of just four internationally recognised awardees. &nbsp;&nbsp;</p><p style="text-align: justify;">Speaking on the occasion, Jane Chopping, Policy Officer at MRCP(UK), said, "We are delighted to present Dr. M.I. Sahadulla with the 2024 International PACES Champion Award in recognition of his exceptional commitment and dedication to the conduct of the PACES exams." This accolade stands as a testament to Dr. Sahadulla’s leadership and the high standards maintained by KIMSHEALTH in the field of medical education and clinical examination. &nbsp;&nbsp;</p><p style="text-align: justify;">Medical Dialogues had earlier reported that Ushalakshmi Breast Cancer Foundation and KIMS USHALAKSHMI Centre for Breast Diseases based out of Hyderabad along with Brahma Kumaris are proud to have achieved a second new Guinness World Record title for ''Highest views of a Breast Cancer Awareness lesson on YouTube in 24 hours''. A record 6218 people from across the world have viewed this Guinness World record Presentation on YouTube &amp; benefited from this historic and landmark empowerment drive. Presenting the Guinness World Record (GWR) at KIMS Hospitals, Mr Rishi Nath, the Asia Pacific Adjudicator for this Record Event complimented Dr P Raghu Ram for his lucid Presentation for over 40 minutes.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/applications-open-lady-tata-memorial-trust-young-researcher-award-2025-check-all-details-143678"><b>Also Read:Applications Open! Lady Tata Memorial Trust Young Researcher Award 2025; Check All Details</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

316. Chennai Corporation to recruit 60 doctors for Urban Health Centres

     Sat, 19 Apr 2025 04:00:55 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/02/10/273479-maharashtra-resident-doctors-to-strike-indefinitely-from-feb-7-demanding-stipend-regularization.webp' /><p><b>Chennai: </b>The Greater Chennai Corporation (GCC) has announced plans to recruit 60 doctors on a contractual basis to address critical shortage of doctors at <a href="https://medicaldialogues.in/topics/urban-health-and-wellness-centres">Urban Health and Wellness Centres </a>(UHWC) across the city. However, councillors have urged that the appointments be made on a permanent basis rather than temporary contracts. </p><p>The Urban Health and Wellness Centres, inaugurated two years ago by Chief Minister M.K. Stalin under the Union Government’s <a href="https://medicaldialogues.in/topics/ayushman-bharat" rel="nofollow">Ayushman Bharat scheme</a>, were intended to enhance primary healthcare delivery in urban areas. Each centre was envisioned to have a full-time doctor, a nurse, and support staff to serve local communities. However, many centres in areas such as Manali, Madhavaram, KK Nagar, and Kodungaiyur still function without doctors, leaving patients to rely on overcrowded primary health centres and government hospitals.&nbsp;</p><p>Medical Dialogues had previously reported that as many as 500 Urban Health and Wellness Centres (UHWCs), spread across the state, were virtually inaugurated by Tamil Nadu Chief Minister M K Stalin. The UHWCs, intended to function as ancillary units of Urban Primary Health Centres, are located in areas under civic bodies such as corporations, including the Greater Chennai Corporation and municipalities.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/tamil-nadu/tamil-nadu-cm-launches-500-urban-health-and-wellness-centres-112578" style="background-color: rgb(255, 255, 255);"><b>Also Read: Tamil Nadu CM launches 500 Urban Health and Wellness Centres</b></a></p><p>Under the new initiative, the Chennai City Urban Health Mission—a wing of the National Health Mission—plans to complete the recruitment by the end of April. The contract positions are open to doctors under the age of 40, offering a monthly salary of ₹60,000 for an 11-month term. Alongside doctors, the GCC will also recruit 60 nurses, multi-purpose health workers, and support staff to ensure these centres are fully operational.</p><p>According to TOI, however, ever since their inauguration, they have been marred with vacancies and poor services. MDMK Councillor S Jeevan of Kodungaiyur said the centre in his ward, covering dense areas like Erukkanchery, Kodungaiyur, Vyasarpadi, and Moolakadai with a population of 80,000, is functioning without a doctor for a year. "I have spoken about this multiple times in council. Yet, we don't have doctors. Nurses treat patients. Many patients have started going to private clinics," he said.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/doctors-association-urges-cm-to-grant-govt-job-to-wife-of-doctor-who-died-during-covid-19-142081"><b>Also Read: Doctors' Association urges CM to grant Govt Job to wife of doctor who died during COVID-19</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">Speaking to <a href="https://timesofindia.indiatimes.com/city/chennai/gcc-to-hire-60-doctors-for-uhwcs/articleshow/120321074.cms" rel="nofollow">TOI</a>, CPI Councillor from Tondiarpet, M Renuka, said, except for doctors studying PG, no one even participates in the recruitment drive. "UHWCs function from 8 am to 10 am, and 4 pm to 6 pm. During breaks, doctors do private consultations too. Yet, they quit in less than three months or when they get a PG seat or MRB posting," she said.</span></div></div><p>Councillors argue that offering permanent positions to the doctors would ensure their work is officially recorded in service registers, enabling them to qualify for the service doctors quota in postgraduate medical courses. Jeevan said that while civil engineers were being recruited for permanent posts by the GCC, doctors, who were important, were kept in temporary positions.</p>

317. Renowned Neurologist Dr Shirish Valsangkar commits suicide

     Sat, 19 Apr 2025 04:00:48 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283674-untitled-design-18.webp' /><p style="text-align: justify; "><b>Solapur: </b>In a tragic incident, a city-based renowned neurologist, Dr Shirish Padmakar Valsangkar, owner of Valsangkar Hospital, also known as the S P Institute of Neurosciences, committed <a href="https://medicaldialogues.in/topics/doctor-suicide" target="_blank">suicide</a> after shooting himself in the head with his licensed revolver at his residence.&nbsp;</p><p style="text-align: justify; ">Dr. Valsangkar, widely regarded as the pride of Solapur for his exceptional expertise and knowledge in the field of neurology, breathed his last after being rushed to his own hospital, where he had treated countless patients over the years. He provided his medical services not only in Solapur but also in Maharashtra and around the world.&nbsp;</p><p style="text-align: justify; ">The reason why the doctor took his own life remains unknown and is yet to be determined. However, the preliminary investigation report by the police indicates that Dr. Valsangkar had been under stress over the past few days.</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/62-year-old-doctor-found-dead-in-hostel-room-146305" target="_blank">62-year-old Radiologist found dead</a></b></p><p style="text-align: justify; ">The incident took place after Dr. Valsangkar had dinner with his family at his house around 8 p.m. At approximately 8:30 p.m., he suddenly got up and went to the bathroom, carrying his licensed revolver. There, he reportedly shot himself in the head and collapsed. Upon discovering the incident, his family rushed him to the hospital, where his son, also a doctor, attempted to treat him. Sadly, despite all efforts, Dr. Valsangkar passed away around 9:30 p.m.</p><p style="text-align: justify; ">As soon as the news of Dr. Shirish Valsangkar’s death spread, many well-known doctors and his patients came to pay their respects. His sudden death shocked the entire medical community in Solapur and across the state.</p><p style="text-align: justify; ">As per <a href="https://marathi.indiatimes.com/maharashtra/solapur/solapur-news-famous-neurologist-dr-shirish-valsangkar-ends-life-medical-field-in-shock/articleshow/120414054.cms" rel="nofollow">Marathi India times</a>, Dr. Shirish Valsangkar was the first neurologist in Solapur. Dr. Valsangkar had started a state-of-the-art hospital to treat the brain in various and sophisticated ways. He was known as Dr. Shirish Valsangkar, who revolutionized the field of neurology in Solapur.&nbsp;</p><p style="text-align: justify; ">Shocked over the incident, Dr Sachin Baldawa, a neurosurgeon from Solapur told <a href="https://timesofindia.indiatimes.com/city/kolhapur/renowned-neurologist-shirish-padmakar-valsangkar-ends-life-in-solapur/articleshow/120414096.cms" rel="nofollow">TOI</a>, "It is a shocking development for all of us."</p><p style="text-align: justify; ">“He was rushed to a hospital but succumbed during treatment. While the exact reason behind his extreme step is being ascertained, preliminary information suggests he had been under stress for the past few days. The body has been sent for investigation,” an police official told PTI.&nbsp;</p><p>Dr. Shirish Padmakar Valsangkar was a highly respected neurologist and the founder of the SP Institute of Neurosciences (Valsangkar Hospital) in Solapur, Maharashtra. Known as a pioneer in the field of neurology in the region, he was instrumental in transforming neurological care in South-West Maharashtra. His vision and commitment led to the establishment of one of the region’s most advanced centers for brain and spine-related disorders.</p><p>He pursued his medical education at Dr. V. M. Medical College, Solapur, earning his MBBS and MD under Shivaji University. To further his expertise, Dr. Valsangkar achieved MRCP (UK) from the Royal College of Physicians, London. He received comprehensive clinical training both in India and the United Kingdom. In India, his formative years included internships at CPR Hospital, Kolhapur, and the Primary Health Centre in Kurduwadi, followed by postgraduate training at General Hospital, Solapur, and senior registrarship at Bombay Hospital. In the UK, he held various academic and clinical positions at prestigious institutions including Maida Vale Neurological Hospital (London), Derbyshire Royal Infirmary, and the Midland Centre for Neurosurgery and Neurology.</p><p>In 1999, he founded the SP Institute of Neurosciences in Solapur with the aim of offering specialized and multidisciplinary care. The hospital grew to provide a wide range of neurological services including neurology, neurosurgery, neurointervention, neurorehabilitation, and pain management. Dr. Valsangkar was known for treating complex conditions such as epilepsy, stroke, brain tumors, neuromuscular diseases, and movement disorders.</p><p>Beyond clinical work, Dr. Valsangkar actively contributed to research and academic advancement. He authored several scientific papers focusing on cerebrospinal fluid LDH in meningitis, treatment protocols for epilepsy, and stroke prognosis.&nbsp;</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/upset-over-wedding-cancellation-doctor-jumps-to-death-in-front-of-train-145710" target="_blank">Upset over wedding cancellation, doctor jumps to death in front of train</a></b></p>

318. KEM Hospital Professor Accused of Sexual Harassment by 6 Doctors, Suspended

     Sat, 19 Apr 2025 04:00:42 -0000

     <img src='https://medicaldialogues.in/h-upload/2022/10/15/188064-sexual-harassment.webp' /><p style="text-align: justify; "><b>Mumbai:</b>&nbsp;A senior doctor at the BMC-run <a href="https://medicaldialogues.in/topics/kem-hospital">KEM Hospital </a>in Parel has been suspended after a complaint was filed against him by six women doctors, who accused him of <a href="https://medicaldialogues.in/topics/sexual-harassment">sexual harassment</a>. The doctor has also been booked under <a href="https://medicaldialogues.in/topics/bns-2023">Bharatiya Nyaya Sanhita</a> (BNS) sections 74 (acts of unwelcome physical contact, advances, or sexually coloured remarks), 75 (use of criminal force with intent to outrage modesty) and 79 (protection from actions intended to insult modesty).</p><p style="text-align: justify; ">Meanwhile, taking action against the doctor, who works as a Professor in the forensic medicine and toxicology department at the hospital, the hospital has now barred him from attending work or taking up any work linked to his profession privately, TOI has reported.</p><p style="text-align: justify; ">The action has been taken after the doctors filed the complaint against doctor on April 12 at Bhoiwada police station and in the complaint, they detailed multiple instances of inappropriate sexual conduct. They also submitted a written complaint to the head of the forensic medicine department Dr. Harish Pathak and the dean of the hospital Dr. Sangeeta Rawat, on April 10. </p><p style="text-align: justify; ">The previous day i.e. on April 9, the six doctors reportedly approached the doctor's wife as well and told her about their experiences. Addressing this, the FIR mentioned, "She assured us she would speak to him and that he would stop his misbehaviour."</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/tamil-nadu-directs-formation-of-internal-complaints-committee-in-government-hospitals-143655" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Tamil Nadu directs formation of Internal Complaints Committee in Government Hospitals</i></b></a></p><p style="text-align: justify; ">The professor's lawyer, Tamhankar, has approached the sessions court seeking&nbsp;<a href="https://medicaldialogues.in/topics/anticipatory-bail">anticipatory bail</a>. The matter has been listed for hearing today.</p><p style="text-align: justify; ">As per the latest media report by the <a href="https://timesofindia.indiatimes.com/city/mumbai/kem-prof-suspended-after-6-women-doctors-file-sexual-harassment-fir/amp_articleshow/120414986.cms" rel="nofollow">Times of India</a>, after receiving the complaint, Bhoiwada police station pasted a notice on the door of the doctor's residence inside KEM campus asking him to present himself for questioning. Commenting on this, senior police inspector Sachin Kadam informed that the notice was pasted after repeated attempts to reach the doctor failed. He added, "His phone is switched off and teams sent to his house on at least three occasions found the door locked."</p><p style="text-align: justify; ">Meanwhile, the civic authorities and the hospital's central internal complaints committee under the Prevention of Sexual Harassment Act have also instituted their own probes.</p><p style="text-align: justify; ">Amid the allegations of sexual harassment, the doctor recently told TOI on a WhatsApp call, "I have full faith in the judiciary. I am aware of the complaint and will cooperate with the POSH committee and police."</p><p style="text-align: justify; ">Commenting on the matter, Dr. Rawat informed that back in 2021, a similar complaint was filed by a doctor against the accused professor. Later, the complainant had moved abroad and could not pursue the case. Dr. Rawat added, "This time, I escalated the matter to the additional municipal chief and director, BMC hospitals."</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/guwahati-doctor-held-for-alleged-sexual-harassment-of-patient-146315" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Guwahati Doctor held for alleged sexual harassment of patient</i></b></a></p>

319. Thyroid Cancer Red Flag: FDA Adverse Reporting Data Analysis Shows Alerts on Semaglutide, Tirzepatide Use

     Sat, 19 Apr 2025 03:30:30 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/11/282671-weight-loss-medications-and-thyroid-cancer.webp' /><p style="text-align: justify; "><strong>Lebanon:</strong> A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has raised important safety concerns regarding a potential link between <a href="https://medicaldialogues.in/topics/thyroid-cancer">thyroid cancer </a>and several popular <a href="https://medicaldialogues.in/topics/weight-loss-medication">weight-loss medications</a>.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Published in <em>Endocrinology, Diabetes &amp; Metabolism</em>, the study sheds light on the possible association between glucagon-like peptide-1 (GLP-1) receptor agonists and an elevated risk of thyroid cancer. These medications—commonly prescribed for obesity and type 2 diabetes—have gained immense popularity in recent years. However, questions about their long-term safety continue to surface, particularly concerning thyroid health.</p><p style="text-align: justify; ">"These findings highlight the need for ongoing research and vigilant safety monitoring when using these medications for managing obesity," the researchers reported.</p><p style="text-align: justify; ">GLP-1 receptor agonists such as <strong><a href="https://medicaldialogues.in/topics/semaglutide">semaglutide </a>(Ozempic and Rybelsus)</strong> and Dual GIP &amp;GLP-1 Receptor Agonist <strong><a href="https://medicaldialogues.in/topics/tirzepatide">tirzepatide </a>(Mounjaro)</strong> have been widely adopted for weight-loss management due to their efficacy in reducing appetite and promoting weight reduction. Despite their growing clinical use, researchers have noted emerging concerns about their potential association with thyroid malignancies, prompting this comprehensive safety evaluation.</p><p style="text-align: justify; ">Against the above background, <strong>Christophe Abi Zeid Daou</strong> from the Department of Otolaryngology and Head and Neck Surgery at the American University of Beirut Medical Center, Lebanon, and colleagues aimed to explore the potential link between thyroid cancer and weight-loss medications.</p><p style="text-align: justify; ">For this purpose, the researchers reviewed adverse event reports recorded in the FAERS database from 2004 through the first quarter of 2024. To assess the strength of the associations, they conducted a disproportionality analysis—a statistical approach used in pharmacovigilance studies to detect signals of potential drug-related risks. Reporting odds ratios (RORs) were calculated to quantify the likelihood of thyroid cancer events associated with various weight-loss and anti-diabetic medications.</p><p style="text-align: justify; ">The following were the key findings of the study:</p><ul><li style="text-align: justify; "><strong>Semaglutide</strong> was linked to a significantly higher risk of thyroid cancer (ROR = 7.61).</li><li style="text-align: justify; "><strong>Dulaglutide</strong> also showed a notable association with thyroid cancer (ROR = 3.59).</li><li style="text-align: justify; "><strong>Liraglutide</strong> demonstrated the strongest association among the drugs studied (ROR = 15.59).</li><li style="text-align: justify; "><strong>Tirzepatide</strong> was associated with an elevated risk of thyroid cancer (ROR = 2.09).</li><li style="text-align: justify; "><strong>Metformin</strong> showed a weak inverse association, potentially indicating a protective effect (ROR = 0.588).</li><li style="text-align: justify; "><strong>No significant associations</strong> with thyroid cancer were observed for <strong>topiramate</strong>, <strong>dapagliflozin</strong>, or <strong>insulin glargine</strong>.</li></ul><p style="text-align: justify; ">While the findings offer valuable insights into possible safety concerns, the authors emphasized the limitations of the FAERS database, which relies on voluntary and spontaneous reporting and lacks a control group—factors that prevent drawing definitive causal conclusions. Nonetheless, the study highlights a potential safety signal that warrants further investigation.</p><p style="text-align: justify; ">“The study calls for ongoing safety monitoring and patient counselling when prescribing these medications, emphasizing the importance of informed clinical decisions and continued research into the long-term effects of weight-loss therapies,” the researchers concluded.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Abi Zeid Daou C, Aboul Hosn O, Ghzayel L, Mourad M. Exploring Connections Between Weight-Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database. Endocrinol Diabetes Metab. 2025 Mar;8(2):e70038. doi: 10.1002/edm2.70038. PMID: 40055991; PMCID: PMC11889434.</p></div><p style="text-align: justify; "><br></p>

320. Clopidogrel Outperforms Aspirin in Reducing Cardiovascular Events Post-PCI: SMART-CHOICE 3 Trial

     Sat, 19 Apr 2025 03:15:40 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/16/283214-clopidogrel.webp' /><p style="text-align: justify; ">South Korea: The SMART-CHOICE 3 trial demonstrated that in patients who had completed the standard course of <a href="https://medicaldialogues.in/topics/dual-antiplatelet-therapy-dapt">dual antiplatelet therapy (DAPT)</a> following <a href="https://medicaldialogues.in/topics/percutaneous-coronary-intervention-pci">percutaneous coronary intervention (PCI)</a>, <a href="https://medicaldialogues.in/topics/clopidogrel-monotherapy">clopidogrel monotherapy </a>(75 mg/day) significantly reduced the 3-year cumulative incidence of adverse events (4.4% vs. 6.6%) and myocardial infarction rates (1.0% vs. 2.2%) compared to <a href="https://medicaldialogues.in/topics/aspirin">aspirin</a>.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">In their study published in<em> The Lancet, </em>the researchers noted that stroke rates were similar between the two groups, and there was no significant difference in bleeding risk. These findings highlight the safety and efficacy of clopidogrel as a long-term monotherapy option in high-risk patients post-PCI.</p><p style="text-align: justify; ">Given the ongoing uncertainty around the optimal long-term antiplatelet strategy for patients undergoing percutaneous coronary intervention, identifying the most effective and safest maintenance therapy remains a clinical priority. While dual antiplatelet therapy is the standard initial approach, the best monotherapy to follow after its completion is still under debate.</p><p style="text-align: justify; ">To address this, Prof Ki Hong Choi, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, and colleagues designed the study to evaluate and compare the efficacy and safety of clopidogrel versus aspirin monotherapy in patients who had completed the standard duration of DAPT following PCI with drug-eluting stents. </p><p style="text-align: justify; ">For this purpose, the researchers conducted a multicentre, randomised, open-label trial across 26 sites in South Korea. They enrolled patients aged 19 years or older who were at high risk of recurrent ischaemic events—such as those with a history of myocardial infarction, diabetes requiring medication, or complex coronary lesions—and who had completed the standard duration of DAPT after undergoing PCI.</p><p style="text-align: justify; ">These patients were randomly assigned in a 1:1 ratio to receive either clopidogrel (75 mg daily) or aspirin (100 mg daily) as oral monotherapy. The primary outcome measured was the cumulative incidence of a composite of all-cause death, myocardial infarction, or stroke in the intention-to-treat population. Adverse events were recorded as part of the secondary endpoints. </p><p style="text-align: justify; ">Key Findings:</p><ul><li style="text-align: justify; ">A total of 5,542 patients were assessed for eligibility between 2020, and 2023, and 5,506 were randomly assigned to receive either clopidogrel (n=2,752) or aspirin (n=2,754) monotherapy. The median time from PCI to randomisation was 17.5 months.</li><li style="text-align: justify; ">Over a median follow-up of 2.3 years, the primary composite endpoint occurred in 92 patients on clopidogrel and 128 on aspirin, with a 3-year incidence of 4.4% vs 6.6%, respectively (HR 0.71).</li><li style="text-align: justify; ">Death from any cause occurred in 50 patients in the clopidogrel group and 70 in the aspirin group (3-year incidence 2.4% vs 4.0%; HR 0.71).</li><li style="text-align: justify; ">Myocardial infarction was reported in 23 patients on clopidogrel and 42 on aspirin (3-year incidence 1.0% vs 2.2%; HR 0.54).</li><li style="text-align: justify; ">Stroke occurred in 23 patients in the clopidogrel group and 29 in the aspirin group (3-year incidence 1.3% in both; HR 0.79).</li><li style="text-align: justify; ">Bleeding risk was similar between the two groups, with a 3-year incidence of 3.0% in both arms (HR 0.97).</li><li style="text-align: justify; ">Clopidogrel was not linked to a higher rate of adverse events compared to aspirin.</li></ul><p style="text-align: justify; ">"Among high-risk patients who had completed the standard duration of dual antiplatelet therapy following PCI, clopidogrel monotherapy significantly lowered the cumulative risk of death, myocardial infarction, and stroke compared to aspirin, without increasing bleeding risk," the authors concluded. </p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY; SMART-CHOICE 3 investigators. Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. Lancet. 2025 Apr 12;405(10486):1252-1263. doi: 10.1016/S0140-6736(25)00449-0. Epub 2025 Mar 30. PMID: 40174599.</p></div><p style="text-align: justify; "><br></p>

321. Study Shows Early Dual Drug Therapy Could Prevent 5,000 Heart Attacks per Decade

     Sat, 19 Apr 2025 02:45:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283654-mdtv-2025-04-19t112653758.webp' /><div class="pasted-from-word-wrapper"><div style="text-align: justify; ">A new study by Imperial College London and Lund University has found that thousands of <a href="https://medicaldialogues.in/topics/heart-attacks">heart attacks</a>, <a href="https://medicaldialogues.in/topics/strokes">strokes</a>, and deaths could be prevented annually with the early use of two affordable <a href="https://medicaldialogues.in/topics/cholesterol">cholesterol</a>-lowering drugs—statins and ezetimibe. The research, published recently, underscores the potential of this low-cost combination therapy to save lives and ease healthcare burdens worldwide.</div><div style="text-align: justify;"><a href="https://medicaldialogues.in/topics/cardiovascular-disease">Cardiovascular disease</a> is the leading cause of death globally, with heart attacks being the most common event. Survivors are at the highest risk of a second heart attack in the first year due to increased <a href="https://medicaldialogues.in/topics/blood-vessel">blood vessel</a> sensitivity. While statins are widely used, ezetimibe is often not prescribed early due to concerns about side effects. However, researchers found that the combination therapy is both safe and significantly more effective when started promptly.</div><div style="text-align: justify;">To investigate this, scientists analyzed data from 36,000 Swedish heart attack patients treated between 2015 and 2022. Using advanced statistical models to emulate a clinical trial, they compared patients who received statins and ezetimibe within 12 weeks of a heart attack to those who began later or used only statins. Early dual therapy was linked to reduced risk of further heart attacks, strokes, and death.</div><div style="text-align: justify;">“This study shows we could save lives with two low-cost drugs, yet many patients globally don’t receive them together,” said Prof. Kausik Ray of Imperial. “It’s time for care pathways to change.”</div><div style="text-align: justify;">Co-author Dr. Margret Leosdottir added that global treatment guidelines should be updated to reflect the benefits of early combination therapy that has minimal side effects. The study calls for immediate action to improve post-heart attack care and prevent unnecessary suffering.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div></div></div>

322. Chronic Pain May Quadruple Risk of Depression: Study Finds

     Sat, 19 Apr 2025 02:30:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283651-mdtv-2025-04-19t111907651.webp' /><div class="pasted-from-word-wrapper"><div style="text-align: justify; ">A new study published in <i><a href="https://medicaldialogues.in/topics/Science-Advances">Science Advances</a></i> reveals that individuals suffering from <a href="https://medicaldialogues.in/topics/chronic-pain">chronic pain</a>—defined as lasting three months or more—are up to four times more likely to develop depression. Chronic pain affects nearly 30% of people worldwide, and those with pain in multiple body sites face an even higher risk of <a href="https://medicaldialogues.in/topics/depression">depression </a>compared to those with pain in a single area.</div><div style="text-align: justify;">To reach these findings, the researchers analyzed data from 431,038 participants in the UK Biobank, following their health outcomes over 14 years. Participants reported pain in areas including the head, neck, back, hips, knees, and more. The researchers assessed the relationship between pain reports and depression diagnoses, alongside measuring inflammation levels to better understand potential underlying mechanisms.</div><div style="text-align: justify;">The study also points to <a href="https://medicaldialogues.in/topics/inflammation">inflammation </a>as a possible biological link. The team identified elevated levels of inflammatory markers, such as C-reactive protein (CRP), in individuals experiencing both chronic pain and depression. This suggests that inflammation may play a key role in connecting the two conditions.</div><div style="text-align: justify;">Researchers from Yale University emphasized the close link between physical and mental health. “Pain isn’t only physical,” said Dr. Dustin Scheinost, Associate Professor at Yale School of Medicine. “Our study adds to the evidence that physical conditions can have mental health consequences.”</div><div style="text-align: justify;">“We often think of brain health or mental health as separate from cardiac or liver health,” said Scheinost. “But all of these body systems influence each other.”</div><div style="text-align: justify;">The findings underscore the need for integrated approaches in healthcare, recognizing how chronic physical conditions like pain can significantly impact mental well-being. </div><div style="text-align: justify;">Reference: https://medicine.yale.edu/news-article/inflammation-may-be-the-link-between-chronic-pain-and-depression/</div><div style="text-align: justify;"></div><div></div></div>

323. Spot Capillary HbA1c Testing Boosts Type 2 Diabetes Detection in High-Risk Patients, Study Finds

     Sat, 19 Apr 2025 02:15:53 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/12/282737-hba1c-testing.webp' /><p style="text-align: justify; "><strong>China</strong>: A recent cluster randomized controlled trial has demonstrated that point-of-care capillary <a href="https://medicaldialogues.in/topics/hba1c">HbA1c </a>(POC-cHbA1c) testing can significantly improve early detection of<a href="https://medicaldialogues.in/topics/type-2-diabetes-t2d"> type 2 diabetes (T2D) </a>in high-risk individuals within primary care.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">"Compared to traditional venous HbA1c testing, POC-cHbA1c testing led to twice the screening uptake, delivered quicker results, reduced the need for follow-up visits, and identified more previously undiagnosed cases of type 2 diabetes," the researchers reported in <em><a href="https://medicaldialogues.in/topics/bmc-medicine">BMC Medicine</a>. </em></p><p style="text-align: justify; ">The delayed diagnosis of type 2 diabetes increases the risk of complications, making the high number of undiagnosed cases in Hong Kong a growing public health concern. Point-of-care capillary HbA1c testing offers a convenient, timely, and comparably accurate alternative to traditional venous HbA1c (vHbA1c) testing for diabetes screening. However, evidence from randomized trials is limited.</p><p style="text-align: justify; ">Linda Chan, The Bau Institute of Medical and Health Sciences Education, The University of Hong Kong, Hong Kong SAR, China, and colleagues evaluated the effectiveness of a two-step active opportunistic screening approach using POC-cHbA1c versus usual care with vHbA1c and multiple clinic visits in identifying type 2 diabetes among at-risk patients in primary care. The main outcomes included comparing diabetes detection rates and testing uptake between the two groups. </p><p style="text-align: justify; ">For this purpose, the researchers conducted a cluster randomized controlled trial across eight General outpatient clinics between June 2022 and January 2024, using a two-step active opportunistic screening approach. In the first step, 852 at-risk individuals were identified during routine primary care visits based on specific inclusion and exclusion criteria. In the second step, these patients underwent either point-of-care capillary HbA1c (POC-cHbA1c) testing in the intervention group or venous HbA1c (vHbA1c) testing in the control group.</p><p style="text-align: justify; ">Those with HbA1c levels ≥5.6% were offered a confirmatory oral glucose tolerance test. Clinics were randomized using a computer-generated sequence, and multilevel logistic regression assessed the impact of the intervention on testing uptake, accounting for patient factors and clinic-level clustering. </p><p style="text-align: justify; ">The following were the key findings of the study:</p><ul><li style="text-align: justify; ">The uptake rate for POC-cHbA1c testing was significantly higher than for vHbA1c (76.0% vs 37.5%; OR = 7.06).</li><li style="text-align: justify; ">POC-cHbA1c identified a greater proportion of type 2 diabetes cases (4.2% vs 1.4%).</li><li style="text-align: justify; ">Detection of pre-diabetes was also higher with POC-cHbA1c (11.8% vs 6.9%).</li><li style="text-align: justify; ">Combined detection of type 2 diabetes and pre-diabetes was more likely with POC-cHbA1c (OR = 1.99).</li><li style="text-align: justify; ">The number needed to screen to identify one additional case of type 2 diabetes using POC-cHbA1c versus vHbA1c was 61.</li></ul><p style="text-align: justify; ">"The study highlights the strong potential of POC-cHbA1c testing as an effective screening strategy for type 2 diabetes in primary care. With significantly higher uptake and improved detection rates compared to traditional venous HbA1c testing, POC-cHbA1c can help expand screening coverage, accelerate diagnosis, and support earlier intervention among at-risk individuals," the authors concluded. </p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Chan, L., Yu, E.Y.T., Wan, E.Y.F. et al. Improving type 2 diabetes detection among at-risk individuals – comparing the effectiveness of active opportunistic screening using spot capillary-HbA1c testing and venous HbA1c testing: a cluster randomized controlled trial. BMC Med 23, 190 (2025). https://doi.org/10.1186/s12916-025-04007-z</p></div><p style="text-align: justify; "><br></p>

324. Nasal Etripamil Nearly Twice as Effective as Placebo in Halting PSVT Episodes, Trial Finds

     Sat, 19 Apr 2025 02:15:48 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/10/282404-supraventricular-tachycardia.webp' /><p style="text-align: justify; ">USA: A recent study published in <i><a href="https://speciality.medicaldialogues.in/topics/jama-cardiology">JAMA Cardiology</a> </i>revealed that self-administered etripamil was almost twice as effective as placebo in terminating <a href="https://medicaldialogues.in/topics/supraventricular-tachycardia">paroxysmal supraventricular tachycardia (PSVT)</a> episodes within 30 minutes.</p><p style="text-align: start; "><span style="text-align: justify;">The recent secondary analysis of data from two phase 3 randomized clinical trials has shed light on the potential of self-administered intranasal etripamil in reducing <a href="https://medicaldialogues.in/topics/emergency-department">emergency department (ED) </a>visits among individuals with PSVT. This fast-acting calcium channel blocker, delivered through the nasal route, is being evaluated for its efficacy in managing acute episodes of atrioventricular-nodal-dependent PSVT outside hospital settings.</span></p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Paroxysmal supraventricular tachycardia is characterized by sudden, rapid heart rhythms often requiring immediate intervention to restore normal rhythm. Traditional oral therapies have been limited by delayed onset and potential side effects, making rapid-acting alternatives an area of clinical interest.</p><p style="text-align: justify; ">The analysis combined data from the NODE-301 part 1 and its continuation study, RAPID, which were double-blind, placebo-controlled, and event-driven. Participants were trained to self-administer a 70 mg dose of etripamil at the onset of PSVT symptoms. In the RAPID extension, a second dose was permitted 10 minutes after the first if symptoms persisted. Patients were advised to seek emergency care if symptoms continued beyond 30 minutes. </p><p style="text-align: justify; ">The key findings of the study were as follows:</p><ul><li style="text-align: justify; ">The pooled analysis included 340 patients, with 206 receiving etripamil and 134 receiving a placebo. The average age of participants was 54.7. Women made up nearly 70% of the study population.</li><li style="text-align: justify; ">Before taking the study drug, 370 patients attempted vagal maneuvers, but only 4.6% achieved PSVT termination using this method.</li><li style="text-align: justify; ">PSVT episodes were resolved within 30 minutes in 57.8% of patients who used etripamil, compared to 32.1% in the placebo group.</li><li style="text-align: justify; ">Only 13.6% of patients in the etripamil group required an emergency department visit, compared to 22.4% in the placebo group.</li><li style="text-align: justify; ">This corresponded to an 8.8% absolute and 39% relative reduction in ED visits, with a relative risk of 0.61.</li><li style="text-align: justify; ">Etripamil was generally well-tolerated, with most side effects limited to the nasal administration site.</li><li style="text-align: justify; ">No serious adverse events were reported in patients who received etripamil.</li></ul><p style="text-align: justify; ">Given that PSVT affects approximately 1 in 300 people in the U.S. and leads to substantial healthcare utilization, the availability of an effective at-home treatment could significantly ease the burden on emergency services. The analysis suggests that treating 12 patients with etripamil could prevent one ED visit.</p><p style="text-align: justify; ">While the results are promising, Sean D. Pokorney, Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, and colleagues note that future research is needed to explore further the impact of etripamil on long-term healthcare outcomes and its broader applicability. Pooling data from multiple studies, though necessary to achieve statistical power, also presents certain limitations that future investigations may help address.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Pokorney SD, Camm AJ, Dorian P, et al. Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. Published online April 09, 2025. doi:10.1001/jamacardio.2025.0417</p></div><p style="text-align: justify; "><br></p>

325. Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds

     Sat, 19 Apr 2025 02:15:18 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/01/25/270978-cancer-2.webp' /><p style="text-align: justify; ">In 2022, the American Cancer Society (ACS) updated its nutrition and activity guidelines for cancer survivors, recommending they avoid<a href="https://medicaldialogues.in/topics/obesity"> obesity</a>, stay physically active, eat a healthy diet, and limit alcohol intake. New research by ACS scientists shows a lifestyle aligned with these guidelines is associated with a lower mortality risk among non-<a href="https://medicaldialogues.in/topics/smoking">smoking</a> survivors of obesity-related cancers in the United States. Survivors who maintained a healthy lifestyle both before and after their diagnosis-or those who improved their habits after diagnosis-also had a lower mortality risk. The study is out today in the<i> Journal of the National Cancer Institute</i> (JNCI). </p><p style="text-align: justify;">“A <a href="https://medicaldialogues.in/topics/cancer">cancer</a> diagnosis often motivates people to think about how they can live healthier lives. Many survivors want to know what lifestyle changes they can make to improve their chances of living longer,” said Dr. Ying Wang, senior principal scientist, epidemiology research at the American Cancer Society and lead author of the study. “These findings underscore how making the right lifestyle choices truly affects cancer survival.” </p><p style="text-align: justify; ">Researchers analyzed the lifestyle habits of non-smoking participants from the Cancer Prevention Study-II Nutrition Cohort diagnosed with obesity-related cancers between 1992 and 2002 through 2020. Post-diagnosis adherence to ACS guidelines-body mass index (BMI), physical activity, diet, and alcohol consumption—was scored on a scale from 0 to 8. Models were used to calculate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). </p><p style="text-align: justify; ">Study results showed among 3,742 cancer survivors (average age 67.6 years) with a median follow-up of 15.6 years, 2,430 deaths occurred. Survivors with a score of 6-8 had a 24% lower risk of all-cause mortality (HR = 0.76; 95% CI = 0.68 to 0.85), a 33% lower risk of cardiovascular disease mortality (HR = 0.67; 95% CI = 0.54 to 0.83), and a 21% lower risk of cancer-specific mortality (HR = 0.79; 95% CI = 0.64 to 0.97) compared to those with a score of 0-3. Higher BMI and physical activity scores were associated with lower all-cause mortality. Compared to survivors with a consistently low ACS guideline score (less than 5) both before and after diagnosis, those with a consistently high score (five or more) had lower all-cause and cardiovascular disease mortality. Additionally, survivors who improved their score from low to high had lower all-cause mortality.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">&nbsp;Ying Wang et al, Following the American Cancer Society guideline for cancer survivors and obesity-related cancer survival, JNCI: Journal of the National Cancer Institute (2025). DOI: 10.1093/jnci/djaf051</p>

326. Extreme Heat Poses Threat to Mental Health, reveals research

     Fri, 18 Apr 2025 15:30:49 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/02/23/232874-mental-health-50.webp' /><p style="text-align: justify; ">Rising temperatures across Australia could increase the burden of mental and behavioural disorders (MBD) by almost 50 per cent by 2050, according to a new study from the University of Adelaide. The research highlights the urgent need to act now to protect mental health as the climate warms. </p><p style="text-align: justify; ">Published in<i> Nature Climate Change</i>, the study shows that high temperatures contributed to an annual loss of 8458 <a href="https://medicaldialogues.in/topics/disability">disability</a>-adjusted life years (DALYs), representing 1.8 per cent of total MBD burden in Australia. Young Australians aged 15 to 44 are particularly affected, with most losses linked to living with poor <a href="https://medicaldialogues.in/topics/mental%20health">mental health</a>. </p><p style="text-align: justify;">"The detrimental impacts of climate change on good mental health and emotional states have been increasingly recognised worldwide, and it's only going to get worse unless we act," said lead author Professor Peng Bi, from the University’s School of Public Health. </p><p style="text-align: justify;">MBDs encompass a broad spectrum of symptoms associated with distress or impairment in important functional areas, including an individual’s emotional regulation, cognition or behaviour, and include <a href="https://medicaldialogues.in/topics/anxiety">anxiety</a>, depressive, bipolar affective, <a href="https://medicaldialogues.in/topics/schizophrenia">schizophrenia</a>, alcohol, drug use and other mental and substance use disorders. </p><p style="text-align: justify;">“From mild distress to serious conditions like schizophrenia, rising temperatures are making things harder for millions," said Professor Bi. </p><p style="text-align: justify;">The study, based on data from the Australian Burden of Disease database, found that warmer regions, like those closer to the equator, face higher risks. </p><p style="text-align: justify;">The Northern Territory had the highest predicted relative risk as well as highest average threshold temperature while South Australia and Victoria had the highest proportion of burden attributable to high temperature, with 2.9 per cent (62.6 DALYs per 100,000) and 2.2 per cent (51.1 DALYs per 100,000), respectively. </p><p style="text-align: justify;">"These results underscore the crucial role of policymakers in developing focused public health interventions to minimise the emergence of mental health impacts of climate change, given its significant human, social and financial consequences," said Professor Bi. </p><p style="text-align: justify;">"About 8.6 million Australians aged 16 to 85 will experience an MBD within their lifetime. Factors like income, access to healthcare, and local conditions shape how heat affects mental health, with some areas hit harder than others." </p><p style="text-align: justify;">"Our findings show that climate change will drive up mental health challenges beyond what population growth alone would cause," said first author Dr Jingwen Liu. </p><p style="text-align: justify;">“Young people, who often face these issues early in life, are especially at risk as the climate crisis worsens.” </p><p style="text-align: justify; ">The researchers call for immediate action, including a heat-health action plans to prepare healthcare systems for rising mental health needs, localised solutions, like community programs and green spaces to build resilience and support for vulnerable groups, ensuring those most at risk get the care they need during hot periods. </p><p style="text-align: justify; ">"Policymakers must step up with targeted, people-centred strategies to protect mental health as temperatures climb," said Professor Bi.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Liu, J., Varghese, B.M., Hansen, A. et al. Increasing burden of poor mental health attributable to high temperature in Australia. Nat. Clim. Chang. (2025). https://doi.org/10.1038/s41558-025-02309-x.</p>

327. Baricitinib Shows Long-Term Safety in Severe Alopecia Areata: 4-Year Trial Data

     Fri, 18 Apr 2025 15:30:41 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/04/22/207990-alopecia-areata.webp' /><p style="text-align: justify; ">USA: In a significant advancement for the treatment of severe<a href="https://medicaldialogues.in/topics/alopecia-areata"> alopecia areata (AA)</a>, long-term data from two phase III clinical trials-BRAVE-AA1 and BRAVE-AA2-have confirmed that <a href="https://medicaldialogues.in/topics/baricitinib">baricitinib </a>maintains a consistent and favorable safety profile even after up to four years of use.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The findings, published in the <em><a href="https://medicaldialogues.in/topics/American-Journal-of-Clinical-Dermatology/">American Journal of Clinical Dermatology,</a> </em>highlight that the drug is well-tolerated over extended periods with low incidence rates of serious adverse events (IR 2.6) and no reported cases of serious infections, cardiovascular events, deep vein thrombosis, pulmonary embolism, or death. Additionally, rates of herpes zoster (IR 1.9) and malignancies (IR 0.2) remained stable throughout the follow-up period, reinforcing the long-term safety of baricitinib for patients managing this chronic autoimmune condition. </p><p style="text-align: justify; ">Baricitinib, a Janus kinase (JAK) inhibitor, is one of the first systemic treatments approved for severe alopecia areata and works by targeting the underlying immune dysfunction associated with the condition. Brett King, Department of Dermatology, Yale School of Medicine, New Haven, CT, USA, and colleagues present pooled safety findings on baricitinib treatment for severe alopecia areata based on data from the BRAVE-AA1 (Phase II/III) and BRAVE-AA2 (Phase III) trials, encompassing both the long-term extension and bridging extension phases.</p><p style="text-align: justify; ">For this purpose, the researchers assessed safety data from two groups: patients on continuous baricitinib (2 mg or 4 mg) and all patients who received any dose during the trials. They evaluated treatment-emergent adverse events, key safety concerns, and lab abnormalities. Incidence rates per 100 patient years were calculated based on risk duration. Data cutoffs were May 22, 2023 (BRAVE-AA1), and May 8, 2023 (BRAVE-AA2), with a follow-up of at least 152 weeks. </p><p style="text-align: justify; ">The key findings of the study were as follows:</p><ul><li style="text-align: justify; ">Safety data included 1,303 patients treated with baricitinib, accounting for 2,789.7 patient-years of exposure (median duration: 825 days; maximum: 1,460 days).</li><li style="text-align: justify; ">Most treatment-emergent adverse events were mild to moderate in intensity.</li><li style="text-align: justify; ">The incidence rate (IR) of serious adverse events was low at 2.6 per 100 patient-years.</li><li style="text-align: justify; ">Discontinuation due to adverse events occurred at a low rate (IR = 1.7).</li><li style="text-align: justify; ">These rates were consistent with previously reported data through at least 104 weeks.</li><li style="text-align: justify; ">No new cases of serious infections, opportunistic infections, major cardiovascular events, deep vein thrombosis, or pulmonary embolism were reported during an additional year of follow-up.</li><li style="text-align: justify; ">Rates of non-melanoma skin cancer (IR = 0.1) and other malignancies (IR = 0.2) remained stable.</li><li style="text-align: justify; ">Herpes zoster incidence remained consistent with earlier data (IR = 1.9).</li><li style="text-align: justify; ">Laboratory test changes showed stable trends over time.</li><li style="text-align: justify; ">There were no deaths in either BRAVE-AA1 or BRAVE-AA2 trials.</li></ul><p style="text-align: justify; ">"The long-term safety findings from the BRAVE-AA1 and BRAVE-AA2 trials align with earlier data from the baricitinib clinical program for alopecia areata, showing no new safety concerns or signals even with treatment durations extending up to four years," the authors concluded.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">King, B., Mostaghimi, A., Shimomura, Y. et al. Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment. Am J Clin Dermatol (2025). https://doi.org/10.1007/s40257-025-00932-0</p></div><p style="text-align: justify; "><br></p>

328. Postoperative Rehabilitation demonstrated preventive role against relapse after osseous temporomandibular joint ankylosis surgery: Study

     Fri, 18 Apr 2025 15:30:09 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/05/08/237688-osteonecrosis-of-the-jaw.webp' /><p style="text-align: justify; ">A new study published in the journal of <i>BMC Oral Health</i> showed that during the unusually long clinical follow-up period of 24 months, postoperative rehabilitation was found effective for prevention of&nbsp; recurrence following TMJA surgery.</p><p style="text-align: justify; ">Temporomandibular joint ankylosis (TMJA) is a disorder in which the temporomandibular joint (TMJ) becomes permanently stuck in a forced position due to an intracapsular lesion, resulting in significantly reduced mandible motion. As a result, not only severe trismus, but also masticatory function and facial deformities might impair aesthetics in afflicted people. </p><p style="text-align: justify; ">TMJA is classified into fibrous ankylosis and bony ankylosis, with the latter frequently causing a severe condylar dysfunction and impairing quality of life (QOL). Gap arthroplasty (GA), which involves excising any bony adhesion between the joint space and mandibular condyle without inserting it into the resulting gap, and interpositional gap arthroplasty (IPG), which involves creating a gap and then inserting an artificial material or temporalis myofascial flap (TMF) for example, are two related surgical procedures that have been reported.</p><p style="text-align: justify;">The goal of surgical therapy for TMJA is to improve patient quality of life by reducing ankylosis, restoring condylar function, avoiding ankylosis recurrence, and enhancing facial attractiveness. Thus, this study sought to clarify and analyze the association between the operational method, the rehabilitation time, and maximum incisal opening (MIO), with an emphasis on mouth opening following surgical treatment for TMJA.</p><p style="text-align: justify; ">12 patients who had surgery for gap or interpositional arthroplasty were included. The course of maximal incisal opening in patients was split by surgical procedure, gap size, and rehabilitation duration, with a focus on relapse of maximal incisal opening. The average recurrence of maximum incisal opening following surgery in patients with a gap size ≥ 15 mm was 12.0 ± 11.2 mm, whereas in those with a gap size &lt; 15 mm was 8.9 ± 12.6 mm.</p><p style="text-align: justify; ">The average relapse of maximum incisal opening following surgery in patients with gap arthroplasty was 12.3 ± 7.6 mm, whereas those with interpositional arthroplasty was 7.5 ± 15.2 mm. After surgery, patients with less than 12 months of rehabilitation had an average relapse of 14.1 ± 10.7 mm, whereas those with more than 12 months had an average recurrence of 7.4 ± 16.3 mm.</p><p style="text-align: justify; ">Overall, the findings of this retrospective study over a relatively long clinical follow-up period of 24 months demonstrate the relevance of postoperative rehabilitation in avoiding recurrence following TMJA surgery.</p><p style="text-align: justify; ">Source:</p><p style="text-align: justify; ">Ezoe, Y., Nogami, S., Otake, Y., Chiba, M., Takahashi, T., &amp; Yamauchi, K. (2025). Clinical course of jaw function recovery following surgical treatment in patients with temporomandibular joint ankylosis- correlation with mouth opening rehabilitation. BMC Oral Health, 25(1), 423. <a href="https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-025-05806-9" rel="nofollow">https://doi.org/10.1186/s12903-025-05806-9</a></p>

329. Golden eyes: How gold nanoparticles may one day help to restore people's vision

     Fri, 18 Apr 2025 15:15:59 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283369-retinal-disorder.webp' /><p style="text-align: justify; ">&nbsp;A new study by Brown University researchers suggests that gold nanoparticles-microscopic bits of gold thousands of times thinner than a human hair-might one day be used to help restore vision in people with <a href="https://medicaldialogues.in/topics/macular%20degeneration">macular degeneration</a> and other retinal disorders. </p><p style="text-align: justify;">In a study published in the journal <i>ACS Nano</i> and supported by the National Institutes of Health, the research team showed that nanoparticles injected into the retina can successfully stimulate the visual system and restore vision in mice with retinal disorders. The findings suggest that a new type of visual prosthesis system in which nanoparticles, used in combination with a small laser device worn in a pair of glasses or goggles, might one day help people with retinal disorders to see again. </p><p style="text-align: justify;">“This is a new type of retinal prosthesis that has the potential to restore vision lost to retinal degeneration without requiring any kind of complicated surgery or genetic modification,” said Jiarui Nie, a postdoctoral researcher at the National Institutes of Health who led the research while completing her Ph.D. at Brown. “We believe this technique could potentially transform treatment paradigms for retinal degenerative conditions.” </p><p style="text-align: justify;">Nie performed the work while working in the lab of Jonghwan Lee, an associate professor in Brown’s School of Engineering and a faculty affiliate at Brown’s Carney Institute for Brain Science, who oversaw the work and served as the study’s senior author. </p><p style="text-align: justify; ">Retinal disorders like macular degeneration and retinitis pigmentosa affect millions of people in the U.S. and around the world. These conditions damage light-sensitive cells in the retina called photoreceptors-the “rods” and “cones” that convert light into tiny electric pulses. Those pulses stimulate other types of cells further up the visual chain called bipolar and ganglion cells, which process the photoreceptor signals and send them along to the brain. </p><p style="text-align: justify;">This new approach uses nanoparticles injected directly into the retina to bypass damaged photoreceptors. When infrared light is focused on the nanoparticles, they generate a tiny amount of heat that activates bipolar and ganglion cells in much the same way that photoreceptor pulses do. Because disorders like macular degeneration affect mostly photoreceptors while leaving bipolar and ganglion cells intact, the strategy has the potential to restore lost vision. </p><p style="text-align: justify;">In this new study, the research team tested the nanoparticle approach in mouse retinas and in living mice with retinal disorders. After injecting a liquid nanoparticle solution, the researchers used patterned near-infrared laser light to project shapes onto the retinas. Using a calcium signal to detect cellular activity, the team confirmed that the nanoparticles were exciting bipolar and ganglion cells in patterns matched the shapes projected by the laser. </p><p style="text-align: justify;">The experiments showed that neither the nanoparticle solution nor the laser stimulation caused detectable adverse side effects, as indicated by metabolic markers for inflammation and toxicity. Using probes, the researchers confirmed that laser stimulation of the nanoparticles caused increased activity in the visual cortices of the mice-an indication that previously absent visual signals were being transmitted and processed by the brain. That, the researchers say, is a sign that vision had been at least partially restored, a good sign for potentially translating a similar technology to humans. </p><p style="text-align: justify;">For human use, the researchers envision a system that combines the nanoparticles with a laser system mounted in a pair of glasses or goggles. Cameras in the goggles would gather image data from the outside world and use it to drive the patterning of an infrared laser. The laser pulses would then stimulate the nanoparticles in people’s retinas, enabling them to see. </p><p style="text-align: justify;">The approach is similar to one that was approved by the Food and Drug Administration for human use a few years ago. The older approach combined a camera system with a small electrode array that was surgically implanted in the eye. The nanoparticle approach has several key advantages, according to Nie. </p><p style="text-align: justify;">For starters, it’s far less invasive. As opposed to surgery, “an intravitreal injection is one of the simplest procedures in ophthalmology,” Nie said. </p><p style="text-align: justify;">There are functional advantages as well. The resolution of the previous approach was limited by the size of the electrode array — about 60 square pixels. Because the nanoparticle solution covers the whole retina, the new approach could potentially cover someone’s full field of vision. And because the nanoparticles respond to near-infrared light as opposed to visual light, the system doesn’t necessarily interfere with any residual vision a person may retain. </p><p style="text-align: justify;">More work needs to be done before the approach can be tried in a clinical setting, Nie said, but this early research suggests that it’s possible. </p><p style="text-align: justify;">“We showed that the nanoparticles can stay in the retina for months with no major toxicity,” Nie said of the research. “And we showed that they can successfully stimulate the visual system. That’s very encouraging for future applications.”</p><p style="text-align: justify;">Reference:</p><p style="text-align: justify;">Jiarui Nie, Kyungsik Eom, Hafithe M. AlGhosain, Intravitreally Injected Plasmonic Nanorods Activate Bipolar Cells with Patterned Near-Infrared Laser Projection, ACS Nano, DOI: 10.1021/acsnano.4c14061.</p>

330. Vaginal Birth Linked to Higher Risk of Midlife Urinary Incontinence: SWAN Cohort Study

     Fri, 18 Apr 2025 15:15:52 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/01/16/230193-urinary-incontinence-50.webp' /><p style="text-align: justify; ">Canada: A recent longitudinal analysis based on the Study of Women's Health Across the Nation (SWAN) cohort has shed light on how <a href="https://medicaldialogues.in/topics/childbirth">childbirth </a>experiences-particularly the number of children a woman has and the mode of delivery-can influence the risk of <a href="https://medicaldialogues.in/topics/stress-urinary-incontinence">urinary incontinence (UI)</a> during midlife.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The analysis showed that <a href="https://medicaldialogues.in/topics/vaginal-birth">vaginal births</a> significantly raised the risk of stress (OR 2.11) and mixed urinary incontinence (OR 1.89) in midlife compared to cesarean deliveries. Women with both vaginal and cesarean births had even higher odds of mixed incontinence (OR 2.17). In contrast, urge incontinence was more closely linked to aging than childbirth.</p><p style="text-align: justify; ">The findings were published online in<em> Scientific Reports</em> on 07 April 2025. </p><p style="text-align: justify; ">Parity has been shown to increase the risk of urinary incontinence, but the extent of this risk appears to vary based on the mode of delivery. To explore this relationship further, Nikki L Stephenson, Department of Obstetrics &amp; Gynecology, University of Calgary, Calgary, AB, Canada, and colleagues examined how different delivery methods—vaginal versus cesarean—were associated with the prevalence of urge, stress, and mixed urinary incontinence during midlife. </p><p style="text-align: justify; ">For this purpose, the researchers examined the association between mode of delivery and subtypes of urinary incontinence using data from the SWAN cohort. They compared women who had undergone vaginal, cesarean, or a combination of both delivery types with those who had never given birth, aiming to understand how different childbirth experiences influence the risk of urge, stress, and mixed incontinence in midlife. </p><p style="text-align: justify; ">The key findings of the study were as follows:</p><ul><li style="text-align: justify; ">Women who delivered vaginally had a significantly higher prevalence of all types of urinary incontinence compared to those who were nulliparous or delivered via other modes.</li><li style="text-align: justify; ">No significant differences in urinary incontinence were observed when comparing parous women (regardless of delivery type) with nulliparous women overall.</li><li style="text-align: justify; ">Compared to cesarean deliveries, vaginal births were associated with significantly higher odds of stress urinary incontinence in midlife.</li><li style="text-align: justify; ">Women who had both vaginal and cesarean deliveries faced significantly increased odds of developing mixed urinary incontinence compared to those who delivered exclusively via cesarean section.</li><li style="text-align: justify; ">Urge urinary incontinence was more strongly linked to aging rather than childbirth history.</li><li style="text-align: justify; ">Vaginal deliveries raised the risk of both stress and mixed urinary incontinence in midlife compared to cesarean births.</li><li style="text-align: justify; ">A combination of vaginal and cesarean deliveries further elevated the risk of mixed urinary incontinence during middle age.</li></ul><p style="text-align: justify; ">“Parity and mode of delivery emerge as key factors influencing urinary incontinence in midlife. Parous women face a higher risk of stress and mixed incontinence, while the likelihood of urge incontinence appears lower compared to nulliparous women,” the authors noted. They further observed that “among multiparous women, vaginal delivery is associated with a greater risk of stress and mixed incontinence than cesarean birth.”</p><p style="text-align: justify; ">“These findings highlight the need for further research to validate the results across diverse populations and to better understand the underlying mechanisms driving these associations,” they concluded.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Stephenson, N. L., Brenner, D., Brennand, E., Robert, M., Prisnie, K., &amp; Metcalfe, A. (2025). Longitudinal analysis of the association between parity, mode of delivery and urinary incontinence in midlife using the SWAN cohort data. Scientific Reports, 15(1), 1-8. https://doi.org/10.1038/s41598-025-85603-0</p></div><p style="text-align: justify; "><br></p>

331. Young people with mental disorders less likely to become parents, reveals research

     Fri, 18 Apr 2025 15:15:49 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/01/13/198113-anxiety-4.webp' /><p style="text-align: justify; ">Using Finnish register data from over 1,2 million participants, the study found that both young men and women diagnosed with mental disorders are less likely to become parents compared to those without such diagnoses. The strongest associations were found for <a href="https://medicaldialogues.in/topics/schizophrenia">schizophrenia</a>: persons diagnosed with this disorder were highly unlikely to have their first child by age 39 years. </p><p style="text-align: justify;">Common <a href="https://medicaldialogues.in/topics/mental%20disorders">mental disorders</a>, such as <a href="https://medicaldialogues.in/topics/Depression">depression</a> and <a href="https://medicaldialogues.in/topics/anxiety">anxiety</a>, also reduced the likelihood of parenthood. For example, men diagnosed with depression were 38% less likely to become fathers compared to those without depression diagnosis. Among women, depression was associated with 19% lower likelihood of becoming a mother when compared to persons without depression disorder diagnosis. The similar difference between men and women were also observed for anxiety disorder. </p><p style="text-align: justify;">“The differences between men and women were clear for many disorders, with men having a lower likelihood of having a first child compared to women with the same disorder”, says Dr. Kateryna Golovina, university researcher and first author of the study. </p><h3 style="text-align: justify;">The role of partnership status </h3><p style="text-align: justify;">The study also explored the role of partnership status in the link between mental disorders and parenthood. Since stable relationships are often a key factor in having children, difficulties in forming or maintaining partnerships may partially explain lower parenthood rates among people with mental disorders. </p><p style="text-align: justify;">“We found a clear pattern: men with mental disorders were significantly less likely to cohabit than women with similar diagnoses”, says Associate Professor Christian Hakulinen, PI of the project. </p><h3 style="text-align: justify;">The importance of accessible mental health services </h3><p style="text-align: justify; ">The findings highlight the need for accessible, high-quality mental health services for young people. Providing long-term support may be particularly crucial in helping people with mental disorders navigate life decisions, including family formation. </p><p style="text-align: justify;">“Our research underscores the importance of well-functioning mental health services with low-threshold access, ensuring young people receive the support they need for both their well-being and life aspirations,” says Kateryna Golovina.</p><p style="text-align: justify;">Reference:</p><p style="text-align: justify;">Kateryna Golovina, Ripsa Niemi, Mai Gutvilig, Markus Jokela, Marko Elovainio, Christian Hakulinen, Mental Disorders and Having a First Child Among Young Adults: A Nationwide Register-Based Cohort Study, BJOG An International Journal of Obstetrics &amp; Gynaecology, https://doi.org/10.1111/1471-0528.18151.</p>

332. Opioid-sparing anesthesia significantly improves early postoperative recovery after cardiac surgery: A retrospective cohort study

     Fri, 18 Apr 2025 15:15:45 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/09/27/254384-noncardiac-surgery.webp' /><p style="text-align: justify;">Announcing a new article publication for <i>Cardiovascular Innovations and Applications</i> journal. Mounting evidence indicates that opioid-sparing anesthesia (OSA) decreases opioid-related adverse events. This article examines whether OSA might improve initial recovery after cardiac surgery. </p><p style="text-align: justify;">Data from patients who underwent elective heart surgery between July 2023 and July 2024 were analyzed. Eligible patients were divided into an OSA group or a control group. Patients in the OSA group received 0.5 to 1 μg·kg−1 sufentanil and ultrasound-guided nerve block after anesthetic induction, whereas patients in the control group received traditional high-dose opioid management. Patients in both groups were managed with the same sedatives, muscle relaxants, and other drugs. The main outcome was the overall 15-item Quality of Recovery (QoR-15) survey score 24 hours after surgery. </p><p style="text-align: justify;">A total of 1916 patients were scanned, and 1218 patients were included in the analysis: 392 in the OSA group and 826 in the control group. The QoR-15 global score measured 24 hours after surgery was 119.29 ± 3.25 in the OSA group and 113.87 ± 3.44 in the control group (P &lt; 0.001). The OSA group had lower numeric rating scale scores 24 hours and 72 hours after surgery (P &lt; 0.001) than the control group. The median (interquartile range) postoperative mechanical ventilation time was 1.0 (0–5) hours in the OSA group and 8.0 (6–14) hours in the control group (P &lt; 0.001), and the duration of hospitalization was 11.5 (9–14) days and 12 (10–14) days, respectively (P = 0.012). </p><p style="text-align: justify;">OSA based on ultrasound-guided nerve blocks significantly improved QoR-15 scores after cardiac surgery and is expected to be a reasonable analgesic protocol to improve the prognosis of cardiac patients.</p><p style="text-align: justify;">Reference:</p><p style="text-align: justify;">Dou Dou, Lu Wang and Su Yuan et al. Opioid-sparing Anesthesia Significantly Improves Early Postoperative Recovery after Cardiac Surgery: A Retrospective Cohort Study. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2024.0069.</p>

333. Hearing impairment may be sign of increased risk of Parkinson's disease, reports research

     Fri, 18 Apr 2025 15:15:17 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/03/01/233384-parkinsons-disease-50.webp' /><p style="text-align: justify; ">There may be a link between<a href="https://medicaldialogues.in/topics/hearing-impairment/"> hearing impairment</a> and an increased risk of developing Parkinson's according to research led by Lancaster University. </p><p style="text-align: justify;">This is one of the first studies to examine whether sensory impairments, such as hearing loss, might increase the risk for Parkinson’s or serve as an early warning sign. </p><p style="text-align: justify;">Parkinson's UK reports that an estimated 153,000 people in the UK currently live with Parkinson's, which is the fastest-growing neurological condition in the world. It is estimated that 1 in 37 people in the UK will be diagnosed with Parkinson's in their lifetime. </p><p style="text-align: justify; ">The study entitled “Speech-in-noise hearing impairment is associated with increased risk of Parkinson’s: A UK Biobank Analysis” is published in <i>Parkinsonism and Related Disorders&nbsp;</i></p><p style="text-align: justify;">Researchers analysed data from the UK Biobank, a biomedical database containing data from half a million participants across the UK. They looked at data from 159,395 individuals who had previously undergone a hearing test measuring their ability to detect speech in noisy environments and had no history of Parkinson’s at the time of the assessment. </p><p style="text-align: justify;">Over an average follow-up period of 14.24 years, 810 participants were subsequently diagnosed with <a href="https://medicaldialogues.in/topics/parkinson's-disease">Parkinson’s disease</a>. The analysis revealed a 57% increased risk of Parkinson’s for every 10-decibel increase in baseline hearing impairment. </p><p style="text-align: justify;">Dr Megan Readman, ESRC Post Doctoral Research Fellow from Lancaster University’s Department of Psychology, led the study. </p><p style="text-align: justify;">She said: “These findings are incredibly important; first, this is one of the first studies to look at how hearing impairments may increase risk for Parkinson’s or be an early warning sign of Parkinson’s. </p><p style="text-align: justify;">“Secondly, as our findings suggest, <a href="https://medicaldialogues.in/topics/hearing-loss">hearing loss</a> is intricately related to Parkinson’s so it may be beneficial for auditory functioning and the management of auditory impairment to be considered at the time of diagnosis and follow-up care.” </p><p style="text-align: justify;">However, Dr Readman stressed that it is not clear if the link between Parkinson’s and hearing loss is causal or if there is simply a correlation. </p><p style="text-align: justify;">“We do not know whether hearing loss can cause Parkinson’s, or if there is a common underlying cause for both conditions.” </p><p style="text-align: justify;">The other authors included Yang Wang and Fang Wan, Sally Linkenauger, Trevor Crawford and Christopher Plack plus Ian Fairman who has Parkinson’s and hearing impairment. </p><p style="text-align: justify;">Professor Plack said: “It is increasingly clear that hearing loss is not an isolated condition but is associated with several other disorders. Understanding these links is vital if we are to provide effective patient care, improving independence and quality of life for the individuals concerned." </p><p style="text-align: justify;">By identifying factors that might contribute to its onset, such as hearing impairment, researchers hope to pave the way for new strategies in prevention and care. </p><p style="text-align: justify; ">Dr Readman said: “Our findings suggest hearing impairment is intricately related to Parkinson’s and underscore the potential benefits of addressing auditory function in Parkinson’s diagnosis and follow-up care.”</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Readman, Megan Rose et al., Speech-in-noise hearing impairment is associated with increased risk of Parkinson's: A UK biobank analysis, Parkinsonism &amp; Related Disorder, DOI:10.1016/j.parkreldis.2024.107219&nbsp;</p>

334. Neglected Patellar Tendon Rupture treated with Semitendinosus Tendon graft: A novel technique with good result

     Fri, 18 Apr 2025 15:15:09 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283664-untitled-design-2025-04-19t114851066.webp' /><p style="text-align: justify; ">A patellar tendon rupture must be ruled out in every patient with a knee injury. Overlooked ruptures are difficult to manage because of ligament retraction and surrounding tissue scarring. The case report by Petar Vukman et al published in ‘Cureus journal’ demonstrates that in a neglected injury, one-stage reconstruction with a single semitendinosus tendon autograft can result in a favourable outcome.</p><p style="text-align: justify;">The CASE </p><p style="text-align: justify;">A 23-year-old patient presented to the outpatient clinic and complained of pain in the injured leg, inability to "lock" the knee in extension, and frequent falls, especially while walking down the stairs and downhill. Seven months before the visit, he suffered a gunshot wound (GSW) to his right knee in a mass shooting. </p><p style="text-align: justify; ">GSW irrigation and debridement in addition to external fixation, which bypassed the knee was performed in a nearby hospital. After the postoperative radiograph was taken, external fixation was removed, the GSW was sutured, and he was discharged from the hospital. </p><p style="text-align: justify;">A thorough physical exam revealed no joint effusion, a horizontal scar in the projection of the patellar tendon, a palpable gap in the tendon's midline approximately 10 mm proximal to the tibial tubercle, and proximal translation of the patella. The patient was able to actively elevate the extended leg, but with a 15° extension lag of the knee. Other clinical findings regarding ligament stability and meniscal pathology were within normal limits, with no signs of neurovascular injury or acute inflammation. The radiological examination revealed a bony fragment in a projection of the patellar tendon and patella alta, with the Insall- Salvati ratio and the Caton-Deschamps index calculated at 1.35 and 1.50, respectively. The MRI exam revealed mid- to distal intrasubstance destruction of the patellar tendon tissue </p><p style="text-align: justify;">Surgical technique </p><p style="text-align: justify;">A longitudinal incision was made over the earlier scar with the distal extension, exposing the tendon. Excessive scar tissue was marked and debrided along with the bone fragment. The semitendinosus tendon was identified and stripped with an open striper, leaving distal insertion intact. The muscle was removed, and the free end was whipstitched with FiberLoop. The native patellar tendon was debrided of scar tissue and stitched in the Krakow technique with no. 2 FiberWire. The patellar tendon insertion site was identified, debrided, and curetted, and the healthy bone cradle was exposed. </p><p style="text-align: justify;">With the fluoroscopic control, one guide pin was placed in the projection of the tibial tubercle and the other through the midline of the patella. After the correct position was determined, tunnels were over-drilled with a 6mm reamer. The graft was pulled from medial to lateral through the tunnel, then parallel to the patellar tendon to the patellar tunnel, and then back on the medial side, parallel to the tendon to its insertion. </p><p style="text-align: justify;">After reducing the patella to its height, defined with the intersection of its lower pole with the intercondylar notch roof, the graft was sutured to its insertion and surrounding soft tissue with a non-absorbable suture. </p><p style="text-align: justify; "> No. 2 FiberWire was used to reinsert it into the bone cradle, which was then secured together through the tunnel. The McLaughlin augmentation with 2mm FiberTape was put in through the patellar tunnel while the knee was bent at 70°. It was then secured on the side of the tibial tubercle with a PushLock anchor. Reconstruction of the surrounding soft tissue was performed using absorbable sutures. The wound was irrigated and sutured in a standard manner; the knee was placed in a tutor cast in full extension.</p><p style="text-align: justify; ">At the one-year follow-up, the patient walked without pain, had a full range of motion, and had enough muscle strength in the upper leg. The MRI showed the injured leg had almost the same Insall-Salvati ratio and Caton- Deschamps index as the uninjured leg.</p><p style="text-align: justify;">Further reading: </p><p style="text-align: justify;">Neglected Patellar Tendon Rupture Treated With a Single Semitendinosus Tendon in One-Stage Reconstruction Surgery: A Case Report of an Unusual Injury Mechanism Petar Vukman et al Cureus 17(3): e80699. DOI 10.7759/cureus.80699</p>

335. OSA Patients Face Double the Risk of RSV Infection and Severe Complications: Study Finds

     Fri, 18 Apr 2025 15:00:33 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/05/12/209486-obstructive-sleep-apnea-1.webp' /><p style="text-align: justify; ">Taiwan: Patients with obstructive sleep apnea (OSA) may face a significantly increased risk of contracting respiratory syncytial virus (RSV) and experiencing severe outcomes, according to a large retrospective cohort study conducted using data from the TriNetX US Collaborative Database. The findings were published online in the <em>Journal of Medical Virology</em> on 07 April 2025.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Renin Chang, Division of Medical Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, and colleagues conducted a retrospective cohort study to assess the link between <a href="https://speciality.medicaldialogues.in/topics/obstructive-sleep-apnea">obstructive sleep apnea </a>and the risk of <a href="https://medicaldialogues.in/topics/rsv-infection">respiratory syncytial virus infection</a>, along with associated complications, utilizing data from the TriNetX US Collaborative Database.</p><p style="text-align: justify; ">They examined the health records of over 1 million individuals diagnosed with OSA and compared them with a control group of nearly 3.5 million individuals without the condition. To ensure a fair comparison, the groups were matched using propensity score techniques that accounted for 19 different variables, helping to balance their baseline characteristics. </p><p style="text-align: justify; ">Key Findings:</p><ul><li style="text-align: justify; ">Individuals with obstructive sleep apnea were more than twice as likely to contract respiratory syncytial virus compared to those without OSA (0.18% vs. 0.08%).</li><li style="text-align: justify; ">The hazard ratio (HR) for RSV infection among OSA patients was 2.194, indicating a significantly increased risk.</li><li style="text-align: justify; ">Patients with OSA had a higher likelihood of developing<a href="https://medicaldialogues.in/topics/respiratory-failure"> respiratory failure</a> following RSV infection, with an HR of 1.291.</li><li style="text-align: justify; ">The risk of hospitalization due to RSV was also elevated in the OSA group, with an HR of 1.114.</li><li style="text-align: justify; ">The need for admission to intensive care units was greater among OSA patients with RSV, as reflected by an HR of 1.329.</li></ul><p style="text-align: justify; ">The findings were consistent across multiple sensitivity analyses, which considered different follow-up durations, database subgroups, and study timeframes. Subgroup evaluations based on age and sex further supported the overall results, emphasizing the consistency and robustness of the observed associations.</p><p style="text-align: justify; ">The authors suggest that these findings may have important clinical implications. Recognizing OSA as a potential risk factor for RSV infection and its complications could help guide preventive strategies, early interventions, and risk stratification efforts.</p><p style="text-align: justify; ">Given the increasing awareness of RSV’s impact on adult populations—especially those with underlying health conditions—the researchers recommend further investigation to confirm these findings and evaluate whether patients with OSA should be classified as a high-risk group for RSV. </p><p style="text-align: justify; ">"The large-scale, real-world data analysis adds a new dimension to the understanding of RSV vulnerability and highlights the broader systemic impacts of obstructive sleep apnea beyond its well-known effects on sleep quality and cardiovascular health," the authors concluded.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Ssu-Yu Chen, S., Ting-An Lin, T., Chiang, L., Chen, Y., Chen, Y., Hung, M., &amp; Chang, R. (2025). Obstructive Sleep Apnea and Risk of Respiratory Syncytial Viral Infection: A Retrospective Multi-Institution Cohort Study. Journal of Medical Virology, 97(4), e70323. https://doi.org/10.1002/jmv.70323</p></div><p style="text-align: justify; "><br></p>

336. Bariatric Surgery cost effective and Improves Survival in Obese Patients with Compensated Cirrhosis: JAMA

     Fri, 18 Apr 2025 14:45:41 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/03/281510-images-2025-04-03t070324502.webp' /><p style="text-align: justify; ">Researchers have found in a new study that Bariatric surgery in patients with obesity and compensated cirrhosis is linked to improved overall survival while maintaining a highly acceptable health care cost, making it a viable treatment option.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">Obesity and steatotic liver disease are associated with excess morbidity and mortality from cardiovascular, pulmonary, metabolic, and hepatic causes. Bariatric surgery has demonstrated long-term benefits in terms of weight loss and mortality rates, but barriers to its utilization persist. </p><p dir="ltr" style="text-align: justify; ">A study was done to evaluate the impact of bariatric surgery on outcomes and cost-effectiveness among patients with obesity, focusing on those with cirrhosis.This economic evaluation was a retrospective cohort study including US veterans older than 18 years with a body mass index (BMI) higher than 35 or with a BMI higher than 30 and more than 1 major metabolic comorbidity. </p><p dir="ltr" style="text-align: justify; ">These veterans were referred to a structured lifestyle modification program (MOVE!), and a subset proceeded to bariatric surgery, including sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) from 2008 to 2020. Risk set matching was used to match bariatric surgery cases 1:5 with nonsurgical controls. Data were analyzed from September 2008 to September 2023. The primary outcomes were the incremental cost-effectiveness ratio (ICER) of SG or RYGB vs MOVE! over 10 years. </p><p dir="ltr" style="text-align: justify; ">Secondary outcomes included overall survival, quality-adjusted survival, and weight loss achieved. Results The final cohort included 4301 SG, 1906 RYGB, and 31 055 MOVE! participants, among whom 64, 8, and 354, respectively, had cirrhosis. The median (IQR) age of the cohort was 52 (44-59) years; there were 25 581 male patients (68.7%) and 11 681 female (31.3%). Compared with MOVE!, bariatric surgery was associated with longer observed survival (9.67 years vs 9.46 years overall; 9.09 years vs 8.23 years in cirrhosis). The ICER was $132 207 for SG and $159 027 for RYGB in the overall cohort, and $18 679 for SG and $44 704 for RYGB in the cirrhosis cohorts. </p><p dir="ltr" style="text-align: justify; ">Bariatric surgery was cost-effective at a willingness-to-pay threshold of $100 000 per quality-adjusted life-year among patients with cirrhosis. Bariatric surgery was associated with improved survival and expected weight loss and was cost-effective. These findings support the expanded use of bariatric surgery in appropriately selected patients, including those with cirrhosis, to improve outcomes and reduce long-term health care costs.</p><div style="text-align: justify;"></div><p dir="ltr" style="text-align: justify; ">Reference:</p><p dir="ltr" style="text-align: justify; ">Bansal S, Bader A, Mahmud N, Kaplan DE. Survival and Cost-Effectiveness of Bariatric Surgery Among Patients With Obesity and Cirrhosis. JAMA Surg. Published online April 02, 2025. doi:10.1001/jamasurg.2025.0490</p><div style="text-align: justify;"></div><div style="text-align: justify; "></div></div>

337. Maternal exposure to phthalates during pregnancy can affect newborn's metabolism and brain development: Study

     Fri, 18 Apr 2025 14:45:06 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/11/25/262157-pregnancy-50-3.webp' /><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">A newly published study by researchers from Emory University, The University of North Carolina at Chapel Hill, and Columbia University found that a mother's exposure to <a href="https://medicaldialogues.in/topics/phthalate">phthalates </a>during <a href="https://medicaldialogues.in/topics/pregnancyhttps://medicaldialogues.in/topics/pregnancy">pregnancy</a> can affect their newborn’s metabolism and<a href="https://medicaldialogues.in/topics/brain-development"> brain development</a>.</p><p style="text-align: justify; ">Phthalates are a group of widely used plasticizers commonly found in a variety of cosmetics and personal care products, such as shampoos, soaps, and detergents, as well as plastic food and beverage containers. Previous research showed phthalates can affect hormones and suggested they may be linked to health effects in mothers and babies.</p><p style="text-align: justify; ">The study, led by researchers at Emory’s Rollins School of Public Health and published in<i> Nature Communications&nbsp;</i>on Wednesday, was the first to explore and find evidence of how a pregnant woman’s exposure to phthalates influences their baby’s metabolism at birth.</p><h3 style="text-align: justify;">Main Takeaways</h3><ul><li style="text-align: justify;">Prenatal phthalate levels in the mother’s blood during pregnancy were associated with lower levels of key neurotransmitter precursors (related to tyrosine and tryptophan metabolism) important for brain development in the newborn’s blood soon after birth.</li><li style="text-align: justify;">Higher prenatal phthalate levels were also associated with biological changes linked to lower information processing (or attention) and excitability (or arousal) scores in newborns. </li><li style="text-align: justify;">These findings suggest that a mother’s exposure to phthalates during pregnancy may influence her newborn’s metabolism soon after birth. Furthermore, exposure to phthalates while babies are still in the uterus may also have lasting effects on infant brain development. </li></ul><h3 style="text-align: justify;">What The Experts Say</h3><p style="text-align: justify;">“This was the first study to demonstrate that a mother’s exposure to phthalates can impact their baby’s metabolome and also the first to show that these biological changes can impact newborn development. This is important because there is a common belief that the placenta protects the baby from a lot of harmful substances, but this study supports that phthalates are able to cross through the placenta and actually impact the baby’s biology before they are even born and negatively affect their development over time,” said Susan Hoffman, PhD, study first author and recent graduate of the Epidemiology PhD program at the Rollins School of Public Health.</p><p style="text-align: justify; ">“We are seeing that once pregnant women are exposed to phthalates, these chemicals not only enter their body and disrupt maternal metabolism, but these exposures also impact the metabolism and neurobehavioral functioning of newborns. And we found these substances are staying with them in the body after they are born, as we did see some indication of a biological disruption occurring among the newborn babies that has a further impact on the neurodevelopment system,” says Donghai Liang, PhD, study lead author and associate professor of environmental health at the Rollins School of Public Health.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Hoffman, S.S., Tang, Z., Dunlop, A. et al. Impact of prenatal phthalate exposure on newborn metabolome and infant neurodevelopment. Nat Commun 16, 2539 (2025). https://doi.org/10.1038/s41467-025-57273-z.</p></div>

338. India's Father of Angioplasty Cardiologist Dr Mathew Samuel Kalarickal Passes Away at 77

     Fri, 18 Apr 2025 14:14:24 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283605-mathew-samuel-kalarickal.avif' /><p style="text-align: justify; "><b>New Delhi:</b> Cardiologist Dr Mathew Samuel Kalarickal, widely revered as the 'Father of Angioplasty' in India, passed away on April 18, 2025, at Apollo Hospital in Chennai. He was 77 years old. His passing marks the end of a transformative era in Indian cardiology, where he played a pivotal role in introducing and advancing interventional cardiac procedures in the country.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify;"><b>Early Life and Education</b></p><p style="text-align: justify;">Born on January 6, 1948, in Kottayam, Kerala, Dr Kalarickal pursued his undergraduate studies at Union Christian College, Aluva. He earned his MBBS from Government Medical College, Kottayam, in 1974, followed by an MD from Stanley Medical College, Chennai, in 1978, and a DM in Cardiology from Madras Medical College in 1981. He began his medical career as a tutor in pediatric surgery.​</p><p style="text-align: justify;"><b>Global Training and Return to India</b></p><p style="text-align: justify;">Inspired by the pioneering work of Dr Andreas Grüntzig, the Swiss physician known as the father of coronary angioplasty, Dr Kalarickal reached out to him through correspondence. Invited to Zurich on a scholarship, he trained under Dr Grüntzig and later accompanied him to the United States, where he conducted advanced research at Emory University in Atlanta. After gaining international experience, Dr Kalarickal returned to India in 1986 and performed the country's first coronary angioplasty.​</p><p style="text-align: justify;"><b>Professional Achievements</b></p><p style="text-align: justify;">Dr Kalarickal was instrumental in advancing coronary angioplasty, carotid and coronary stenting in India. He also founded the National Angioplasty Registry of India to standardize and monitor angioplasty procedures nationwide. His contributions extended to the development of medical devices, holding patents for innovations such as the electronic algometer and the jugular venous pressure scale. He was among the early adopters of bioresorbable stents, which naturally dissolve in the body after restoring blood flow.​</p><p style="text-align: justify;"><b>Honors and Recognition</b></p><p style="text-align: justify;">In recognition of his groundbreaking work, Dr Kalarickal was awarded the Padma Shri, India's fourth-highest civilian honor, in 2000. He also received the Dr. B.C. Roy Award and the Doctor of Science Award for his contributions to medicine.​</p><p style="text-align: justify;"><b>Legacy and Personal Life</b></p><p style="text-align: justify;">Dr Kalarickal served as the Director of Interventional Cardiology and Cardiac Catheterization Laboratories at Apollo Hospitals, Chennai. He was also associated with other leading hospitals, including Lilavati Hospital, Breach Candy Hospital, and Saifee Hospital in Mumbai. Over his career, he handled more than 15,000 cases, leaving an indelible mark on the field of cardiology.​</p><p style="text-align: justify;">He is survived by his wife, Beena Mathew, and children, Sam Mathew and An Mary Mathew.​</p><p style="text-align: justify;"><i><b>Also Read: <a href="https://medicaldialogues.in/news/health/doctors/rip-dr-cherian-pioneer-of-cardiac-surgery-in-india-no-more-142245">RIP Dr Cherian: Pioneer of Cardiac Surgery in India No More</a></b></i></p><p style="text-align: justify;"><b>Final Rites</b></p><p style="text-align: justify; "><a href="https://www.onmanorama.com/news/kerala/2025/04/18/mathew-thomas-kalarickal-india-father-angioplasty-passes-away.html?utm" rel="nofollow">Onmanorama </a>reports that Dr Kalarickal's funeral will be held on April 21, 2025, at 2:00 PM at his residence in Mangalam, Kottayam, followed by the burial at St. Peter's Mar Thoma Church cemetery at 3:00 PM.</p></div></div>

339. Unpaid stipend, illicit means to show amount transactions: Telangana medicos allege stipend discrepancies

     Fri, 18 Apr 2025 13:40:01 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/02/11/273738-stipend.webp' /><p style="text-align: justify; "><b>Hyderabad:</b>&nbsp;House surgeons and resident doctors at the <a href="https://medicaldialogues.in/topics/private-medical-colleges">private medical colleges</a> in Telangana have alleged that most of the institutes do not pay any <a href="https://medicaldialogues.in/topics/stipend">stipends</a> to them.&nbsp;</p><p style="text-align: justify; ">Further, several colleges take stipend amounts from the students and show transfer of amounts to students using illicit means, Deccan Chronicle has reported.</p><p style="text-align: justify; ">Some of the students at the private medical colleges have stated that either they do not receive stipends at all or get nominal amounts, such as Rs 10,000 for the resident doctors and Rs 2,000 for the MBBS interns.</p><p style="text-align: justify; ">As per <a href="https://medicaldialogues.in/topics/pgmer-2023">PGMER 2023</a> Regulations, the post-graduate students undergoing post-graduate Degree/Diploma/Super-speciality courses in all the institutions shall be paid a stipend at par with the stipend being paid to the post-graduate students of State Government medical institutions/Central Government medical institutions, in the State/Union Territory where the institution is located.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Regarding the issue of stipend for the MBBS interns, the NMC <a href="https://medicaldialogues.in/topics/crmi-regulations-2021">CRMI Regulations</a>, 2021 states that the interns shall be paid a stipend as fixed by the appropriate authority applicable to the institution/ University or State.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/what-action-taken-against-medical-colleges-over-non-payment-of-stipend-heres-what-nmc-says-143451" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: What Action Taken Against Medical Colleges over Non-Payment of Stipend? Here's What NMC says</i></b></a></p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">While these regulations specify that the medical colleges must pay stipends to MBBS interns and resident doctors, NMC in the Maintenance of Standards of Medical Education Regulations, 2023, has specified what penalties may be imposed on the institute for violation of its rules. As per these regulations, NMC can take action against a medical institute for violation of any of the regulations and such penalties could include withholding and withdrawal of accreditation for five academic years and a penalty of Rs 1 crore.</p><p style="text-align: justify; ">The Telangana Government had also released a Government Order in 2023, as per which, the resident doctors get stipend ranging from Rs 54,000 to Rs 64,000 per month and an MBBS intern gets about Rs 25,000 per month.</p></div><p style="text-align: justify; ">However, as per the Deccan Chronicle report, the MBBS interns and resident doctors at private medical colleges in Telangana have alleged that they do not get any stipend or get a meagre amount from the institutes.</p><p style="text-align: justify; ">As per the latest report by <a href="https://www.deccanchronicle.com/southern-states/telangana/stipends-elude-interns-residents-at-pvt-medical-colleges-1873321" rel="nofollow">Deccan Chronicle</a>, the resident doctors at Kamineni Hospital get Rs 35,000 as stipend, students at Malla Reddy get Rs 15,000, and students at Apollo and Bhaskar get Rs 10,000 each. Meanwhile, many other colleges, such as Mamata Medical College, Chalmeda Anand Rao Institute of Medical Sciences and Prathima Medical College, show transfer of amounts to students through bank transactions but take the amounts back.</p><p style="text-align: justify; ">In this regard, last year a complaint was raised by Dr Ashok, pursuing MD Radiology in Bhaskar Medical College and submitted to all relevant authorities, including the Telangana and National Medical Commission, Directorate of Medical Education, Income-Tax, Enforcement Directorate and the Health Minister of Telangana. However, no steps were taken.&nbsp;</p><p style="text-align: justify; ">Commenting on this, Dr Ashok told Deccan Chronicle, "Bhaskar Medical College has failed to pay a stipend to us, which is in violation of the aforesaid regulation. They take blank cheques from students and credit the amounts to show documentation of the amount credited, but later they debit the same amount, leaving only Rs 10,000 per month with students."</p><p style="text-align: justify; ">Speaking to the Daily, the Chairman of Malla Reddy Health City, Dr. Ch. Bhadra Reddy said, "We pay around Rs 4,500 to interns and Rs 20,000 to residents. This is because we are getting only 50% of the fee as directed by AFRC. The fee for a regular MBBS course is Rs 7 lakh per year and Rs 23 lakh per year for management quota students."</p><p style="text-align: justify; ">According to the institute's website, the MBBS course fee per year if Rs 19 lakh for general seats, and the fees goes up to Rs 60 lakh per year for PG specialties. The website further mentions that the stipend for PG residents is up to Rs 49,000 per month.</p><p style="text-align: justify; ">Meanwhile, commenting on the issue, a second-year resident from MNR Medical College, Sangareddy, shard that the college had forced the students to open a bank account in a bank of their choice and asked them to share a signed blank cheque of the same.&nbsp;</p><p style="text-align: justify; ">She told the Daily, "Using this, they credit around Rs 55-60,000 in that account every month and then withdraw the same also. In case the cheque bounces or some other issue occurs, they ask the students to pay back in cash. When objected, the college authorities said, “This is how management works."</p><p style="text-align: justify; ">"With so much hard work, by the end of the day, all we want is our degree and certificate, which the college can hold back if we don't comply by their rules. This is why most students have not raised objections at a larger level," she added.</p><p style="text-align: justify; ">Last year in November, the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission</a> (NMC) slapped show-cause notices on altogether 198 medical colleges for not complying with the Commission's directives to upload the details of the stipend paid to the interns and resident doctors.&nbsp;</p><p style="text-align: justify; ">Medical Dialogues had reported that, back then, releasing a list of those 198 medical colleges on 28.11.2024, NMC specified that the failure of those colleges to submit the information regarding stipends was "considered seriously".</p><div class="pasted-from-word-wrapper"><div class="inside-post-ad-2 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_2"></div></div><p style="text-align: justify; ">When NMC conducted a preliminary survey across India, it reflected that around 26% of the private medical colleges do not pay any stipend to interns and resident doctors. Around 54% were not paying stipends on par with government medical colleges and around 15% of the colleges take the amounts back from students.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/stipend-parity-for-private-medical-students-originally-entitled-to-govt-medical-college-admissions-bombay-hc-seeks-states-response-145929" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Stipend parity for private medical students originally entitled to Govt medical college admissions- Bombay HC seeks state's response</i></b></a></p>

340. NEET PG 2025 Registrations Open! Here's How To Apply...

     Fri, 18 Apr 2025 13:32:03 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283565-neet-pg-2025.webp' /><p>New Delhi- The National Board of Examinations in Medical Sciences (<a href="http://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) has opened the registration window for the National Eligibility and Entrance Test-Postgraduate (<a href="https://medicaldialogues.in/topics/neet-pg" target="_blank">NEET PG</a>) exam for the PG medical admissions this academic year 2025.</p><p> The information bulletin has been released on the official website of NBEMS. All the interested candidates are advised to take note of the schedule and registration instructions as mentioned below.</p><div class="pasted-from-word-wrapper"><p dir="ltr"><u><b>SCHEDULE</b></u></p><div dir="ltr"><table><colgroup><col width="54"><col width="362"><col width="208"></colgroup><tbody><tr><td><p dir="ltr">S.NO</p></td><td><p dir="ltr">PROCESSES</p></td><td><p dir="ltr">TIMELINES</p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Online Submission of Application Form.</p></td><td><p dir="ltr">17th April 2025 (03:00 PM Onwards) to 07th May 2025 (Till 11:55 PM).</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City).</p></td><td><p dir="ltr">09th May 2025 to 13th May 2025</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Pre-Final Selective Edit Window to rectify Deficient/Incorrect Images</p><p dir="ltr">-Photograph</p><p dir="ltr">-Signatures</p><p dir="ltr">-Thumb Impression.</p></td><td><p dir="ltr">17th May 2025 to 21st May 2025</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Final Selective Edit Window to rectify Deficient / Incorrect Images Photograph Signatures Thumb Impression (No further opportunity shall be given).</p></td><td><p dir="ltr">24th May 2025 to 26th May 2025</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Informing the Test City to the candidates.</p></td><td><p dir="ltr">02nd June 2025</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Issue of Admit Cards.</p></td><td><p dir="ltr">11th June 2025</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Examination Date.</p></td><td><p dir="ltr">15th June 2025</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Declaration of Result</p></td><td><p dir="ltr">By 15th July 2025</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Cut-off date for completion of internship towards eligibility for NEET-PG 2025.</p></td><td><p dir="ltr">31st July 2025</p></td></tr></tbody></table></div></div><p><b><u>Information for Candidates</u></b></p><p>NEET-PG 2025 is the eligibility-cum-ranking examination for admission to various MD/MS/PG Diploma courses of 2025-26 admission session. Admissions to Post MBBS DNB Courses, Post MBBS Direct 6 year DrNB courses and NBEMS diploma courses are also undertaken through NEETPG.</p><p>NEET-PG 2025 will be conducted by NBEMS. The role of NBEMS is limited to the conduct of NEET-PG, declaration of the result and handing over the result to the designated counseling authority. NBEMS has no role in counseling and allotment of PG seats. Verification of documents and eligibility determination of the candidates shall be undertaken at the time of counseling/admission process by the concerned authority.</p><p>Candidate may kindly note that appearance in NEET-PG does not confer any automatic rights to secure a Post graduate MD/MS/Post Graduate Diploma seat. The selection and admission to Postgraduate seats in any medical institutions recognized for running MD/ MS/Post Graduate Diploma courses as per the National Medical Commission (NMC) Act, 2019 and the Post Graduate Medical Education Regulations, 2023 is subject to fulfilling the admission criteria, eligibility, medical fitness and such criteria as may be prescribed by the respective universities, medical institutions, the NMC, State/Central Government.</p><p>Candidates are advised to read the Information Bulletin carefully and go through the instructions regarding submission of online application form given in the information bulletin as well as on NEET-PG 2025 index page on NBEMS website before starting online submission process for NEET-PG 2025 .</p><p>Candidates are deemed to have read, agreed and accepted the Information Bulletin and the terms and conditions in the Information Bulletin for NEET-PG 2025 on completing the online submission of application form.</p><p>Candidate should ensure that all the information entered during the online submission of application form is correct and factual. Information provided by the candidates in the online application form shall be treated as correct. The responsibility of correctness of information in the application form shall be of the concerned candidate. The option of editing certain information entered in the application form shall be available to the candidates during the edit window. NBEMS will not entertain, under any circumstances, any request for change in the information provided by the candidates after closure of the edit window. Please refer Chapter on Instructions to fill Application Form for details regarding Edit Window.&nbsp;</p><p>NBEMS itself does not edit /modify/alter any information entered by the candidates at the time of online submission of application form under any circumstances. There is no provision of accessing the application form to make any changes in the information provided in the application form after closure of edit window. Such requests to make any changes shall not be entertained. Candidates, however, shall be able to rectify the deficiencies in their application (if so communicated by NBEMS) regarding images uploaded, by the prescribed cut-off dates.</p><p>Please refer Chapter on Instructions to Fill NEET-PG Application Form. Candidates are advised to review their applications submitted and rectify the deficiencies, if found any, within the window as detailed below. Candidates may note that deficiency in the application form pertaining to images uploaded may be communicated to them by NBEMS, however, it shall be the sole responsibility of the applicant to ensure that the application submitted is complete in all aspects as per the information bulletin. If any deficiency in the application which was not communicated by NBEMS to the applicant before conduct of the examination, is noted at any later stage, this would not create any equity in favour of the candidate and confer any rights on to the candidates for grant of eligibility for the examination.</p><p><b>Edit Window:</b> Candidates who have successfully submitted their payment for the application during Application Submission window shall only be allowed to edit their applications during 09th May 2025 to 13th May 2025. No new application can be registered or payment can be made during edit window. However, the balance fee required, if any, in case of change in candidate category and/or PwD status can be paid during the edit window. Any information/document can be changed/corrected during the edit window except for Name, Test City, Nationality, Mobile Number and Email ID. Information can be edited any number of times before the closure of the edit window. The last submitted information will be saved in records.</p><p><b>Final Edit Window: </b>Deficiency related to images uploaded (photograph, Signature, Thumb Impression) shall be intimated to the concerned candidates and same can be corrected during the Pre-Final Selective edit window i.e. 17th May 2025 to 21st May 2025. A list of such applicants who would fail to rectify their images in the application form shall be published on NBEMS website and a FINAL Selective Edit window will be opened from 24th May 2025 to 26th May 2025 for them to enable them to rectify the images as per image upload guidelines. Applications of such candidates who would fail to rectify their images even during this FINAL edit window shall be rejected. No further opportunity shall be given to make corrections.</p><p>Candidates are advised to submit the images in their application as per prescribed image upload guidelines. Failure to submit images as per guidelines and/or failure to rectify the images shall invite rejection of the application.</p><p>Application for NEET-PG 2025 can only be submitted online through NBEMS website.</p><p>There is no other methodology for application submission. Application submitted through any other mode shall be summarily rejected.</p><p>A candidate can submit NEET-PG 2025 application form only once. If a candidate is found to have submitted more than one application form for NEET-PG 2025, NBEMS may issue admit card to the application bearing higher order Application number (application ID) and cancel other application(s) forfeiting the fee for them. In an event any unfair practice is detected by NBEMS at any stage of examination/admission process, NBEMS may cancel the candidature of such candidates and debar them from appearing in any examinations conducted by NBEMS as per provisions of the Unfair Means Guidelines.</p><p>Candidates who fail to submit duly completed applications with requisite documents and/or fail to rectify the deficiencies in their applications by the last date prescribed for rectification shall be declared ineligible. Admit Card shall not be issued to candidates who are declared ineligible before conduct of examination. In such cases, the entire fees will be forfeited.</p><p>Applications of candidates producing false or fabricated information/records will not be considered and such candidates will be further debarred from appearing in the future examinations of NBEMS. Action as deemed appropriate by NBEMS will be taken if false or fabricated records/ information is submitted or any unfair means are used.</p><p>Candidates are advised to ensure that the information provided is factual and supported with documents. Columns marked (*) in the application form are mandatory and can not be left blank. In the event of rejection of the application form, no correspondence/request for re-consideration will be entertained.</p><p>Candidates should ensure before applying for the examination that their MBBS degree is recognized as per provisions of the NMC Act, 2019 and the Post Graduate Medical Education Regulations, 2023. If it is found at any time that MBBS degree is not recognized, the candidature / result of the candidate shall be cancelled/ deemed to be cancelled.</p><p>Candidates should go through this bulletin carefully for eligibility criteria before applying. Queries pertaining to eligibility and other issues will only be entertained if the information requested is not given in the bulletin of information or NBEMS website. No Queries of the Guardians/Parents will be entertained on telephone with regard to the eligibility and disclosure of the results.</p><p>Submission of incomplete online application form not in accordance with prescribed instructions shall invite rejection of the application. In such cases, the examination fee shall not be refunded.&nbsp;</p><p>Candidate found ineligible at any stage of NEET-PG 2025 Examination, will not be permitted to appear in the examination. In an unlikely event of any ineligible candidate appearing and/or passing the NEET-PG 2025 examination, the results/candidature of such candidate shall be cancelled and/or is deemed to be cancelled, even if result has been declared or score card has been issued.</p><p>NBEMS reserves the right to withdraw permission, if any, granted inadvertently to any candidate who is not eligible to appear in the NEET-PG 2025 Examinations even though the admit card/roll number has been issued or name/roll number is displayed on NBEMS website.</p><p>Fee shall neither be carried forward to a future exam nor refunded under any circumstances. Application once submitted can not be withdrawn.</p><p>Candidates’ eligibility is purely provisional &amp; is subjected to the fulfilment of eligibility criteria as prescribed in this Information Bulletin.</p><p>Instructions in the Information Bulletin are liable to change based on decisions taken by the NBEMS / MoHFW / NMC / DGHS from time to time.</p><p>There is no equity or any rights that are / or deemed to be arising in favour of candidate. Candidates are required to refer to the latest bulletin or corrigendum that may be issued to incorporate these changes. Refer NBEMS website in for latest updates or corrigendum.</p><p>The existing schedule, pattern, policy and guidelines are for ready reference only but in no way, they are or are ought to be treated as representative or acknowledgment of fact that NBEMS is bound to follow the same in future.</p><p>NBEMS reserves its absolute right to alter, amend, modify or apply any or some of the instructions/ guidelines contained in this information bulletin.</p><p>In case of any ambiguity in interpretation of any of the instructions / terms / rules / criteria regarding the determination of eligibility/conduct of examinations / registration of candidates/information contained herein, the interpretation of the NBEMS shall be final and binding in nature. In case of any discrepancy in the information contained in English and Hindi version of the bulletin, the information mentioned in English language shall be considered final.</p><p>Request shall not be entertained for change in date/center of examination under any circumstances. Candidates are advised not to canvass for such representation.</p><p>Admit Cards for NEET-PG 2025 can be downloaded at NBEMS website from 11th June 2025 onwards. Candidates found ineligible before conduct of the examination shall not be issued admit cards.</p><p>Result of NEET-PG 2025 shall be published on NBEMS websites </p><p>NEET-PG 2025 shall be conducted by NBEMS at various exam centres engaged for the purpose. Candidates are advised to familiarise themselves with the route and location of the exam centre well in advance to avoid any last minute delay in arrival to the exam centre. Please refer Chapter on details of Test Day Procedures.</p><p>The examination test centre staff on duty is authorized to verify the identity of candidates and may take steps to verify and record the identity of candidates. Candidates are required to extend requisite cooperation.</p><p>Possession/Use of mobile phones/Electronic devices is strictly prohibited in the premises of NBEMS test Centres. Candidates shall be liable for penal action for Possession/ Use of Mobile phones/ Electronic devices. Resorting to use of any unfair practice in NEET-PG 2025 shall be dealt with as per the Unfair Mean Guidelines of NBEMS. Such candidates shall be imposed academic and/or criminal punishments as may be applicable. Please go through guidelines detailed in Chapter on use of unfair means in the examination.</p><p>Demo Test: A demo test shall be available for the benefit of candidates to familiarise themselves with the Computer Based Test format at website Candidates will be able to access the Demo test tentatively from 05th June 2025 onwards.</p><p>The candidates should communicate with NBEMS regarding matters related to NEET-PG 2025 as per prescribed Protocols only, detailed under Chapter on Communication Protocols.</p><p>Candidates are encouraged to communicate for NEET-PG 2025 through “Helpdesk” tab which can be accessed after the applicant login to its application account. The correspondence through post should be addressed to the Executive Director, National Board of Examinations in Medical Sciences, Medical Enclave, Mahatma Gandhi Marg, Ansari Nagar, New Delhi110029. Candidates are requested to superscribe the envelope with the subject matter of the correspondence for expeditious processing.</p><p>The Registration for NEET-PG 2025 at the time of Counseling to be conducted by designated counseling authority will be as per the details of candidates submitted in NBEMS NEET-PG 2025. Hence, candidates are advised to maintain their same Registration details e.g. mobile number, Email ID etc. as provided in the NBEMS NEET-PG 2025 application form.</p><p>The jurisdiction for court cases/disputes shall be at New Delhi only.</p><p><b><u>Instructions to Fill Online NEET-PG 2025 Application Form</u></b></p><p><b>New User Registration: </b>All candidates desirous of applying for NEET-PG 2025 shall be required to create an online profile of themselves to generate a UserID and Password.</p><p><b>Applicant Login: </b>This User ID and Password so created will allow the candidate to login as an applicant for NEET-PG 2025 session and register an online application. The “Go to Application” link will allow the applicant to continue with the application submission immediately after user creation.</p><p>If the Login password is lost, it can be retrieved by clicking “Forgot Your Password”.</p><p><b>Name of Candidate: </b>Please mention your full name as in Primary Medical Qualification Certificate. Name as entered by the candidate while creating his/her User ID shall be reflected in a non-editable format in his/her examination application form. No change in the name shall be permissible under any circumstances after submission of an application. The candidate shall be required to produce his/her Govt issued ID proof bearing same name at the test centre on the test day to seek entry. It is strongly advised not to submit an application with an error in the candidate’s name as it shall not be allowed to be edited after application submission. If the user has entered his/her name wrongly while registering the user, please create another user with correct name.</p><p><b>Gender and Date of Birth:</b> Indicate your gender and Day, Month &amp; Year of your birth. Please enter the correct date of birth carefully while registering the user.</p><p><b>Nationality: </b>Please choose your nationality amongst the options given: Indian, Non-Resident Indian (NRI), Overseas Citizen of India (OCI) and Non OCI Foreign Nationals. Indian Citizens who are not NRI should choose Indian. An Indian Citizen should choose Non-Resident Indian, if he/she is an NRI. If you are a Foreign National but also an Overseas Citizen of India (OCI), please choose OCI. Foreign Nationals who are not an OCI should choose Non OCI Foreign National.</p><p><b>Email ID: </b>Email ID chosen by the candidate shall be verified through a system generated OTP for user creation. Same email ID can not be used for registration of any other user concurrently. Please note that all email correspondence with the candidate shall be done at this email ID only. Email chosen by the candidate shall be the primary means to communicate with the candidate for examination purposes. Information related to examinations shall be sent at this email ID. Candidates shall also be able to communicate with NBEMS through this registered email only. Correspondence received from any other email ID of the candidate shall not be entertained. Therefore, candidates are advised to choose the email ID carefully. Candidates are required to use same Email ID for counseling Registration Form of designated counseling authority as used in NBEMS NEET-PG 2025 Application Form.</p><p><b>Mobile No. :</b> Please provide a unique mobile number for receiving Examinations related communications sent through SMS. Mobile number chosen by the candidate shall NOT be the primary means to communicate with the candidate for examination purposes. Same Mobile No. as used for NBEMS NEET-PG 2025 Registration will be used at the time of Registration for Counseling.</p><p>The User ID / Application ID and password so generated shall be sent to the registered email ID of the candidate for future records.</p><p>The index page of NEET-PG 2025 at NBEMS website provides a quick link, “Already Registered? To login”. The online application form for NEET-PG 2025 can be accessed through this quick link after successful creation of User ID.</p><p>The candidate can login using his/her User ID and Password. </p><p>The application submission process can be completed either in a single sitting or in multiple sittings, as per the candidate's choice, during the application submission window. However, once an application is successfully completed &amp; submitted, it shall be available for editing certain field only during the “edit window”.</p><p>Candidates are advised not to complete &amp; submit their online application in a haste so as to avoid any errors in providing information. Request for making any changes in date of birth, name, category, nationality or any other information provided in the application shall be summarily rejected. NBEMS does not edit/modify/change any information provided by the candidates in their applications of its own. Candidates has the option to make corrections in any information except name, nationality, test city, mobile number and email ID during the edit window.</p><p>The candidate shall be required to provide information as asked under various heads. It is strongly recommended to keep the required information handy before start filing the application. Please read the User Manual available at the index page of NEET-PG 2025 for step wise details asked in the application form.</p><p>Upload of Prescribed Images (Photograph, Scanned Signatures and Thumb Impression): Please refer Image Upload Instructions available at NBEMS website and at the end of this information bulletin for details of specifications for uploading photograph, signatures and thumb impression. Images which are not as per prescribed specification shall not be considered and may lead to rejection of the application. Please ensure that uploaded photograph is a RECENT photograph and in any case should have not been taken more than 3 months before the date of application submission. Uploading a photograph which is not a recent one or which is not as per prescribed image upload guidelines as detailed in this information bulletin and/or failure to rectify the same in the final edit window shall invite rejection of the application.</p><p>The test city can be selected from available choices on first come first serve basis. While the city will be chosen by the candidate himself / herself at the time of online submission of application form, allotment of test centre / venue in the chosen city shall be done by NBEMS.</p><p>After selection of test city, the candidate shall be required to pay the prescribed examination fee online. The fee can not be paid through any mode other than the payment gateway available in online application form.</p><p>Candidates shall be prompted to preview the entire application before submission in order to make any corrections, if so required. They shall be required to submit the application after agreeing to the “declaration”. This shall complete the entire process of application submission.</p><p>Acknowledgement of Application Submission: An acknowledgement email shall be sent to the registered email ID confirming submission of an application by the candidate. Submission of application shall be completed only after successful payment of examination fee. Candidate should confirm the status of payment in the application form PDF where ’S’ would stand for “Successful” and “F” would stand for “Failed”.</p><p><b>Edit Window:</b> Candidates who have successfully submitted their payment for the application during Application Submission window shall only be allowed to edit their applications during 09th May 2025 to 13th May 2025. No new application can be registered or payment can be made during edit window. However, the balance fee required, if any, in case of change in candidate category and/or PwD status can be paid during the edit window. Any information/document can be changed/corrected during the edit window except for Name, Test City, Nationality, Mobile Number and Email ID. Information can be edited any number of times before the closure of the window. The last submitted information will be saved in records.</p><p>All editable fields in the application form shall be open for the candidate to make any corrections, if so required. Details of field which can not be edited are mentioned below. Information entered in the application form can be changed during the “Edit Window”. However, following fields in the application form shall remain non-editable:</p><p>• Name of the Candidate </p><p>• Email ID </p><p>• Mobile number </p><p>• Nationality </p><p>• Test City&nbsp;</p><p>No editing in information provided shall be permissible in the application form, once edit window is over.</p><p>NBEMS disclaims any liability that may arise due to incorrect information provided by the candidate during online application form submission.</p><p>Subsequent to closure of edit window, deficiency, if any related to images uploaded, in the application form shall be communicated to concerned candidates:</p><p>Final Edit Window: Deficiency related to images uploaded (photograph, Signature, Thumb Impression) shall be intimated to the concerned candidates and same can be corrected during the Prefinal edit window i.e. 17th May 2025 to 21st May 2025. A list of such applicants who would fail to rectify their images in the application form shall be published on NBEMS website and a FINAL Edit window will be opened from 24th May 2025 to 26th May 2025 for them to enable them to rectify the images as per image upload guidelines. Applications of such candidates who would fail to rectify their images even during this FINAL edit window shall be rejected. No further opportunity shall be given to make corrections. Candidates are advised to submit the images in their application as per prescribed image upload guidelines. Failure to submit images as per guidelines and/or failure to rectify the images shall invite rejection of the application.</p><p>If a candidate updates his/her category or PWD status during the edit window which requires him/her to make any payment of the difference in Examination Fee to NBEMS, that difference of examination fee needs to be deposited online during the edit window itself.</p><p>NBEMS does not edit /modify/alter any information entered by the candidates at the time of online submission of application form under any circumstances.</p><p>Any requests for change in category, Date of Birth, PWD status etc by NBEMS shall not be entertained. Candidates are advised to carefully enter the information in the application form. The Category/PwD status filled by the candidates while applying for NEET-PG 2025 will not be changed by Medical Counseling Committee (MCC) of DGHS, Govt of India at the time of counseling. The details of the candidates will be pre-populated in Counseling Registration Form as provided by them while filling up the NBEMS Application form for NEET-PG 2025. Any representation in this regard will not be entertained by MCC.</p><p>Candidates who fail to submit duly completed applications with requisite documents and/or fail to rectify the deficiencies in their applications by the last date prescribed for rectification shall be declared ineligible. Admit Card shall not be issued to candidates who are declared ineligible. In such cases, the entire fees will be forfeited.&nbsp;</p><p><b><u>SUMMARY OF STEPS IN ONLINE APPLICATION FORM SUBMISSION</u></b></p><p>The following sequence shall be observed while filing the online application form:</p><p> Fill the user registration form to generate User ID / Application ID and Password.</p><p> User ID and Password will be sent through SMS and Email. </p><p> Complete the application form and upload your Photograph, Scanned signature, Thumb impression &amp; Prescribed documents.</p><p> Choose your Test City and pay Examination Fee </p><p> Agree to the declaration and Submit Application </p><p> Take a print out of the filled Application form with Transaction ID printed on it and payment status mentioned as “S” (Successful) for records.</p>

341. Send him to some Jungle, UP Minister orders doctor's transfer for not welcoming him

     Fri, 18 Apr 2025 12:45:56 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/19/283646-mdtv-2025-04-19t110412023.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify; "><a href="https://medicaldialogues.in/topics/Controversy">Controversy</a> has erupted in Uttar Pradesh after the State Minister Sanjeev Gond 'ordered' the <a href="https://medicaldialogues.in/topics/transfer">transfer</a> of a physically challenged doctor for failing to welcome him when he arrived at a hospital for an inauguration.</p><div id="ATS_mid1"></div><p style="text-align: justify;">Angry over the incident, the Minister ordered that the doctor be transferred out of his constituency and "to some jungle". A video of the minister's angry phone call ordering the transfer of the said doctor has now gone viral. In the video, the doctor could be seen pleading that he was attending to a patient. Further, the minister claimed that the doctor did not know how to behave.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/health/doctors/didnt-greet-me-properly-up-minister-orders-transfer-of-doctor-attending-patient-146789"><b>'Didn't Greet Me Properly': UP Minister Orders Transfer of Doctor Attending Patient</b></a></i></div><div></div></div><div class="pasted-from-word-wrapper"></div></div>

342. 4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry

     Fri, 18 Apr 2025 12:43:23 -0000

     <img src='https://medicaldialogues.in/h-upload/2022/10/20/188554-banned-new.webp' /><p style="text-align: justify; "><b>Delhi:</b> The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of fixed dose combinations (FDCs) in the anti-diabetic segment. These FDCs, including popular oral therapies combining metformin, glimepiride, voglibose, and dapagliflozin, were previously licensed by various State Licensing Authorities (SLAs) without due approval or evaluation by the Drugs Controller General of India (DCGI).</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify;">The banned combinations were flagged in a recent circular (File No. 4-01/2023-DC (Misc. 3)) issued by the CDSCO, which noted that these drugs were being marketed in violation of the New Drugs and Clinical Trials (NDCT) Rules, 2019. The CDSCO stated:</p><p style="text-align: justify;"><i>“It has come to the notice of this Directorate that certain Fixed Dose Combination (FDC) drugs have been licensed for manufacture, sale, and distribution without prior evaluation of safety and efficacy... This poses a serious risk to public health and safety.”</i></p><p style="text-align: justify;"><b>Among the Antidiabetic agents, strengths of FDCs listed as either cancelled or voluntarily surrendered following show-cause notices are:</b></p><p style="text-align: justify;">1. Metformin Hydrochloride IP 500mg (as extended release form) + Glimepiride IP 3mg + Dapagliflozin Propanediol Monohydrate IP eq. to Dapagliflozin 10mg film coated bilayered tablets</p><p style="text-align: justify;">2. Glimepiride IP 1mg &amp; Metformin HCL IP 500mg Tablet</p><p style="text-align: justify;">3. Glimepiride IP 2mg, Metformin Hydrochloride IP (As Sustained Release form) 500mg and Voglibose IP 0.3mg Tablet</p><p style="text-align: justify;">4. Metformin Hydrochloride IP (As Prolonged-Release) 500mg &amp; Voglibose IP 0.2mg Tablet</p><p style="text-align: justify;">The CDSCO has warned that such unapproved dosage strength of FDCs, when not subjected to adequate scientific scrutiny, may lead to adverse drug reactions, dangerous interactions, and compromised patient safety.</p><p style="text-align: justify;">Upon investigation, manufacturers claimed that the licenses were granted by SLAs, suggesting they had not knowingly violated regulatory rules. However, the CDSCO emphasized the lack of uniform enforcement of the NDCT Rules across states as a contributing factor to such lapses.</p><p style="text-align: justify;">The DCGI has directed all State and UT Drug Controllers to, <i>“Ensure that the FDCs in annexure &amp; any other unapproved FDCs shall not be allowed for manufacture, sale, &amp; distribution in the country.”</i></p><p style="text-align: justify; ">Regulators have also been instructed to conduct investigations and take action as per the provisions of the Drugs and Cosmetics Act, 1940.</p></div></div></div>

343. MP hospital's license suspended over fake cardiologist case

     Fri, 18 Apr 2025 12:23:38 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283514-mdtv-2025-04-18t124257701.webp' /><div class="pasted-from-word-wrapper"><div class="article-text-desc entry-content clearfix single-post-content"><div id="post-content-inner" class="row post-content-inner"><div class="details-content-story"><div><div class="story"><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The license of <a href="https://medicaldialogues.in/topics/missionary-hospital" target="_blank">Mission Hospital</a> in Damoh, where seven patients died due to botched angiography and angioplasty procedures allegedly performed by the fake UK-based cardiologist, <a href="https://medicaldialogues.in/topics/narendra-vikramaditya-yadav" target="_blank">Narendra Vikramaditya Yadav</a> aka 'Dr John Camm', has been suspended. The hospital has been directed to halt the admission of new patients.</p><div id="ATS_mid1"></div><p style="text-align: justify;">The Madhya Pradesh health department took action after finding that the hospital’s license had expired on March 31, 2025, and it could not renew the license because it failed to fix the shortcomings that were pointed out earlier by the authorities.</p><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_1"><div class="header-non-loggedin-ad"><div class="advert-panel"></div></div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808"></a></i></div><div></div></div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-cardiologist-case-mp-hospitals-license-suspended-146806"><b>Fake Cardiologist Case: MP Hospital's license suspended</b></a></i></div></div></div></div></div></div></div><div class="entry-terms post-tags clearfix"></div></div>

344. NEET PG 2025 on June 15 in double shifts, new time-bound sections announced

     Fri, 18 Apr 2025 12:15:20 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283511-mdtv-2025-04-18t123300072.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper" style="text-align: justify; ">The long-awaited NEET PG 2025 information bulletin is here. The National Board of Examinations in Medical Sciences (NBEMS), NBE, has finally released the information bulletin for NEET PG 2025 aspirants on its official website. The bulletin contains all the details, including the application process and exam fee, eligibility criteria, scheme of examination, admit card, test day do's and don'ts, counselling, reservation and exam centres for NEET PG 2025.</div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">Medical Dialogues has been extensively reporting on the outrage that followed after the NBE's announcement to hold the PG medical entrance test, NEET PG 2025, for this academic year's admissions in double shifts. Since the announcement, the doctors across the country have been demanding a single shift conduction of the exam.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/news/health/doctors/didnt-greet-me-properly-up-minister-orders-transfer-of-doctor-attending-patient-146789"></a></i></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/news/education/5-years-service-rs-2577-lakh-penalty-haryana-bond-policy-for-mbbs-admissions-146781"></a></i></div><div></div></div><div class="pasted-from-word-wrapper"><div></div></div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808"><b>Outrage over NEET PG 2025 double shifts: Take a look at what it's all about</b></a></i></div></div></div>

345. Indian-origin Dr Mumtaz Patel elected President of Royal College of Physicians

     Fri, 18 Apr 2025 12:14:42 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283593-dr-mumtaz-patel-prcp-2025.webp' /><p style="text-align: justify; "><span style="background-color: rgb(248, 248, 248);">New&nbsp;</span>Delhi: An Indian-origin Dr Mumtaz Patel has been elected as the 123rd president of the UK's&nbsp;<a href="https://medicaldialogues.in/topics/royal-college-of-physicians" target="_blank" style="background-color: rgb(249, 249, 249);">Royal College of Physicians</a>, pledging to modernise the institution and reaffirm its role as the leading voice for its members.</p><div class="pasted-from-word-wrapper"> <p style="text-align: justify; ">Dr Patel is a consultant nephrologist based in Manchester. She is currently RCP senior censor and vice president for education and training, and has been acting as president since June 2024. Before being elected as senior censor, she was global vice president and has held various educational roles, including training programme director and RCP regional adviser.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/maharashtra/maharashtra-medical-council-elections-set-for-april-3-145966"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/04/02/281379-doctor.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/maharashtra-medical-council-elections-set-for-april-3-145966"><b><u><span class="read-this-also">Also Read:</span>Maharashtra Medical Council Elections set for April 3</u></b></a><div></div></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">She is an NHS England <a href="https://medicaldialogues.in/topics/pg-medical-courses" target="_blank">postgraduate</a> associate dean in the north-west and has established a strong track record in education, training, assessment, and research. She has designed and delivered several educational and leadership courses in the UK and internationally and is actively involved in assessment as an experienced PACES examiner.</p> <p style="text-align: justify; ">The RCP president is chair of the RCP Council and a member of the Board of Trustees. The president is elected for a recommended 4-year term, commencing as soon as possible after 14 April 2025. RCP Council will decide whether to support the incumbent president in each annual election. However, annual challenge remains a possibility. The Royal College of Physicians (RCP) is a professional membership body with 40,000 members in the UK and around the world working to improve patient care and reduce illness. The activities focus on educating, improving, and influencing for better health and care.</p> <p style="text-align: justify; ">Voting was open between 17 March and 14 April 2025. The election was supported independently by Civica Election Services and conducted using the single transferable vote electoral system. 5151 votes were cast for president, with a turnout of 36.3% across RCP elections 2025. This is the highest turnout in RCP elections since the presidential election in 2002. Dr Patel received 2239 votes with a margin of 682 votes over the next-placed candidate.</p><p style="text-align: justify; "> Dr Mumtaz Patel said,<b> </b>“As president, I will lead the RCP to be the best organisation it can be, supporting our members throughout every career stage to deliver the best possible healthcare for our patients. I will bring passion, commitment, vision, a values-driven approach, and more than 20 years of RCP experience to the role.”</p> <p style="text-align: justify; ">Dr Diana Walford CBE, chair of the RCP Board of Trustees, said, “On behalf of the Board of Trustees, I warmly congratulate Dr Mumtaz Patel on becoming the next president of the RCP. Dr Patel takes on this vital role following a challenging period for the college, and I am confident in her ability to lead with integrity, rebuild trust among our members, and restore the lustre to this illustrious college. I look forward to working with Dr Patel in this important next chapter in the RCP’s long history.”</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/maharashtra/dr-rajesh-sawarbandhe-take-over-as-ima-nagpur-president-146100"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/04/04/281689-whatsapp-image-2025-04-04-at-41324-pm.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/dr-rajesh-sawarbandhe-take-over-as-ima-nagpur-president-146100"><b><u><span class="read-this-also">Also Read:</span>Dr Rajesh Sawarbandhe take over as IMA Nagpur President</u></b></a><div></div></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Dr Anthony Martinelli and Dr Catherine Rowan, co-chairs of the RCP Resident Doctor Committee, said, “The Resident Doctor Committee is pleased to congratulate Dr Patel on her election. We look forward to working with her to improve conditions, support, and career prospects for early career doctors.” “Together, we can ensure that the next generation of physicians is empowered, valued, and equipped to thrive in a changing healthcare landscape. Last week, the Resident Doctor Committee launched the 2025 RCP Next Generation Survey. The national survey, inviting resident doctors to share their experiences of working and training in the NHS, will run from 9 April to 5 May 2025 and is open to all resident doctors working in a UK clinical setting,” they added.</p></div>

346. Haryana’s MBBS bond policy: Serve 5 years, pay Rs 25.77 lakh penalty

     Fri, 18 Apr 2025 12:03:43 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283509-mdtv-2025-04-18t122445707.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Students getting admitted to the <a href="https://medicaldialogues.in/topics/mbbs-course">MBBS courses</a> at the government medical colleges in Haryana will have to undergo compulsory <a href="https://medicaldialogues.in/topics/government-service">government service</a> for 5 years after completing their Undergraduate medical education. If the students choose to opt out of the bond service liability, they will have to pay Rs 23,19,381 (for female students) to Rs 25,77,090 (for male students) as a penalty.</p><div id="ATS_mid1"></div><p style="text-align: justify;">Meanwhile, for the students getting admitted to Government Aided Medical College (MAMC, Agroha), the bond amount is Rs 21,90,000 for male students and Rs 19,71,000 for female students.</p></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/education/5-years-service-rs-2577-lakh-penalty-haryana-bond-policy-for-mbbs-admissions-146781"><b>5 years service, Rs 25.77 lakh penalty: Haryana Bond Policy for MBBS admissions</b></a></i></div><div></div></div><div class="pasted-from-word-wrapper"></div></div>

347. Health Bulletin 18/ April/ 2025

     Fri, 18 Apr 2025 11:54:18 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283508-health-bulletin-2025-04-18t122023406.webp' /><p style="text-align: justify; "><b>Here are the top health news for the day:</b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Haryana’s MBBS bond policy: Serve 5 years, pay Rs 25.77 lakh penalty</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Students getting admitted to the <a href="https://medicaldialogues.in/topics/mbbs-course">MBBS courses</a> at the government medical colleges in Haryana will have to undergo compulsory <a href="https://medicaldialogues.in/topics/government-service">government service</a> for 5 years after completing their Undergraduate medical education. If the students choose to opt out of the bond service liability, they will have to pay Rs 23,19,381 (for female students) to Rs 25,77,090 (for male students) as a penalty.</p><div id="ATS_mid1"></div><p style="text-align: justify;">Meanwhile, for the students getting admitted to Government Aided Medical College (MAMC, Agroha), the bond amount is Rs 21,90,000 for male students and Rs 19,71,000 for female students.</p></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/education/5-years-service-rs-2577-lakh-penalty-haryana-bond-policy-for-mbbs-admissions-146781">5 years service, Rs 25.77 lakh penalty: Haryana Bond Policy for MBBS admissions</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Send him to some Jungle, UP Minister orders doctor's transfer for not welcoming him</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;"><a href="https://medicaldialogues.in/topics/Controversy">Controversy</a> has erupted in Uttar Pradesh after the State Minister Sanjeev Gond 'ordered' the <a href="https://medicaldialogues.in/topics/transfer">transfer</a> of a physically challenged doctor for failing to welcome him when he arrived at a hospital for an inauguration.</p><div id="ATS_mid1"></div><p style="text-align: justify;">Angry over the incident, the Minister ordered that the doctor be transferred out of his constituency and "to some jungle". A video of the minister's angry phone call ordering the transfer of the said doctor has now gone viral. In the video, the doctor could be seen pleading that he was attending to a patient. Further, the minister claimed that the doctor did not know how to behave.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/health/doctors/didnt-greet-me-properly-up-minister-orders-transfer-of-doctor-attending-patient-146789">'Didn't Greet Me Properly': UP Minister Orders Transfer of Doctor Attending Patient</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>NEET PG 2025 on June 15 in double shifts, new time-bound sections announced</b></div></div><div class="pasted-from-word-wrapper" style="text-align: justify;">The long-awaited NEET PG 2025 information bulletin is here. The National Board of Examinations in Medical Sciences (NBEMS), NBE, has finally released the information bulletin for NEET PG 2025 aspirants on its official website. The bulletin contains all the details, including the application process and exam fee, eligibility criteria, scheme of examination, admit card, test day do's and don'ts, counselling, reservation and exam centres for NEET PG 2025.</div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">Medical Dialogues has been extensively reporting on the outrage that followed after the NBE's announcement to hold the PG medical entrance test, NEET PG 2025, for this academic year's admissions in double shifts. Since the announcement, the doctors across the country have been demanding a single shift conduction of the exam.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div><b></b></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/news/health/doctors/didnt-greet-me-properly-up-minister-orders-transfer-of-doctor-attending-patient-146789"></a></i></b></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/news/education/5-years-service-rs-2577-lakh-penalty-haryana-bond-policy-for-mbbs-admissions-146781"></a></i></b></div><div></div></div><div class="pasted-from-word-wrapper"><div></div></div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808">Outrage over NEET PG 2025 double shifts: Take a look at what it's all about</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>MP hospital's license suspended over fake cardiologist case</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">The license of <a href="https://medicaldialogues.in/topics/missionary-hospital" target="_blank">Mission Hospital</a> in Damoh, where seven patients died due to botched angiography and angioplasty procedures allegedly performed by the fake UK-based cardiologist, <a href="https://medicaldialogues.in/topics/narendra-vikramaditya-yadav" target="_blank">Narendra Vikramaditya Yadav</a> aka 'Dr John Camm', has been suspended. The hospital has been directed to halt the admission of new patients.</p><div id="ATS_mid1"></div><p style="text-align: justify;">The Madhya Pradesh health department took action after finding that the hospital’s license had expired on March 31, 2025, and it could not renew the license because it failed to fix the shortcomings that were pointed out earlier by the authorities.</p><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_1"><div class="header-non-loggedin-ad"><div class="advert-panel"></div></div></div></div><div class="pasted-from-word-wrapper"><div><b></b></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808"></a></i></b></div><div></div></div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-cardiologist-case-mp-hospitals-license-suspended-146806">Fake Cardiologist Case: MP Hospital's license suspended</a></i></b></div></div>

348. RIMS Director removed after Governing Body order

     Fri, 18 Apr 2025 11:36:15 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283580-doctor-removed.webp' /><p style="text-align: justify; "><b>Ranchi: </b>Within a few months of being appointed as the Director of <a href="https://medicaldialogues.in/topics/rims-ranchi" target="_blank">Rajendra Institute of Medical Sciences</a> (RIMS), Ranchi, Dr Raj Kumar has been recently removed from his position on the grounds of negligence in fulfilling his duties, delay in departmental work, and failure to follow government instructions.</p><p style="text-align: justify; ">The decision was taken by the governing council of the institute, which recommended his removal to the state health department. Acting on it accordingly, the department announced the removal order on Thursday night. &nbsp;&nbsp;</p><p style="text-align: justify; ">Dr Raj Kumar, who earlier worked as a neurosurgery professor at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, was appointed as the RIMS Director on January 31, 2024, for a three-year term. &nbsp;</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/rims-ranchi-ms-orthopaedics-medico-falls-to-death-from-3rd-floor-of-hostel-building-136878" target="_blank">RIMS Ranchi MS Orthopaedics medico falls to death from 3rd floor of hostel building</a></b></p><p style="text-align: justify; ">However, the institute observed that he often deliberately ignored official orders and did not cooperate in carrying out important tasks, which led to pending departmental work. This was continuing for days since he was appointed. Due to his unsatisfactory performance, the institute decided to remove him as per the&nbsp;<a href="https://www.newindianexpress.com/nation/2025/Apr/18/rims-director-removed-from-post-with-immediate-effect-for-negligence-in-ranchi" rel="nofollow">TNIE</a> report.</p><p style="text-align: justify; ">During a recent review meeting of the RIMS department, the health minister expressed serious disappointment with the functioning of the institute. He criticised the way Dr Kumar was handling the departmental work and warned that anyone who makes a mistake will face consequences, regardless of their position.</p><p style="text-align: justify; ">An official press communique issued in this regard mentioned,<i> "When the entire department was reviewed during the governing body meeting, the minister himself was shocked. The pace of work was slow, instructions were being flouted, and the responsible officers were turning a blind eye."</i></p><p style="text-align: justify; ">“Serious questions were raised, especially on the working style of RIMS director Dr. Rajkumar - he not only ignored the instructions issued by the Council of Ministers, Governing Council and the department but also shirked responsibility,” said the health minister.</p><p style="text-align: justify; ">Further, he added, “I have not come to become a minister, but to deliver work. Whoever does well will be rewarded, but those who keep the department in the dark will not be spared at any cost, and direct action will be taken against them. Leniency will not be tolerated if the system has to be improved."</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/rims-ranchi-junior-resident-doctor-molested-by-patient-inside-elevator-accused-arrested-134648" target="_blank">RIMS Ranchi junior resident doctor molested by patient inside elevator, accused arrested</a></b></p>

349. Boehringer Ingelheim appoints Shashank Deshpande as Chairman of Board of Managing Directors

     Fri, 18 Apr 2025 11:01:22 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283581-shashank-deshpande-50.webp' /><p style="text-align: justify; "><b>Ingelheim</b>: <a href="https://medicaldialogues.in/topics/Boehringer-Ingelheim">Boehringer Ingelheim</a> has announced that Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors, a responsibility that he will take on in addition to his current role leading the Human Pharma Business Unit. He will take over the Chairman’s mandate from Hubertus von Baumbach per July 1, 2025.</p><p style="text-align: justify; ">In a parallel move, Christian Boehringer, since 2007 Chairman of the Shareholders’ Committee, has decided to step down from his role with effect from June 30, 2025. </p><p style="text-align: justify; ">To fill this role, the Shareholders’ Committee has appointed Hubertus von Baumbach, currently Chairman of the Board of Directors, as his successor, effective July 1, 2025.</p><div class="pasted-from-word-wrapper"><div><p style="text-align: justify; ">Christian Boehringer commented, “I look back at the past 18 years with great fulfillment, having worked with three CEOs and seen Boehringer grow to become the global pharma company it is today. I now hand over the baton to my cousin Hubertus, and very much look forward to working together with him on the Shareholders’ Committee.”</p></div><div><p style="text-align: justify; ">Hubertus von Baumbach served 16 years on the Board of Managing Directors, nine of which as Chairman. He added: “I want to thank Christian for his many years of leadership and dedication to the company. During his tenure the company changed fundamentally. I am very thankful for the trust I have been given with my new role. I wish Shashank much success; with his many years of industry experience in the US, Japan and Germany, he will lead Boehringer through the next growth phase towards 2035. In the many years that I have worked with Shashank I have seen and come to appreciate the strength of his leadership, of his values, and of his commitment to patients.” </p></div><div><p style="text-align: justify; ">Shashank Deshpande responded, “I am thankful that the shareholders entrust me with the Chairman’s role on the Board. I want to acknowledge Hubertus’ leadership of the company these past nine years. You’ve built a great team and it’s a true pleasure to be part of it. We are fully focused on bringing our strong pipeline to the market as fast as possible, and I am highly motivated to lead our organization to achieve this for the benefit of the patients and animals we serve."</p><div><p style="text-align: justify; ">Hubertus von Baumbach joined Boehringer Ingelheim in 2001. He held various leadership positions in Finance &amp; Controlling, until he was appointed to the Board of Managing Directors in 2009, initially with responsibility for Finance and Animal Health, and from 2016 as Chairman of the Board. </p></div><div></div><div><p style="text-align: justify; ">Shashank Deshpande joined Boehringer Ingelheim in 2012, following a decade in pharma in the US. He took on various human pharma leadership positions in Germany and Japan, ultimately as Country Managing Director Japan. In 2023, Deshpande joined the Board of Managing Directors, with responsibility for Animal Health. In 2024, he was given responsibility for Human Pharma. Shashank Deshpande holds a Master’s degree in Business Administration from the University of Hamburg, Germany.</p></div></div></div>

350. SIT formed to probe alleged sexual assault on patient at Gurugram Hospital

     Fri, 18 Apr 2025 11:00:40 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/04/276953-probe.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Gurugram: Police on&nbsp;</span>Thursday set up a special investigation team (SIT) to probe the alleged<span style="text-align: justify;">&nbsp;</span><a href="https://medicaldialogues.in/topics/sexual-assault" target="_blank" style="background-color: rgb(249, 249, 249); text-align: justify;">sexual assault</a><span style="text-align: justify;">&nbsp;case of a flight attendant who was on a ventilator in </span><a href="https://medicaldialogues.in/topics/medanta-hospital" target="_blank" style="background-color: rgb(249, 249, 249); text-align: justify;">Medanta Hospital</a><span style="text-align: justify;">, officials said.</span></p><p style="text-align: justify; ">According to a police spokesperson, Police Commissioner Vikas Kumar Arora constituted the seven-member SIT led by Dr Arpit Jain, DCP (headquarters), who is also an MBBS doctor.&nbsp;</p><p style="text-align: justify;">The other members in the SIT included two ACPs, two SHOs, an in-charge of the Sector 40 crime unit and the investigating officer of the case, he added.</p><p style="text-align: justify;">After four days of investigation, police have not identified the accused yet. The investigation so far has not proven the allegations of the flight attendant, police said, news agency PTI reported.</p><p style="text-align: justify;">Medical Dialogues recently reported that a 46-year-old trainee air hostess has lodged a police complaint alleging sexual assault by a ward staffer while she was on the ventilator in the ICU during treatment at Medanta Hospital in Gurugram. While hospital authorities did not refute the claims, they stated that they are cooperating with the police and that the allegations have not yet been substantiated. &nbsp;</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/rape-allegations-rock-medanta-patient-alleges-sexual-assault-by-hospital-staff-while-on-ventilator-146770"><b>Also Read:Rape allegations rock Medanta: Patient Alleges Sexual Assault by Hospital Staff While on Ventilator</b></a></p><p style="text-align: justify;">A senior investigating officer on condition of anonymity, said that the CCTV footage of the hospital shows that the woman on the ventilator was not alone for a single moment. Police are questioning the staff members of the hospital, he added.</p><p style="text-align: justify;">"The SIT has started an investigation with all angles. The picture will clear soon," said the spokesperson of Gurugram police, reports PTI.</p><p style="text-align: justify;">The 46-year-old woman, in her complaint, has alleged that the man carried out digital rape on her on April 6 in the hospital ICU room where two other nurses were also present, and after getting discharged on April 13, she narrated her ordeal to her husband.</p><p style="text-align: justify;">On Wednesday, the hospital said that it is fully cooperating with the probe and her allegations have not been substantiated yet.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/doctor-accused-of-sexually-assaulting-teen-at-his-clinic-arrested-145053"><b>Also Read:Doctor accused of sexually assaulting teen at his clinic, arrested</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

351. Punjab to deploy security guards at all Govt Hospitals, says PCMSA

     Fri, 18 Apr 2025 10:15:28 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283562-security-guards.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Hoshiarpur: T</span><span style="background-color: rgb(255, 255, 255);">he</span><a href="https://medicaldialogues.in/topics/punjab-civil-medical-services-association" target="_blank"> Punjab Civil Medical Services Association</a><span style="background-color: rgb(255, 255, 255);"> (PCMSA) on thursday said that&nbsp;</span>the government has agreed in principle to deploy security guards at all state-run hospitals.</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">In a statement, the Punjab Civil Medical Services Association (PCMSA) said the guards from the Punjab Ex-Servicemen Corporation (PESCO) will be stationed at hospitals round the clock, news agency PTI reported.</p><p style="text-align: justify; ">The assurance was conveyed to the PCMSA representatives during a meeting held with the principal secretary, health and family welfare, Kumar Rahul, director health services Hitinder Kaur, and director of the Punjab Health Systems Corporation, Anil Goyal, it said.</p><p style="text-align: justify;">PCMSA president Akhil Sareen said the decision follows detailed deliberations between Health Minister <a href="https://medicaldialogues.in/topics/balbir-singh" target="_blank">Balbir Singh</a>, Finance Minister Harpal Singh Cheema, and the principal secretary.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/punjab/violence-at-hospitals-punjab-doctors-decry-lack-of-security-measures-146713"><b>Also Read:Violence at Hospitals: Punjab Doctors decry lack of security measures</b></a></p><p style="text-align: justify;">According to the proposal, the deployment of PESCO security guards will be ensured at all district hospitals, sub-divisional hospitals, and community health centres where medico-legal case (MLC) services are provided.</p><p style="text-align: justify;">Morning-hour security will also be arranged at the remaining CHCs and Employees' State Insurance (ESI) hospitals, he said.</p><p style="text-align: justify;">The proposal is expected to be sent to the Finance Department for formal approval in the coming days and is likely to be cleared within the next two to three weeks, Sareen said, reports PTI.</p><p style="text-align: justify;">The PCMSA lauded the state government for its "responsiveness towards this sensitive issue" and expressed hope that adequate security arrangements would be in place in the near future.</p><p style="text-align: justify;">Medical Dialogues had earlier reported that the Punjab Civil Medical Services Association (PCMSA) has raised concerns as the state is witnessing a renewed wave of violence against healthcare professionals at government hospitals, triggering serious concern over the state’s inability to implement promised security measures for healthcare workers. Despite repeated assurances, no concrete action has followed, leaving doctors and medical staff dangerously vulnerable, especially during night shifts. In the past week alone, three horrific incidents of violence have been reported across various public healthcare facilities, putting the lives of on-duty doctors and staff at grave risk.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/clash-erupts-at-dera-bassi-hospital-5-injured-146604"><b>Also Read:Clash erupts at Dera Bassi Hospital, 5 injured</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

352. Cipla arm Medispray Goa facility classified as VAI by USFDA

     Fri, 18 Apr 2025 09:35:02 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/05/17/238420-cipla-50-3.webp' /><p style="text-align: justify; "><b>Mumbai:</b>&nbsp;<a href="https://medicaldialogues.in/topics/Cipla">Cipla </a>has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the manufacturing facility of Medispray Laboratories Private Limited, a wholly-owned subsidiary of the Company (‘Medispray’) located in Kundaim, Goa as Voluntary Action Indicated (VAI).</p><p style="text-align: justify; ">Voluntary action indicated (VAI), means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.</p><p style="text-align: justify; "><i><b>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/present-relevant-data-about-dose-in-patient-cdsco-panel-tells-cipla-on-fdc-of-torsemide-plus-spironolactone-5mg25-mg-145767">Present relevant data about dose in patient: CDSCO Panel Tells Cipla on FDC of Torsemide Plus Spironolactone 5mg/25 mg</a></b></i></p><p style="text-align: justify; ">The facility was inspected between 14th – 20th January, 2025. Following the inspection, the company had initially received one observation in Form 483,.</p><p style="text-align: justify; "><b><i>Read also:&nbsp;<a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/cipla-goa-facility-gets-one-usfda-observation-141890" style="background-color: rgb(204, 204, 204);">Cipla Goa facility gets one USFDA observation</a></i></b></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p><span style="text-align: justify;">Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in its home markets of India, South Africa, North America, and key regulated and emerging markets. It has strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective, and CNS segments. It has 47 manufacturing sites around the world which produces 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to its 80+ markets.</span></p><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/cipla-gets-cdsco-panel-nod-for-phase-iii-ct-of-inhaled-itraconazole-dry-powder-for-inhalation-10-mg-capsules-146699">Cipla gets CDSCO Panel nod for Phase-III CT of Inhaled Itraconazole dry powder for inhalation 10 mg capsules</a></i></b>&nbsp;&nbsp;&nbsp;&nbsp;</p><p style="text-align: justify; "><br></p>

353. Medical Bulletin 18/ April/ 2025

     Fri, 18 Apr 2025 09:30:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283504-top-medical-2025-04-18t120005954.webp' /><p style="text-align: justify; "><b>Here are the top medical news for the day:</b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Study Reveals How Kids’ Mattresses Release Hidden Toxins</b></div><div style="text-align: justify;">A new study published in Environmental Science &amp; Technology has found that children's mattresses emit toxic chemicals linked to developmental and hormonal disorders. Researchers, led by Prof. Miriam Diamond from the University of Toronto, measured indoor air quality in 25 bedrooms of children aged 6 months to 4 years. They detected high levels of phthalates, flame retardants, and UV filters—especially near the beds.</div><div style="text-align: justify;">To trace the source, the team also tested 16 new children’s mattresses using lab simulations. The results showed that a child’s body heat and weight significantly increased the release of these chemicals into the air. Despite bans on certain chemicals in toys, many of the same substances were found in mattresses, which remain poorly regulated.</div><div style="text-align: justify;">The phthalates and organophosphate ester flame retardants measured in this study are hormone disruptors and linked to neurological harms, including learning disorders, reduced IQ scores, behavioural problems, and impaired memory, said the researchers.</div><div style="text-align: justify;">Some are also linked to childhood asthma and cancer. Several UV filters are hormone disruptors. Children are uniquely vulnerable to exposure, given that they are still developing, have hand-to-mouth behaviours, and have breathing rates ten times higher than adults.</div><div style="text-align: justify;">They also have more permeable skin and three times the skin surface area relative to their body weight than adults. Flame retardants are linked to neurological, reproductive, and hormonal harm as well as cancer, and also have no proven fire-safety benefit as used in mattresses.</div><div style="text-align: justify;">The researchers call for manufacturers to be more vigilant about the chemicals in children’s mattresses through testing.</div><div style="text-align: justify;">The authors recommend decluttering children’s sleeping areas by reducing the number of pillows, blankets, and toys. They also recommend washing and refreshing your child’s bedding and bed clothing frequently since this act as a protective barrier to reduce exposure.</div><div style="text-align: justify;">References: Young Children’s Exposure to Chemicals of Concern in Their Sleeping Environment: An In-Home Study, Sara Vaezafshar, Sylvia Wolk, Victoria H. Arrandale, Roxana Sühring, Erica Phipps, Liisa M. Jantunen, and Miriam L. Diamond, Environmental Science &amp; Technology Letters Article ASAP, DOI: 10.1021/acs.estlett.5c00051</div><div></div><div></div><div></div><div></div><div style="text-align: justify;"><b>New Study Links E-Cigarette Use to Increased Risk of COPD and Hypertension</b></div><div style="text-align: justify;">A large-scale study led by Johns Hopkins Medicine has revealed that exclusive use of e-cigarettes is significantly associated with an increased risk of chronic obstructive pulmonary disease (COPD), and may also be linked to a slight rise in high blood pressure among adults aged 30 to 70. The analysis, published in Nicotine &amp; Tobacco Research used medical data from nearly 250,000 individuals over a four-year period, providing one of the most comprehensive examinations to date of vaping’s long-term health impacts.</div><div style="text-align: justify;">The study analyzed health outcomes across several tobacco use groups: exclusive e-cigarette users, exclusive combustible cigarette users, dual users, and non-users. Of the 249,190 participants, 3,164 were exclusive e-cigarette users, while over 33,000 used only combustible cigarettes. During the follow-up period, researchers documented over 23,000 new cases of hypertension, more than 13,000 new cases of type 2 diabetes, and nearly 8,000 new cases of COPD. Exclusive e-cigarette use was found to be significantly associated with the development of COPD, and in a specific sub-group aged 30–70, with a slight increase in hypertension risk. However, it was not significantly linked to heart failure, atherosclerotic cardiovascular disease, or type 2 diabetes.</div><div style="text-align: justify;">In contrast, exclusive use of traditional cigarettes was strongly associated with higher risk across all measured outcomes, including heart failure and cardiovascular disease. Dual users—those who smoked both e-cigarettes and combustible cigarettes—had slightly higher risk levels than exclusive smokers, further emphasizing the dangers of continued traditional cigarette use.</div><div style="text-align: justify;">Dr. Michael Blaha, senior author of the study and professor of cardiology and epidemiology at the Johns Hopkins University School of Medicine, highlighted the importance of the findings in shaping public understanding and policy. “There remains great uncertainty about the relative harm of e-cigarettes as compared to traditional smoking. Until now, there has been scant longitudinal data in large high-quality datasets linking exclusive e-cigarettes use to new-onset cardiometabolic health conditions,” he said. “This study suggests that e-cigarettes have definite potential health risks, although the risks may be less than what is seen for traditional combustible cigarette smoking alone.”</div><div style="text-align: justify;">The researchers noted that while e-cigarettes are often marketed as a safer alternative to smoking, their aerosols can contain dangerous organic compounds and high levels of nicotine, posing risks especially for younger users.</div><div style="text-align: justify;">Reference: John Erhabor, Zhiqi Yao, Erfan Tasdighi, Emelia J Benjamin, Aruni Bhatnagar, Michael J Blaha, E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research Program, Nicotine &amp; Tobacco Research, 2025;, ntaf067, https://doi.org/10.1093/ntr/ntaf067</div><div></div><div style="text-align: justify;"><b>Systematic Reviews Shows Tech Use May Cut Dementia Risk</b></div><div style="text-align: justify;">A new study published in Nature Human Behavior finds that regular technology use is actually linked to a 58% lower risk of cognitive impairment in older adults. </div><div style="text-align: justify;">To investigate the connection between digital device usage and cognitive health, researchers conducted a meta-analysis of 136 previously published studies, analyzing data from over 400,000 adults aged 50 and older. This large-scale, systematic review allowed the team to assess trends across diverse populations and identify consistent patterns in cognitive outcomes.</div><div style="text-align: justify;">Their findings directly challenge the emerging concept of "digital dementia"—a term used to describe technology-induced memory loss and concentration difficulties. Instead, the research shows that regular engagement with digital devices is associated with better cognitive aging outcomes, primarily due to the mental stimulation and adaptability required to use modern technology.</div><div style="text-align: justify;">Dr. Michael K. Scullin, associate professor of psychology and neuroscience at Baylor and co-author of the study explained that older adults, who often learned to use digital tools later in life, face cognitive challenges like adapting to new software, troubleshooting devices, or filtering digital content. These tasks, though sometimes frustrating, help stimulate the brain. He refers to this as “digital scaffolding”—using technology like reminders, GPS, and online tools to maintain independence and support brain function.</div><div style="text-align: justify;">Beyond cognitive stimulation, the study highlights how digital technology enhances social connectivity, which is a key factor in reducing dementia risk. Tools like video calls, messaging apps, and email help older adults stay in touch with loved ones, reducing isolation and supporting mental health.</div><div style="text-align: justify;">The findings suggest a shift in how we view digital engagement in older adults—not as a risk, but as a potential tool for maintaining cognitive health and independence.</div><div style="text-align: justify;">“You can flip on the news on just about any day and see people talking about how technologies are harming us,” said Scullin. “We found the opposite—technology use appears to benefit brain health.”</div><div style="text-align: justify; ">Reference: Benge, J.F., Scullin, M.K. A meta-analysis of technology use and cognitive aging. Nat Hum Behav (2025). https://doi.org/10.1038/s41562-025-02159-9</div></div>

354. AP: 232 health staff caught tampering with Facial Recognition Attendance

     Fri, 18 Apr 2025 09:13:30 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/04/22/236613-facial-recognition-technology.webp' /><p><b>Vijayawada: </b>In a major breach of digital integrity in public services, 232 government health employees in&nbsp;<a href="https://medicaldialogues.in/state-news/andhra-pradesh">Andhra Pradesh</a> have been caught tampering with <a href="https://medicaldialogues.in/topics/facial-recognition-based-attendance-system">facial recognition-based attendance</a> systems using State-issued iPhones. An internal review has revealed 460 manipulation attempts across 26 districts, raising serious concerns about accountability in public services and the reliability of digital governance systems.</p><p>The tampering involved altering the date and time settings on iPhones to falsify attendance records in the Medical and Family Welfare Department, a discovery that has alarmed senior health administrators and triggered a deeper investigation into loopholes in the digital monitoring infrastructure. </p><p>The employees involved include civil assistant surgeons, assistant professors, consultants, programme coordinators, staff nurses, MLHPs, data entry operators, and even members from the MD National Health Mission. </p><p>Officials revealed that some staff were repeat offenders—one employee attempted to manipulate the system 14 times, while others made multiple attempts ranging from 6 to 12 times.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/delhi-aiims-launches-facial-recognition-access-control-system-to-enhance-patient-safety-136697"><b>Also Read: Delhi AIIMS launches Facial Recognition Access Control System to enhance patient safety</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">According to the news reports, Srikakulam reported the highest number of violations, with 25 employees making 61 attempts. It was followed by the NTR district with 24 staff involved in 49 attempts, Parvathipuram Manyam (16 staff, 39 attempts), Annamayya (13 staff, 33 attempts), and Bapatla (12 staff, 32 attempts). Several other districts—such as Konaseema, Prakasam, Visakhapatnam, Kakinada, and Krishna—also recorded a significant number of cases.</span></div></div><p>The Facial Recognition System (FRS) was introduced after earlier incidents of staff manipulating fingerprint-based systems using latex thumb covers. However, the iPhone-related exploitation has exposed new vulnerabilities in the digital attendance mechanism. </p><p>Logs from the automated mobile syncing systems helped detect irregularities, triggering the audit that exposed the widespread misuse. In response, health department officials are now exploring measures such as locking device settings, implementing periodic audits, and activating real-time alerts to prevent further misuse. </p><p>Complicating the issue, sources say employee unions are lobbying to shield the guilty, raising concerns about possible delays in enforcing disciplinary action. This has sparked calls for transparent and swift intervention to restore credibility in public healthcare governance.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/tn-govt-doctors-oppose-implementation-of-facial-recognition-based-attendance-system-136192" style="background-color: rgb(255, 255, 255);"><b>Also Read: TN Govt Doctors Oppose Implementation of Facial Recognition-based Attendance System</b></a></p><p>Speaking to <a href="https://www.newindianexpress.com/states/andhra-pradesh/2025/Apr/16/232-health-staff-in-andhra-pradesh-caught-faking-attendance" rel="nofollow">TNIE</a>, BV Rao, Deputy Director of Health and Family Welfare and State FRS Nodal Officer, said that charge memos would be issued to all staff found to have tampered with the Facial Recognition System (FRS), following verification, as 10 individuals have raised objections. He stated that strict action would be taken against the errant staff.</p><p>According to TNIE, he added that, going forward, attendance will be monitored from the server, which has been updated following the issue coming to light on Thursday. He clarified that the problem was limited to iPhone users, with no complaints reported from Android users. He admitted that some individuals who were absent or reported late manipulated the FRS to alter the timestamp after reaching their workplace.</p>

355. No HC Relief to Doctors Who Missed Medical Council Registration Deadline

     Fri, 18 Apr 2025 09:06:57 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/03/13/234194-madras-high-court.webp' /><p style="text-align: justify; "><b>Chennai:</b>&nbsp;The <a href="https://medicaldialogues.in/topics/madras-high-court">Madras High Court</a> recently denied relief to a group of doctors, who were termed ineligible for the post of Assistant Surgeons for not having the required registration with the <a href="https://medicaldialogues.in/topics/tnmc">Tamil Nadu Medical Council</a> (TNMC).</p><p style="text-align: justify; ">Relying on judicial precedent and noting that the candidates had registered with the medical Council after the deadline, the HC bench comprising Justice C.V. Karthikeyan observed, <i>"The reasons stated therein would directly apply to these cases also wherein the Registration by the Tamil Nadu Medical Council/third respondent was after the crucial date on 15.07.2023."</i></p><p style="text-align: justify; "><i>"In the result, these Writ Petitions are dismissed. There shall be no order as to costs. Consequently, connected Miscellaneous Petitions are closed,"</i>&nbsp;ordered the Court.</p><p style="text-align: justify; ">All the petitioners were duly qualified for the post of Assistant Surgeon (General), since they had completed their Bachelor of Medicine and Bachelor of Surgery (MBBS) Degree. Thereafter, they were issued with a Provisional Certificate. Consequently, they also completed their one-year internship programme, and on completing the internship, they were issued a Provisional Certificate-II. After receiving those particular certificates, they applied to the Tamil Nadu Medical Council for registration as Registered Medical Practitioners.</p><p style="text-align: justify; ">The petitioners had applied for permanent registration between 12.07.2024-12.08.2024. By 13.08.2024, all the applications had been approved by the Council, and they had chosen the slots between 16.07.2024 to 16.09.2024 to verify the certificates for permanent registration, i.e. beyond the cut-off date 15.07.2024.</p><p style="text-align: justify; ">Filing the pleas, the petitioners sought records relating to the selection list issued after the notification dated 15.03.2024, with all specific reference to Clause 6B(III) modified by Notification dated 14.05.2024 and selection list dated 20.02.202,5 and to quash the same so far as the non-inclusion of these petitioners.</p><p style="text-align: justify; ">While considering these pleas, the High Court bench noted that the Court had occasion to examine similar batch of pleas in the case of Dr.M.Sai Ghanesh Vs. Government of Tamil Nadu, represented by its Secretary, <a href="https://medicaldialogues.in/topics/medical%20recruitment%20board">Medical Services Recruitment Board</a>, Chennai and others.</p><p style="text-align: justify; ">In that case, the Court had noted that the Notification under which they had so applied for the said post, contained a further requirement that the candidates should not only have completed their course and also their Internship, but they also should be recognised by the Medical University and the University should have issued a Provisional Certificate.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/madras-hc-denies-relief-to-doctor-seeking-extension-to-join-govt-service-for-pg-studies-146423" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Madras HC Denies Relief to Doctor seeking Extension to Join Govt Service for PG Studies</i></b></a></p><p style="text-align: justify; ">Further, to be called a Registered Medical Practitioner, the doctors also need to get registered with the Tamil Nadu Medical Council. For this, the doctors need to apply to the Council and, after verifying the applications, the Council issues them certificates approving that the petitioners are qualified to practice as Medical Professionals.</p><p style="text-align: justify; ">In that case, the petitioners had argued that when they applied to the medical council for registration, there was congestion in the said portal and they were not allotted slots within the date which they expected; therefore, they were not allotted slots within the date which they expected, and they were able to get their certificates only on a later date i.e. after 15.07.2024.&nbsp;</p><p style="text-align: justify; ">At this outset, it had been argued that irrespective of the fact that the candidates had registered themselves with the Tamil Nadu Medical Council after 15.07.2024, it could not be denied or disputed that they had actually registered themselves and therefore, they were otherwise eligible to be considered for selection to the post of Assistant Surgeon (General) as called for in the Notification. It was contended that the rejection of their applications was with the mala-fide intention.</p><p style="text-align: justify; ">However, the HC bench, relying on orders passed by the Supreme Court, noted that the Notification calling for applications for posts of Assistant Surgeons was straightforward and clear.&nbsp;</p><p style="text-align: justify; "><i>"There cannot be any other interpretation of the wordings in the Notification, which stipulated that the last date for registration with the Tamil Nadu Medical Council was 15.07.2024. There was no provision provided in the Notification that for individual candidates, on a pick and choose method, this particular process could be extended according to the whims and fancies of either the respondents or to put it also quite widely by this Court. The date has been prescribed and the date cannot be changed midway through the recruitment process. The result which would only flow from opening up the gates further would be catastrophic. There would not only be just these three petitioners but hundreds and hundreds of other candidates, who would have also similarly registered themselves with the Tamil Nadu Medical Council after 15.07.2024 and who would have written the examination and who would now seek a right to be considered for selection. This would throw the Notification into the dustbin and this Court cannot permit it to do so,"</i> the Court had noted at this outset.</p><p style="text-align: justify; "><i>"The Hon'ble Supreme Court has held that the Notification as issued is sacrosanct and any selection process should be done only in accordance with the guidelines given in the said Notification. The Notification cannot be tampered with and cannot be altered and cannot be modified and the date given therein cannot be extended either by the Court or by the respondents, unless the Rules permit,"</i> the HC bench further observed.</p><p style="text-align: justify; ">The Court further noted that while the initial date was 15.05.2024, it was uniformly extended to 15.07.2024. Further, the bench observed that the petitioners had applied for the post of Assistant Surgeon (General) only on the basis of the said Notification.&nbsp;</p><blockquote style="text-align: justify; "><i>"They had subjected themselves to be qualified as required under the terms of the Notification. They had projected that they would be eligible to be selected and they would abide by the terms and conditions in the Notification. After the process commenced and after it had nearly concluded, now they cannot claim that the date in the Notification should be changed and they must be permitted and must also be considered to be recruited for the said post. This would only lead to extreme arbitrariness,"</i> the Court noted.</blockquote><blockquote style="text-align: justify; "><i>"One of the petitioners was able to get the certificate registered on 22.07.2024, another one was able to get it registered on 16.07.2024. The moot question which this Court will have to put to itself is to the date to which the Court should extend the cut-off date. Should it be extended to 22.07.2024 to accommodate one of the writ petitioners or should it be extended to 16.07.2024 to accommodate one writ petitioner and exclude the other writ petitioners. This would only lead to extreme prejudice caused by the judicial process and that is impermissible. The respondents had determined the cut-off date on 15.07.2024 and the petitioners had taken a conscious decision to apply for the post with the intention that they would be comply with the requisite qualification on or before 15.07.2024. If they had failed to do so, then they cannot call upon this Court to extend the date to any other arbitrary date. This Court is not the Selection Board. This Court cannot take on the role of a supervisor over and above the Recruitment Board and issue directions extending the cut-off date. That would only lead to extreme arbitrariness and open up the flood gates for hundreds and hundreds of other candidates. It would also prejudice the right of those candidates, who had diligently obtained the certificate on or before 15.07.2024. As a matter of fact, it is also seen that there were also candidates, who had obtained the certificate only on 11.07.2024 and had applied online and had obtained the slots had physically gone over to the Tamil Nadu Medical Council and were able to get their certificates verified and received the certificates on or before 15.07.2024 and found themselves eligible. If the petitioners had any interest, they could have adopted the same procedure,"</i> it had further noted.</blockquote><p style="text-align: justify; ">The bench had dismissed the argument that merely because a candidate had applied online, he would sit in front of the computer at home 24 hours a day and not move a little finger to ensure that the registration was done within the stipulated time. It also opined that if the petitioners had been diligent enough like others were, they could have gone over physically to the office of the Tamil Nadu Medical Council and sought verification of their certificates then and there, and could have found themselves eligible for being selected.</p><p style="text-align: justify; ">Referring to this HC order in the case of Dr.M.Sai Ghanesh Vs. Government of Tamil Nadu, represented by its Secretary, Medical Services Recruitment Board, Chennai and others, the Court observed, "The reasons stated therein would directly apply to these cases also wherein the Registration by the Tamil Nadu Medical Council/third respondent was after the crucial date on 15.07.2023."</p><p style="text-align: justify; ">With this observation, the HC bench comprising Justice C.V. Karthikeyan dismissed the pleas and denied granting relief to the candidates.</p><p style="text-align: justify; "><b><i>To view the order, click on the link below:</i></b></p><p style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/madras-hc-tnmc-registration-283513.pdf"><b><i>https://medicaldialogues.in/pdf_upload/madras-hc-tnmc-registration-283513.pdf</i></b></a></p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/tn-assistant-surgeons-recruitment-row-hc-to-decide-on-rejection-of-400-applications-143886" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: TN Assistant Surgeons Recruitment row- HC to decide on rejection of 400+ applications</i></b></a></p>

356. BDS Admissions in Haryana: Check out complete fee structure here

     Fri, 18 Apr 2025 08:49:35 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283393-bds-fee-structure.webp' /><p style="text-align: justify; "><b>Haryana-</b> Through a notification, the Director of Medical Education &amp; Research (<a href="https://medicaldialogues.in/topics/dmer-haryana" target="_blank">DMER), Haryana</a>, has released the fee structure for the Bachelor of Dental Surgery (<a href="https://medicaldialogues.in/topics/bds" target="_blank">BDS</a>) Degree Course at Government, Government Aided, and private dental colleges in the State of Haryana.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The concerned aspirants seeking admission to the BDS course in Haryana-based dental colleges can check out the complete fee structure mentioned below:</p><p dir="ltr" style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/seeking-mbbs-admissions-in-haryana-check-out-complete-fee-structure-here-146746" style="background-color: rgb(255, 255, 255);"><b>Also Read:&nbsp;</b>Seeking MBBS admissions in Haryana? Check out complete fee structure here</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>FEE STRUCTURE OF BDS COURSE IN PGIDS, ROHTAK</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="149"><col width="424"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>PARTICULARS</b></p></td><td><p dir="ltr" style="text-align: center; "><b>FEES</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Tuition Fee.</p></td><td><p dir="ltr">37500/-</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Admission Fee.</p></td><td><p dir="ltr"> 2500/-</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Student fee.</p></td><td><p dir="ltr">2500/-</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Medical Fund.</p></td><td><p dir="ltr">1250/-</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Security Deposit </p></td><td><p dir="ltr">2500/- refundable</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Dilapidated Fund </p></td><td><p dir="ltr">600/-</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Furniture Charges </p></td><td><p dir="ltr">650/-</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Magazine Fee </p></td><td><p dir="ltr">150/-</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Athletic Fund </p></td><td><p dir="ltr">600/-</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Registration Fee </p></td><td><p dir="ltr">1500/-</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">RadhaKrishan Fund </p></td><td><p dir="ltr">100/-</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">Development Fund </p></td><td><p dir="ltr">1500/- </p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">Sports Fee </p></td><td><p dir="ltr">150/-</p></td></tr><tr><td><p dir="ltr">14</p></td><td><p dir="ltr">Youth Welfare Fee </p></td><td><p dir="ltr">500/-</p></td></tr><tr><td><p dir="ltr">15</p></td><td><p dir="ltr">NSS Fee </p></td><td><p dir="ltr">10/-</p></td></tr><tr><td><p dir="ltr">16</p></td><td><p dir="ltr">Youth Red Cross Subscription Fee </p></td><td><p dir="ltr">80/-</p></td></tr><tr><td><p dir="ltr">17</p></td><td><p dir="ltr">Total </p></td><td><p dir="ltr">52090/-</p></td></tr><tr><td><p dir="ltr">18</p></td><td><p dir="ltr">Fee for NRI candidates </p></td><td><p dir="ltr">10,000 US Dollars at the time of admission, 5000 Dollars per annum for 4 years.</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><u>FEE STRUCTURE FOR THE BDS COURSE IN PRIVATE DENTAL COLLEGES AFFILIATED TO PT. BD SHARMA UHS, ROHTAK</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="149"><col width="424"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>FEE HEAD</b></p></td><td><p dir="ltr" style="text-align: center; "><b>ANNUAL FEE</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Tuition Fee including Development Charges.</p></td><td><p dir="ltr">Rs. 2.80 lakhs with an annual increase of 5%</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Tuition Fee of NRI Students.</p></td><td><p dir="ltr">44,000 US dollars (for the entire course)</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">College Security Refundable.</p></td><td><p dir="ltr">Rs. 1.00 lacs adjustable with the last fee</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">University Charges </p></td><td><p dir="ltr">Actual</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Examination Charges </p></td><td><p dir="ltr">Actual</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Library Fee </p></td><td><p dir="ltr">Rs. 3000/-</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Equipment and Maintenance charges </p></td><td><p dir="ltr">Rs. 2500/-</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Sports and Medical Charges </p></td><td><p dir="ltr">Rs. 2000/-</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Internet Charges (if provided) </p></td><td><p dir="ltr">Rs. 1000/-</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Hostel Fee </p></td><td><p dir="ltr">Not more than Rs. 75000/- or actual (whichever is less) + Mess Charges on an actual basis. No charges for fan and lighting in the hostel.</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">Transport Fee (if availed by the student) </p></td><td><p dir="ltr">Actual</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><u>FEE STRUCTURE OF THE BDS COURSE RUNNING UNDER PDM UNIVERSITY, BAHADURGARH, JHAJJAR</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="157"><col width="104"><col width="104"><col width="104"><col width="104"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>COURSE NAME</b></p></td><td><p dir="ltr" style="text-align: center; "><b>ADMISSION FEE (ONE TIME)</b></p></td><td><p dir="ltr" style="text-align: center; "><b>TUTION FEES</b></p></td><td><p dir="ltr" style="text-align: center; "><b>OTHER ACADEMIC CHARGES</b></p></td><td><p dir="ltr" style="text-align: center; "><b>TOTAL ANNUAL FEE</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">For Indian students </p></td><td><p dir="ltr">Rs. 4200/- -</p></td><td><p dir="ltr">Rs. 1,63,000/ </p></td><td><p dir="ltr">Rs. 32000/- </p></td><td><p dir="ltr">Rs. 1,95,000/</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">For NRI Students </p></td><td><p dir="ltr">USD 200 </p></td><td><p dir="ltr">USD 6000 </p></td><td><p dir="ltr">USD 500 </p></td><td><p dir="ltr">USD 6500</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; ">Meanwhile, the course fee per annum (In Rs) for the BDS course of SGT University for the Indian candidates is 4,00,000/-, caution money (one-time refundable) is 50,000/-, alumni fee (one-time) (Non-Refundable) is 2,500/-.</p><p dir="ltr" style="text-align: justify; ">In addition, the Course Fee Per Annum (in US Dollars) for the NRI candidates is $7,850, Caution Money (Onetime) (Refundable) (in US Dollars) is $1,120 and Alumni Fee (Onetime) (Non-Refundable) (in US Dollars) is $60.</p><p dir="ltr" style="text-align: justify; "><b><u><i>To view the fee structure, click the link below</i></u></b></p><p dir="ltr" style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/dmer-haryana-releases-bds-fee-structure-for-govt-private-dental-colleges-for-2025-26-session-283394.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/dmer-haryana-releases-bds-fee-structure-for-govt-private-dental-colleges-for-2025-26-session-283394.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>

357. Morepen Medtech name changed to Morepen Medipath

     Fri, 18 Apr 2025 08:45:16 -0000

     <img src='https://medicaldialogues.in/h-upload/2021/09/30/161294-morepen-labs.webp' /><p style="text-align: justify; "><b>Gurugram:</b>&nbsp;<span style="background-color: rgb(255, 255, 255);"><a href="https://medicaldialogues.in/topics/Morepen-labs">Morepen Labs</a> has announced that the&nbsp;</span>name of its subsidiary, 'Morepen Medtech Limited' has been changed to ‘Morepen Medipath Limited'.</p><p style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);">"Pursuant to the certificate of incorporation issued by the Registrar of Companies, consequent to name change dated April 17, 2025, the name of ‘Morepen Medtech Limited’, a subsidiary company, has been changed to ‘Morepen Medipath Limited’, effective from even date," the Company stated in a BSE filing.</span></p><div class="pasted-from-word-wrapper" style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/morepen-labs-receives-anti-allergy-api-loratadine-approval-for-export-to-china-145856">Morepen Labs receives anti-allergy API Loratadine approval for export to China</a></i></b></div><div class="pasted-from-word-wrapper"><div style="text-align: justify; "><p>Medical Dialoguess team had earlier reported that the company had announced the addition of more than 1,000 professionals to its salesforce over the next three years, with over 200 team members expected to join in FY26 alone.</p><p><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/morepen-labs-plans-to-employ-over-1000-professionals-146502">Morepen Labs plans to employ over 1000 professionals</a></i></b></p><p>Morepen Laboratories, established in 1984, has a strong presence in APIs, medical devices, and finished formulations. In the medical devices segment, Morepen has installed over 12.33 million glucometers and sold nearly 1.65 billion blood glucose strips, driving expansion into tier-2 and tier-3 cities.</p></div></div>

358. Zirakpur Council President Among 18 Booked for Dera Bassi Hospital Violence

     Fri, 18 Apr 2025 08:42:23 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/12/16/228047-womans-eyes-go-missing-after-post-mortem-two-doctors-arrested.webp' /><p><b>Mohali: </b>The president of the Zirakpur Municipal Council and son of the Mohali Congress President have&nbsp;been booked for allegedly instigating a violent <a href="https://medicaldialogues.in/topics/clash">clash</a> at the <a href="https://medicaldialogues.in/topics/dera-bassi-hospital">Dera Bassi Civil Hospital</a>. The incident, rooted in an ongoing feud in Mukandpur village, escalated into a public brawl that has drawn serious police and judicial attention.&nbsp;</p><p>According to the police, video evidence has emerged showing the son of Mohali Congress president directing his supporters to physically assault members of a rival group. The clash is reportedly linked to tensions that have been building since the 2023 panchayat elections. A total of 18 individuals have been booked in connection with the violence.</p><p>Medical Dialogues had previously reported that in a shocking turn of events that unfolded at Dera Bassi Civil Hospital in Punjab's Mohali, a violent clash between two groups left at least five people injured, officials said on Saturday. Following the incident, the doctors of the hospital went on a strike and staged a dharna. A case has been registered in connection with the clash that took place, they said.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/clash-erupts-at-dera-bassi-hospital-5-injured-146604" style="background-color: rgb(255, 255, 255);"><b>Also Read: Clash erupts at Dera Bassi Hospital, 5 injured</b></a></p><p>An attempt to murder case was registered following a complaint by Ranjit Singh, also known as Minta — the husband of AAP-backed village sarpanch Suman Devi. Singh sustained serious injuries during the incident.</p><p>In response to the incident, Mohali SSP Deepak Pareek suspended Dera Bassi SHO Inspector Mandeep Singh for negligence in handling the clashes that occurred both in Mukandpur village and at the hospital, <a href="https://www.hindustantimes.com/cities/chandigarh-news/zirakpur-mc-chief-booked-in-dera-bassi-hospital-clash-case-101744922940920.html" rel="nofollow">Hindustan Times</a> reports.&nbsp;</p><p>A departmental inquiry has been ordered against the SHO, which will be led by a DSP-rank officer. He has since been transferred to police lines, with Inspector Sumit Mor appointed as the new SHO. </p><p>Following the outbreak of violence and growing legal scrutiny, the Punjab and Haryana High Court ordered Udayveer to refrain from performing official duties. The court has appointed the Deputy Commissioner of Mohali to serve as the administrator of the Zirakpur Municipal Council in the interim. The court order followed a no-confidence motion moved by Zirakpur MC councillors against the son of Mohali Congress president, after which the matter was taken to the high court.&nbsp;</p><p>Meanwhile, as the police remanded several accused individuals, six party members were produced before a local court. Three were sent to judicial custody, while accused Honey Pandit and two associates were remanded to extended police custody. Another suspect, hospitalised with a broken leg, was arrested and is expected to appear via video conferencing.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/clash-between-two-groups-at-dera-bassi-civil-hospital-16-booked-135385"><b>Also Read: Clash between two groups at Dera Bassi Civil Hospital, 16 booked</b></a></p><div class="pasted-from-word-wrapper"><div> </div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>According to <a href="https://timesofindia.indiatimes.com/city/chandigarh/fir-against-zirakpur-mc-chief-for-instigating-clash-at-derabassi-hospital/articleshow/120390738.cms" rel="nofollow">TOI</a>, the clash and the subsequent legal actions have deepened the political crisis surrounding Zirakpur's civic body, with tensions simmering between rival factions within the MC. Investigations are ongoing.</p>

359. 3493 Seats available for Bond service allotment of PG medicos: DMER Maharashtra releases vacancy list, check details

     Fri, 18 Apr 2025 08:28:59 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283512-vacancy.webp' /><p style="text-align: justify; "><b>Maharashtra-</b> The Director of Medical Education &amp; Research (<a href="https://medicaldialogues.in/topics/dmer-maharashtra" target="_blank">DMER), Maharashtra</a>, has released the revised vacancy list for online allotment of Government Social responsibility service (Bond Service) to Postgraduate (PG) degree holders.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The list has been released on the official website of DMER Maharashtra. As per the list, a total of 3493 seats are vacant across 69 Institutes.</p></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/dmer-maharashtra-releases-seat-matrix-for-mph-nutrition-160-seats-up-for-grabs-142519"><b>Also Read:&nbsp;</b>DMER Maharashtra Releases Seat Matrix for MPH Nutrition, 160 Seats Up For Grabs</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><i>Below are the details-</i></b></p><p dir="ltr" style="text-align: justify; "><b><u>SEAT VACANCIES</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="53"><col width="363"><col width="208"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>INSTITUTES</b></p></td><td><p dir="ltr" style="text-align: center; "><b>SEAT VACANCY</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">BARC Mumbai.</p></td><td><p dir="ltr">16</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">BMC-BAI JERABAI WADIA HOSPITAL FOR CHILDREN, PAREL.</p></td><td><p dir="ltr">3</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">BMC-BHARATRATNA DR. BABASAHEB AMBEDKAR HOSPITAL.</p></td><td><p dir="ltr">33</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">BMC-COMPRESSIVE THALASSEMIA CARE, PEADIATRIC CENTER, BORIVALI (E).</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">BMC-GSMC &amp; KEM HOSPITAL</p></td><td><p dir="ltr">79</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">BMC- HBT MEDICAL COLLEGE AND DR RN COOPER HOSPITAL.</p></td><td><p dir="ltr">60</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">BMC-K.B.BHABHA MUNICIPAL GENERAL HOSPITAL, BANDRA.</p></td><td><p dir="ltr">29</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">BMC-KASTURBA HOSPITAL FOR INFECTION DISES.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">BMC-KHAN BAHADUR BHABHA HOSPITAL, KURLA WEST, MUMBAI 70.</p></td><td><p dir="ltr">15</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">BMC-KRATNIJYOTI SAVITRIBAI PHULE HOSPITAL, BORIVALI EAST, MUMBAI.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">BMC-LTMC &amp; SION HOSPITAL.</p></td><td><p dir="ltr">151</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">BMC-MAA. HOSP. CHEMBUR.</p></td><td><p dir="ltr">5</p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">BMC-MANOHAR WAMANRAO DESAI MUNICIPAL GENERAL HOSPITAL.</p></td><td><p dir="ltr">7</p></td></tr><tr><td><p dir="ltr">14</p></td><td><p dir="ltr">BMC-MURLI DEORA MUNICIPAL EYE HOSPITAL.</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">15</p></td><td><p dir="ltr">BMC-PT MADAN MOHAN MALAVIYA SHATABDI HOSPITAL GOVANDI MUMBAI.</p></td><td><p dir="ltr">20</p></td></tr><tr><td><p dir="ltr">16</p></td><td><p dir="ltr">BMC-RAJAWADI HOSP. GHATKOPER (E).</p></td><td><p dir="ltr">41</p></td></tr><tr><td><p dir="ltr">17</p></td><td><p dir="ltr">BMC-S K PATIL HOSPITAL, MALAD EAST.</p></td><td><p dir="ltr">2</p></td></tr><tr><td><p dir="ltr">18</p></td><td><p dir="ltr">BMC-SANT MUKTABAI MUNCIPAL GENERAL HOSPITAL,BARVENAGAR,GHATKOPAR.</p></td><td><p dir="ltr">7</p></td></tr><tr><td><p dir="ltr">19</p></td><td><p dir="ltr">BMC-SETH A. J. B. MUNICIPAL ENT HOSPITAL.</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">20</p></td><td><p dir="ltr">BMC-SIDDHARTH MUNICIPAL GENERAL HOSPITAL.</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">21</p></td><td><p dir="ltr">BMC-SMT. MANSADEVI TULSIDAS AGARWAL HOSPITAL.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">22</p></td><td><p dir="ltr">BMC-SWATANTRYAVEER VINAYAK DAMODAR SAVARKAR HOSPITAL, MULUND EAST.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">23</p></td><td><p dir="ltr">BMC-TNMC &amp; NAIR HOSPITAL.</p></td><td><p dir="ltr">66</p></td></tr><tr><td><p dir="ltr">24</p></td><td><p dir="ltr">BMC-V N DESAI MUNICIPAL GENERAL HOSPITAL.</p></td><td><p dir="ltr">15</p></td></tr><tr><td><p dir="ltr">25</p></td><td><p dir="ltr">BMC-WADIA MATERNITY HOSPITAL, PAREL.</p></td><td><p dir="ltr">2</p></td></tr><tr><td><p dir="ltr">26</p></td><td><p dir="ltr">Cancer AURANGABAD.</p></td><td><p dir="ltr">14</p></td></tr><tr><td><p dir="ltr">27</p></td><td><p dir="ltr">GGMC MUMABI.</p></td><td><p dir="ltr">108</p></td></tr><tr><td><p dir="ltr">28</p></td><td><p dir="ltr">GMC AKOLA.</p></td><td><p dir="ltr">102</p></td></tr><tr><td><p dir="ltr">29</p></td><td><p dir="ltr">GMC ALIBAG-RAIGAD.</p></td><td><p dir="ltr">57</p></td></tr><tr><td><p dir="ltr">30</p></td><td><p dir="ltr">GMC AMBEJOGI BEED.</p></td><td><p dir="ltr">95</p></td></tr><tr><td><p dir="ltr">31</p></td><td><p dir="ltr">GMC AMBERNATH.</p></td><td><p dir="ltr">48</p></td></tr><tr><td><p dir="ltr">32</p></td><td><p dir="ltr">GMC AMRAVATI.</p></td><td><p dir="ltr">38</p></td></tr><tr><td><p dir="ltr">33</p></td><td><p dir="ltr">GMC AURANGABAD.</p></td><td><p dir="ltr">109</p></td></tr><tr><td><p dir="ltr">34</p></td><td><p dir="ltr">GMC BARAMATI.</p></td><td><p dir="ltr">75</p></td></tr><tr><td><p dir="ltr">35</p></td><td><p dir="ltr">GMC BHANDARA</p></td><td><p dir="ltr">27</p></td></tr><tr><td><p dir="ltr">36</p></td><td><p dir="ltr">GMC BULDHANA.</p></td><td><p dir="ltr">49</p></td></tr><tr><td><p dir="ltr">37</p></td><td><p dir="ltr">GMC CHANDRAPUR.</p></td><td><p dir="ltr">94</p></td></tr><tr><td><p dir="ltr">38</p></td><td><p dir="ltr">GMC DHARASHIV</p></td><td><p dir="ltr">44</p></td></tr><tr><td><p dir="ltr">39</p></td><td><p dir="ltr">GMC DHULE.</p></td><td><p dir="ltr">90</p></td></tr><tr><td><p dir="ltr">40</p></td><td><p dir="ltr">GMC GADCHIROLI.</p></td><td><p dir="ltr">40</p></td></tr><tr><td><p dir="ltr">41</p></td><td><p dir="ltr">GMC GONDIA.</p></td><td><p dir="ltr">95</p></td></tr><tr><td><p dir="ltr">42</p></td><td><p dir="ltr">GMC GT CAMA MUMBAI.</p></td><td><p dir="ltr">49</p></td></tr><tr><td><p dir="ltr">43</p></td><td><p dir="ltr">GMC HINGOLI</p></td><td><p dir="ltr">35</p></td></tr><tr><td><p dir="ltr">44</p></td><td><p dir="ltr">GMC JALGAON.</p></td><td><p dir="ltr">94</p></td></tr><tr><td><p dir="ltr">45</p></td><td><p dir="ltr">GMC JALNA</p></td><td><p dir="ltr">26</p></td></tr><tr><td><p dir="ltr">46</p></td><td><p dir="ltr">GMC KOLHAPUR</p></td><td><p dir="ltr">85</p></td></tr><tr><td><p dir="ltr">47</p></td><td><p dir="ltr">GMC LATUR</p></td><td><p dir="ltr">91</p></td></tr><tr><td><p dir="ltr">48</p></td><td><p dir="ltr">GMC MIRAJ</p></td><td><p dir="ltr">109</p></td></tr><tr><td><p dir="ltr">49</p></td><td><p dir="ltr">GMC NAGPUR.</p></td><td><p dir="ltr">114</p></td></tr><tr><td><p dir="ltr">50</p></td><td><p dir="ltr">GMC NANDED.</p></td><td><p dir="ltr">79</p></td></tr><tr><td><p dir="ltr">51</p></td><td><p dir="ltr">GMC NANDURBAR.</p></td><td><p dir="ltr">79</p></td></tr><tr><td><p dir="ltr">52</p></td><td><p dir="ltr">GMC NASHIK.</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">53</p></td><td><p dir="ltr">GMC PARBHANI.</p></td><td><p dir="ltr">47</p></td></tr><tr><td><p dir="ltr">54</p></td><td><p dir="ltr">GMC PUNE- BJGMC PUNE.</p></td><td><p dir="ltr">114</p></td></tr><tr><td><p dir="ltr">55</p></td><td><p dir="ltr">GMC RATNAGIRI.</p></td><td><p dir="ltr">44</p></td></tr><tr><td><p dir="ltr">56</p></td><td><p dir="ltr">GMC SATARA.</p></td><td><p dir="ltr">79</p></td></tr><tr><td><p dir="ltr">57</p></td><td><p dir="ltr">GMC Sindhudurg.</p></td><td><p dir="ltr">79</p></td></tr><tr><td><p dir="ltr">58</p></td><td><p dir="ltr">GMC SOLAPUR.</p></td><td><p dir="ltr">105</p></td></tr><tr><td><p dir="ltr">59</p></td><td><p dir="ltr">GMC WASHIM.</p></td><td><p dir="ltr">27</p></td></tr><tr><td><p dir="ltr">60</p></td><td><p dir="ltr">GMC YAVATMAL.</p></td><td><p dir="ltr">97</p></td></tr><tr><td><p dir="ltr">61</p></td><td><p dir="ltr">GMC-INDIRA GANDHI GOVT. MEDICAL COLLEGE NAGPUR.</p></td><td><p dir="ltr">109</p></td></tr><tr><td><p dir="ltr">62</p></td><td><p dir="ltr">GMC-TRUAMA CARE CENTER NAGPUR.</p></td><td><p dir="ltr">8</p></td></tr><tr><td><p dir="ltr">63</p></td><td><p dir="ltr">HBT TRAUMA CARE CENT, JOGESHWARI, MUMBAI.</p></td><td><p dir="ltr">23</p></td></tr><tr><td><p dir="ltr">64</p></td><td><p dir="ltr">MAHARASHTRA INSTITUTE OF MENTAL HEALTH, PUNE.</p></td><td><p dir="ltr">3</p></td></tr><tr><td><p dir="ltr">65</p></td><td><p dir="ltr">NMC Nashik.</p></td><td><p dir="ltr">80</p></td></tr><tr><td><p dir="ltr">66</p></td><td><p dir="ltr">PIMPRI CHINCHWAD MUNICIPAL CORPORATION POSTGRADUATE INSTITUTE YCM HOSPITAL, PIMPRI.</p></td><td><p dir="ltr">38</p></td></tr><tr><td><p dir="ltr">67</p></td><td><p dir="ltr">PMC PUNE.</p></td><td><p dir="ltr">60</p></td></tr><tr><td><p dir="ltr">68</p></td><td><p dir="ltr">TATA MEMORIAL CENTRE, KHARGHAR, NEW MUMBAI.</p></td><td><p dir="ltr">9</p></td></tr><tr><td><p dir="ltr">69</p></td><td><p dir="ltr">TMC-RGM COLLEGE KALVA THANE.</p></td><td><p dir="ltr">76</p></td></tr><tr><td></td><td><p dir="ltr" style="text-align: center; "><b>TOTAL</b></p></td><td><p dir="ltr" style="text-align: center; "><b>3493</b></p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);">Directorate of Medical Education and Research (DMER) Maharashtra supervises the Medical Education i.e. Under Graduate , Post Graduate and Super Specialisation. It also co-ordinates the Research activities in Fundamental Research , Applied Research &amp; Operational Research in the Institutions under its control and through Out-reach Services. This enables the Government to improve Health Status of the people in the society.</span></p></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u><i>To view the list, click the link below</i></u></b></p><p dir="ltr" style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/dmer-maharashtra-283515.pdf">https://medicaldialogues.in/pdf_upload/dmer-maharashtra-283515.pdf</a><a href="https://medicaldialogues.in/pdf_upload/dmer-maharashtra-283515.pdf" target="_blank"></a></p><p dir="ltr" style="text-align: justify; ">List of eligible candidates:&nbsp;<a href="https://medicaldialogues.in/pdf_upload/winter-2024-pg-medical-pass-candidate-list-283541.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/winter-2024-pg-medical-pass-candidate-list-283541.pdf</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><br></p></div><div class="pasted-from-word-wrapper"><div></div></div>

360. Telangana Medical Council raids Cardiac Centre, Technician poses as Doctor

     Fri, 18 Apr 2025 08:00:30 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/08/282107-fake-doctor.webp' /><p style="text-align: justify; "><b>Hyderabad: </b>A disturbing case of quackery has come to light at Sharat Cardiac Care Centre in Sri Sri Nagar, Suryapet, where a medical technician allegedly posed as a doctor and conducted a 2D Echo test on a patient in the absence of a clinical cardiologist. &nbsp;</p><p style="text-align: justify; ">The <a href="https://medicaldialogues.in/topics/fake-doctor" target="_blank">fake doctor</a>, identified as Vanam Sarat Chandra, was reportedly caught handing over a 2D Echo report to a patient while claiming to be a doctor. At the time of the inspection, neither the clinical cardiologist nor Dr Shireesha (MBBS) were present at the facility.&nbsp;</p><p style="text-align: justify; ">The <a href="https://medicaldialogues.in/topics/telangana-medical-council" target="_blank">Telangana State Medical Council </a>(TSMC) discovered the incident during a surprise inspection on Wednesday after receiving complaints about the centre. The inspection was led by TSMC officials, Dr. V. Naresh Kumar and Dr. M. Rajeev.</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/quacks-found-operating-cosmetic-clinics-after-medical-council-inspections-146037" target="_blank">Quacks found operating cosmetic clinics after Medical Council inspections</a></b></p><p style="text-align: justify; ">According to TSMC, a forgery case will be registered against the accused as per the NMC Act for claiming to be a doctor and providing medical services, and action will be taken accordingly.&nbsp;</p><p style="text-align: justify; ">Apart from discovering the technician's fraud, the council also noted that the centre was operating after receiving permission under the name of a heart specialist, Dr Leela Krishna. Following this, the council issued notices to Dr Leela Krishna and Dr Shireesha, reports <a href="https://telanganatoday.com/telangana-technician-caught-issuing-heart-scan-posing-as-doctor-in-suryapet" target="_blank">Telangana Today</a>.&nbsp;</p><p style="text-align: justify; ">In the notice, the council sought a written explanation regarding the use of their names, and action will be taken based on the Ethics Committee’s decision after they submit the explanation.&nbsp;</p><p style="text-align: justify; ">In a statement, TSMC said, “During inspections, it was found that a 2D echo technician, Vanam Sarat Chandra, provided a 2D echo report to a patient, claiming to be a doctor himself. The clinical cardiologist and Dr. Shireesha (MBBS) were not present in the facility. Moreover, it was also noted that the Cardiac Care Centre had received the permission to operate under the name of a heart specialist Dr Leela Krishna.''</p><p style="text-align: justify; ">TSMC Chairman of Public Relations Committee, Dr V Naresh Kumar, in a press release, said, "Such actions are against medical ethics and professional rules of conduct. They also endanger the health of patients. We have received complaints that similar instances are taking place in several other Cardiac Care Centres, and inspections will be conducted on such centres, and appropriate action will be taken."</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/telangana-medical-council-cracks-whip-on-fake-doctor-in-rangareddy-143503" target="_blank">Telangana Medical Council cracks whip on fake doctor in Rangareddy</a></b></p>

361. USFDA approves Alembic Pharma anticonvulsant drug Carbamazepine

     Fri, 18 Apr 2025 07:17:17 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/01/19/230521-usfda-50.webp' /><p style="text-align: justify; "><b>Vadodara:</b>&nbsp;<span style="background-color: rgb(255, 255, 255);"><a href="https://medicaldialogues.in/topics/alembic-pharma">Alembic Pharmaceuticals Limited</a> announced that the US Food &amp; Drug Administration (USFDA) has approved its Abbreviated New Drug Application (ANDA) for Carbamazepine Tablets USP, 200 mg.</span></p><div class="pasted-from-word-wrapper" style="text-align: justify; ">The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tegretol Tablets, 200 mg, of Novartis Pharmaceuticals Corporation. Carbamazepine Tablets USP, 200 mg are indicated for use as an anticonvulsant drug. It is also indicated in the treatment of the pain associated with true trigeminal neuralgia.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><p>True Trigeminal Neuralgia (also known as Classical Trigeminal Neuralgia) is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain. It's characterized by sudden, severe, electric shock-like facial pain that typically affects one side of the face.&nbsp;</p></div><div class="pasted-from-word-wrapper" style="text-align: justify; "> </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Carbamazepine Tablets USP, 200 mg have an estimated market size of US$ 32 million for twelve months ending December 2024 according to IQVIA. </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Alembic has a cumulative total of 222 ANDA approvals (196 final approvals and 26 tentative approvals) from USFDA.&nbsp;</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><p>Earlier, Medical Dialogues reported that the company also received final approval from the USFDA for its ANDA for Pantoprazole Sodium for Injection, 40 mg/vial, intended for the treatment of pathological hypersecretion conditions including Zollinger-Ellison (ZE) Syndrome in adults.</p><p><i style="background-color: rgb(255, 255, 255);"><b>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-bags-usfda-final-approval-for-pantoprazole-sodium-for-injection-for-gerd-145937" style="background-color: rgb(255, 255, 255);">Alembic Pharma bags USFDA final approval for Pantoprazole Sodium for Injection for GERD</a></b></i></p></div><div class="pasted-from-word-wrapper" style="text-align: justify; "> Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Alembic's brands, marketed through a field force of over 5200 are well recognized by doctors and patients. </div><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-appoints-prag-goel-as-vice-president-sales-and-marketing-megacare-enteron-and-osteofit-business-divisions-140817">Alembic Pharma appoints Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit business divisions)</a></i></b></p>

362. Indian-Origin Doctor Convicted in $2.3 million healthcare fraud case

     Fri, 18 Apr 2025 07:15:12 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/12/30/267048-arrest-50-1.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">New York:&nbsp;</span>A U.S. federal court in Pennsylvania has convicted a<span style="text-align: justify;">n Indian-origin doctor for his involvement</span>&nbsp;in multiple healthcare frauds, including a $2.3 million conspiracy involving the illegal distribution of controlled substances.&nbsp;</p><p style="text-align: justify; ">Neil Anand, 48, was also convicted of money laundering on Tuesday in a federal court in Pennsylvania, the department said on Wednesday.</p><p style="text-align: justify;">In the conspiracy to illegally distribute drugs, he issued pre-signed medical prescriptions for oxycodone that were used by interns to enable just nine patients collect 20,850 tablets, it said, news agency IANS reported.</p><p style="text-align: justify;">Oxycodone is an opioid painkiller that can be highly addictive and is one of the substances behind the drug epidemic sweeping the US.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/international/indian-american-doctor-pleads-guilty-to-submitting-claims-for-fraudulent-prescriptions-107524"><b>Also Read:Indian-American Doctor pleads guilty to submitting claims for fraudulent prescriptions</b></a></p><p style="text-align: justify;">Anand also issued "medically unnecessary prescription medications" in what prosecutors called "Goody Bags" through pharmacies he owned if they wanted to get the controlled drugs, and billed health insurance companies and government insurance plans for the unneeded medicines.</p><p style="text-align: justify;">The insurance companies and plans paid $2.3 million for the medicines in the "Goody Bags", the prosecutors said.</p><p style="text-align: justify;">When Anand became aware of the investigation, he transferred about $1.2 million to an account in his father's name and for the benefit of his minor daughter, to conceal the proceeds from the fraud, according to the prosecutors.</p><p style="text-align: justify;">One of the government lawyers who prosecuted him was Arun Bodapati, who works in the Justice Department's Criminal Division's Fraud Section.</p><p style="text-align: justify;">Anand is scheduled to be sentenced in August.</p><p style="text-align: justify;">He was originally charged in 2019 with four others, three of whom were described as medical graduates of foreign universities without licence to practice medicine in the US, reports IANS.</p><p style="text-align: justify;">On December 14, 2017, an Indian-American doctor was arrested on 39 charges of unlawful distribution of prescription opioids and healthcare fraud, officials said.</p><p style="text-align: justify;">The cardiologist was based in the US state of Nevada.</p><p style="text-align: justify;">The 58-year-old doctor allegedly prescribed opioids such as fentanyl, hydrocodone and oxycodone. Opiods are substances which act on opioid receptors to produce morphine-like effects.</p><p style="text-align: justify;">Cardiologist Devendra Patel allegedly prescribed the aforementioned drugs without legitimate medical cause on a routine basis from May 2014 to September 2017, according to an announcement made by US Attorney General Jeff Sessions and other law enforcement officials.</p><p style="text-align: justify;">The accused, Devendra Patel, had appeared in a federal court in Reno city of Nevada and pleaded not guilty, the US media reported.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/liver-doc-calls-blueprint-ceo-bryan-johnson-a-fraud-sparks-debate-145900"><b>Also Read:Liver doc calls Blueprint CEO Bryan Johnson a 'fraud', sparks debate</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

363. Concerned over NEET PG 2025 Double-Shifts, Doctors move Health Minister

     Fri, 18 Apr 2025 07:07:06 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283370-neet-pg-2025.webp' /><p style="text-align: justify; "><b>New Delhi:</b>&nbsp;Raising concerns regarding the National Eligibility-Entrance Test for Postgraduate (NEET-PG) exam being held in double shifts, the doctors have now written to the <a href="https://medicaldialogues.in/topics/Union%20Health%20Minister">Union Health Minister</a>, Shri J P Nadda, and sought his intervention in this regard.</p><p style="text-align: justify; ">Writing to the Minister, the d<span style="background-color: rgb(255, 255, 255);">octors under the </span><a href="https://medicaldialogues.in/topics/indian-medical-association-junior-doctors-network" style="background-color: rgb(255, 255, 255);">Indian Medical Association Junior Doctors' Network</a><span style="background-color: rgb(255, 255, 255);"> (IMA-JDN)&nbsp;</span>pointed out that while the decision to hold NEET PG 2024 in double shifts had to be taken due to a lack of sufficient time to allocate the centres and ensure security protocols, no such problem exists this year.&nbsp;</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/04/17/283451-neet-pg-2025.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/outrage-over-neet-pg-2025-double-shifts-take-a-look-at-what-its-all-about-146808"><span class="read-this-also">Also Read:</span>Outrage over NEET PG 2025 double shifts: Take a look at what it's all about</a><div></div></div></div><p style="text-align: justify; ">"We write this letter with the utmost respect and concern on behalf of thousands of NEET-PG aspirants across the country, who are distressed by the recent decision to conduct the <a href="https://medicaldialogues.in/topics/neet-pg-2025">NEET-PG 2025</a> examination in two shifts once again. We humbly wish to bring to your kind attention the issues being faced by candidates due to this policy, and to request your esteemed intervention for greater transparency and fairness in the examination process," the letter mentioned.</p><p style="text-align: justify; ">"It is pertinent to recall that during the uncertainty around NEET-PG 2024, the reason cited by <a href="https://medicaldialogues.in/topics/nbems">NBE</a> and <a href="https://medicaldialogues.in/topics/NMC">NMC</a> for conducting the exam in two shifts was the lack of sufficient time for centre allocation and ensuring security protocols, especially when the exam was rescheduled and over 2 lakh doctors were involved. However, in the current year, there has been no such logistical constraint or last-minute change, and yet the exam is scheduled in two shifts—raising genuine concerns among aspirants," it further added.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/neet-pg-2025-registrations-begin-today-at-3-pm-exam-in-two-shifts-nbe-146768" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: NEET PG 2025 Registrations begin Today at 3 PM, Exam in two-shifts: NBE</i></b></a></p><p style="text-align: justify; ">IMA-JDN pointed out the concerns regarding the normalisation method between the two shifts of the NEET PG exam. Referring to the PG medical entrance exam held last year, in which there were allegations regarding the disparity between the two shifts of the exam, the letter mentioned, "The primary issue with the two-shift model is the lack of transparency in the normalisation process. Last year, it was widely observed that Shift 2 was significantly more difficult, leading to disparities in scores and relative rankings. This not only affected the performance of deserving candidates but also created a sense of uncertainty and demoralisation."</p><p style="text-align: justify; ">"Moreover, aspirants are not provided access to their own answer keys or response sheets, nor are they permitted to challenge discrepancies. Thousands of emails and representations to NBE and NMC have gone unanswered, leaving students helpless and anxious. These diminish the credibility of the examination process," the letter added.</p><p style="text-align: justify; ">Medical Dialogues reported that doctors across the country were upset over the conduct of the upcoming <a href="https://medicaldialogues.in/topics/neet-pg-2025">NEET PG 2025</a> exam after the <a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a> announced that it would be held in two shifts on June 15, 2025. While the first shift is scheduled from 9:00 AM to 12:30 PM, the second shift is scheduled from 3:30 PM to 7:00 PM.</p><div class="pasted-from-word-wrapper"><div class="inside-post-ad-3 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_3"></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The doctors expressed their concerns primarily over the normalization process. Even though the normalization formula was introduced for NEET PG 2024 to adjust the scores across different exam shifts to ensure fairness, critics have argued that the process is flawed.</p><div class="inside-post-ad-2 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_2"></div><p style="text-align: justify; ">A few candidates who appeared in the second shift of the <a href="https://medicaldialogues.in/topics/neet-pg-2024">NEET PG 2024</a> exam had questioned the normalization formula adopted by <a href="https://medicaldialogues.in/topics/nbems">NBEMS</a> and further claimed that the board had scammed them in the name of a competitive exam. They pointed out that the Shift 2 paper was tougher compared to Shift 1 and further termed the process of calculating scores as debatable. These concerns were also raised before the Supreme Court, where the aspirants prayed for transparency in the NEET PG 2024 exam.</p></div><p style="text-align: justify; ">Recently, a poll conducted by Shiksha.com revealed that when asked about their opinions on the two-shift NEET PG 2025 examination, 89% of the of the respondents in the poll opposed the idea. While 89% of respondents said "No" to the NEET PG exam in two shifts, 9% respondents supported the idea and the remaining 2% were undecided.</p><p style="text-align: justify; ">Despite the protests and demands from the aspirants to hold the upcoming PG entrance test in a single shift, NBEMS has not yet announced any changes in its plans of holding the exam in double shifts.</p><p style="text-align: justify; ">Commenting on the matter, the National Secretary of IMA JDN Standing Committee, Dr. Indranil Deshmukh, said, "On behalf of 2 lakhs NEET-PG aspirants, we express serious concern over the decision to conduct NEET-PG 2025 in two shifts, despite the absence of any logistical urgency this year. The lack of transparency in the normalisation process, unequal difficulty levels across shifts, and denial of access to answer keys and response sheets have raised genuine concerns among candidates regarding the fairness of the process. We urge the authorities to consider conducting the exam in a single shift, ensure transparency in score calculation, and expand CBT centres to all districts. A just and transparent process is essential to uphold the credibility of medical education and protect the aspirations of our young doctors."</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/neet-pg-controversy-doctor-criticizes-double-shift-format-raises-transparency-issues-146617" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: NEET PG Controversy: Doctor criticizes double shift format, raises transparency issues</i></b></a></p></div>

364. Delhi to launch Ayushman cards for all aged above 70 by April end

     Fri, 18 Apr 2025 06:50:09 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/08/09/247079-ayushman-card.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">New Delhi:&nbsp;</span><span style="text-align: justify;">The Delhi government is set to roll out&nbsp;</span><span style="text-align: justify;">Ayushman Cards for all income groups aged above 70 by the end of April 2025.&nbsp;</span><span style="text-align: justify;">This initiative, part of the </span><a href="https://medicaldialogues.in/topics/ayushman-bharat" target="_blank" style="text-align: justify; background-color: rgb(249, 249, 249);">Ayushman Bharat</a><span style="text-align: justify;"> Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), aims to provide health insurance coverage of up to Rs 5 lakh per family per year for secondary and tertiary care hospitalisation.</span></p><p style="text-align: justify; ">Delhi CM <a href="https://medicaldialogues.in/topics/rekha-gupta" target="_blank">Rekha Gupta</a>, along with other cabinet ministers, today chaired a meeting at which MLAs and officials from the state and central governments were present.</p><p style="text-align: justify;">According to an ANI report, the meeting aimed to focus on implementing and distributing Ayushman cards and Opening Arogya Mandir in the National Capital.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/delhi-govt-to-enroll-1-lakh-ayushman-bharat-by-april-10-prioritizing-the-poorest-146035"><b>Also Read:Delhi Govt to enroll 1 lakh in Ayushman Bharat by April 10, Prioritizing the Poorest</b></a></p><p style="text-align: justify;">"To implement Ayushman Bharat (scheme), which Delhi has received after years of waiting, we held a meeting today to ensure that all the cards are made and reach the public as soon as possible. All the MLAs have been assigned the task. Efforts are underway to extend benefits to senior citizens aged above 70. Work should start immediately to identify the location of 1139 Arogya Mandirs to be opened in every corner of Delhi, because Delhi has suffered a lot due to the time wasted by the previous governments. We do not want more time to be wasted. Our government will start working on this today," said Chief Minister Gupta.</p><p style="text-align: justify;">Senior citizens aged 70 and above from all income groups are eligible for the Ayushman Card. The card provides health insurance coverage of up to Rs 5 lakh per family per year, covering 1500+ medical procedures.</p><p style="text-align: justify;">The Delhi government plans to open 1139 Arogya Mandirs across the city. These will offer healthcare services that are different from those offered by Mohalla clinics in structure and operation. The MLAs have been tasked with coordinating with District Magistrates to distribute existing Ayushman Cards and work on opening Arogya Mandirs.</p><p style="text-align: justify;">"The MLAs have been directed to coordinate with District Magistrates (DMs) to distribute the existing Ayushman Cards as quickly as possible and also to work on the opening of Arogya Mandirs in all parts of the state," said Delhi CM Gupta.</p><p style="text-align: justify;">Meanwhile, Delhi Health Minister Pankaj Singh reiterated that the government will build 1139 Ayushman Arogya Mandirs for the people of Delhi.</p><p style="text-align: justify;">"Our target is to build 1139 Ayushman Arogya Mandirs for the people of Delhi, and we will achieve this target. This was a matter of discussion. It was discussed how we can provide this facility to the elderly above 70 years of age as soon as possible. Our Arogya Mandirs will be totally different from Mohalla clinics, you will see the difference in structure and working. The people of Delhi will like it," he said, reports ANI.</p><p style="text-align: justify;">A memorandum of understanding between the Delhi government and the Union Ministry of Health and Family Welfare for implementing Ayushman Bharat Pradhan Mantri Jan Arogya Yojana was signed on April 5 2025, in New Delhi.</p><p style="text-align: justify;">After signing the MoU, the Delhi government officially launched PM ABHIM and started distributing Ayushman Bharat cards under PM JAY on April 10, 2025.</p><p style="text-align: justify;"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/ab-pm-jay-30-crore-ayushman-cards-issued-with-48-crore-uttar-pradesh-tops-the-list-123044"><b>Also Read:AB PM-JAY: 30 crore Ayushman Cards issued, With 4.8 crore Uttar Pradesh tops the list</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

365. Dental Breakthrough: Lab-Grown Teeth May Offer a Natural Alternative to Fillings and Missing Teeth

     Fri, 18 Apr 2025 06:45:50 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283457-1500x900-for-fact-check-97.webp' /><p style="text-align: justify; ">Scientists have recreated the early environment of tooth development in the lab, using a specially designed material that enables dental cells to communicate, offering new insights into how natural teeth could one day be grown outside the human body.</p><div class="pasted-from-word-wrapper"> <p>In a recent scientific development, researchers at King’s College London have made significant progress toward enabling adults to regrow their own teeth. Published in the<i> ACS Macro Letters</i> journal, this research introduces a promising alternative to traditional dental treatments by offering a potentially natural method for tooth repair and regeneration.</p> <p style="text-align: justify; ">For over a decade, scientists at King’s College London’s Faculty of Dentistry, Oral &amp; Craniofacial Sciences have been exploring the possibilities of lab-grown teeth. Their latest collaborative study with Imperial College London has led to the development of a novel biomaterial that replicates the natural conditions of early tooth development. This innovation allows cells to communicate in a way that initiates the formation of tooth structures.</p> <p style="text-align: justify; ">Xuechen Zhang, from the Faculty of Dentistry, Oral &amp; Craniofacial Sciences, King’s College London, and author of the study said: <i>“Fillings aren’t the best solution for repairing teeth. Over time, they will weaken tooth structure, have a limited lifespan, and can lead to further decay or sensitivity. Implants require invasive surgery and good combination of implants and alveolar bone. Both solutions are artificial and don’t fully restore natural tooth function, potentially leading to long-term complications."</i></p> <p style="text-align: justify; ">Discussing possible approaches to using this breakthrough in clinical settings, Xuechen added: <i>“We have different ideas to put the teeth inside the mouth. We could transplant the young tooth cells at the location of the missing tooth and let them grow inside mouth. Alternatively, we could create the whole tooth in the lab before placing it in the patient’s mouth. For both options, we need to start the very early tooth development process in the lab.”</i></p> <p style="text-align: justify; ">Corresponding author of the study, Dr Ana Angelova Volponi from King’s College London, emphasised the broader implications of this research: <i>“As the field progresses, the integration of such innovative techniques holds the potential to revolutionise dental care, offering sustainable and effective solutions for tooth repair and regeneration.”</i></p> <p style="text-align: justify; "><b>Reference:</b> Zhang X, Contessi Negrini N, Correia R, Sharpe PT, Celiz AD, Angelova Volponi A. Generating Tooth Organoids Using Defined Bioorthogonally Cross-Linked Hydrogels. ACS Macro Lett. 2024 Dec 17;13(12):1620-1626. doi: 10.1021/acsmacrolett.4c00520. Epub 2024 Nov 12. PMID: 39532305; PMCID: PMC11656705.</p></div>

366. Weight-loss drug use risen sharply among children and adults with type 1 diabetes: Study

     Fri, 18 Apr 2025 06:30:23 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/01/16/198342-type-1-diabetes.webp' /><p style="text-align: justify; ">Popular prescription<a href="https://medicaldialogues.in/topics/weight-loss"> weight-loss </a>drugs called<a href="https://medicaldialogues.in/topics/glp-1-receptor-agonist"> GLP-1 receptor agonists </a>are now frequently used by <a href="https://medicaldialogues.in/topics/type-1-diabetes">type 1 diabetes</a> patients, despite limited data on the drugs’ safety and effectiveness in this patient population, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. </p><p style="text-align: justify; ">GLP-1 receptor agonists were developed more than two decades ago to treat <a href="https://medicaldialogues.in/topics/type-2-diabetes">type 2 diabetes</a>. Some GLP-1 receptor agonists were subsequently approved for reducing <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease </a>risk and for treating obesity in the general patient population. Many type 1 diabetes patients began taking GLP-1 receptor agonists-despite the fact that the drugs are thought to put type 1 diabetes patients at risk for developing hypoglycemia, a potentially life-threatening low-blood sugar condition. Because of this risk, patients with type 1 diabetes have been excluded from GLP-1 receptor agonists clinical trials. </p><p style="text-align: justify;">About two million Americans have type 1 diabetes, according to the Centers for Disease Control and Prevention. The autoimmune condition occurs in individuals whose bodies do not produce enough<a href="https://medicaldialogues.in/topics/insulin"> insulin</a> and requires lifelong insulin therapy to regulate blood sugar levels. </p><p style="text-align: justify;">For their study, the researchers analyzed more than 200,000 de-identified medical records of individuals with type 1 diabetes from 2008 to 2023 and found that the obesity rate among type 1 diabetes patients increased for all age groups and ethnicities during this period. </p><p style="text-align: justify;">The analysis also found that the use of GLP-1 receptor agonists rose sharply as the obesity rate increased across groups. In the highest obesity category, the proportion of adult patients using these medications increased from about 4% in 2008–2011 to about 33% in 2020–2023. </p><p style="text-align: justify; ">The study was published online March 3 in<i> Diabetes, Obesity and Metabolism</i>. </p><p style="text-align: justify; ">“These findings highlight the urgent need for better data-including clinical trials-on the effectiveness and safety of GLP-1 receptor agonists in people with type 1 diabetes, to inform clear guidelines on their use in these patients,” says study senior author Jung-Im Shin, MD, PhD, an associate professor in the Bloomberg School’s Department of Epidemiology. </p><p style="text-align: justify;">The study’s first author, Yunwen Xu, PhD, is a postdoctoral researcher in the same department. </p><p style="text-align: justify;">Type 1 diabetes was not treatable until the development of insulin treatments in the 1920s. Historically, people with type 1 diabetes tended to be thin, because insulin deficiency led to the breakdown of fat and muscle for energy, causing weight loss. However, insulin treatments, combined with an environment that promotes weight gain, have contributed to an increased obesity burden in this population and created a demand for GLP-1 receptor agonists. </p><p style="text-align: justify;">The new study covered 217,442 patients with type 1 diabetes from more than 30 health systems across the U.S. The data came from electronic health records in a large commercial database and covered the period from October 2008 to September 2023. </p><p style="text-align: justify;">The researchers grouped the data by three-year periods, starting with October 2008 to September 2011 and ending with October 2020 to September 2023. In keeping with other recent studies, and with trends in the wider population, they found that the prevalence of obesity among type 1 diabetes patients rose significantly from the first period to the last: from 18% to 26% among youth ages 2–19 and from 30% to 38% among adults age 20 and older. This prominent upward trend was seen among whites, Blacks, Hispanics, and Asians; among men and women; and among patients covered by Medicaid, Medicare, and commercial health insurers. </p><p style="text-align: justify; ">The rate of GLP-1 receptor agonist use, as measured by prescriptions, rose even faster. This rapid rise occurred in every one of the five weight categories, from normal weight to severe obesity, and among youth and adults. Four percent of severely obese adults with type 1 diabetes had prescriptions for GLP-1 receptor agonists during the 2008–11 period, whereas that figure rose to 33% in 2020–23. Among severely obese youth with type 1 diabetes, fewer than 3% used GLP-1 receptor agonists in 2008–11, but 21%-a sevenfold increase-used them in 2020–23. </p><p style="text-align: justify;">As part of the study, the researchers also quantified the use of different GLP-1 receptor agonists in each period. </p><p style="text-align: justify; ">“In the most recent periods, there were big increases in the use of semaglutide and tirzepatide-the most potent versions of these drugs for weight loss—which again underscores the need for clinical trial data on these patients,” Xu says. </p><p style="text-align: justify; ">The scientists currently are following up with a more targeted study in type 1 diabetes patients, quantifying the risk of serious hypoglycemia associated with the use of GLP-1 receptor agonists.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Yunwen Xu PhD, Justin B. Echouffo Tcheugui MD, Josef Coresh MD, Morgan E. Grams MD, Elizabeth Selvin PhD, Michael Fang PhD, Jung-Im Shin MD, Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States, Diabetes Obesity and Metabolism, https://doi.org/10.1111/dom.16300.</p>

367. Pune Police seeks clarity in Sassoon Hospital report on woman's death

     Fri, 18 Apr 2025 06:30:14 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/08/282135-deenanath-mangeshkar-hospital.webp' /><div class="pasted-from-word-wrapper"><p><span style="text-align: justify;">Pune:&nbsp;</span><span style="text-align: justify;">Pune police have cited ''ambiguity'' and sought clarity from Sassoon General Hospital (SGH) in the latter's report on the death of a pregnant woman who was allegedly denied admission by </span><a href="https://medicaldialogues.in/topics/deenanath-mangeshkar-hospital" target="_blank" style="background-color: rgb(249, 249, 249); text-align: justify;">Deenanath Mangeshkar Hospital</a><span style="text-align: justify;">. &nbsp;&nbsp;</span></p><p style="text-align: justify;">Tanisha Bhise, the wife of the private secretary of BJP MLC Amit Gorkhe, was refused admission over non-payment of a deposit of Rs 10 lakh in the last week of March. She died in another hospital after giving birth to twin daughters. &nbsp; &nbsp; &nbsp;</p><p style="text-align: justify;">The final report prepared by a committee of the <a href="https://medicaldialogues.in/topics/sassoon-general-hospital" target="_blank">Sassoon General Hospital</a> was submitted to the government and the Pune police on Wednesday. &nbsp;&nbsp;</p><p style="text-align: justify;">Medical Dialogues recently reported that a six-member expert panel of Sassoon General Hospital and BJ Medical College has been constituted to investigate the death of a young mother who was allegedly denied admission at Deenanath Mangeshkar Hospital in Pune on March 28 due to the non-payment of a Rs 10 lakh advance deposit, after the city police approached the institution for assistance. This marks the fourth committee set up to investigate the incident, following three previous committees that have already submitted their reports—the most recent being the third report from the Pune Municipal Corporation’s (PMC) Maternal Death Review Panel. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/sassoon-hospital-submits-final-report-in-pregnant-womans-death-case-146766"><b>Also Read:Sassoon Hospital submits final report in Pregnant woman's death case</b></a></p><p style="text-align: justify;">"The report is ambiguous and not specific on the charges levelled against the hospital and doctor. We have asked the committee for a specific report. If the report is specific, the negligence aspect will be more clear and will determine if it attracts any criminal offence," a senior police official said, news agency PTI reported.</p><p style="text-align: justify;">Three reports, one by a committee set up by the state health department, another by the charity commissioner and a maternal mortality report were submitted to the government earlier. &nbsp;&nbsp;</p><p style="text-align: justify;"><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/mmc-issues-notice-to-former-gynaecologist-over-pregnant-womans-death-146495">Also Read:Maharashtra Medical Council Issues Notice to Gynaecologist over Pregnant woman's death</a>. &nbsp; &nbsp;</b></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>

368. Ferric Carboxymaltose fails to reduce hospitalization and death among Heart Failure Patients: JAMA

     Fri, 18 Apr 2025 06:15:21 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/21/279502-heart-failure-4.webp' /><p style="text-align: justify; ">Researchers have found in a new study that in patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death. Further it did not lower the total number of heart failure hospitalizations compared to a placebo, including in patients with a transferrin saturation below 20%.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">Uncertainty remains about the efficacy of intravenous iron in patients with heart failure and iron deficiency. A study was done to assess the efficacy and safety of ferric carboxymaltose in patients with heart failure and iron deficiency. </p><p dir="ltr" style="text-align: justify; ">This multicenter, randomized clinical trial enrolled 1105 patients with heart failure (defined as having a left ventricular ejection fraction of ≤45%) and iron deficiency (serum ferritin level &lt;100 ng/mL; or if transferrin saturation was &lt;20%, a serum ferritin level between 100 ng/mL and 299 ng/mL) at 70 clinic sites in 6 European countries from March 2017 to November 2023. </p><p dir="ltr" style="text-align: justify; ">The median follow-up was 16.6 months (IQR, 7.9-29.9 months). Administration of ferric carboxymaltose (n = 558) initially given at an intravenous dose of up to 2000 mg that was followed by 500 mg every 4 months (unless stopping criteria were met) vs a saline placebo (n = 547). The primary end point events were (1) time to cardiovascular death or first heart failure hospitalization, (2) total heart failure hospitalizations, and (3) time to cardiovascular death or first heart failure hospitalization in patients with a transferrin saturation less than 20%. All end point events were measured through follow-up. </p><p dir="ltr" style="text-align: justify; ">The end points would be considered statistically significant if they fulfilled at least 1 of the following conditions: (1) P ≤ .05 for all 3 of the end point comparisons, (2) P ≤ .025 for 2 of the end point comparisons, or (3) P ≤ .0167 for any of the 3 end point comparisons (Hochberg procedure). </p><p dir="ltr" style="text-align: justify; ">Results Of the 1105 participants (mean age, 70 years [SD, 12 years]; 33% were women), cardiovascular death or first heart failure hospitalization (first primary outcome) occurred in 141 in the ferric carboxymaltose group vs 166 in the placebo group (hazard ratio, 0.79 [95% CI, 0.63-0.99]; P = .04). The second primary outcome (total heart failure hospitalizations) occurred 264 times in the ferric carboxymaltose group vs 320 times in the placebo group (rate ratio, 0.80 [95% CI, 0.60-1.06]; P = .12). The third primary outcome (cardiovascular death or first heart failure hospitalization in patients with a transferrin saturation &lt;20%) occurred in 103 patients in the ferric carboxymaltose group vs 128 patients in the placebo group (hazard ratio, 0.79 [95% CI, 0.61-1.02], P = .07). </p><p dir="ltr" style="text-align: justify; ">A similar amount of patients had at least 1 serious adverse event in the ferric carboxymaltose group (269; 48.2%) vs in the placebo group (273; 49.9%) (P = .61). In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.</p><div style="text-align: justify;"></div><p dir="ltr" style="text-align: justify; ">Reference:</p><p dir="ltr" style="text-align: justify; ">Anker SD, Friede T, Butler J, et al. Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial. JAMA. Published online March 30, 2025. doi:10.1001/jama.2025.3833</p><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div></div>

369. Darbapoetin Alfa In Chemotherapy Induced Anaemia: Check out 5 takeaways from recent study

     Fri, 18 Apr 2025 06:00:10 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283374-option-1.webp' /><p style="text-align: justify; ">Darbepoetin alfa significantly reduces the reliance on blood transfusions while boosting hemoglobin levels in cancer patients experiencing chemotherapy-induced anemia, a recent Indian study has reported.</p><p style="text-align: justify; ">A recent real-world retrospective study published in Frontiers in Oncology was conducted at Narayana Super-specialty Hospital-Howrah, a tertiary care center in Kolkata, India; enrolled 523 patients with advanced or metastatic solid tumors undergoing palliative myelosuppressive therapy over a six-year period. </p><p style="text-align: justify; ">The study analyzed electronic health records to evaluate the impact of darbepoetin alfa (Cresp®, 200 mcg subcutaneous injection by Dr Reddy’s Laboratories, administered biweekly) on chemotherapy-induced anemia. The study included adults (≥18 years) with advanced or metastatic solid tumors who had completed at least two cycles of palliative myelosuppressive chemotherapy. Eligible patients had an Hb level of ≤10.0 g/dL at diagnosis, though those with Hb levels between 10.0 and 11.0 g/dL were included if symptomatic for anemia. Enrollment required at least one dose of darbepoetin alfa. The study excluded pediatric patients, those with early-stage solid tumors receiving curative treatment, individuals with hematological malignancies, patients on targeted therapy alone or with non-myelosuppressive agents, and those previously exposed to recombinant erythropoietin. </p><p style="text-align: justify; ">The primary endpoint of the study was to measure the change in hemoglobin levels from baseline to post-treatment. Secondary endpoints included the reduction in blood transfusion dependence, improvements in patient-reported anemia symptoms such as fatigue and dyspnea, and the occurrence of treatment-emergent adverse events (TEAEs) such as hypertension, deep vein thrombosis (DVT), and arrhythmias.</p><p style="text-align: justify; ">The median age of the cohort was 55 years, and patients were divided based on cancer type, chemotherapy regimen, treatment response, and administered doses of darbepoetin alfa.</p><p style="text-align: justify; "><b>Key findings of the study include:</b></p><p style="text-align: justify; "><b>Significant Hemoglobin Improvement: </b>Patients exhibited a marked increase in mean hemoglobin levels from a baseline of 8.56 ± 0.45 g/dL to 10.84 ± 0.92 g/dL resulting in a statistically significant 2.28 g/dL rise (P&lt;.001). The benefit of darbepoetin alfa was observed consistently across all analyzed subgroups, including different cancer types (gastrointestinal, head and neck, lung, breast, genitourinary, gynecological malignancies, and others), chemotherapy types (single-agent and combination regimens), chemotherapy protocols (taxane + platinum, gemcitabine + platinum, fluoropyrimidine-based, single-agent taxane, platinum monotherapy, and others). Figure 1.</p><p style="text-align: justify; "><b>Change in Hemoglobin in Relation to Cancer Therapy Response:</b> A subgroup analysis revealed that patients demonstrating a partial response to cancer therapy experienced the highest hemoglobin increment (2.66 ± 0.51 g/dL), compared to those with stable disease (1.86 ± 0.82 g/dL) or progressive disease (1.40 ± 0.59 g/dL). Furthermore, patients receiving more than four doses of Darbepoetin alfa showed a superior hemoglobin improvement compared to those administered only four or fewer doses.</p><p style="text-align: justify; "><b>Reduction in Blood Transfusion Dependence:</b> At baseline, 50 patients (9.6%) required blood transfusion. Following darbepoetin alfa administration, only 22 patients continued to need transfusions, corresponding to a risk reduction of 56%. </p><p style="text-align: justify; "><b>Improvement in Anemia-Related Symptoms:</b> Patient-reported outcomes highlighted significant alleviation in symptoms such as fatigue and dyspnea (P&lt;.001 for both), indicating the quality-of-life benefits linked to improved hemoglobin levels after darbepoetin alfa treatment.</p><p style="text-align: justify; "><b>Favorable Tolerability Profile:</b> Adverse events were relatively infrequent. Hypertension (5.4%), deep vein thrombosis (2.9%), and arrhythmias (0.8%) were the most commonly observed treatment-emergent adverse events. </p><p style="text-align: justify; ">Given the risks of frequent blood transfusions, such as thromboembolic events and immune complications in palliative cancer care, this study demonstrated that erythropoiesis-stimulating agents (ESAs) like Darbepoetin alfa play a critical role in managing chemotherapy-induced anemia (CIA).</p><div contenteditable="false" data-width="577" style="left:24%;width:577px;" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2025/03/26/280303-new-animation-10.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="236907Sw9m0RyYzkOiNpQi0Se4U6bCex62hEK2065264" data-watermark="false" style="width: 100%; float: none;" info-selector="#info_item_1742972065742"><div class="inside_editor_caption image_caption hocalwire-draggable float-none" id="info_item_1742972065742"><br></div></div><p style="text-align: justify; ">Figure: Mean increment in hemoglobin (Hb) levels across subgroups from baseline to end of treatment. Statistically significant (P&lt;.001) increment in mean Hb levels was recorded across all subgroups.</p><p style="text-align: justify; ">This study highlighted the efficacy and tolerability of Darbepoetin alfa (Cresp® by Dr Reddy’s Laboratories) in addressing chemotherapy-induced anemia (CIA) in Indian real-world settings. Darbepoetin alfa increased hemoglobin levels, reduced the need for blood transfusions, and improved the quality of life among cancer patients undergoing chemotherapy.</p><p style="text-align: justify; ">GGI-CO-A1-AQS-300021457-NB-C25-1139</p><p style="text-align: justify; "><b>Reference: </b>Chandrakanth M, Agarwala V, Sopory P, Nayak H, Parikh PM, Roy M, De R, Narayan P, Barai AT, Mandal K, Basu M, Kumar S,Uppal RS, Naqvi SMH and Desai R (2025) Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients.Front. Oncol. 15:1418327.doi: 10.3389/fonc.2025.1418327</p>

370. USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

     Fri, 18 Apr 2025 05:30:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/01/10/197365-bristol-myers-squibb-4.webp' /><p style="text-align: justify; "><b>Princeton:&nbsp;</b><a href="https://medicaldialogues.in/topics/Bristol-Myers-Squibb">Bristol Myers Squibb</a> has announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS&nbsp;(mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), simplifying treatment for patients and physicians by reducing the required echo monitoring for eligible patients in the maintenance phase and expanding patient eligibility by reducing contraindications.</p><p style="text-align: justify; ">CAMZYOS is a FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">“In addition to the established efficacy of CAMZYOS, these meaningful updates to the label reinforce the strong safety profile of the therapy. With robust clinical and real-world data and more than 15,000 patients prescribed CAMZYOS in the U.S.,&nbsp;this medicine has redefined the treatment landscape for symptomatic obstructive HCM and can have a significant impact for patients living with the condition,” said Al Reba, senior vice president, Cardiovascular &amp; Immunology Commercialization at Bristol Myers Squibb. “Simplifying treatment by reducing the frequency of echo monitoring not only improves the patient experience, but will also save time for cardiologists, allowing them to treat more patients.”</p><p style="text-align: justify; ">FDA-approved updates include reduced frequency of required echo monitoring from once every 12 weeks to every 6 months for patients with left ventricular ejection fraction (LVEF) ≥55% and a Valsalva left ventricular outflow tract (LVOT) gradient &lt;30 mmHg (or Valsalva LVOT ≥30 mmHg without up-titration) who have reached the maintenance phase (at Week 12 or later).</p><p style="text-align: justify; ">Additionally, CAMZYOS is no longer contraindicated with moderate CYP2C19 inhibitors and strong CYP3A4 inhibitors, which were adjusted to drug interactions. This provides physicians with greater flexibility in prescribing CAMZYOS to a broader group of eligible patients, with revised dosing and monitoring.</p><p style="text-align: justify; ">The approved label update is supported by long-term clinical and real-world data, including analyses of results from the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program, real-world experience from three single-center studies, and ongoing clinical data reinforcing the safety profile of CAMZYOS through 3.5 years.</p><p style="text-align: justify; ">CAMZYOS is included in both the ESC and AHA/ACC/Multisociety clinical guidelines as a recommended option for patients with persistent symptoms on a first-line therapy&nbsp;and is established as a standard of care for the treatment of adults with symptomatic obstructive HCM, supported by a growing body of evidence.</p><p style="text-align: justify; ">The full U.S. Prescribing Information for CAMZYOS includes a Boxed WARNING for the risk of heart failure. CAMZYOS reduces left ventricular ejection fraction (LVEF) and can cause heart failure due to systolic dysfunction. Echocardiogram assessments of LVEF are required prior to and during treatment with CAMZYOS. Initiation of CAMZYOS in patients with LVEF &lt;55% is not recommended. Interrupt CAMZYOS if LVEF is &lt;50% at any visit or if the patient experiences heart failure symptoms or worsening clinical status. Concomitant use of CAMZYOS with certain cytochrome P450 inhibitors or discontinuation of certain cytochrome P450 inducers may increase the risk of heart failure due to systolic dysfunction; therefore, the use of CAMZYOS is contraindicated with strong CYP2C19 inhibitors and moderate to strong CYP2C19 inducers or moderate to strong CYP3A4 inducers. Because of the risk of heart failure due to systolic dysfunction, CAMZYOS is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the CAMZYOS REMS PROGRAM.</p></div>

371. SSKM to launch West Bengal's first budget hospital

     Fri, 18 Apr 2025 05:15:27 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/02/05/200647-sskm.webp' /><p><b>Kolkata:</b>&nbsp;To improve access to quality healthcare, <a href="https://medicaldialogues.in/state-news/west-bengal" style="background-color: rgb(249, 249, 249);">West Bengal</a>’s first ‘budget hospital’ is set to begin operations inside the SSKM Hospital premises before the upcoming Durga Puja. This innovative project, introduced under the leadership of <a href="https://medicaldialogues.in/topics/mamata-banerjee" style="background-color: rgb(249, 249, 249);">Chief Minister Mamata Banerjee</a>, marks a new chapter in the state’s healthcare sector.</p><p>According to the news reports, the 10-storeyed hospital building, constructed under a Public-Private Partnership (PPP) model, will initially make its first two floors operational for patients. The construction began in November 2023, and the facility promises corporate hospital-like services at a fraction of the cost. </p><p>Medical Dialogues had previously reported that Chief Minister Mamata Banerjee has come out with a new concept for Bengal's health sector, 'budget hospital'. A plan to set up such a hospital at the SSKM Hospital campus in Kolkata had already been taken.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/budget-hospitals-to-be-set-up-across-bengal" style="background-color: rgb(255, 255, 255);"><b>Also Read: Budget hospitals to be set up across Bengal</b></a></p><p>The new 10-storey facility will feature a total of 131 beds, comprising 8 VIP suites, 102 tastefully designed cabins, 16 ICU beds, 5 HDU units, and additional recovery beds.</p><p>While the treatment pricing is yet to be finalized, patients can expect costs to be 70–80% lower than those in private corporate hospitals. </p><p>The project was inspired by the successful PPP model implemented at Woodburn Ward, also located within SSKM, which saw high patient satisfaction and financial viability. Building on that success, the Woodburn Ward is also being upgraded, with the number of cabins being increased from 36 to 60.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/24-hour-search-for-bed-patient-dies-after-3-government-hospitals-denied-treatment-in-kolkata-137619" style="background-color: rgb(255, 255, 255);"><b>Also Read: 24-hour Search for Bed: Patient dies after 3 Government Hospitals denied treatment in Kolkata</b></a></p><p>According to the<a href="https://www.millenniumpost.in/bengal/states-first-budget-hospital-at-sskm-hosp-set-to-partially-open-before-puja-606555" rel="nofollow"> Millennium Post</a>, the ‘budget hospitals’ will be set up gradually in all the districts. There are plans to open such a hospital in other medical colleges in Kolkata, such as Calcutta Medical College and Hospital, RG Kar Medical College, NRS Medical College and Hospital, Calcutta National Medical College and Hospital, Burdwan Medical College, North Bengal Medical College, Bankura Sammilani Medical College, etc. These hospitals would be equipped with facilities like private cabins with ACs and TVs, single, double, and four-bedded cabins, ICUs, etc.</p>

372. AIIMS Leads the Way- 3 Indian Hospitals in World's Best list

     Fri, 18 Apr 2025 04:00:51 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283554-hospital-1.webp' /><p style="text-align: justify; "><b>New Delhi:</b>&nbsp;Altogether, three hospitals in India- the <a href="https://medicaldialogues.in/topics/all-india-india-institute-of-medical-sciences">All India Institute of Medical Sciences </a>(AIIMS), Delhi, Post Graduate Institute of Medical Sciences and Research (PGIMER), Chandigarh, and Medanta-the Medicity in Gurgaon have been recognised among the top 250 best hospitals across the world.&nbsp;</p><p style="text-align: justify; ">Newsweek and Statista, in their "World's Best Hospitals 2025" report, have recognised AIIMS, New Delhi, as the 97th best hospital in the world. Back in 2023, AIIMS earned the 122nd rank in the same report. Its position was further improved in 2024, when AIIMS ranked 113th in the list. Now the institute has moved up 16 spots as it has earned the 97th rank in the list.</p><p style="text-align: justify; ">Apart from AIIMS, two other Indian hospitals made the top 250 list. Two other institutes- Medanta-the Medicity in Gurgaon and Postgraduate Institute of Medical Sciences and Research (PGIMER) in Chandigarh- have featured in the list. While Medanta improved its rank from 166th in 2024 to 146th in 2025, PGIMER also improved from 246th rank in 2024 to 166th rank this year.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/malpractice-no-transparency-in-nirf-ranking-madras-hc-stay-on-2025-list-145541" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Malpractice, no transparency in NIRF Ranking? Madras HC stay on 2025 list</i></b></a></p><p style="text-align: justify; ">As per the latest media report by <a href="https://www.business-standard.com/health/aiims-delhi-ranked-among-world-best-hospitals-2025-medanta-pgimer-125041800175_1.html" rel="nofollow">Business Standard</a>, this is the sixth year of the report providing an annual ranking to the institutes across the world. This year, it evaluated more than 2,400 hospitals across 30 countries and measured the performance of the hospitals through patient satisfaction, clinical outcomes, hygiene standards, and peer recommendations from thousands of medical professionals.&nbsp;</p><p style="text-align: justify; ">All India Institute of Medical Sciences, also known as <a href="https://medicaldialogues.in/topics/AIIMS%20Delhi">AIIMS Delhi</a>, is a globally acclaimed public medical research university and hospital based in New Delhi, India. The AIIMS Act, of 1956 govern the institute and operates autonomously under the Ministry of Health and Family Welfare. The main campus of AIIMS, New Delhi is located in Ansari Nagar, Delhi.</p><p style="text-align: justify; ">As a government-run institute, AIIMS offers largely subsidised treatment. Its inclusion in the top 100 hospitals across the world recognises the quality of public healthcare in India. AIIMS was not the only public institute to make the list. </p><p style="text-align: justify; ">PGIMER Chandigarh, which was founded in 1962, and Medanta have also been recognised among the top 250 hospitals. Medanta has been a leading name in private healthcare since 2009 and it has been recognised as one of the top hospitals across the world for its excellence in specialised fields such as cardiology, oncology, and organ transplantation, as well as its commitment to adapting cutting-edge medical technologies.</p><p style="text-align: justify; ">Meanwhile, the Mayo Clinic and the Cleveland Clinic in the United States topped the list, followed by Toronto General in Canada and Johns Hopkins Hospital, while Sweden’s Karolinska University Hospital rounded out the top five.</p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/top-medical-colleges-in-india-excel-in-teaching-but-lag-in-research-analysis-of-nirf-2024-rankings-reveal-143320" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Top Medical Colleges in India Excel in Teaching but Lag in Research, Analysis of NIRF 2024 rankings reveal</i></b></a></p>

373. DME Chhattisgarh Releases FMG Internship Allotment List, Scrutiny, Joining Process To Begin Tomorrow

     Fri, 18 Apr 2025 04:00:45 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283503-allotment-1.webp' /><p style="text-align: justify; "><b>Chhattisgarh- </b>The Director of Medical Education (<a href="https://medicaldialogues.in/topics/dme-chhattisgarh" target="_blank">DME), Chhattisgarh</a>, has released the allotment list of seats in institutes given to the eligible candidates based on their preference and institute selection under Foreign Medical Graduates (<a href="https://medicaldialogues.in/topics/fmg" target="_blank">FMG</a>) Internship Counselling for the academic year 2025. Therefore, DME Chhattisgarh is going to conduct the scrutiny and joining process from tomorrow.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">As per the notice issued by the DME Chhattisgarh in this regard, the scrutiny and joining process will be conducted from tomorrow, i.e. 19th April 2025 and will end on 30th April 2025. With this, the joining of the allotted institute will also take place on 30th April 2025. Below is the schedule-</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/chhattisgarh-fmg-internship-counselling-fmge-2023-2024-pass-outs-eligible-edit-option-available-for-pre-registered-candidates-146505"><b>Also Read:&nbsp;</b>Chhattisgarh FMG Internship Counselling: FMGE 2023, 2024 Pass-Outs Eligible, Edit Option Available for Pre-Registered Candidates</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>SCHEDULE</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="297"><col width="276"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>PROCESS DETAILS</b></p></td><td><p dir="ltr"><b>DATE AND TIME</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Starting date of scrutiny and joining (Physical Mode/Offline Mode).</p></td><td><p dir="ltr">Date 19 April 2025, Time from 11:00 AM.</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Last Date for Scrutiny (Physical Mode/Offline Mode).</p></td><td><p dir="ltr">Date 30 April 2025, Time 05:00 PM</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Last date for joining the allotted institute (Physical Mode/Offline Mode).</p></td><td><p dir="ltr">Date 30 April 2025, Time 05:00 PM</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; ">Meanwhile, the concerned candidate should take a printout of the Allotment Letter from his/her login portal and appear at the allotted institute within the date with the required original documents and their self-attested copies, get the documents verified and take joining at the institute. In case of non-reporting on the prescribed date and time, the allotment of the concerned candidate will be considered automatically cancelled.</p><p dir="ltr" style="text-align: justify; ">Moreover, the Chhattisgarh FMG Internship Counselling Provisional Allotment List for Session 2025 has been released on the official website of DME Chhattisgarh. As per the Provisional Allotment List, a total of 223 candidates were allotted based on their preference and institute selection under FMG Internship Counselling 2025. </p><p dir="ltr" style="text-align: justify; ">The list also contains important information such as FMGE Roll No, CG Registration No, Candidate Name, Allotted Institute Name, Choice No, CG Domicile, Merit Group, DOB, FMGE Score and Merit Position.</p><p dir="ltr" style="text-align: justify; "><b><u><i>To view the notice, click the link below</i></u></b></p></div><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/17-04-2025-fmg-2025-allotment-notice--283536.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/17-04-2025-fmg-2025-allotment-notice--283536.pdf</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u><i></i></u></b></p></div><div class="pasted-from-word-wrapper"><div></div></div>

374. Systematic Reviews Shows Tech Use May Cut Dementia Risk

     Fri, 18 Apr 2025 03:00:36 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283502-mdtv-2025-04-18t115725140.webp' /><div class="pasted-from-word-wrapper"><div style="text-align: justify; ">A new study published in <i>Nature Human Behavior</i> finds that regular technology use is actually linked to a 58% lower risk of <a href="https://medicaldialogues.in/topics/cognitive-impairment">cognitive impairment</a> in older adults. </div><div style="text-align: justify;">To investigate the connection between digital device usage and <a href="https://medicaldialogues.in/topics/cognitive-health">cognitive health</a>, researchers conducted a meta-analysis of 136 previously published studies, analyzing data from over 400,000 adults aged 50 and older. This large-scale, systematic review allowed the team to assess trends across diverse populations and identify consistent patterns in cognitive outcomes.</div><div style="text-align: justify;">Their findings directly challenge the emerging concept of "digital dementia"—a term used to describe technology-induced memory loss and concentration difficulties. Instead, the research shows that regular engagement with digital devices is associated with better cognitive aging outcomes, primarily due to the mental stimulation and adaptability required to use modern technology.</div><div style="text-align: justify;">Dr. Michael K. Scullin, associate professor of <a href="https://medicaldialogues.in/topics/Psychology">psychology </a>and <a href="https://medicaldialogues.in/topics/neuroscience">neuroscience </a>at Baylor and co-author of the study explained that older adults, who often learned to use digital tools later in life, face cognitive challenges like adapting to new software, troubleshooting devices, or filtering digital content. These tasks, though sometimes frustrating, help stimulate the brain. He refers to this as “digital scaffolding”—using technology like reminders, GPS, and online tools to maintain independence and support brain function.</div><div style="text-align: justify;">Beyond cognitive stimulation, the study highlights how digital technology enhances social connectivity, which is a key factor in reducing dementia risk. Tools like video calls, messaging apps, and email help older adults stay in touch with loved ones, reducing isolation and supporting mental health.</div><div style="text-align: justify;">The findings suggest a shift in how we view digital engagement in older adults—not as a risk, but as a potential tool for maintaining cognitive health and independence.</div><div style="text-align: justify;">“You can flip on the news on just about any day and see people talking about how technologies are harming us,” said Scullin. “We found the opposite—technology use appears to benefit brain health.”</div><div style="text-align: justify;">Reference: Benge, J.F., Scullin, M.K. A meta-analysis of technology use and cognitive aging. Nat Hum Behav (2025). https://doi.org/10.1038/s41562-025-02159-9</div><div></div><div></div><div></div><div></div><div></div><div></div></div>

375. Patients with severe systemic lupus erythematosus have increased risk of pericarditis recurrence: JAMA

     Fri, 18 Apr 2025 03:00:28 -0000

     <img src='https://medicaldialogues.in/h-upload/2022/06/09/178265-pericarditis.webp' /><p style="text-align: justify; ">A new study published in the <i>Journal of American Medical Association</i> showed that younger patients with severe systemic lupus erythematosus (SLE) were more likely to experience a recurrence of pericarditis within the first year following the original diagnosis.</p><p style="text-align: justify; ">The most prevalent cardiac symptom of systemic lupus erythematosus (SLE) is pericarditis, which is described as inflammation of the serosal sac surrounding the heart. About 20% of SLE patients have pericarditis. From minor chest discomfort that is made worse by resting flat and relieved by leaning forward to crippling symptoms of severe chest pain and dyspnea, patients may have a wide range of symptoms. </p><p style="text-align: justify; ">The patients may be at higher risk of recurrence due to potential overlapping immunological-mediated pathways, given the widespread immune dysregulation linked to SLE. Yoo Jin Kim and colleagues therefore carried out this study to look at the risk factors and frequency of pericarditis recurrence in SLE patients.</p><p style="text-align: justify; ">A well-characterized, single-site prospective cohort of a varied group of SLE patients treated at a tertiary medical facility and enrolled between 1988 and 2023 was retrospectively analyzed in this cohort research. The patients with pericarditis who were included in the Hopkins Lupus Cohort were shortlisted. </p><p style="text-align: justify; ">Pericarditis recurrence was evaluated. Pericarditis was defined using the Safety of Estrogens in Systemic Lupus Erythematosus National Assessment version of the SLE Disease Activity Index (SELENA-SLEDAI). Clinical data from every follow-up visit following the initial pericarditis event was reviewed. Recurrent episodes were those that happened at least six weeks following the initial event that was noted.</p><p style="text-align: justify; ">In the Hopkins Lupus Cohort, 590 out of 2,931 individuals had a history of pericarditis. Electrocardiograms or specialized imaging were used to confirm the diagnosis of pericarditis in 21 individuals (3.6), with 100% agreement between database and clinical diagnoses. Recurrent pericarditis occurred in 120 patients (20.3%) with a median (IQR) follow-up of 6.7 (2.5-13.6) years and 5,277 years of follow-up. While 59 patients (49.2%) had two or more recurrences, the majority of patients (61 people [50.8%]) only had one recurrence.</p><p style="text-align: justify; ">Younger age, prednisone therapy for current SLE disease, and duration since the first episode were all significantly linked to recurrence in multivariable analysis. Overall, this study reported the rate of recurrent pericarditis among SLE patients and risk variables linked to recurrence in this cohort analysis of individuals with SLE and a history of pericarditis.&nbsp;</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Kim, Y. J., Lovell, J., Diab, A., Magder, L. S., Goldman, D., Petri, M., Fava, A., &amp; Adamo, L. (2025). Incidence and factors associated with recurrent pericarditis in lupus. JAMA Network Open, 8(2), e2461610. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830584" rel="nofollow">https://doi.org/10.1001/jamanetworkopen.2024.61610</a></p>

376. New Study Links E-Cigarette Use to Increased Risk of COPD and Hypertension

     Fri, 18 Apr 2025 02:45:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283501-mdtv-2025-04-18t115210154.webp' /><div class="pasted-from-word-wrapper"><div style="text-align: justify; ">A large-scale study led by Johns Hopkins Medicine has revealed that exclusive use of e-cigarettes is significantly associated with an increased risk of <a href="https://medicaldialogues.in/topics/chronic-obstructive-pulmonary-disease">chronic obstructive pulmonary disease</a> (<a href="https://medicaldialogues.in/topics/COPD">COPD</a>), and may also be linked to a slight rise in high blood pressure among adults aged 30 to 70. The analysis, published in<i><a href="https://medicaldialogues.in/topics/Nicotine-&amp;-Tobacco-Research"> Nicotine &amp; Tobacco Research</a></i> used medical data from nearly 250,000 individuals over four years, providing one of the most comprehensive examinations to date of <a href="https://medicaldialogues.in/topics/Vaping">vaping’s </a>long-term health impacts.</div><div style="text-align: justify;">The study analyzed health outcomes across several <a href="https://medicaldialogues.in/topics/tobacco">tobacco </a>use groups: exclusive e-cigarette users, exclusive combustible cigarette users, dual users, and non-users. Of the 249,190 participants, 3,164 were exclusive e-cigarette users, while over 33,000 used only combustible <a href="https://medicaldialogues.in/topics/cigarettes">cigarettes</a>. During the follow-up period, researchers documented over 23,000 new cases of hypertension, more than 13,000 new cases of type 2 diabetes, and nearly 8,000 new cases of COPD. Exclusive e-cigarette use was found to be significantly associated with the development of COPD, and in a specific sub-group aged 30–70, with a slight increase in hypertension risk. However, it was not significantly linked to heart failure, atherosclerotic cardiovascular disease, or type 2 diabetes.</div><div style="text-align: justify;">In contrast, exclusive use of traditional cigarettes was strongly associated with higher risk across all measured outcomes, including heart failure and cardiovascular disease. Dual users—those who smoked both e-cigarettes and combustible cigarettes—had slightly higher risk levels than exclusive smokers, further emphasizing the dangers of continued traditional cigarette use.</div><div style="text-align: justify;">Dr. Michael Blaha, senior author of the study and professor of cardiology and epidemiology at the Johns Hopkins University School of Medicine, highlighted the importance of the findings in shaping public understanding and policy. “There remains great uncertainty about the relative harm of e-cigarettes as compared to traditional smoking. Until now, there has been scant longitudinal data in large high-quality datasets linking exclusive e-cigarettes use to new-onset cardiometabolic health conditions,” he said. “This study suggests that e-cigarettes have definite potential health risks, although the risks may be less than what is seen for traditional combustible cigarette smoking alone.”</div><div style="text-align: justify;">The researchers noted that while e-cigarettes are often marketed as a safer alternative to smoking, their aerosols can contain dangerous organic compounds and high levels of nicotine, posing risks especially for younger users.</div><div style="text-align: justify;">Reference: John Erhabor, Zhiqi Yao, Erfan Tasdighi, Emelia J Benjamin, Aruni Bhatnagar, Michael J Blaha, E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research Program, Nicotine &amp; Tobacco Research, 2025;, ntaf067, https://doi.org/10.1093/ntr/ntaf067</div><div></div></div>

377. Study Reveals How Kids’ Mattresses Release Hidden Toxins

     Fri, 18 Apr 2025 02:30:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283497-mdtv-2025-04-18t114304602.webp' /><div class="pasted-from-word-wrapper"><div style="text-align: justify; ">A new study published in <i><a href="https://medicaldialogues.in/topics/environmental-science-technology">Environmental Science &amp; Technology</a></i> has found that children's mattresses emit toxic chemicals linked to developmental and <a href="https://medicaldialogues.in/topics/hormonal-disorders">hormonal disorders</a>. Researchers, led by Prof. Miriam Diamond from the University of Toronto, measured indoor air quality in 25 bedrooms of children aged 6 months to 4 years. They detected high levels of phthalates, flame retardants, and UV filters—especially near the beds.</div><div style="text-align: justify;">To trace the source, the team also tested 16 new children’s mattresses using lab simulations. The results showed that a child’s body heat and weight significantly increased the release of these chemicals into the air. Despite bans on certain chemicals in toys, many of the same substances were found in mattresses, which remain poorly regulated.</div><div style="text-align: justify;">The phthalates and organophosphate ester flame retardants measured in this study are hormone disruptors and linked to neurological harms, including learning disorders, reduced IQ scores, behavioural problems, and impaired memory, said the researchers.</div><div style="text-align: justify;">Some are also linked to childhood <a href="https://medicaldialogues.in/topics/asthma">asthma </a>and <a href="https://medicaldialogues.in/topics/cancer">cancer</a>. Several UV filters are hormone disruptors. Children are uniquely vulnerable to exposure, given that they are still developing, have hand-to-mouth behaviours, and have breathing rates ten times higher than adults.</div><div style="text-align: justify;">They also have more permeable skin and three times the skin surface area relative to their body weight than adults. Flame retardants are linked to neurological, reproductive, and hormonal harm as well as cancer, and also have no proven fire-safety benefit as used in mattresses.</div><div style="text-align: justify;">The researchers call for manufacturers to be more vigilant about the chemicals in children’s mattresses through testing.</div><div style="text-align: justify;">The authors recommend decluttering children’s sleeping areas by reducing the number of pillows, blankets, and toys. They also recommend washing and refreshing your child’s bedding and bed clothing frequently since this act as a protective barrier to reduce exposure.</div><div style="text-align: justify;">References: Young Children’s Exposure to Chemicals of Concern in Their Sleeping Environment: An In-Home Study, Sara Vaezafshar, Sylvia Wolk, Victoria H. Arrandale, Roxana Sühring, Erica Phipps, Liisa M. Jantunen, and Miriam L. Diamond, Environmental Science &amp; Technology Letters Article ASAP, DOI: 10.1021/acs.estlett.5c00051</div><div></div><div></div></div>

378. Meat or veg? Plant-based protein linked to a longer life, research shows

     Fri, 18 Apr 2025 00:15:21 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/16/283210-plant-based-protein.webp' /><p style="text-align: justify; ">A global study by experts at the University of Sydney has shown that countries which consume more plant-based proteins-such as chickpeas, tofu and peas-have longer adult life expectancies. </p><p style="text-align: justify; ">Published in <i>Nature Communications</i>, Dr Alistair Senior, PhD candidate Caitlin Andrews and their team in the Charles Perkins Centre studied food supply and demographic data between 1961-2018 from 101 countries, with the data corrected to account for population size and wealth, to understand whether the type of protein a population consumed had an impact on longevity. </p><p style="text-align: justify;">First author Caitlin Andrews said: "Our study suggests a mixed picture when it comes to comparing the health impacts of meat- versus plant-based protein at a population level. </p><p style="text-align: justify;">“For the under-fives, a food system that supplies large amounts of animal-based proteins and fats – such as meat, eggs and dairy – lowered rates of infant mortality. However, for adults, the reverse was true, where plant-based proteins increased overall life expectancy.” </p><h3 style="text-align: justify; ">Methodology </h3><p style="text-align: justify;">To understand the impact of plant- and animal-based protein diets on human longevity, the researchers analysed publicly available data about the food supply of 101 countries across a 60-year period. The data included the amount of food produced per country, along with the levels of calories, proteins and fats available for consumption. </p><p style="text-align: justify;">The countries studied represented a range of food systems, including countries where the consumption of animal-based protein is higher, such as Australia, the US, Sweden and Argentina, and areas where the consumption of plant-based foods is more prevalent such as Pakistan and Indonesia. </p><p style="text-align: justify;">In order to compare the impact of different countries’ food supplies on life expectancy, the researchers corrected the data to take into account the differences in wealth and population size between countries. Having done this, they found that countries where overall availability of plant-based proteins were higher, such as India, had relatively longer life expectancies than countries where animal-based proteins was more readily available, such as the US. </p><h3 style="text-align: justify; ">Animal-based proteins and health conditions </h3><p style="text-align: justify;">Eating high levels of animal-based protein, particularly processed meat, has long been linked to a range of chronic conditions such as cardiovascular disease, type 2 diabetes and certain types of cancer. </p><p style="text-align: justify;">Meanwhile, plant proteins – including legumes, nuts and whole grains – are associated with a lower risk or chronic diseases and overall mortality rates, with studies suggesting that plant-based diets have contributed to the longevity in the most long-lived communities on the planet – Okinawa in Japan, Ikaria in Greece and Loma Linda in California. </p><p style="text-align: justify; ">Lead investigator Dr Senior said: “Protein is a crucial part of the human diet, but as eating habits change and developed countries look to decarbonise, where we get our protein from has come under greater scrutiny. </p><p style="text-align: justify; ">“The knowledge that plant-based protein is associated with a longer life is really important as we consider not only how our diets impact our own longevity, but the health of the planet.”&nbsp;&nbsp;</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Andrews, C.J., Raubenheimer, D., Simpson, S.J. et al. Associations between national plant-based vs animal-based protein supplies and age-specific mortality in human populations. Nat Commun 16, 3431 (2025). https://doi.org/10.1038/s41467-025-58475-1</p>

379. Can heart failure with preserved ejection fraction be prevented?

     Thu, 17 Apr 2025 16:00:30 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/17/278873-heart-failure-3.webp' /><p style="text-align: justify; ">An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating institutions has discovered a natural mechanism that protects the heart from <a href="https://medicaldialogues.in/topics//heart-failure">heart failure </a>with preserved <a href="https://medicaldialogues.in/topics/ejection-fraction">ejection fraction</a> (HFpEF), a serious condition in need of effective treatment. The team reports in <i>Circulation</i>, a journal of the American Heart Association, that when the cardioprotective mechanism fails, it promotes the development of HFpEF. Importantly, restoring the mechanism prevents the progression of the condition. The findings provide a promising therapeutic target to prevent and treat this life-threatening disease. </p><p style="text-align: justify;">“HFpEF is a complex, multifactorial disease associated with metabolic stress. One of the factors involved is the toxic accumulation of lipids in heart cells,” said co-author Dr. Tamer Mohamed, associate professor of surgery and director of the Laboratory for Cardiac Regeneration at Baylor. “This study was the result of a productive multidisciplinary collaboration. We worked with slices of human hearts affected by HFpEF, a method developed in my lab at Baylor, integrating the findings with the results from studies in mouse and rat models of the condition to better understand what drives this lipid overload.” </p><p style="text-align: justify;">The team began by assessing gene changes in hearts from people diagnosed with metabolic <a href="https://medicaldialogues.in/topics/stress">stress</a> along with various cardiovascular complications and found alterations in the expression of 488 genes. “We found particularly relevant the simultaneous reduction of the expression of genes XBP1 and EDEM2 in human HFpEF hearts,” Mohamed said. </p><p style="text-align: justify;">The link between EDEM2 and other conditions has been studied, but its role in the heart remains unexplored. </p><p style="text-align: justify;">“We discovered that the XBP1 protein regulates the Edem2 gene in animal models and that EDEM2 was downregulated in hearts from individuals with metabolic disorders and in mouse models,” Mohamed said. “Further evidence supported the involvement of EDEM2 and XBP1 in cardiovascular diseases and lipid regulation.” </p><p style="text-align: justify;">To investigate whether XBP1 and EDEM2 were directly involved in lipid toxicity and HFpEF, the researchers removed the Xbp1 or the Edem2 gene in mice. Consequently, these mice became more vulnerable to metabolic stress-induced heart lipid toxicity and cardiac dysfunction. “It was exciting to see that restoring XBP1 or EDEM2 alleviated lipid overload in the heart and reversed HFpEF,” Mohamed said. </p><p style="text-align: justify;">This comprehensive study uncovered that XBP1 and EDEM2 work together to maintain a healthy lipid balance in heart cells. The findings provide molecular and functional evidence that deficiency of XBP1-EDEM2 leads to lipid toxicity in the heart, accelerating the onset and development of heart failure in metabolic disorders. </p><p style="text-align: justify;">“Our findings support further study of the XBP1s and EDEM2 pathway as a promising therapeutic target for mitigating cardiac lipotoxicity and progression of HFpEF,” Mohamed said.</p><p style="text-align: justify;">Reference:</p><p style="text-align: justify; ">Oveena Fonseka, Rida Raja, XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity, Circulation, https://doi.org/10.1161/CIRCULATIONAHA.124.072194.</p>

380. Digital Replication technique may accurately restore original crown morphology, suggests study

     Thu, 17 Apr 2025 15:30:40 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283498-untitled-design-2025-04-18t114638519.webp' /><p style="text-align: justify; ">Researchers have found in a new study that Digital replication technique successfully restored the original crown morphology with high accuracy. However, the dimensional accuracy of all-ceramic crowns varied with the type of CAD/CAM porcelain material used, with lithium disilicate glass-ceramic demonstrating the most superior results.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The study aimed to evaluate the three-dimensional accuracy of computer-aided design and computer-aided manufacturing (CAD/CAM) in fabricating all-ceramic crowns using various cuttable materials, assessed through reverse engineering. </p><p dir="ltr" style="text-align: justify; ">The original resin tooth morphology of the left maxillary mesial incisor and left maxillary first molar from a standard resin tooth model, along with the two corresponding prepared teeth, were scanned and imported into exocad software. The digitally reproduced crown morphology was utilized to fabricate crowns from cut porcelain-reinforced resin ceramic (Uh group, Upcera Hyramic), lithium disilicate glass-ceramic (e.max group, IPS e.max Cad), and zirconia ceramic (Ue group, Upcera Explore). </p><p dir="ltr" style="text-align: justify; ">All specimens were subsequently rescanned, and the root mean square (RMS) values were calculated after overlaying with the original crown CAD data using the 3D analysis software Geomagic Studio 2013 to compare the dimensional accuracy. Results: Among the mesial incisor and first molar specimens, the e.max group demonstrated the highest dimensional accuracy of the all-ceramic crowns, followed by the Ue group, while the Uh group exhibited the lowest accuracy.</p><p dir="ltr" style="text-align: justify; "> The differences in dimensional accuracy among the three groups were statistically significant (P &lt; 0.05). The digital replication technique effectively restored the original crown morphology with a high degree of accuracy. For the same CAM pattern, the dimensional accuracy of all-ceramic crowns varied depending on the CAD/CAM porcelain material, with lithium disilicate glass-ceramic showing the superior results.</p><div style="text-align: justify;"></div><p dir="ltr" style="text-align: justify; ">Reference:</p><p dir="ltr" style="text-align: justify; ">Wang, H., Qu, W., Wang, T. et al. Accuracy analysis of all-ceramic crowns with different materials in CAD/CAM digital replication mode. BMC Oral Health 25, 491 (2025). https://doi.org/10.1186/s12903-025-05892-9</p><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div><div style="text-align: justify;"></div></div>

381. Early Gestational Diabetes Raises Postpartum Diabetes Risk, finds study

     Thu, 17 Apr 2025 15:15:40 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/06/21/241706-gestational-diabetes-50.webp' /><p style="text-align: justify;">Researchers have discovered in a new study that women diagnosed with gestational diabetes mellitus (GDM) earlier than 24 weeks of pregnancy, termed early GDM, are almost twice as prone to developing diabetes mellitus (DM) post-delivery as those diagnosed with later pregnancy. The findings demonstrate that early GDM not only has a greater risk of postpartum diabetes but also is linked to more cases of impaired glucose tolerance following delivery. The study was published in the <i>Journal of Diabetes and Its Complications</i> by Sarah J. and fellow researchers.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify;">GDM is usually screened for at or after 24 weeks' gestation, but increased early diagnosis has been more frequent as prenatal care remains more proactive. But whether early detection was linked to poorer outcomes postpartum has been subject to ongoing research until now.</p><p dir="ltr" style="text-align: justify;">The research was a systematic review and meta-analysis of the evidence. Researchers reviewed PubMed, EMBASE, WHO International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials from inception until March 2023. Researchers included observational studies and randomized controlled trials that contrasted the postpartum rate of DM among women diagnosed with early GDM (earlier than 24 weeks) compared to women with standard GDM (diagnosed at or later than 24 weeks).</p><p dir="ltr" style="text-align: justify;">The primary outcome was the diagnosis rate of postpartum diabetes. Secondary outcomes included postpartum visit attendance, completion and interpretation of oral glucose tolerance tests (OGTT), and glycated hemoglobin (HbA1c) levels. A total of 11 studies involving 1,573 women with early GDM and 3,340 with standard GDM were included in the final analysis.</p><p dir="ltr" style="text-align: justify;">Key Findings</p><p dir="ltr" style="text-align: justify;">Early GDM group (n = 1,573):</p><p dir="ltr" style="text-align: justify;">• Postpartum diabetes: 12.8%</p><p dir="ltr" style="text-align: justify;">• Impaired glucose tolerance: 24.7%</p><p dir="ltr" style="text-align: justify;">• Mean age: 30.2–37.0 years</p><p dir="ltr" style="text-align: justify;">• Mean BMI: 24.4–35.6 kg/m²</p><p dir="ltr" style="text-align: justify;">Standard GDM group (n = 3,340):</p><p dir="ltr" style="text-align: justify;">• Postpartum diabetes: 6.1%</p><p dir="ltr" style="text-align: justify;">• Impaired glucose tolerance: 13.0%</p><p dir="ltr" style="text-align: justify;">• Mean age: 28.9–32.8 years</p><p dir="ltr" style="text-align: justify;">• Mean BMI: 23.6–36.0 kg/m²</p><p dir="ltr" style="text-align: justify;">• Risk of postpartum diabetes: Almost twice (RR = 1.89) in early GDM</p><p dir="ltr" style="text-align: justify;">• Risk of impaired glucose tolerance: Almost twice (RR = 1.84) in early GDM</p><p dir="ltr" style="text-align: justify;"><span>•&nbsp;</span>Follow-up duration: Primarily 5–12 weeks after delivery, one study up to 6 years</p><p dir="ltr" style="text-align: justify;">This study affirmed that women with GDM diagnosed earlier than 24 weeks of pregnancy have a considerably increased risk of developing diabetes after delivery compared with those diagnosed after this time point. With approximately 13% of early GDM patients advancing to postpartum diabetes compared with slightly over 6% in usual GDM, the results underscore the necessity for increased vigilance, early intervention, and prolonged postpartum surveillance in this at-risk population.</p><p dir="ltr" style="text-align: justify;">Reference:</p><p dir="ltr" style="text-align: justify;">Weingarten, S. J., Levy, A. T., Al-Kouatly, H. B., &amp; McLaren, R. A., Jr. (2025). Postpartum diabetes mellitus among patients with early gestational diabetes: A systematic review and meta-analysis. Journal of Diabetes and Its Complications, 109038, 109038. https://doi.org/10.1016/j.jdiacomp.2025.109038</p><div style="text-align: justify;"></div></div>

382. Yoga Effective Alternative to Strength Training for Knee Osteoarthritis: JAMA

     Thu, 17 Apr 2025 15:00:34 -0000

     <img src='https://medicaldialogues.in/h-upload/2022/08/05/182674-yoga.webp' /><p style="text-align: justify;">Researchers have found in a randomized clinical trial that patients with knee osteoarthritis (OA) experienced comparable benefits from yoga as from conventional strength training. The findings suggest that yoga is noninferior to strength training and may be considered a viable treatment option for managing knee OA. A recent trial from Southern Tasmania, Australia, showed that yoga was noninferior to conventional strengthening exercise for decreasing knee pain at 12 weeks in adults over 40 with knee OA. The study was conducted by Bedru J. and colleagues published in <i>JAMA Network Open</i>.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify;">Knee osteoarthritis is a prevalent degenerative joint disease leading to pain, stiffness, and loss of mobility, particularly in elderly populations. Exercise is an integral part of OA treatment, yet there has been limited evidence for the relative effects of different exercise types, including yoga and strengthening, on patients with knee pain and functional recovery.</p><p dir="ltr" style="text-align: justify;">This parallel-arm, active-controlled, single-center randomized clinical trial enrolled 117 patients, 58 to yoga and 59 to strengthening. All patients had a baseline knee pain score of 40 or greater on a 100-mm visual analog scale (VAS), which is moderate to severe pain. The average age was 62.5 years (SD 8.3), and 72.6% were women.</p><p dir="ltr" style="text-align: justify;">The intervention lasted for 24 weeks, during which the participants went through 12 weeks of supervised yoga or strengthening exercise (two in-person sessions and one home session weekly), followed by another 12 weeks of unsupervised home sessions. The main outcome was the difference in knee pain during 12 weeks measured with the VAS. A prespecified non inferiority margin of 10 mm was used to assess whether yoga was not inferior to strengthening by a clinically significant amount. Secondary outcomes were WOMAC pain, function, and stiffness scores, patient global assessment, physical performance tests, depression (PHQ-9), neuropathic pain, and quality of life (AQoL-8D).</p><p dir="ltr" style="text-align: justify;">Results</p><p dir="ltr" style="text-align: justify;">• The trial discovered that the 12-week difference in VAS knee pain between groups was similar.</p><p dir="ltr" style="text-align: justify;">• The difference between pain decrease using yoga compared with strengthening was −1.1 mm (95% CI, −7.8 to 5.7 mm) and stayed within the prespecified margin of noninferiority, which demonstrated that yoga was no worse than strengthening exercises at lessening pain.</p><p dir="ltr" style="text-align: justify;">Significantly, 7 of 27 secondary outcomes that were measured at 12 and 24 weeks were in favor of yoga, statistically significant. The yoga group had superior improvement in:</p><p dir="ltr" style="text-align: justify;">• WOMAC pain: −44.5 mm (95% CI, −70.7 to −18.3)</p><p dir="ltr" style="text-align: justify;">• WOMAC function: −139 mm (95% CI, −228.3 to −49.7)</p><p dir="ltr" style="text-align: justify;">• WOMAC stiffness: −17.6 mm (95% CI, −30.9 to −4.3)</p><p dir="ltr" style="text-align: justify;">• Patient global assessment: −7.6 mm (95% CI, −15.1 to −0.2)</p><p dir="ltr" style="text-align: justify;">• 40-m fast walk test: +1.8 seconds (95% CI, 0.4 to 3.2)</p><p dir="ltr" style="text-align: justify;"><span>•&nbsp;</span>Also, depression (PHQ-9) at 12 weeks was better in the yoga group with a between-group difference of −1.1 (95% CI, −1.9 to −0.2), and quality of life (AQoL-8D) at 24 weeks was better in the yoga group (difference of 0.04; 95% CI, 0.00 to 0.07). Mild adverse events were reported equally by both groups, and no serious adverse events were linked to the interventions.</p><p dir="ltr" style="text-align: justify;">This randomized clinical trial found that yoga was noninferior to strengthening exercises for decreasing knee pain in people with knee osteoarthritis. In addition, yoga also had modest but significant benefits in joint function, patient-reported outcomes, and mental well-being through 24 weeks. These results substantiate the role of yoga as an effective, holistic exercise approach in OA management programs.</p><p dir="ltr" style="text-align: justify;">Reference:</p><p dir="ltr" style="text-align: justify;">Abafita BJ, Singh A, Aitken D, et al. Yoga or Strengthening Exercise for Knee Osteoarthritis: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(4):e253698. doi:10.1001/jamanetworkopen.2025.3698</p></div>

383. THC Exposure before Birth May Impair Infant Lung Development and Function, reveals research

     Thu, 17 Apr 2025 15:00:33 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/01/18/269710-pregnancy-50-4.webp' /><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Using <a href="https://medicaldialogues.in/topics/cannabis">cannabis</a> products during <a href="https://medicaldialogues.in/topics/pregnancyhttps://medicaldialogues.in/topics/pregnancy">pregnancy</a> may negatively affect offspring lung development and function, according to new research. The study is published in the <i>American Journal of Physiology-Lung Cellular and Molecular Physiology </i>and has been chosen as anAPSselect article for April.</p><p style="text-align: justify;">Cannabis products are commonly used during pregnancy, despite guidelines from the American College of Obstetricians and Gynecologists recommending abstinence of use in pregnancy given limited safety data regarding for the unborn child. The psychoactive ingredient in cannabis products, delta-9-tetrahydrocannabidol (THC) crosses the placenta and emerging data suggest prenatal THC use is associated with higher risk of stillbirth,<a href="https://medicaldialogues.in/topics/preterm-birth"> preterm birth </a>and low birth weight.</p><p style="text-align: justify;">THC edibles are the second most common form of cannabis consumption in pregnant individuals after <a href="https://medicaldialogues.in/topics/smoking">smoking</a>. High-quality research on the direct effects of cannabis and THC exposure during pregnancy is lacking due to the different cannabis plant strains, range of available cannabis products, common co-use with other substances and restrictions on human cannabis research.</p><p style="text-align: justify;">In this study, pregnant nonhuman primates were given a THC cookie-representing the equivalent of a “heavy human medical cannabis dose”-in addition to their regular diet. They continued to eat the cookies throughout pregnancy and after giving birth. During pregnancy, researchers measured fetal lung development with MRI. </p><p style="text-align: justify;">After birth, the research team performed assessments to determine the THC-exposed infants’ lung capacity, volume and forced expiratory flow (the amount of air that is forcibly exhaled within a specific time period). They also examined fluid from the exposed newborns’ lungs and analyzed their DNA and RNA. </p><p style="text-align: justify;">Some of the findings associated with prenatal THC exposure include: </p><ul><li style="text-align: justify;">Reduced fetal lung volume beginning mid-pregnancy in the second trimester. </li></ul><ul><li style="text-align: justify; ">Changes to expression in more than 700 genes in newborns’ lungs. </li></ul><ul><li style="text-align: justify;">Significant decrease in key growth factors for lung development in exposed infants. </li></ul><p style="text-align: justify;">“There are several key findings that highlight the potential adverse impact of THC exposure on offspring lung function and development,” the researchers wrote. The results suggest “prenatal THC exposure may have an important influence on future respiratory health, and further studies in human populations are needed.”</p><p style="text-align: justify;">Reference:</p><p style="text-align: justify;">Qing Ma, Hanxiang Liu, Ming Liu, TrkB signaling promotes alveolar capillary angiogenesis following perinatal hyperoxic damage, American Journal of Physiology-Lung Cellular and Molecular Physiology, https://doi.org/10.1152/ajplung.00334.2023.</p></div>

384. Willis Covered Stent Promising in Treating Intracranial Blood Blister-Like Aneurysms: Case Series Findings

     Thu, 17 Apr 2025 15:00:33 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/08/282089-blood-blister-like-aneurysms.webp' /><p style="text-align: justify; ">China: A recent case series published in<em> <a href="https://medicaldialogues.in/topics/bmc-surgery">BMC Surgery</a></em> has highlighted the potential of the Willis covered stent (WCS) as a viable option for managing intracranial blood blister-like aneurysms (BBAs), a rare but challenging subset of <a href="https://medicaldialogues.in/topics/aneurysm">aneurysms </a>associated with high rates of rupture and mortality.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Sheng Guan, Department of Neurointervention, Zhengzhou University First Affiliated Hospital, Henan, Zhengzhou, China, and colleagues reviewed the medical records of 21 consecutive patients who underwent <a href="https://medicaldialogues.in/topics/endovascular-treatment">endovascular treatment</a> with the WCS between July 2017 and July 2022. BBAs are typically located at non-branching sites of the internal carotid artery and are structurally fragile due to the absence of key arterial layers, making treatment particularly complex.</p><p style="text-align: justify; ">This series involved 15 female and six male patients with an average age of 51.6 years. The immediate postoperative results were encouraging—angiographic evaluations confirmed complete occlusion of all aneurysms without endoleak. While the parent artery remained patent in all cases, the procedure was not without complications. Occlusion of the ophthalmic artery was noted in five patients, accounting for 23.8% of the cases. Additionally, one patient developed delayed thrombosis of the stent three days post-surgery.</p><p style="text-align: justify; ">During an average angiographic follow-up period of just over nine months, all aneurysms remained completely sealed. There were no cases of aneurysm rupture, recurrence, or need for retreatment. Mild to moderate asymptomatic in-stent stenosis was detected in two individuals. Clinical follow-up, which spanned an average of 20 months, revealed excellent functional outcomes—20 patients scored a zero on the modified Rankin Scale (mRS), indicating no disability, while one scored a one.</p><p style="text-align: justify; ">The Willis-covered stent, designed initially for use in complex intracranial pathologies such as pseudoaneurysms and carotid-cavernous fistulas, offers a promising treatment avenue for BBAs. Its structure—a combination of a balloon-expandable stent and a polytetrafluoroethylene membrane—enables it to seal the aneurysm while maintaining vessel integrity.</p><p style="text-align: justify; ">Despite the encouraging outcomes, the researchers emphasized that the procedure is not without risks, particularly for technical challenges related to stent delivery and potential complications like branch artery occlusion or in-stent stenosis. Given the small sample size and limited follow-up duration, they called for larger prospective studies with longer observation periods to validate these findings and refine treatment protocols.</p><p style="text-align: justify; ">“The findings from the case series add to the growing body of evidence supporting the Willis covered stent as a safe, feasible, and effective option for the endovascular management of blood blister-like aneurysms,” the authors noted.</p><p style="text-align: justify; ">However, they cautioned that its use warrants careful attention to potential procedural challenges, including stent delivery difficulties and related complications, to ensure the best possible clinical outcomes. </p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Jin, Y., Guo, X., Chen, Z. et al. Endovascular treatment of intracranial blood blister-like aneurysms with the Willis covered stent: a case series. BMC Surg 25, 140 (2025). https://doi.org/10.1186/s12893-025-02874-0</p></div><p style="text-align: justify; "><br></p>

385. Covert or latent Toxoplasma gondii infection significantly correlated with CKD, reveals research

     Thu, 17 Apr 2025 15:00:18 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283500-ckd.webp' /><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">Covert or latent Toxoplasma gondii infection is significantly correlated with chronic kidney disease, according to research published in BMC Nephrology. Patients with chronic kidney disease are susceptible to acquiring opportunistic parasites due to acquired immunodeficiency caused by uremia. </p><p dir="ltr" style="text-align: justify; ">Therefore, the present case–control study attempted to determine the prevalence of Toxoplasma gondii infection and the associated risk factors among patients with chronic kidney disease undergoing hemodialysis and healthy controls who were registered at the Iranian National Registry Center for Toxoplasmosis in Mazandaran Province, northern Iran. </p><p dir="ltr" style="text-align: justify; ">A total of 212 patients with chronic kidney disease and 200 healthy controls were enrolled in this study. Informed consent and a questionnaire were obtained from all subjects. Blood samples were collected from each participant, and the serum was screened for anti-Toxoplasma antibodies (immunoglobulin G and immunoglobulin M). Polymerase chain reaction assay was performed to detect circulating Toxoplasma gondii in the blood samples of patients and controls using the primer pair targeting the repetitive element gene. </p><p dir="ltr" style="text-align: justify; ">Results indicated that out of 412 participants, 67.92 percent of patients and 15.5 percent of control subjects were positive for anti-Toxoplasma immunoglobulin G, but all participants were negative for anti-Toxoplasma immunoglobulin M. Also, considering polymerase chain reaction assays with the repetitive element target, the prevalence of Toxoplasma gondii infection was 24.1 percent in case subjects, while none of the control subjects tested positive. Among the polymerase chain reaction-positive cases, 34 (66.7 percent) had Toxoplasma immunoglobulin G positivity. </p><p dir="ltr" style="text-align: justify; ">The results from the multiple multinomial logistic regression revealed that the seroprevalence of anti-Toxoplasma gondii immunoglobulin G antibodies in patients with chronic kidney disease was 3.12 times higher than in healthy controls (odds ratio = 3.12; 95 percent confidence interval = 0.43, 14.8; P &lt; 0.001). Also, there was a significant association between the seroprevalence of Toxoplasma gondii infection and age, having a cat at home, and the level of glomerular filtration rate in these patients. The findings demonstrate a highly significant association between latent Toxoplasma gondii infection and chronic kidney disease, mostly in the late stages. Thus, regular screening for Toxoplasma gondii infection in these patients is strongly recommended to prevent the reactivation of latent infections. </p><p dir="ltr" style="text-align: justify; ">A combination of serological screening, chemoprophylaxis, and polymerase chain reaction follow-up for patients at risk of reactivation should effectively reduce the likelihood of latent infection reactivation.</p><p dir="ltr" style="text-align: justify; ">Reference:</p><p dir="ltr" style="text-align: justify; ">Montazeri, M., Fakhar, M., Sedighi, O. et al. Latent Toxoplasma gondii infection and associated risk factors among patients with chronic kidney disease: a registry-based study. BMC Nephrol 26, 163 (2025). https://doi.org/10.1186/s12882-025-04079-2</p></div>

386. Surgery Beneficial for Recurrent Diverticulitis Without Added Risk:JAMA

     Thu, 17 Apr 2025 15:00:05 -0000

     <img src='https://medicaldialogues.in/h-upload/2020/04/27/127857-diverticulitis.webp' /><p>Researchers have found in a new study that among patients with recurrent diverticulitis, surgery may offer a viable option to prevent future episodes and enhance quality of life, without increasing the risk of complications. The study was published in <i>JAMA Surgery</i> by Alexandre S. and colleagues. This outcome is based on the 4-year follow-up data of the Laparoscopic Elective Sigmoid Resection Following Diverticulitis (LASER) randomized clinical trial.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The trial, which was carried out in six hospitals in Finland, randomized 90 patients between October 2014 and October 2018. All the patients were followed up for four years, and the outcomes were compared between October 2023 and November 2024. The primary objective was to determine whether surgical intervention has significant advantages over conservative approaches, particularly in long-term environments.</p><p dir="ltr">The LASER trial was an open-label randomized controlled trial of 90 adult patients (mean age ~55.6 years; 31% male and 69% female) with a clinical diagnosis of recurrent, chronic painful, or complicated diverticulitis. Patients were randomly allocated in a 1:1 ratio to either receive elective laparoscopic sigmoid resection or remain on conservative treatment. Quality of life was assessed by the Gastrointestinal Quality of Life Index (GIQLI), and recurrence and complication rates were monitored over a time frame of four years by intention-to-treat and per-protocol analyses.</p><p dir="ltr">Key Findings</p><p dir="ltr">• 90 patients were recruited (28 men [31%], 62 women [69%]; mean age ~55.6 years).</p><p dir="ltr">• 45 patients were allocated to surgery; 45 to conservative management.</p><p dir="ltr">• 32% (14 of 44) in the conservative group switched over to surgery within 4 years.</p><p dir="ltr">• GIQLI scores at 4 years: 115.3 (surgery) vs 109.8 (conservative); mean difference 5.54 (95% CI, −2.98 to 14.06), not statistically significant.</p><p dir="ltr">• Recurrence of diverticulitis: 6 of 38 (16%) in the surgery group (10% post-surgery), vs 34 of 37 (92%) in conservative group.</p><p dir="ltr"><span>•&nbsp;</span>Severe complications: 4 patients (10%) in the surgery group vs 5 patients (11%) in conservative group.</p><p dir="ltr">Elective sigmoid resection in patients with recurrent or complicated diverticulitis greatly lowers the risk of recurrence without a rise in severe complications. Yet, it does not provide a substantial improvement in long-term quality of life over conservative management. These results indicate that patients with severely compromised QOL can gain more from initial surgery, whereas conservative management is still a valid choice for patients with milder symptoms or intact QOL.</p><p dir="ltr">Reference:</p><p dir="ltr">Santos A, Mentula P, Pinta T, et al. Sigmoid Resection vs Conservative Treatment After Diverticulitis: Prespecified 4-Year Analysis of the LASER Randomized Clinical Trial. JAMA Surg. Published online April 09, 2025. doi:10.1001/jamasurg.2025.0572</p><div></div></div>

387. HEALEY ALS Trial: Pridopidine Shows No Impact on Disease Progression in ALS

     Thu, 17 Apr 2025 14:45:41 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/18/283556-untitled-design-2025-04-18t150020578.webp' /><p style="text-align: justify; ">USA: A recent study evaluating pridopidine for treating <a href="https://medicaldialogues.in/topics/amyotrophic-lateral-sclerosis-als">amyotrophic lateral sclerosis (ALS)</a> has found no significant effect on <a href="https://medicaldialogues.in/topics/disease-progression">disease progression</a>. Conducted as part of the HEALEY ALS Platform Trial, the 24-week investigation assessed whether pridopidine could slow functional decline in individuals with ALS, a neurodegenerative disorder characterized by progressive muscle weakness and loss of motor function.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The findings were published online in<a href="https://medicaldialogues.in/topics/jama"> JAMA (The Journal of the American Medical Association)</a> on February 17, 2025. </p><p style="text-align: justify; ">Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease with limited treatment options. The sigma-1 (σ1) receptor has gained attention as a potential therapeutic target due to its role in cellular protection and neurodegeneration. Jeremy M. Shefner, MD, PhD, Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, and colleagues aimed to evaluate the effects of pridopidine, a selective σ1-receptor agonist, in slowing ALS progression and preserving motor function. </p><p style="text-align: justify; ">For this purpose, the researchers evaluated pridopidine as part of the HEALEY ALS Platform Trial, a multicenter, phase 2/3 randomized study conducted at 54 sites in the US from January 2021 to July 2022. A total of 163 participants with ALS were assigned to receive either pridopidine or a placebo, with an additional 122 placebo participants included in the analysis. Participants received either 45 mg of oral pridopidine twice daily or a matching placebo for 24 weeks.</p><p style="text-align: justify; ">The primary outcome measured disease progression using a model integrating functional decline and survival, while secondary outcomes assessed respiratory function, bulbar symptoms, and survival-related measures. </p><p style="text-align: justify; ">The key findings of the study were as follows:</p><ul><li style="text-align: justify; ">The trial included 162 patients with a mean age of 57.5 years, of whom 35% were female.</li><li style="text-align: justify; ">A total of 136 participants (84%) completed the study.</li><li style="text-align: justify; ">There was no significant difference between pridopidine and placebo in disease progression (DRR: 0.99, 95% credible interval: 0.80-1.21, probability of DRR &lt;1: 0.55).</li><li style="text-align: justify; ">There were no improvements in ALS functional rating scale components or survival.</li><li style="text-align: justify; ">Pridopidine showed no benefit on secondary outcomes.</li><li style="text-align: justify; ">Common adverse events included falls (28.1% in the pridopidine group vs. 29.3% in the placebo group) and muscular weakness (24.0% vs. 31.7%, respectively).</li></ul><p style="text-align: justify; ">The HEALEY ALS Platform Trial findings indicate that pridopidine did not demonstrate any meaningful impact on disease progression in patients with amyotrophic lateral sclerosis. Over the 24-week study period, there was no significant difference between pridopidine and placebo in terms of disease severity, functional decline, or survival. Additionally, the treatment showed no benefit across key secondary outcomes.</p><p style="text-align: justify; ">"These results suggest that pridopidine may not be an effective therapeutic option for ALS, highlighting the continued need for further research to identify viable treatments that can slow disease progression and improve patient outcomes," the authors concluded. </p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Writing Committee for the HEALEY ALS Platform Trial, HEALEY ALS Platform Trial Study Group. Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial. JAMA. 2025;333(13):1128–1137. doi:10.1001/jama.2024.26429</p></div><p style="text-align: justify; "><br></p>

388. Children exposed to higher ozone levels early in life more likely to develop asthma: JAMA

     Thu, 17 Apr 2025 14:45:11 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/07/08/213749-asthma-in-children-2.webp' /><p style="text-align: justify; "><a href="https://medicaldialogues.in/topics/asthma">Asthma </a>affects more than 6% of U.S. children, making it the most common chronic disease in kids nationwide. It's difficult to isolate any single cause, but one of the most common contributors is<a href="https://medicaldialogues.in/topics/air-pollution"> air pollution</a>: Studies have shown that breathing air with high levels of fine particulate matter, nitrogen dioxide and other environmental pollutants can increase children’s risk of developing asthma. But it’s been unclear whether long-term, early childhood exposure to ozone, the pollutant that most frequently exceeds U.S. air quality standards, contributes to the disease. </p><p style="text-align: justify; ">Logan Dearborn, a doctoral student at the University of Washington, set out to find a possible link. In a study published April 2 in <i>JAMA Network Open</i>, Dearborn and collaborators identified a puzzling trend: Children exposed to higher levels of ozone in their first two years of life were significantly more likely to be diagnosed with asthma or wheezing at ages 4-6-but researchers didn’t observe the increased risk of asthma at ages 8-9. </p><p style="text-align: justify; ">While the researchers couldn’t pin down the exact reason, possible explanations include the changing nature of asthma as kids age, which could lead to a drop-off in formal diagnoses, and the influence of other risk factors and pollutants on asthma as children’s lungs grow. </p><p style="text-align: justify;">“It’s a puzzling finding,” said Dearborn, who led the research in the UW Department of Environmental &amp; Occupational Health Sciences. “It’s something we spent a long time trying to consider, and I don’t know if we ever came up with a satisfying answer. But these findings are important. Even if we only see the effects early in life, there are still all kinds of associated health care costs and stresses for families. There are all sorts of larger contextual factors about having this chronic disease at any point in life.” </p><p style="text-align: justify;">This study relied on data from the Environmental influences on Child Health Outcomes (ECHO) program, a federal research project focused on how a wide range of environmental factors affect children’s health. Researchers drew 1,118 participants from six cities, including Seattle and Yakima, who had low-risk pregnancies and completed validated surveys that asked if their children had been diagnosed with asthma or had experienced wheezing. </p><p style="text-align: justify; ">Researchers estimated exposure in the first two years of a child’s life using a model developed by co-author Dr. Joel Kaufman, a UW professor of environmental and occupational health sciences, of epidemiology and of medicine. They found that a relatively small increase in ozone exposure-2 parts per billion-in a child’s first two years of life was associated with a 31% increase in asthma and 30% increase in wheeze at age 4-6 years. Asthma and wheeze risk at ages 8-9 was not found to be associated with their early life ozone concentration. </p><p style="text-align: justify; ">Researchers also analyzed how exposure to mixtures of three common air pollutants-ozone, nitrogen dioxide and fine particulate matter (PM2.5)-affected asthma outcomes. In this analysis, ozone stood out. </p><p style="text-align: justify;">“We interpret trends, and what we can conclude from this analysis is that when ozone within the air pollution mixture was higher than about 25 parts per billion, we saw a higher probability of asthma regardless of the concentration of nitrogen dioxide,” Dearborn said. “We found a relationship between ozone and asthma only when fine particulate matter was at or above median concentrations, giving novel evidence that the relationship between ozone and childhood asthma may depend on the concentration of other pollutants, like fine particulate matter.” </p><p style="text-align: justify;">The study’s findings highlight the need for more research into the effects of long-term ozone exposure in early life, Dearborn said. Further study could determine why the increased asthma risk related to ozone is not evident at ages 8-9, and whether it increases again later in childhood. </p><p style="text-align: justify;">In the meantime, Dearborn said, researchers and public health officials should pay more attention to the effects of long-term exposure to ozone. </p><p style="text-align: justify; ">“In the United States, ozone regulations only consider a very short time period,” Dearborn said. “We don’t regulate ozone over the long term, and that’s where this analysis fits in. Maybe we should be considering both a short- and a long-term threshold for the regulation of ozone.”&nbsp;&nbsp;</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Dearborn LC, Hazlehurst MF, Sherris AR, et al. Early-Life Ozone Exposure and Asthma and Wheeze in Children. JAMA Netw Open. 2025;8(4):e254121. doi:10.1001/jamanetworkopen.2025.4121</p>

389. Study Warns of Rising Hypertension and Diabetes Cases in Raipur Slum: Urges Early Screening

     Thu, 17 Apr 2025 14:30:48 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/24/279896-type-2-diabetes.webp' /><p style="text-align: justify; ">India: A recent retrospective record-based study conducted in an urban slum of Chhattisgarh has highlighted the significant prevalence of hypertension and diabetes mellitus in the region. The researchers found that hypertension (33%) and diabetes mellitus (16%) were common in the urban slum of Raipur, India.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">"The likelihood of hypertension was more than twice as high among individuals consuming alcohol (aOR: 2.98) and those with diabetes (aOR: 2.55). Similarly, the risk of diabetes increases with advancing age and the presence of hypertension (aOR: 2.57)," the researchers wrote in <em>Cureus</em>. They emphasized that "these findings highlight the importance of early screening and targeted interventions to alleviate the burden of these conditions in underserved communities."</p><p style="text-align: justify; ">Non-communicable diseases continue to be a major health challenge in India, with hypertension and diabetes exerting a disproportionate financial and healthcare burden on underprivileged communities. Given the significant impact of these conditions, Ashish W. Khobragade, Department of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, IND, and colleagues sought to assess their prevalence and identify key risk factors in an urban slum of Raipur city.</p><p style="text-align: justify; ">For this purpose, the researchers conducted a retrospective record-based study in an urban slum of Raipur using data from the population-based screening register maintained at the Urban Health Training Centre, AIIMS Raipur. They extracted information on adults screened between January and December 2023, analyzing sociodemographic details, lifestyle factors, family history of non-communicable diseases, and medication history. The prevalence of diabetes mellitus and hypertension was estimated, and logistic regression was performed to identify key risk factors for both conditions. </p><p style="text-align: justify; ">Key Findings:</p><ul><li style="text-align: justify; ">The study included 1,005 participants with a median age of 48.</li><li style="text-align: justify; ">The prevalence of hypertension was 33%, while diabetes mellitus was observed in 16% of participants.</li><li style="text-align: justify; ">Increased age (aOR: 1.06), alcohol consumption (aOR: 2.98), and diabetes mellitus (aOR: 2.55) were identified as significant risk factors for hypertension.</li><li style="text-align: justify; ">The risk of diabetes mellitus was significantly associated with increasing age (aOR: 1.03) and the presence of hypertension (aOR: 2.57).</li></ul><p style="text-align: justify; ">The study highlights the high prevalence of hypertension and diabetes mellitus in urban slum populations, highlighting their vulnerability to non-communicable diseases.</p><p style="text-align: justify; ">The authors identified advancing age, alcohol consumption, and diabetes mellitus as key risk factors for hypertension, while age and hypertension were significant predictors of diabetes.</p><p style="text-align: justify; ">"Many affected individuals remain unaware of their condition or struggle with disease management. Targeted interventions focusing on lifestyle modifications, early screening, and treatment adherence are essential to reducing the burden of these conditions in underserved communities," they concluded.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Khobragade A W, Ruikar M M, Singh G, et al. (March 21, 2025) The Burden of Hypertension and Diabetes Mellitus and Their Predictors in an Urban Slum of Chhattisgarh, India: A Retrospective Record-Based Study. Cureus 17(3): e80953. doi:10.7759/cureus.80953</p><p style="text-align: justify; "> </p></div><p style="text-align: justify; "><br></p>

390. Outrage over NEET PG 2025 double shifts: Take a look at what it's all about

     Thu, 17 Apr 2025 14:30:27 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283451-neet-pg-2025.webp' /><p style="text-align: justify; ">New Delhi: The long-awaited <a href="https://medicaldialogues.in/topics/neet-pg-2025">NEET PG 2025</a> information bulletin is here. The <a href="https://medicaldialogues.in/topics/nbe">National Board of Examinations in Medical Sciences (NBEMS), NB</a>E, has finally released the information bulletin for NEET PG 2025 aspirants on its official website. The bulletin contains all the details, including the application process and exam fee, eligibility criteria, scheme of examination, admit card, test day do's and don'ts, counselling, reservation and exam centres for NEET PG 2025.</p><p style="text-align: justify; ">Medical Dialogues has been extensively reporting on the outrage that followed after the NBE's announcement to hold the PG medical entrance test, NEET PG 2025, for this academic year's admissions in double shifts. Since the announcement, the <a href="https://medicaldialogues.in/topics/doctors">doctors</a> across the country have been demanding a single shift conduction of the exam.</p><p style="text-align: justify; ">As per the scheme of examination detailed in the information bulletin, the NEET PG 2025 exam for the first shift candidates will begin at 9 AM and the second shift at 3:30 PM.</p><div class="pasted-from-word-wrapper"><div> </div><div></div><h2 style="text-align: justify; "><b>Double Shifts in NEET PG 2025:</b></h2><div><b></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;">NEET PG 2025 shall be conducted on 15th June 2025 through a computer-based examination in a single day. There will be two examination shifts on 15th June 2025. Candidates will be allotted to one of the <a href="https://medicaldialogues.in/topics/double-shift">two shifts</a> by NBEMS.</div><div></div><div style="text-align: justify; ">"The candidates shall not be able to exercise the choice of shift (Morning or Afternoon) in which they shall be allowed to take the examination. The allotment of the shifts to the candidates will be done by NBEMS purely randomly," the NBE stated.</div></div><div class="pasted-from-word-wrapper"><div><b></b></div><div style="text-align: justify; "><b>Allocation of time for NEET-PG 2025 shall be as follows:</b></div><div><b></b></div></div><div class="pasted-from-word-wrapper"><table border="0" cellspacing="0" cellpadding="0" style="text-align: justify; "> <tbody><tr> <td width="340"> <p><b>Activities</b></p> </td> <td width="164"> <p><b>Shift-I Timings</b></p> </td> <td width="163"> <p><b>Shift-II Timings</b></p> </td> </tr> <tr> <td width="340"> <p>Allow Candidates to enter the&nbsp;examination centre and Commence Registration for the test</p> </td> <td width="164"> <p>07:00 AM</p> </td> <td width="163"> <p>01:30 PM</p> </td> </tr> <tr> <td width="340"> <p>Entry closes at Examination Center</p> </td> <td width="164"> <p>08:30 AM</p> </td> <td width="163"> <p>03:00 PM</p> </td> </tr> <tr> <td width="340"> <p>Grant access for Candidate Login</p> </td> <td width="164"> <p>08:45 AM</p> </td> <td width="163"> <p>03:15 PM</p> </td> </tr> <tr> <td width="340"> <p>Candidates log in to read instructions</p> </td> <td width="164"> <p>08:50 AM</p> </td> <td width="163"> <p>03:20 PM</p> </td> </tr> <tr> <td width="340"> <p>Exam Start Time</p> </td> <td width="164"> <p>09:00 AM</p> </td> <td width="163"> <p>03:30 PM</p> </td> </tr> <tr> <td width="340"> <p>Exam End Time</p> </td> <td width="164"> <p>12:30 PM</p> </td> <td width="163"> <p>07:00 PM</p> </td> </tr> </tbody></table></div><div class="pasted-from-word-wrapper"><div><b></b></div><div><b></b></div><div></div><div></div><div></div></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b>Syllabus</b>: The syllabus for the exam shall comprise of subject/knowledge area as per Graduate Medical Education Regulations issued by the National Medical Commission/ the erstwhile Medical Council of India.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><br></div><div class="pasted-from-word-wrapper" style="text-align: justify; ">The examination shall be a multiple-choice questions-based test delivered using a computer-based test (CBT) as per the scheme prescribed.&nbsp;</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><br></div><div class="pasted-from-word-wrapper" style="text-align: justify; ">The exam comprises of 200 Multiple Choice Questions with each question having 4 response options/distractors in English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. Time allotted is 3 hrs 30 minutes.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><br></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b>Marking Scheme and Time Bound Sections</b>:</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><br></div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Allocation of marks for each MCQ shall be as follows:</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><i>Correct Response: 4 Marks</i></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><i>Incorrect Response: 1 Mark shall be deducted</i></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><i> Unattempted Question: Zero</i></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><i><br></i></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">There shall be 25% negative marking for incorrect answers. No marks will be deducted for unattempted questions.&nbsp;</p></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;">During the examination, candidates are given an option to mark any question, whether attempted or not, for review, which means that the candidate has been given an option to go through these questions again before the examination time ends. Candidates may note that such questions, which are marked for review shall be evaluated as per the marking scheme mentioned above.</div><div></div><div style="text-align: justify; ">The question paper for NEET-PG will be divided into five time-bound sections, namely Group A, B, C, D &amp; E. The questions from the subjects of MBBS curriculum shall be distributed across these five sections of 40 questions each. Each section will have 42 minutes of time allotted for the section. Candidates would be restricted to proceed to the next section till completion of the allotted time of the previous section and candidates would not be allowed to review the questions/ modify the responses of a section after the completion of the allotted time of that section. Questions of the next section will start automatically after the completion of the allotted time of the previous section. </div><div style="text-align: justify; ">The candidates must note that the actual number of such time-restricted sections may vary based on the total number of questions in the question paper and operational feasibility in making such sections.</div><div style="text-align: justify; "></div><div style="text-align: justify; "></div></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b><i>NEET-PG 2025 is the eligibility-cum-ranking examination for admission to various MD/MS/PG Diploma courses of 2025-26 admission session. Admissions to Post MBBS DNB Courses, Post MBBS Direct 6 year DrNB courses and NBEMS diploma courses are also undertaken through NEETPG.</i></b></div><h2 style="text-align: justify; "><b>NEET PG 2025 Schedule:</b></h2><div class="pasted-from-word-wrapper"><div class="parent"><div class="child-1"> Starting Date for submission of Online Application: 17th April 2025 (03:00 PM Onwards)</div></div><div class="parent"><div class="child-1">Closing Date for submission of Online Application: 07th May 2025 (Till 11:55 PM)</div></div><div class="parent"><div class="child-1">Edit Window for All Payment Success Applications: 09th May 2025 to 13th May 2025</div></div><div class="parent"><div class="child-1">Pre Final Edit Window to rectify deficient/Incorrect Images: 17th May to 21st May 2025</div></div><div class="parent"><div class="child-1">Final Edit Window to rectify deficient/Incorrect Images: 24th May to 26th May 2025</div></div><div class="parent"><div class="child-1">Informing the Test City to the Candidates: 02nd June 2025</div></div><div class="parent"><div class="child-1">Issue of Admit Card: 11th June 2025</div></div><div class="parent"><div class="child-1">Date of Examination: 15th June 2025</div></div><div class="parent"><div class="child-1">Declaration of Result: By 15th July 2025</div></div><div class="parent"><div class="child-1">Cut-off date for Completion of internship towards eligibility for NEET-PG 2025: 31st July 2025</div></div></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b><i> </i></b></div><div class="pasted-from-word-wrapper"><div style="text-align: justify; "> </div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><i></i></div><div class="pasted-from-word-wrapper"> </div><div class="pasted-from-word-wrapper"><div> </div></div>

391. Breast and colorectal cancer screening rates nearly four-fold higher than lung cancer screening among those eligible: Study

     Thu, 17 Apr 2025 14:30:21 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/05/31/239798-non-small-cell-lung-cancer.webp' /><p style="text-align: justify; "><a href="https://medicaldialogues.in/topics/lung-cancer">Lung cancer </a>screening has the potential to catch lung <a href="https://medicaldialogues.in/topics/cancer">cancer </a>early and save lives-but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals with a history of <a href="https://medicaldialogues.in/topics/smoking">smoking</a>, only 18% of eligible individuals in the U.S. get screened. One suggested explanation has been that those eligible are resistant to receiving preventive healthcare, but a new study published in <i>JAMA </i>and led by researchers at Mass General Brigham indicates otherwise. </p><p style="text-align: justify; ">Researchers from Mass General Brigham sought to investigate use of other preventive healthcare services among individuals eligible for lung cancer screening. Using the 2022 U.S. Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System dataset, the researchers analyzed data from 28,483 individuals aged 50 to 79 who were eligible for lung cancer screening. They found that while only 17-18% of eligible individuals received lung cancer screening, 65% of those eligible received breast and colorectal cancer screening-a nearly 4-fold higher rate. </p><p style="text-align: justify; ">“Our findings show that many individuals eligible for lung cancer screenings are open to receiving preventive care services. The data suggest that these individuals aren’t necessarily resistant to receiving cancer screenings-other factors are likely driving low rates of lung cancer screening,” said first author Alexandra Potter, a researcher in the Division of Thoracic Surgery at MGH. “These other factors may include difficulty assessing eligibility for lung cancer screening. In contrast to breast and colorectal cancer screening eligibility criteria, which are based on age alone, lung cancer screening eligibility criteria are more complex and include both age and multiple smoking history requirements. Challenges accessing lung cancer screening clinics are also likely an important factor driving low rates.” </p><p style="text-align: justify;">The researchers concluded that many individuals eligible for lung cancer screening are already engaged in preventive care. They emphasized that their findings underscore the need for interventions to increase awareness of lung cancer screening and reduce barriers that prevent high-risk individuals from undergoing lung cancer screening. </p><p style="text-align: justify; ">“As a community, we need to work together to improve lung cancer screening awareness and address the notable barriers that currently make it challenging for high-risk individuals to get lung cancer screening,” said senior author Chi-Fu Jeffrey Yang, MD, of the Division of Thoracic Surgery at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system.</p><p style="text-align: justify; ">Reference:</p><p style="text-align: justify; ">Potter AL, Kothagundla S, Haridas C, Chang AEB, Sequist LV, Yang CJ. Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US. JAMA. Published online April 02, 2025. doi:10.1001/jama.2025.2157.</p>

392. Zydus Loses Patent Battle Over Bladder Drug Myrbetriq In US, Jury Trial Set for 2026

     Thu, 17 Apr 2025 13:25:35 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/02/09/231917-zydus-lifesciences-50.webp' /><p style="text-align: justify; "><b>New Delhi: </b>Indian drugmaker Zydus Lifesciences has received a legal setback in the United States after the District Court of Delaware ruled in favour of Astellas Pharma Inc. in a patent litigation related to the widely marketed urology drug Myrbetriq (mirabegron sustained-release tablets).</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify;">In a regulatory filing to the BSE and NSE dated April 17, 2025, Zydus disclosed that the ruling upheld the validity of Astellas' U.S. Patent No. 10,842,780 (“the ‘780 patent”) pertaining to the sustained release formulation of mirabegron, which is used for treating overactive bladder (OAB).</p><p style="text-align: justify;">“The Court passed an order in favour of the innovator on the validity of the ‘780 patent. Infringement of the ’780 patent, damages, and any additional invalidity theories will be litigated at a consolidated jury trial in 2026,” Zydus said in the exchange filing​.</p><p style="text-align: justify; "><b>Background of the Case</b></p><p style="text-align: justify;">The patent battle centers on the formulation of Myrbetriq®, a popular drug sold in the US by Astellas Pharma Inc. for the treatment of overactive bladder. Zydus had challenged the validity of the ‘780 patent held by the innovator company. The litigation was heard by the United States District Court for the District of Delaware.</p><p style="text-align: justify;">“The innovator had filed a case against the Company in the matter pertaining to the validity of its US Patent No. 10,842,780 (‘the ‘780 patent’) held by the innovator, for a sustained release formulation of ‘mirabegron’ marketed in the US by the innovator under the brand name Myrbetriq®,” the company informed​.</p><p style="text-align: justify;">While the court ruled in favour of Astellas on the validity of the patent, other aspects of the litigation—including alleged infringement, potential damages, and other invalidity theories—will be taken up in a consolidated jury trial scheduled for 2026.</p><p style="text-align: justify; "><b>No Immediate Financial Impact</b></p><p style="text-align: justify;">Zydus clarified that the order does not result in any immediate financial penalty or claims.</p><p style="text-align: justify; ">“There is no material financial implication, as on the date of passing the order. We are evaluating the potential impact of the said order on the operations of the Company and the legal remedies available with the Company,” the company stated​.</p><p style="text-align: justify;">The company also noted that the submission of the litigation update was delayed due to its global stakeholder footprint.</p><p style="text-align: justify;">“The submission of information got delayed as the stakeholders are spread across global time zones,” said Dhaval N. Soni, Company Secretary and Compliance Officer at Zydus Lifesciences​</p><p style="text-align: justify; "><b>What’s Next?</b></p><p style="text-align: justify; ">With a consolidated trial scheduled for 2026, Zydus may consider pursuing further legal remedies or settlements. Meanwhile, the company continues to evaluate the impact of the court’s decision on its US market plans concerning the generic version of Myrbetriq®.</p></div></div>

393. Fake Cardiologist Case: MP Hospital's license suspended

     Thu, 17 Apr 2025 12:56:38 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283427-suspended.webp' /><p style="text-align: justify; "><b>Damoh:</b>&nbsp;The license of&nbsp;<a href="https://medicaldialogues.in/topics/missionary-hospital" target="_blank">Mission Hospital</a> in Damoh, where seven patients died due to botched angiography and angioplasty procedures allegedly performed by the fake UK-based cardiologist, <a href="https://medicaldialogues.in/topics/narendra-vikramaditya-yadav" target="_blank">Narendra Vikramaditya Yadav</a> aka 'Dr John Camm', has been suspended. The hospital has been directed to halt the admission of new patients.</p><p style="text-align: justify; ">The Madhya Pradesh health department took action after finding that the hospital’s license had expired on March 31, 2025, and it could not renew the license because it failed to fix the shortcomings that were pointed out earlier by the authorities. &nbsp;</p><p style="text-align: justify; ">Damoh district's Chief Medical and Health Officer (CMHO) Mukesh Jain told PTI that the hospital's management applied for renewal in December last year. The application for renewal of the licence, an official authorisation needed by a healthcare facility to function legally, was returned to the management after some shortcomings were found in the hospital.&nbsp;</p><p style="text-align: justify; "><a href="https://medicaldialogues.in/state-news/madhya-pradesh/fake-cardiologist-held-linked-to-ex-chhattisgarh-speakers-death-146261" target="_blank">Also read- Fake Cardiologist held, linked to Ex-Chhattisgarh Speaker's death</a></p><p style="text-align: justify; ">Jain said the hospital was told to apply again within seven days after fixing the shortcomings in accordance with the Madhya Pradesh Nursing Home and Clinical Establishment (Registration and Licensing) Act, 1973. However, the hospital failed to do so.&nbsp;</p><p style="text-align: justify; ">"The hospital failed to resubmit the application within the stipulated time. So, the license of Mission Hospital has been suspended till further notice. The hospital has been told not to admit new patients. Instructions have been given to shift the patients admitted there to the Damoh district hospital," Jain told reporters.</p><p style="text-align: justify; ">When asked about the reason for the return of the hospital's renewal application, Dr Jain said, "They did not have operators for their pathology lab and blood bank. They also did not have a doctor for anaesthesia."&nbsp;</p><p style="text-align: justify; ">Following the suspension of the license, the lawyer of Mission Hospital, advocate Shashank Shekhar, has informed that the hospital management has decided to approach the court to challenge the administrative order.&nbsp;</p><p style="text-align: justify; ">Advocate Shashank Shekhar told <a href="https://www.thehindu.com/news/national/madhya-pradesh/licence-of-madhya-pradesh-hospital-suspended-following-fake-doctor-row/article69457311.ece" rel="nofollow">The Hindu</a>, “They have suspended the license based on a shortage of technicians and doctors. Most hospitals in the State have a shortage of staff, and especially in many government hospitals, the sanctioned strength is more than the available staff."</p><p style="text-align: justify; ">Medical Dialogues had previously reported that the fake cardiologist was arrested based on a complaint by Damoh district's Chief Medical and Health Officer (CMHO), MK Jain after a former speaker of the Chhattisgarh assembly and 7 other patients lost their lives following a botched cardiac surgery at Apollo Hospital in Bilaspur and Missionary Hospital in Damoh, Madhya Pradesh, respectively.</p><p style="text-align: justify; ">In his complaint, CMHO Jain alleged Dr Camm had committed fraud by performing angiography and angioplasty on patients at the Mission Hospital without being registered with the Madhya Pradesh Medical Council.</p><p style="text-align: justify; ">The accused, whose real name is believed to be Narendra Vikramaditya Yadav, is said to have used the identity of a real doctor from the UK named 'Dr John Camm'. He pretended to be a skilled and experienced heart specialist with a medical degree from the UK and used this fake identity to treat patients in India.</p><p style="text-align: justify; "><b>9 employees of Mission Hospital held</b></p><p style="text-align: justify; ">On Tuesday, the police registered a case against nine persons for allegedly running an illegal cath lab in the hospital, days after the facility was sealed.</p><p style="text-align: justify; ">"Nine persons, including the director of Mission Hospital, have been booked for getting the registration of the cath lab done through online mode based on forged documents," police said.</p><p style="text-align: justify; ">According to an official, the hospital had obtained registration for the cath lab by forging the signature of a Jabalpur-based doctor, Akhilesh Dubey, reports PTI.&nbsp;</p><p style="text-align: justify; ">Mission Hospital’s lawyer, advocate Shashank Shekhar, told The Hindu, “It’s not just the signature that is required for the registration. The process also requires OTP verification through email, and the phone number of the doctor, which we cannot get without his consent. He gave his number and email. There was also a letter of declaration that he had given to the hospital, but it was taken away by the NHRC (National Human Rights Commission) team, which visited Damoh to probe the case."</p><p style="text-align: justify; "><a href="https://medicaldialogues.in/state-news/madhya-pradesh/fake-doctor-posing-as-uk-cardiologist-performs-heart-surgeries-kills-7-146158" target="_blank">Also read- Fake doctor posing as UK Cardiologist performs Heart Surgeries, kills 7</a></p>

394. Radiologist’s licence suspended by Maharashtra Medical Council over PC PNDT Violation

     Thu, 17 Apr 2025 12:45:55 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283406-mdtv-2025-04-17t145124537.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Six years after a civil court had convicted a Pune-based <a href="https://medicaldialogues.in/topics/radiologist">radiologist</a> for illegal sex determination, the Maharashtra Medical Council suspended her license for a period of five years for violating the rules under the <a href="https://medicaldialogues.in/topics/preconception-and-prenatal-diagnostic-techniques-act">Pre-Conception and Prenatal Diagnostic Techniques</a> (PC-PNDT) Act.</p><p style="text-align: justify;">Confirming this, the administrator of MMC, Dr. Vinky Rughwani, informed Indian Express that they recently passed an order to suspend Dr Neena Mathrani's license.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/health/doctors/maharashtra-medical-council-suspends-radiologist-over-pc-pndt-violation-146718"><b>Maharashtra Medical Council suspends Radiologist over PC PNDT Violation</b></a></i></div></div></div>

395. Doctor honey-trapped, blackmailed for Rs 10 lakh; 3 arrested

     Thu, 17 Apr 2025 12:45:44 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283416-mdtv-2025-04-17t151450046.webp' /><div class="pasted-from-word-wrapper"><div class="article-text-desc entry-content clearfix single-post-content"><div id="post-content-inner" class="row post-content-inner"><div class="details-content-story"><div><div class="story"><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">In a recent <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud</a> case, a doctor running a private nursing home in Palwal district was allegedly blackmailed for Rs 10 lakh with threats of being falsely implicated in a sexual harassment case if he failed to pay the money. The doctor fell victim to a <a href="https://medicaldialogues.in/topics/honey-trap" target="_blank">honey trap</a> set by a woman posing as a lawyer, a man pretending to be a Police Assistant sub-inspector, and a woman claiming to be a nurse.</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">The accused successfully extorted money from the doctor by threatening to ruin his reputation both on social media and in the local community. However, after the doctor reported the matter to the police, a special plan was made, leading to the arrest of all three accused.</p><div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/health/doctors/doctor-blackmailed-for-rs-10-lakh-in-honey-trap-3-arrested-146743"><b>Doctor Blackmailed for Rs 10 Lakh in Honey Trap, 3 Arrested</b></a></i></div></div><div class="pasted-from-word-wrapper"><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_1"><div class="medicine_doctor_only"><div class="advert-panel"></div></div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/news/education/hospitals-on-rent-to-set-up-private-medical-colleges-wb-plan-for-mbbs-seats-increase-146741"></a></i></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/news/health/doctors/maharashtra-medical-council-suspends-radiologist-over-pc-pndt-violation-146718"></a></i></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><i><a href="https://medicaldialogues.in/health-news/nmc/nmc-implements-face-based-aadhaar-attendance-in-medical-colleges-146737"></a></i></div><div></div></div></div></div></div></div></div><div class="entry-terms post-tags clearfix"></div></div>

396. Health Ministry Bans Chlorpheniramine Phenylephrine Combo for Children Below 4, Mandates Warning Labels

     Thu, 17 Apr 2025 12:39:15 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/11/16/260966-cough-in-children.webp' /><p style="text-align: justify; "><b>New Delhi:</b> Through a recent Gazette Notification, the Ministry of Health and Family Welfare has officially restricted the use of the widely available fixed dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride in children under four years of age, and directing manufacturers to clearly display a warning on the drug's label and package insert regarding its inappropriateness for this age group.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify;">This FDC is a common formulation found in numerous over-the-counter cold and allergy medications, especially pediatric syrups. The new directive mandates that pharmaceutical manufacturers must now update packaging and marketing materials to include the prescribed warning. Failure to comply could lead to regulatory action, including prohibition of sale.</p><p style="text-align: justify;">The decision, published in the Gazette of India on April 15, follows detailed evaluations by two expert panels, the Subject Expert Committee and the Drugs Technical Advisory Board (DTAB), which both concluded that the combination poses risks to young children and should carry mandatory warning labels.</p><p style="text-align: justify;"><b>Expert Panels Raise Red Flags</b></p><p style="text-align: justify;">According to the government notification,</p><blockquote style="text-align: justify;">“The Central Government is satisfied that the use of the drug fixed dose combination of Chlorpheniramine Maleate + Phenylephrine Hydrochloride is likely to involve risk to children below four years of age and whereas safer alternatives to the said drug are available.”</blockquote><p style="text-align: justify;">This conclusion was reached after the Subject Expert Committee, appointed by the Centre, recommended against the use of this combination in children below four years. It advised that all manufacturers must include a warning on the label, package insert, or promotional literature stating:&nbsp;<i>“Fixed dose combination shall not be used in children below four years of age.”</i></p><p style="text-align: justify;"><b>Drugs Technical Advisory Board Backs Ban for Young Children</b></p><p style="text-align: justify;">Reinforcing the stance, the DTAB also examined the matter and made a similar recommendation, calling for a regulatory restriction under Section 26A of the Drugs and Cosmetics Act, 1940. The board not only endorsed the ban for use in the under-four age group but also stated that the FDC should not be manufactured, sold, or distributed for this demographic unless the label carries the specified cautionary statement.</p><p style="text-align: justify;"><b>Central Government Imposes Nationwide Restriction</b></p><p style="text-align: justify;">Acting on these expert recommendations, the government has issued a formal directive under Section 26A;</p><blockquote style="text-align: justify;">“The Central Government hereby restricts the manufacture, sale or distribution of all formulations of fixed dose combination of Chlorpheniramine Maleate + Phenylephrine Hydrochloride subject to the following condition, that the manufacturers shall mention the warning ‘fixed dose combination shall not be used in children below four years of age’ on the label and package insert or the promotional literature of the drug.”</blockquote><p style="text-align: justify;">The restriction takes immediate effect from the date of publication in the official Gazette, i.e., April 15, 2025.</p><p style="text-align: justify;">The notification has been issued under file number X.11035/132/2024-DR, signed by Rajiv Wadhawan, Adviser (Cost), Ministry of Health and Family Welfare.</p><p style="text-align: justify; ">As the implementation rolls out, both manufacturers and healthcare providers will need to realign their practices to ensure that no formulation of this drug is administered to children under four, thus reinforcing public safety in pediatric medication use.</p></div></div>

397. WB Govt to rent out hospitals for setting up Private Medical Colleges, plan for MBBS seat boost

     Thu, 17 Apr 2025 12:30:15 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283412-mdtv-2025-04-17t150446239.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Aiming to increase the <a href="https://medicaldialogues.in/topics/mbbs-seats">MBBS seats</a> in the State, the Bengal Government is planning to provide hospitals on rent to set up private medical colleges.</p><p style="text-align: justify;">For this, the rent will be Rs 15,000 per bed per month in the municipal corporation areas of West Bengal, Rs 12,000 in municipal areas, and Rs 10,000 per bed per month in the rural areas. Therefore, initially i.e., during the first year, the bed use fee for a private medical college using 300 beds will be Rs 5.4 crore.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/news/education/hospitals-on-rent-to-set-up-private-medical-colleges-wb-plan-for-mbbs-seats-increase-146741"><b>Hospitals on rent to set up Private Medical Colleges- WB Plan for MBBS Seats increase</b></a></i></div><div></div></div><div class="pasted-from-word-wrapper"></div></div>

398. NEET PG 2025: Check out application process, eligibility criteria

     Thu, 17 Apr 2025 12:29:32 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283452-neet-pg-2025.webp' /><p style="text-align: justify; "><b>New Delhi-</b> The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) has finally released the National Eligibility and Entrance Test-Postgraduate (NEET PG) exam information bulletin for the academic year 2025. The information bulletin has been released on the official website of NBEMS</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The <a href="https://medicaldialogues.in/topics/neet-pg" target="_blank">NEET PG </a>exam 2025 information bulletin contains important details such as schedule, eligibility criteria, application process, fees, documents, etc. The NEET PG exam 2025 will be conducted on 15th June 2025 across India and the result is expected to be declared by the 15th July 2025. The exam will be conducted for admission into the MD/MS/PG Diploma Courses, Post MBBS DNB Courses, Direct 6 Years DrNB Courses and NBEMS Diploma Courses of 2025-26 academic session.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/neet-pg-2025-registrations-begin-today-at-3-pm-exam-in-two-shifts-nbe-146768"><b>Also Read:&nbsp;</b>NEET PG 2025 Registrations begin Today at 3 PM, Exam in two-shifts: NBE</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>SCHEDULE</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="54"><col width="362"><col width="208"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>PROCESSES</b></p></td><td><p dir="ltr" style="text-align: center; "><b>TIMELINES</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Online Submission of Application Form.</p></td><td><p dir="ltr">17th April 2025 (03:00 PM Onwards) to 07th May 2025 (Till 11:55 PM).</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City).</p></td><td><p dir="ltr">09th May 2025 to 13th May 2025 </p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Pre-Final Selective Edit Window to rectify Deficient/Incorrect Images </p><p dir="ltr">-Photograph </p><p dir="ltr">-Signatures </p><p dir="ltr">-Thumb Impression.</p></td><td><p dir="ltr">17th May 2025 to 21st May 2025</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Final Selective Edit Window to rectify Deficient / Incorrect Images Photograph Signatures Thumb Impression (No further opportunity shall be given).</p></td><td><p dir="ltr">24th May 2025 to 26th May 2025</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Informing the Test City to the candidates.</p></td><td><p dir="ltr">02nd June 2025</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Issue of Admit Cards.</p></td><td><p dir="ltr">11th June 2025</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Examination Date.</p></td><td><p dir="ltr">15th June 2025</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Declaration of Result </p></td><td><p dir="ltr">By 15th July 2025</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Cut-off date for completion of internship towards eligibility for NEET-PG 2025.</p></td><td><p dir="ltr">31st July 2025 </p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><u>INSTRUCTIONS TO FILL ONLINE NEET PG 2025 APPLICATION FORM</u></b></p><p dir="ltr" style="text-align: justify; ">1 New User Registration.</p><p dir="ltr" style="text-align: justify; ">2 Applicant Login.</p><p dir="ltr" style="text-align: justify; ">3 Name of Candidate.</p><p dir="ltr" style="text-align: justify; ">4 Gender and Date of Birth.</p><p dir="ltr" style="text-align: justify; ">5 Nationality.</p><p dir="ltr" style="text-align: justify; ">6 Email ID.</p><p dir="ltr" style="text-align: justify; ">7 Mobile No.</p><p dir="ltr" style="text-align: justify; ">8 Upload of Prescribed Images (Photograph, Scanned Signatures and Thumb Impression).</p><p dir="ltr" style="text-align: justify; ">9 Acknowledgement of Application Submission.</p><p dir="ltr" style="text-align: justify; ">10 Edit Window.</p><p dir="ltr" style="text-align: justify; "><b><u>STEPS TO FILL THE NEET PG 2025 APPLICATION FORM</u></b></p><p dir="ltr" style="text-align: justify; "><b>STEP 1-</b> Fill the user registration form to generate User ID / Application ID and Password.</p><p dir="ltr" style="text-align: justify; "><b>STEP 2-</b> User ID and Password will be sent through SMS and Email. </p><p dir="ltr" style="text-align: justify; "><b>STEP 3-</b> Complete the application form and upload your Photograph, Scanned signature, Thumb impression &amp; Prescribed documents.</p><p dir="ltr" style="text-align: justify; "><b>STEP 4-</b> Choose your Test City and pay Examination Fee</p><p dir="ltr" style="text-align: justify; "><b>STEP 5-</b> Agree to the declaration and Submit Application</p><p dir="ltr" style="text-align: justify; "><b>STEP 6- </b>Take a print out of the filled Application form with Transaction ID printed on it and payment status mentioned as “S” (Successful) for records.</p><p dir="ltr" style="text-align: justify; "><b><u>EXAMINATION FEES</u></b></p><p dir="ltr" style="text-align: justify; ">The examination fees for the General, OBC and EWS is Rs 3500/- and SC, ST, PWD is Rs 2500/-.</p><p dir="ltr" style="text-align: justify; "><b><u>ELIGIBILITY CRITERIA</u></b></p><p dir="ltr" style="text-align: justify; "><b><i>ELIGIBILITY CRITERIA FOR INDIAN MEDICAL GRADUATES</i></b></p><p dir="ltr" style="text-align: justify; ">Candidates who have completed their MBBS from India must</p><p dir="ltr" style="text-align: justify; ">1 Possess MBBS degree or Provisional MBBS Pass Certificate recognized as per the provisions of the NMC Act, 2019 and the Post Graduate Medical Education Regulations, 2023</p><p dir="ltr" style="text-align: justify; ">AND</p><p dir="ltr" style="text-align: justify; ">Possess Permanent or Provisional registration certificate of MBBS qualification issued by the NMC/ the erstwhile Medical Council of India or State Medical Council</p><p dir="ltr" style="text-align: justify; ">AND </p><p dir="ltr" style="text-align: justify; ">Have Completed one year of internship or are likely to complete the internship on or before 31st July 2025.</p><p dir="ltr" style="text-align: justify; "><b><i>ELIGIBILITY CRITERIA FOR FOREIGN MEDICAL GRADUATES</i></b></p><p dir="ltr" style="text-align: justify; ">Indian citizens or overseas citizens of India who have obtained their Primary Medical Qualifications from Medical Colleges outside India should have qualified the Foreign Medical Graduate Examination (Screening Test) as per Screening Test Regulations, 2002 which is conducted by National Board of Examinations in Medical Sciences. Further, they should have been registered with the NMC / the erstwhile Medical Council of India or State Medical Council and should have completed their internship or likely to complete their internship on or before 31st July 2025. </p><p dir="ltr" style="text-align: justify; "><b><i>ELIGIBILITY CRITERIA FOR FOREIGN NATIONALS</i></b></p><p dir="ltr" style="text-align: justify; ">1 Their basic Medical Qualification, equivalent to MBBS, should be recognized by the NMC. </p><p dir="ltr" style="text-align: justify; ">2 Foreign Nationals desirous of appearing in NEET-PG and those, who are required to have security clearance as per the Ministry of Home Affairs (MHA) requirements, shall obtain the security clearance from Ministry of Home Affairs, Govt. of India before applying for NEET-PG. The security clearance shall be required to be submitted while applying for NEET-PG.</p><p dir="ltr" style="text-align: justify; ">3 The NMC may, on payment of the prescribed fee for registration, grant temporary registration for the duration of the Post Graduate course limited to the medical college/institution to which he/she is admitted for the time being exclusively for pursuing postgraduate studies. Provided further that temporary registration to such foreign national shall be subject to the condition that such person is duly registered with appropriate registering authority in his own country where from he has obtained his Basic Medical qualification, and is duly recognized by the corresponding Medical Council or concerned authority and Permission/No Objection Certificate from the medical council of that country to allow undertaking Post Graduation in India has also been obtained.</p><p dir="ltr" style="text-align: justify; ">4 Candidates are advised not to canvas with NBEMS for eligibility in NEET PG or issuance of admit card. Queries, if any, can be submitted through Communication Web Portal only. Canvassing in any form shall invite rejection of the application</p><p dir="ltr" style="text-align: justify; "><b><u><i><br></i></u></b></p><div></div></div>

399. Health Bulletin 17/ April/ 2025

     Thu, 17 Apr 2025 12:27:55 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283382-health-bulletin-2025-04-17t123304328.webp' /><p style="text-align: justify; "><b>Here are the top medical news for the day:</b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>NMC to roll out face-based Aadhaar attendance in Medical colleges from May 1</b></div></div><div class="pasted-from-word-wrapper" style="text-align: justify;">In a move to streamline faculty attendance and leverage biometric technology, the National Medical Commission (NMC) has announced that all medical colleges and institutions will transition to a face-based Aadhaar authentication system via the NMC AEBAS platform from May 1, 2025. At present, all private/ government medical colleges in the country are marking attendance of faculty and staff through the AEBAS (Aadhar Enabled Biometric Attendance System) system.</div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify;">The new system, replacing the current fingerprint-based biometric authentication, aims to improve user-friendliness and enhance accuracy in attendance marking. FACE-based Aadhaar Authentication, already deployed in other government offices through NIC, will now be implemented across medical institutions using a mobile app-based interface.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div><b></b></div><div></div></div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/health-news/nmc/nmc-implements-face-based-aadhaar-attendance-in-medical-colleges-146737">NMC implements Face-Based Aadhaar Attendance in Medical Colleges</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Radiologist’s licence suspended by Maharashtra Medical Council over PC PNDT Violation</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">Six years after a civil court had convicted a Pune-based <a href="https://medicaldialogues.in/topics/radiologist">radiologist</a> for illegal sex determination, the Maharashtra Medical Council suspended her license for a period of five years for violating the rules under the <a href="https://medicaldialogues.in/topics/preconception-and-prenatal-diagnostic-techniques-act">Pre-Conception and Prenatal Diagnostic Techniques</a> (PC-PNDT) Act.</p><p style="text-align: justify;">Confirming this, the administrator of MMC, Dr. Vinky Rughwani, informed Indian Express that they recently passed an order to suspend Dr Neena Mathrani's license.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/health/doctors/maharashtra-medical-council-suspends-radiologist-over-pc-pndt-violation-146718">Maharashtra Medical Council suspends Radiologist over PC PNDT Violation</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>WB Govt to rent out hospitals for setting up Private Medical Colleges, plan for MBBS seat boost</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">Aiming to increase the <a href="https://medicaldialogues.in/topics/mbbs-seats">MBBS seats</a> in the State, the Bengal Government is planning to provide hospitals on rent to set up private medical colleges.</p><p style="text-align: justify;">For this, the rent will be Rs 15,000 per bed per month in the municipal corporation areas of West Bengal, Rs 12,000 in municipal areas, and Rs 10,000 per bed per month in the rural areas. Therefore, initially i.e., during the first year, the bed use fee for a private medical college using 300 beds will be Rs 5.4 crore.</p></div><div class="pasted-from-word-wrapper"><div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b><i><a href="https://medicaldialogues.in/news/education/hospitals-on-rent-to-set-up-private-medical-colleges-wb-plan-for-mbbs-seats-increase-146741">Hospitals on rent to set up Private Medical Colleges- WB Plan for MBBS Seats increase</a></i></b></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Doctor honey-trapped, blackmailed for Rs 10 lakh; 3 arrested</b></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">In a recent <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud</a> case, a doctor running a private nursing home in Palwal district was allegedly blackmailed for Rs 10 lakh with threats of being falsely implicated in a sexual harassment case if he failed to pay the money. The doctor fell victim to a <a href="https://medicaldialogues.in/topics/honey-trap" target="_blank">honey trap</a> set by a woman posing as a lawyer, a man pretending to be a Police Assistant sub-inspector, and a woman claiming to be a nurse.</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify;">The accused successfully extorted money from the doctor by threatening to ruin his reputation both on social media and in the local community. However, after the doctor reported the matter to the police, a special plan was made, leading to the arrest of all three accused.</p><div><p style="text-align: justify;"><b><i>For more information, click on the link below:</i></b></p></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify; "><b><i><a href="https://medicaldialogues.in/news/health/doctors/doctor-blackmailed-for-rs-10-lakh-in-honey-trap-3-arrested-146743">Doctor Blackmailed for Rs 10 Lakh in Honey Trap, 3 Arrested</a></i></b></div></div><div class="pasted-from-word-wrapper"><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post" id="inside_post_content_ad_1"><div class="medicine_doctor_only"><div class="advert-panel"></div></div></div></div><div class="pasted-from-word-wrapper"><div><b></b></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/news/education/hospitals-on-rent-to-set-up-private-medical-colleges-wb-plan-for-mbbs-seats-increase-146741"></a></i></b></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/news/health/doctors/maharashtra-medical-council-suspends-radiologist-over-pc-pndt-violation-146718"></a></i></b></div><div></div></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><div class="pasted-from-word-wrapper"><div><b><i><a href="https://medicaldialogues.in/health-news/nmc/nmc-implements-face-based-aadhaar-attendance-in-medical-colleges-146737"></a></i></b></div><div></div></div>

400. NMC to roll out face-based Aadhaar attendance in Medical Colleges from May 1

     Thu, 17 Apr 2025 12:15:51 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283405-mdtv-2025-04-17t144653394.webp' /><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper" style="text-align: justify; ">In a move to streamline faculty attendance and leverage biometric technology, the National Medical Commission (NMC) has announced that all medical colleges and institutions will transition to a face-based Aadhaar authentication system via the NMC AEBAS platform from May 1, 2025. At present, all private/ government medical colleges in the country are marking attendance of faculty and staff through the AEBAS (Aadhar Enabled Biometric Attendance System) system.</div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify;">The new system, replacing the current fingerprint-based biometric authentication, aims to improve user-friendliness and enhance accuracy in attendance marking. FACE-based Aadhaar Authentication, already deployed in other government offices through NIC, will now be implemented across medical institutions using a mobile app-based interface.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div></div><div></div></div><p style="text-align: justify;"><i><b>For more information, click on the link below:</b></i></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><i><a href="https://medicaldialogues.in/health-news/nmc/nmc-implements-face-based-aadhaar-attendance-in-medical-colleges-146737"><b>NMC implements Face-Based Aadhaar Attendance in Medical Colleges</b></a></i></div><div></div></div><div class="pasted-from-word-wrapper"></div></div>

401. Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets

     Thu, 17 Apr 2025 12:00:55 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/01/25/230934-novo-nordisk-50.webp' /><div class="pasted-from-word-wrapper"><p style="text-align: justify; "><b>New Delhi:</b> In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE) studies conducted in USA and Canada, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the drug major Novo Nordisk India to conduct clinical trial in India to establish safety and efficacy of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation in Indian population.</p><p style="text-align: justify; ">This came as Novo Nordisk India sought approval for Semaglutide tablets of 1.5 mg, 4 mg, and 9 mg of a new formulation based on the BE studies conducted in the USA and Canada.</p><p style="text-align: justify; ">In light of earlier SEC recommendations dated 11.09.2024, the firm presented the difference in the manufacturing process of approved formulation of Semaglutide tablets 3 mg, 7 mg and 14 mg and proposed new formulation of Semaglutide tablets 1.5 mg, 4 mg, 9 mg along with regulatory approval status of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation. </p><p style="text-align: justify; ">The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed that Semaglutide tablets 1.5 mg, 4 mg, and 9 mg of the new formulation are equivalent to the approved doses of Semaglutide tablets 3 mg, 7 mg, and 14 mg, respectively. </p><p style="text-align: justify; ">Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults.</p><p style="text-align: justify; ">GLP-1 is a physiological hormone that promotes glycemic control via several different mechanisms, including insulin secretion, slowing gastric emptying, and reducing postprandial glucagon secretion. The homeostasis of glucose is dependent on hormones such as insulin and amylin, which are secreted by the beta cells of the pancreas. Semaglutide is 94% similar to human GLP-1.</p><p style="text-align: justify; ">Analogs of this hormone, such as semaglutide, stimulate the synthesis of insulin by stimulating pancreatic islet cells and reducing glucagon secretion. They directly bind with selectivity to the GLP-1 receptor, causing various beneficial downstream effects that reduce blood glucose in a glucose-dependent fashion</p><p style="text-align: justify; ">At the recent SEC meeting for Endocrinology and Metabolism held on 25th March 2025, the expert panel noted the difference in the manufacturing process of approved formulations of Semaglutide tablets 3 mg, 7 mg, and 14 mg and proposed new formulations of Semaglutide tablets 1.5 mg, 4 mg, and 9 mg, along with the regulatory approval status of Semaglutide tablets 1.5mg, 4 mg, and 9 mg of new formulation.</p><p style="text-align: justify; ">After detailed deliberation, the committee recommended conducting a clinical trial in India to establish the safety and efficacy of Semaglutide tablets 1.5 mg, 4 mg, and 9 mg of the new formulation in the Indian population.</p><p style="text-align: justify; ">Also Read: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/cipla-gets-cdsco-panel-nod-for-phase-iii-ct-of-inhaled-itraconazole-dry-powder-for-inhalation-10-mg-capsules-146699">Cipla gets CDSCO Panel nod for Phase-III CT of Inhaled Itraconazole dry powder for inhalation 10 mg capsules</a></p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>

402. Ghaziabad hospital inspected after patient's death, License suspended

     Thu, 17 Apr 2025 12:00:44 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/01/11/268639-medical-negligence-1.webp' /><p><b>Ghaziabad:</b> Following the death of a 45-year-old patient, the health department has temporarily suspended the license of Rati Hospital in Loni. The hospital is also under investigation for several regulatory violations. </p><p>The action came after the patient’s family filed a complaint alleging negligence. A surprise inspection led by Dr. Davi Lal revealed multiple violations, prompting the department to take immediate steps against the hospital.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/woman-dies-at-jalpaiguri-medical-college-hospital-family-alleges-negligence-146716"><b>Also Read: Woman dies at Jalpaiguri Medical College Hospital, family alleges negligence</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">Speaking to <a href="https://timesofindia.indiatimes.com/city/noida/no-doctors-man-45-dies-government-seals-private-hospital/articleshow/120356170.cms" rel="nofollow">TOI</a>, Health Department official Dr Davi Lal said the team found several violations at the hospital. "The premises were very unclean, there was no segregation of biomedical waste, and the hygiene of the labour room was not maintained properly," he said.</span></div></div><p>During the inspection, no doctor was present on the hospital premises. The inspection also revealed that, although the hospital was only licensed for OPD, IPD, and general surgery, it was illegally operating maternal wards without the necessary approvals or registered medical professionals.</p><p>As per the news reports, the 15-bed facility had two patients admitted at the time of inspection — one had recently given birth, while the other was in the emergency ward. Both patients were reportedly receiving care solely from nursing staff in the absence of qualified doctors.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/3-doctors-booked-after-pregnant-woman-dies-at-up-hospital-146524"><b>Also Read: 3 doctors booked after pregnant woman dies at UP Hospital</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">According to TOI, the hospital was found not to be following prescribed standards, and many discrepancies were identified in their documentation. "Due to this serious negligence, the health department has sealed the operation theatre and labour room of the hospital, and the hospital's licence has been temporarily suspended," the official said.</span></div></div><p>He also mentioned that all types of medical services would remain closed in the hospital until the investigation was completed, and that the health department had started a detailed and in-depth investigation of the case. </p><p>This incident has raised concerns over the regulation and oversight of private hospitals in the district, which currently has 299 registered private healthcare facilities.</p>

403. Novo Nordisk promotes Rishang Deoras to Global Director - Diabetes Commercial Unit

     Thu, 17 Apr 2025 12:00:30 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283442-rishang-deoras-50-1.webp' /><p><a href="https://medicaldialogues.in/topics/Novo-Nordisk" style="text-align: justify;">Novo Nordisk</a>&nbsp;has&nbsp;promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.</p><div class="pasted-from-word-wrapper"><div style="text-align: justify; "><span style="background-color: rgb(249, 249, 249);">Deoras shared the news in a LinkedIn post, stating,&nbsp;</span>"I'm excited to share that I've been promoted to Global Director - Diabetes Commercial Unit.&nbsp;<span style="background-color: rgb(249, 249, 249);">A heartfelt thanks to Imran MK Shaik for the wonderful opportunity and for your unwavering support &amp; trust throughout the years. It has been a privilege to be part of your leadership team &amp; witness the remarkable growth journey we have embarked on together</span>,"&nbsp;<span style="background-color: rgb(249, 249, 249);">Rishang Deoras shared in a post on&nbsp;</span><span style="background-color: rgb(249, 249, 249);">LinkedIn.</span></div></div><div class="pasted-from-word-wrapper"><div style="text-align: justify;">"As I reflect on my professional journey, I feel incredibly fortunate to have been associated with industry leading brands &amp; portfolio and had the opportunity to work alongside some of the exceptional leaders and amazing colleagues. I’d like to extend my gratitude to my mentors &amp; couple of senior leaders within the industry who have inspired me throughout &amp; had a positive influence on my career - Camilla Sylvest, Tina Abild Olesen, Thomas Thestrup-Terp, John Dawber, Melvin D'Souza, Anand Shetty, Omar Sherief Mohammad, Mukti Sadhan Nath, Ramanathan Varadarajan, Sanjay Murdeshwar, Gagan Singh, Amit Bhakri, Manik Kaul, Ruchika Singhal, Atul Tandon, Smita Saha. Lastly, a big thank you to my incredible team for the dedication &amp; relentless efforts in making a difference for millions of people with diabetes around the globe,"&nbsp;<span style="background-color: rgb(249, 249, 249);">Rishang stated.</span></div></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">Rishang re-joined Novo Nordisk in 2019 as Global Marketing Manager - GLP1 Diabetes, Obesity, Rare Diseases &amp; Devices (Cluster Head Marketing). Previously, he held the position of Product Manager (Modern Insulins Portfolio &amp; Corporate Hospitals Strategy) at Novo Nordisk. Between his tenures at Novo Nordisk, he worked with GSK Consumer Healthcare India as Expert Marketing Manager (Horlicks) and with <a href="https://medicaldialogues.in/topics/AstraZeneca">AstraZeneca </a>as Senior Marketing Lead (Cardiovascular, Renal &amp; Metabolic portfolio).</p><p style="text-align: justify; ">Deoras began his career in 2010 as an Associate Product Manager at Zydus Cadila.</p></div>

404. Over 400 Govt doctors sacked due to their prolonged absence from duty

     Thu, 17 Apr 2025 11:15:14 -0000

     <img src='https://medicaldialogues.in/h-upload/2023/11/23/226087-terminated.webp' /><p style="text-align: justify; "><b>Mumbai:</b> More than 400 doctors posted as probationary medical officers at healthcare facilities across Maharashtra have been <a href="https://medicaldialogues.in/topics/doctors-terminated" target="_blank">terminated</a> for being absent from duty for a long time. &nbsp;</p><p style="text-align: justify; ">The action was taken by the Maharashtra Health Department on Wednesday after the department found that these doctors had not reported to work for an extended period.</p><p style="text-align: justify; ">These doctors were appointed as probationary medical officers under the ‘Group A’ government service category. According to the rules, if a probationary doctor stays absent for more than a week without permission, the government can either extend their probation period by up to a year or terminate their services altogether.</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/gmers-medical-college-terminates-four-professors-faces-backlash-144925" target="_blank">GMERS Medical College terminates 4 professors, faces backlash</a></b></p><p style="text-align: justify; ">Akola district in Vidarbha saw the highest number of terminations, while more than 45 doctors whose services were terminated were from Mumbai, Thane and Konkan.</p><p style="text-align: justify; ">Specifying the reason, an official from the health department told <a href="https://www.hindustantimes.com/cities/mumbai-news/400-doctors-terminated-101744830621788.html" rel="nofollow">HT</a>, “Many of these doctors did not complete their services as they have gone for higher studies or joined better jobs." &nbsp;</p><p style="text-align: justify; ">Medical Dialogues had earlier reported that Maharashtra's public healthcare system is likely to reel under a worsening staffing crisis, as more than 500 specialist doctors have refused to take up government jobs, compelling the state to cancel their appointments. The vacancies, meant for gynaecologists, paediatricians, anaesthetists, and other specialists, were part of a recruitment drive aimed at strengthening public hospitals, especially in rural and tribal areas.&nbsp;</p><p style="text-align: justify; ">However, poor pay, inadequate infrastructure, and delays in the hiring process have pushed many doctors to turn their backs on government appointments and opt for private practice or out-of-state opportunities instead.</p><p style="text-align: justify; ">Despite multiple recruitment attempts, Maharashtra’s public hospitals remain short-staffed, especially in rural and tribal regions. Many hospitals lack essential medical equipment and support staff, making it difficult for specialists to function effectively.</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/is-maharashtra-having-a-medical-meltdown-500-appointments-cancelled-as-specialists-opt-out-143967" target="_blank">Is Maharashtra having a Medical Meltdown? 500+ Appointments cancelled as Specialists Opt Out</a></b></p>

405. 2 MBBS Students Suspended for Impersonation in NEET 2024

     Thu, 17 Apr 2025 11:00:34 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283427-suspended.webp' /><p style="text-align: justify; "><b>Rajasthan-</b>&nbsp;The authorities of Dr Sampurnanand Medical College, Jodhpur, Rajasthan, have suspended two <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS</a> students for allegedly appearing as dummy candidates in the National Eligibility and Entrance Test-Undergraduate (NEET UG) 2024.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The MBBS students have been identified as Mehla from the batch of 2022 and Vishnoi from the batch of 2023. Both students were suspended by the Principal, BS Jodha, till further orders after the CBI investigation proved their involvement in the NEET 2024 fraud.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/irregularities-in-neet-2024-cbi-registers-fresh-case-against-2nd-year-medical-student-who-appeared-as-proxy-candidate-137861"><b>Also Read:&nbsp;</b>Irregularities in NEET 2024: CBI registers fresh case against 2nd-year Medical student who appeared as proxy candidate</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">In this regard, talking to <a href="https://www.etvbharat.com/en/!bharat/neet-ug-2024-fraud-two-rajasthan-mbbs-students-suspended-for-appearing-as-dummy-candidates-enn25041701959" target="_blank" rel="nofollow">ETVBharat </a>Media News Report, Jodhpur Medical College Principal Dr BS Jodha said, "The CBI investigation has found that the accused Bhagirathram Vishnoi had appeared in the exam as a dummy candidate in place of his brother Gopal Ram. Similarly, Harshit Mehla had appeared in the exam in place of Vineet Godara."</p><p dir="ltr" style="text-align: justify; ">Last year, the NEET exam for the academic year 2024 was held on May 5, which stirred up a lot of controversy due to certain anomalies, including several students scoring impossible full marks, the exam being announced on the day of the Lok Sabha election results much before the scheduled date, and toppers reportedly being from the same exam centre.</p><p dir="ltr" style="text-align: justify; ">Around 24 lakh candidates had appeared for <a href="https://medicaldialogues.in/topics/neet-ug-2024" target="_blank">NEET UG 2024</a>&nbsp;. The prestigious exam was mired in controversy due to discrepancies. Meanwhile, students reported that the centre gave them question papers with pre-marked answers, then withdrew them. However, the <a href="https://medicaldialogues.in/topics/nta" target="_blank">NTA</a>, which conducts the exam, said it re-examined over 100 candidates.</p><p dir="ltr" style="text-align: justify; ">On this, Medical Dialogues had reported last year that a case had been registered in the investigation into the irregularities in the conduct of NEET UG 2024. In this regard, CBI booked a medical student, who was caught taking the UG medical entrance examination for an aspirant in Navi Mumbai.&nbsp;</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/neet-paper-leak-scandal-rocks-bihar-questions-answers-allegedly-given-to-20-aspirants-day-before-exam-128376"><b>Also Read:&nbsp;</b>NEET Paper Leak Scandal Rocks Bihar: Questions-Answers allegedly given to 20 Aspirants Day Before Exam</a></div><div class="pasted-from-word-wrapper"><div></div></div>

406. Haryana PG medical admissions: Check out speciality-wise fee structure

     Thu, 17 Apr 2025 11:00:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283403-fee-structure.webp' /><p style="text-align: justify; "><b>Haryana-</b> The Director of Medical Education and Research (<a href="https://medicaldialogues.in/topics/dmer-haryana" target="_blank">DMER), Haryana</a>, has released the fee structure for PG medical courses- MD/ MS at the medical colleges in Haryana.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">The concerned aspirants seeking admission to the <a href="https://medicaldialogues.in/topics/md-ms" target="_blank">MD, MS</a> and PG courses in Haryana-based medical colleges can check out the complete fee structure.</p></div><div class="pasted-from-word-wrapper"><p data-start="101" data-end="592" class="">The notification outlines the tuition and additional charges applicable to students enrolling in private unaided medical colleges affiliated with Pt. B.D. Sharma University of Health Sciences, Rohtak, as well as private universities such as SGT University, Gurugram, and Al-Falah University, Faridabad.</p> <p data-start="594" data-end="1112" class="">For colleges affiliated with Pt. B.D. Sharma UHS, the annual tuition fees vary based on the specialty. Pre-clinical courses will cost Rs 3.52 lakh per year, para-clinical courses Rs 5.52 lakh per year, and clinical specialties Rs 14.02 lakh per year. A 10% increase in tuition is applicable annually. In addition to tuition, candidates must pay a refundable security deposit of ₹50,000, thesis fee of Rs 25,000, and charges for library, internet, research facilities, medical services, and hostel accommodation as per actuals.</p> <p data-start="1114" data-end="1463" class="">SGT University has also detailed its fee structure. Indian students will pay between rs 10 lakh and 45 lakh annually depending on the course. For instance, MD Radiodiagnosis is priced at 45 lakh per annum, while basic sciences such as Anatomy and Physiology are 10 lakh. NRI candidates will be charged fees ranging from $16,970 to $83,520 per year.</p> <p data-start="1465" data-end="1858" class="">Similarly, Al-Falah University, Faridabad, has set its tuition fees for Indian residents between 7.20 lakh and 32.90 lakh per annum. MD Anatomy and MD Biochemistry are the most affordable, while specialities such as Dermatology, General Surgery, and Obstetrics &amp; Gynaecology have the highest fees. NRI students will pay between $24,890 and $80,000 per year depending on the chosen discipline.</p></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">Below is the detailed fee structure-</p></div><div class="pasted-from-word-wrapper" style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/seeking-mbbs-admissions-in-haryana-check-out-complete-fee-structure-here-146746"><b>Also Read:&nbsp;</b>Seeking MBBS admissions in Haryana? Check out complete fee structure here</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>FEE STRUCTURE FOR THE MD AND MS COURSES RUNNING IN PRIVATE UNAIDED MEDICAL COLLEGES AFFILIATED TO Pt BD SHARMA UHS, ROHTAK</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="273"><col width="300"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>FEE HEAD</b></p></td><td><p dir="ltr" style="text-align: center; "><b>PROPOSED FEE FOR MD MS COURSES</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Tuition fee includes development charges.</p></td><td><p dir="ltr">Pre-clinical specialties- Rs 3.52 Lakh + 10% annual increase</p><p dir="ltr">Para-clinical specialties- Rs 5.52 Lakh + 10% annual increase</p><p dir="ltr">Clinical specialities- Rs 14.02 Lakh + 10% annual increase</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">College Security.</p></td><td><p dir="ltr">Rs. 50,000 (refundable)</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">University Charges.</p></td><td><p dir="ltr">Actual</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Thesis Charges.</p></td><td><p dir="ltr">25,000</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Library Charges.</p></td><td><p dir="ltr">10,000</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Research and Consumables Charges.</p></td><td><p dir="ltr">30,000</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Medical Charges.</p></td><td><p dir="ltr">6,000</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">GYM and Sport Charges (if provided).</p></td><td><p dir="ltr">As per actual.</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Internet Charges (if provided).</p></td><td><p dir="ltr">As per actual</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Continuing Medical Education Charges.</p></td><td><p dir="ltr">10,000</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">Hostel Charges.</p></td><td><p dir="ltr">For Non-AC Room- Not more than 75,000 p.a or actual.</p><p dir="ltr">Mess Charges on an actual basis.</p><p dir="ltr">For AC Room- Not more than 1 Lakh per annum, or actual </p><p dir="ltr">No separate electricity charges for fan and lighting in the hostel</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">Transport Fee (if availed by the student).</p></td><td><p dir="ltr">As per actual</p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">Power Backup Charges.</p></td><td><p dir="ltr">10,000</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; ">The fee structure for the PG courses run under SGT Medical College, Hospital and Research Institute, as fixed by Shree Guru Gobind Singh Tricentenary (SGT) University, Budhera, Gurugram (Private University).</p><p dir="ltr" style="text-align: justify; "><b><u>SHREE GURU GOBIND SINGH TRICENTENARY (SGT) UNIVERSITY</u></b></p><p dir="ltr" style="text-align: justify; "><b><i>FEE FOR INDIAN CANDIDATES (IN LAKHS PER ANNUM)</i></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="114"><col width="153"><col width="153"><col width="153"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>COURSE</b></p></td><td><p dir="ltr" style="text-align: center; "><b>COURSE FEE</b></p></td><td><p dir="ltr" style="text-align: center; "><b>CUTION MONEY ONETIME REFUNDABLE</b></p></td><td><p dir="ltr" style="text-align: center; "><b>ALUMNI FEE (ONE-TIME REFUNDABLE)</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">MD (Anatomy)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">MD (Biochemistry)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">MD (Community Medicine)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">MD (Forensic Medicine)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">MD (Microbiology)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">MD (Pathology)</p></td><td><p dir="ltr">17 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">MD (Physiology)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">MD (Pharmacology)</p></td><td><p dir="ltr">10 Lakh</p></td><td><p dir="ltr">0.5</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">MD Dermatology, Venerology &amp; Leprosy</p></td><td><p dir="ltr">40 Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">MS Orthopedics</p></td><td><p dir="ltr">32 Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">MS Ophthalmology</p></td><td><p dir="ltr">29 Lakh </p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">MD General Medicine</p></td><td><p dir="ltr">35Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">MD Respiratory Medicine</p></td><td><p dir="ltr">29Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">14</p></td><td><p dir="ltr">MD Psychiatry</p></td><td><p dir="ltr">29Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">15</p></td><td><p dir="ltr">MD Paediatrics</p></td><td><p dir="ltr">32Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">16</p></td><td><p dir="ltr">MS General Surgery</p></td><td><p dir="ltr">30Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">17</p></td><td><p dir="ltr">MS Otorhinolaryngology</p></td><td><p dir="ltr">22Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">18</p></td><td><p dir="ltr">MD Anesthesiology</p></td><td><p dir="ltr">20Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">19</p></td><td><p dir="ltr">MD Radiodiagosis</p></td><td><p dir="ltr">45Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr><tr><td><p dir="ltr">20</p></td><td><p dir="ltr">MS Obstetrics &amp; Gynaecology</p></td><td><p dir="ltr">35Lakh</p></td><td><p dir="ltr">3.0</p></td><td><p dir="ltr">2500</p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><i>FEE FOR NRI CANDIDATES (IN US DOLLARS) $</i></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="114"><col width="153"><col width="153"><col width="153"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>COURSE</b></p></td><td><p dir="ltr"><b>COURSE FEE</b></p></td><td><p dir="ltr"><b>CUTION MONEY ONETIME REFUNDABLE</b></p></td><td><p dir="ltr"><b>ALUMNI FEE (ONE-TIME REFUNDABLE)</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">MD (Anatomy)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">MD (Biochemistry)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">MD (Community Medicine)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">MD (Forensic Medicine)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">MD (Microbiology)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">MD (Pathology)</p></td><td>28850</td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">MD (Physiology)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">MD (Pharmacology)</p></td><td><p dir="ltr">16970</p></td><td><p dir="ltr">833</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">MD Dermatology, Venerology &amp; Leprosy</p></td><td><p dir="ltr">67730</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">MS Orthopedics</p></td><td><p dir="ltr">55000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">MS Ophthalmology</p></td><td><p dir="ltr">55000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">MD General Medicine</p></td><td><p dir="ltr">62990</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">MD Respiratory Medicine</p></td><td><p dir="ltr">50000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">14</p></td><td><p dir="ltr">MD Psychiatry</p></td><td><p dir="ltr">50000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">15</p></td><td><p dir="ltr">MD Paediatrics</p></td><td><p dir="ltr">55000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">16</p></td><td><p dir="ltr">MS General Surgery</p></td><td><p dir="ltr">51200</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">17</p></td><td><p dir="ltr">MS Otorhinolaryngology</p></td><td><p dir="ltr">35000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">18</p></td><td><p dir="ltr">MD Anesthesiology</p></td><td><p>35000</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">19</p></td><td><p dir="ltr">MD Radiodiagosis</p></td><td><p>83520</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr><tr><td><p dir="ltr">20</p></td><td><p dir="ltr">MS Obstetrics &amp; Gynaecology</p></td><td><p>62990</p></td><td><p dir="ltr">5000</p></td><td><p dir="ltr">42</p></td></tr></tbody></table></div><p style="text-align: justify; ">Fee structure for the PG courses run under Al-Falah University, Faridabad, Haryana (Private University) </p><p style="text-align: justify; "><b><u>AL-FALAH UNIVERSITY, FARIDABAD, HARYANA (PRIVATE UNIVERSITY)</u></b></p></div><div class="pasted-from-word-wrapper"><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="51"><col width="114"><col width="153"><col width="153"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>COURSE</b></p></td><td><p dir="ltr"><b>FEE FOR THE INDIAN RESIDENTS STUDENTS (IN INR IN LACS)PER ANNUM </b></p></td><td><p dir="ltr"><b>FEE FOR THE NRI STUDENTS (IN USD OR EQUIVALENT IN INDIAN RS)</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">MD (Anatomy)</p></td><td><p dir="ltr">7.20 Lakh</p></td><td><p dir="ltr">24,890</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">MD (Biochemistry)</p></td><td><p dir="ltr">7.20 Lakh</p></td><td><p dir="ltr">24,890</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">MD (Community Medicine)</p></td><td><p dir="ltr">9.12 Lakh</p></td><td><p dir="ltr">25,890</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">MD (paediatrics)</p></td><td><p dir="ltr">29.90 Lakh</p></td><td><p dir="ltr">80,000</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">MD (Microbiology)</p></td><td><p dir="ltr">7.20 Lakh</p></td><td><p dir="ltr">24,890</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">MD (Pathology)</p></td><td><p dir="ltr">14.55 Lakh</p></td><td><p dir="ltr">29,890</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">MD (Physiology)</p></td><td><p dir="ltr">7.20 Lakh</p></td><td><p dir="ltr">24,890</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">MD Dermatology, Venerology &amp; Leprosy</p></td><td><p dir="ltr">32.90 Lakh</p></td><td><p dir="ltr">80,000</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">MS General Surgery</p></td><td><p dir="ltr">29.90 Lakh</p></td><td><p dir="ltr">80,000</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">MD Anesthesiology</p></td><td><p dir="ltr">17.90 Lakh</p></td><td><p dir="ltr">60,000</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">MS Obstetrics &amp; Gynaecology</p></td><td><p dir="ltr">29.90 Lakh</p></td><td><p dir="ltr">80,000</p></td></tr></tbody></table></div></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u><i>To view the notification, click the link below</i></u></b></p><p dir="ltr" style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/mdmscoursefee-283404.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/mdmscoursefee-283404.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>

407. Kin alleges medical negligence in 44-year-old man's death

     Thu, 17 Apr 2025 10:45:11 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/05/17/238478-medical-negligence-2.webp' /><p><b>Srinagar: </b>In an unfortunate incident, a 44-year-old man has reportedly died due to alleged <a href="https://medicaldialogues.in/topics/medical-negligence">medical negligence </a>at the<a href="https://medicaldialogues.in/topics/chest-disease-hospital"> Chest Disease (CD) hospital</a>&nbsp;in Srinagar. The incident, which has raised concerns over patient care, is currently under investigation, according to officials.&nbsp;</p><p>The deceased, a resident of the Dalgate area of Srinagar had visited the Chest Disease Hospital on Wednesday morning after complaining of chest pain. Family members claim that despite his distress, the attending doctor failed to provide proper treatment.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/kota-shocker-doctors-allegedly-operate-on-paralysed-father-instead-of-injured-son-146773"><b>Also Read: Kota Shocker: Doctors allegedly operate on paralysed father instead of injured son</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">As per the recent media reports by </span><a href="https://risingkashmir.com/man-dies-of-alleged-medical-negligence-at-srinagars-cd-hospital/" rel="nofollow">Rising Kashmir</a><span style="background-color: rgb(249, 249, 249);">, they alleged that the doctor, who was present at the hospital, didn’t treat him well. “As we tried to seek proper treatment for Rafiq, the doctor misbehaved with us,” they said, adding that the doctor also ran away from the ward after the death of the patient. &nbsp;</span></div></div><p>The family has demanded swift action against the doctor and urged higher authorities to intervene and ensure accountability. </p><p>In response to the allegations, an official from the CD Hospital confirmed that an inquiry has been initiated. According to Rising Kashmir, “Investigation is going on and any negligence will face the strict action,” the official added—(KNO).</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/woman-dies-at-jalpaiguri-medical-college-hospital-family-alleges-negligence-146716"><b>Also Read: Woman dies at Jalpaiguri Medical College Hospital, family alleges negligence</b></a></p><div class="pasted-from-word-wrapper"><div><span style="background-color: rgb(249, 249, 249);">Medical dialogues had previously reported that allegations of medical negligence have emerged following the death of a 50-year-old woman who was undergoing treatment at Jalpaiguri Government Medical College &amp; Hospital (JGMCH). The incident has triggered protests by her grieving family. According to the news reports, the woman had suffered a fractured leg after slipping at her home on March 31. She was immediately taken to JGMCH by her son, where doctors plastered her left leg and discharged her after initial treatment. Despite being treated, the woman continued to complain of leg pain even after a week.&nbsp;</span></div></div>

408. MediBuddy ropes in Sagar Saha as Director of Sales & Growth

     Thu, 17 Apr 2025 10:30:46 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283425-sagar-saha-50.webp' /><p><span style="text-align: justify;">MediBuddy has appointed Sagar Saha as its new Director of Sales &amp; Growth.</span></p><div class="pasted-from-word-wrapper" style="text-align: justify; "><span style="background-color: rgb(249, 249, 249);">Sharing the news via a LinkedIn post</span>,&nbsp;<span style="background-color: rgb(249, 249, 249);">Saha expressed his enthusiasm about the new role, stating,&nbsp;</span>"Excited to announce my new role as Director of Sales &amp; Growth at MediBuddy."</div><div class="pasted-from-word-wrapper" style="text-align: justify; ">"Returning to the healthcare sector after a decade with a fresh perspective, lots of learning and enthusiasm. Looking forward to contributing to the team's success and driving growth in this dynamic industry," he said.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><p>Saha brings over 10+ years of experience in Sales, Sales strategy, SaaS product sales &amp; AD sales, B2B Sales, Business Development, Business Expansion, Key Accounts Management, Team Management, Market Research etc.</p></div><p style="text-align: justify; ">Prior to joining Medibuddy, he served as Assistant Vice President – Sales, Strategic Partnerships &amp; Product Strategy at Marsh McLennan.</p><p style="text-align: justify; ">Over the course of his career, Saha has been associated with several organizations including Practo, Vahan, NIRA, Various startups, LoveThisStuff.com, Bharat Sanchar Nigam.</p><p style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);">He is&nbsp;</span><span style="background-color: rgb(255, 255, 255);">well-versed in Sales &amp; Marketing programs / Strategies to improve product awareness and business growth. He has&nbsp;</span><span style="background-color: rgb(255, 255, 255);">expertise in formulating Marketing research, B2B &amp; B2C Sales, prospecting customer approach, etc. for market identification and penetration &amp; conceptualizing sales promotional strategies.</span></p><div class="pasted-from-word-wrapper"><b style="text-align: justify;"><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/medibuddy-secures-rs-148-crore-funding-to-drive-strategic-acquisitions-continued-expansion-116754">MediBuddy secures Rs 148 crore funding to drive strategic acquisitions, continued expansion</a></i></b><br></div>

409. AIIMS Fellowship Programme July 2025 Registrations OPEN, Know All admission Details Here

     Thu, 17 Apr 2025 10:24:14 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283397-fellowship-programe-july-2025.webp' /><p style="text-align: justify; "><b>New Delhi-</b> The All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/aiims-new-delhi" target="_blank">AIIMS), New Delhi</a>, is conducting the registration process for the Fellowship programme for the July 2025 session. Candidates who are willing to appear for the said programme can apply till 23 April 2025, 5:00 pm, Monday.</p><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; ">In this regard, AIIMS New Delhi has released the <a href="https://medicaldialogues.in/topics/fellowship-programme" target="_blank">Fellowship programme</a> July 2025 session prospectus for the candidates. The prospectus includes important details such as schedule, fees, seat matrix, eligibility, documents, etc. Below are the details-</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/uro-oncology-fellowship-programme-duration-2-years-not-1-aiims-issues-corrigendum-146728"><b>Also Read:&nbsp;</b>Uro-Oncology Fellowship Programme duration 2 years, not 1: AIIMS issues corrigendum</a></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>SCHEDULE</u></b></p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="50"><col width="262"><col width="156"><col width="156"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>PARTICULARS</b></p></td><td><p dir="ltr"><b>DATES</b></p></td><td><p dir="ltr"><b>DAYS</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Status of Registration for correction of rejected images / other deficiencies through the Registration Status Tab of their MyPage after Login. Application &amp; Rejected application with reason for rejection. Applicants are required to check their status on 28.04.2025 through the Registration Status of My Page after Login.</p></td><td><p dir="ltr"> 28 April 2025 </p></td><td><p dir="ltr">MONDAY</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Last date for submission of required documents for regularisation of the Rejected Application. No Correspondence will be entertained after 30.04.2025 under any circumstances and candidates are requested not to contact the Examination Section. </p></td><td><p dir="ltr">30 April 2025 </p></td><td><p dir="ltr">WEDNESDAY</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Last date for the Ministry of Health &amp; Family Welfare, Govt. of India to forward an approval regarding “No Objection” to the Foreign National for appearing in the Fellowship Programme Entrance Examination for the July 2025 session. </p></td><td><p dir="ltr">30 April 2025 </p></td><td><p dir="ltr">WEDNESDAY</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Submission of Certificate for Scribe and/or Compensatory time as applicable (Performa A-1/A-2/ A-3 of Appendix A) </p></td><td><p dir="ltr">30 April 2025 </p></td><td><p dir="ltr">WEDNESDAY</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Finalisation of Centres and allotment of Roll Nos/Admit Card on the website. </p></td><td><p dir="ltr">05 May 2025 </p></td><td><p dir="ltr">MONDAY </p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Date of Online (CBT) mode Examination </p></td><td><p dir="ltr">10 May 2025 </p></td><td><p dir="ltr">SATURDAY</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Expected date of declaration of Result (Stage I) </p></td><td><p dir="ltr">19 May 2025 </p></td><td><p dir="ltr">MONDAY </p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Departmental Assessment </p></td><td><p dir="ltr">29 &amp; 30 May 2025 </p></td><td><p dir="ltr">THURSDAY &amp; FRIDAY</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Final Result</p></td><td><p dir="ltr">05 June 2025 </p></td><td><p dir="ltr">THURSDAY </p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Last date for admission in the course of the Fellowship Programme </p></td><td><p dir="ltr">31 August 2025</p></td><td></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><u>ONLINE REGISTRATION &amp; SUBMISSION OF APPLICATION FORM</u></b></p><p dir="ltr" style="text-align: justify; ">The candidate should fill in the Online Application with utmost care and follow the instructions and help manual, step by step. The candidate should fill in the Online Application form correctly. An incorrectly filled form may lead to rejection. </p><p dir="ltr" style="text-align: justify; ">A candidate seeking admission to the Entrance Examination is required to submit his/her application in the prescribed format. The cost of the Application Form includes the fee for the entrance examination, which is non-refundable and no correspondence in this regard will be entertained. The candidate is required to go through the Prospectus carefully and acquaint himself/herself with all requirements with regard to filling in the online application form. </p><p dir="ltr" style="text-align: justify; ">After selecting the online registration, fill in the mandatory details asked for and deposit the prescribed fee through Debit, Credit card and Net Banking. After submitting the fees, fill in the required information step by step. Follow the Instructions scrupulously.</p><p dir="ltr" style="text-align: justify; ">It will be the responsibility of the candidate to ensure that the correct details are filled in the Registration Slip. The Institute will not be responsible for any incorrect information/cancellation of candidature/loss, or lack of communication, etc., due to wrongly wrong-filled online Application form. </p><p dir="ltr" style="text-align: justify; ">All applicants are required to ensure that the Photo/Signature/Left Thumb Impression is uploaded according to the instructions provided in the Prospectus. Failure to do so may result in rejection of applications.</p><p dir="ltr" style="text-align: justify; "><b><u>APPLICATION FEES</u></b></p><p dir="ltr" style="text-align: justify; ">The application fee for the General &amp; OBC category is Rs 2000/- + applicable transaction charges, for SC, ST &amp; EWS category is Rs 1600/- + applicable transaction charges, however, OPH candidates are exempted from any fee. Meanwhile, the admission fees are Rs 125/- for open candidates and Rs 1295/- for Sponsored Candidates.</p><p dir="ltr" style="text-align: justify; "><b><u>ELIGIBILITY FOR FELLOWSHIP PROGRAMMES</u></b></p><p dir="ltr" style="text-align: justify; ">1 a MD/MS Postgraduate degree or other Equivalent Degree recognised by the MCI/ National Medical Commission in the respective discipline. </p><p dir="ltr" style="text-align: justify; ">b 3 years post PG teaching Experience as Senior Resident or equivalent post after obtaining the PG Degree in the concerned discipline only from an MCI / NMC recognised permitted medical Institute/College.</p><p dir="ltr" style="text-align: justify; ">2 DM/M.Ch. or other Equivalent Degree recognised by the Medical Council of India / National Medical Commission.</p><div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr" style="text-align: justify; "><b><u>SCHEME OF MARKING</u></b></p><p dir="ltr" style="text-align: justify; ">1 Each correct response will get a score of 1 mark. </p><p dir="ltr" style="text-align: justify; ">2 Each incorrect response will get a score of -1/3 (minus one-third). </p><p dir="ltr" style="text-align: justify; ">3 No credit will be given for the questions not answered or marked for review (Questions marked for review shall be considered as unanswered.</p><p dir="ltr" style="text-align: justify; "><b><u>NUMBER OF SEATS</u></b></p><p dir="ltr" style="text-align: justify; ">As per the seat matrix, a total of 91 seats are vacant across 16 Fellowship Programmes in AIIMS New Delhi. The facilities for the Fellowship Programme are available in the following Subjects for the July 2025 Session-</p><div dir="ltr"><table style="text-align: justify; "><colgroup><col width="52"><col width="364"><col width="208"></colgroup><tbody><tr><td><p dir="ltr" style="text-align: center; "><b>S.NO</b></p></td><td><p dir="ltr" style="text-align: center; "><b>DEPARTMENT</b></p></td><td><p dir="ltr" style="text-align: center; "><b>TOTAL SEATS</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Anesthesiology, Pain Medicine and Critical Care.</p></td><td><p dir="ltr">5</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Cardiac-Anaesthesia &amp; Critical Care.</p></td><td><p dir="ltr">1</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Clinical Epidemiology Unit (CEU).</p></td><td><p dir="ltr">8</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Cardio Thoracic &amp; Vascular Surgery.</p></td><td><p dir="ltr">3</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Otorhinolaryngology &amp; Head &amp; Neck Surgery.</p></td><td><p dir="ltr">1</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Gastroenterology &amp; Human Nutrition Unit.</p></td><td><p dir="ltr">9</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Medical Oncology.</p></td><td><p dir="ltr">1</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Neuroanaesthesiology &amp; Neurocritical Care.</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Neurology.</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Neurosurgery.</p></td><td><p dir="ltr">14</p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">Obstetrics &amp; Gynaecology.</p></td><td><p dir="ltr">6</p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">Centre for Dental Education &amp; Research (CDER).</p></td><td><p dir="ltr">4</p></td></tr><tr><td><p dir="ltr">13</p></td><td><p dir="ltr">Orthopaedics.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">14</p></td><td><p dir="ltr">Radiodiagnosis and Interventional Radiology.</p></td><td><p dir="ltr">5</p></td></tr><tr><td><p dir="ltr">15</p></td><td><p dir="ltr">Surgical Disciplines.</p></td><td><p dir="ltr">8</p></td></tr><tr><td><p dir="ltr">16</p></td><td><p dir="ltr">Urology.</p></td><td><p dir="ltr">8</p></td></tr><tr><td></td><td><p dir="ltr" style="text-align: center; "><b>TOTAL</b></p></td><td><p dir="ltr" style="text-align: center; "><b>91</b></p></td></tr></tbody></table></div><p dir="ltr" style="text-align: justify; "><b><u><i>To view the prospectus, click the link below</i></u></b></p><p dir="ltr" style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/aiims-opens-fellowship-programme-registrations-for-july-2025-session-know-all-details-here-283398.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/aiims-opens-fellowship-programme-registrations-for-july-2025-session-know-all-details-here-283398.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"><div></div></div>

410. 5 years service, Rs 25.77 lakh penalty: Haryana Bond Policy for MBBS admissions

     Thu, 17 Apr 2025 09:36:13 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/05/281776-government-bond-service.webp' /><p style="text-align: justify; "><b>Chandigarh:</b>&nbsp;Students getting admitted to the <a href="https://medicaldialogues.in/topics/mbbs-course">MBBS courses</a> at the government medical colleges in Haryana will have to undergo compulsory <a href="https://medicaldialogues.in/topics/government-service">government service</a> for 5 years after completing their Undergraduate medical education. If the students choose to opt out of the bond service liability, they will have to pay Rs 23,19,381 (for female students) to Rs 25,77,090 (for male students) as a penalty.</p><p style="text-align: justify; ">Meanwhile, for the students getting admitted to Government Aided Medical College (MAMC, Agroha), the bond amount is Rs 21,90,000 for male students and Rs 19,71,000 for female students.</p><p style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);"><b>Details of the <a href="https://medicaldialogues.in/topics/service-bond">Service Incentive Bond</a> policy in Haryana:</b></span></p><p style="text-align: justify; ">The Haryana Government laid down the rules for the government in-service bond through a notification dated 21.12.2022. Through the notification, the Department of Medical Education and Research (DMER) introduced the policy to incentivise doctors to opt for Government Service upon completing their MBBS Degree course from Government/Government Aided Medical Colleges in the State of Haryana.</p><p style="text-align: justify; ">The intent for introducing such a policy was to provide affordable, quality medical care to the public and to bridge the gap between demand and supply of medical professionals for quality healthcare in the State, and incentivize MBBS doctors graduating from Government/Government Aided Medical Colleges established by the State of Haryana to to serve in Government sector for further up scaling and strengthening overall health facilities in the State.</p><p style="text-align: justify; "><b>Applicability:</b>&nbsp;</p><p style="text-align: justify; ">This policy was made applicable for the candidates admitted in the MBBS course in the Government Medical Colleges from the academic session 2020-2021 onwards and candidates admitted in the MBBS course in Government Aided Medical College(s)- MAMC, Agroha, from the Academic Session 2022-2023 onwards.</p><p style="text-align: justify; ">However, the policy does not apply to the candidates admitted under the NRI quota in Government/Government Aided Medical Colleges established by the State of Haryana.</p><p style="text-align: justify; "><b>Bond Amount:</b>&nbsp;</p><p style="text-align: justify; "><i>"The Government of Haryana with the objective stated in the preamble introduces “Service Incentive Bond” to incentivize the MBBS graduates to opt for Government Service after completion of MBBS degree in lieu of a bond of Rs 30 lakh - Minus Total Annual Fee with a concession of 10% on bond amount for female candidates,"</i> stated the notification.</p><p style="text-align: justify; ">The course fee for students pursuing MBBS courses at Government Medical Colleges is Rs 4,22,910, and the course fee for students at Government Aided Medical Colleges is Rs 8,10,000. Accordingly, the bond amount is Rs 25,77,090 for male students at GMCs and Rs 23,19,381 for female students.</p><p style="text-align: justify; "> At Government Aided Medical College, the bond amount is Rs 21,90,000 for male and Rs 19,71,000 for female students.</p><p style="text-align: justify; "><b>Duration of Bond Period:</b>&nbsp;</p><p style="text-align: justify; ">As per the Government notification, the total duration of the Service Incentive Bond shall be five years starting from the completion of the MBBS course.</p><p style="text-align: justify; "><b>Salient Features of Service Incentive Bond in Haryana:</b>&nbsp;</p><p style="text-align: justify; ">A.(1) The bond shall be in the shape of a collateral free education loan.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">(2) Upon completion of MBBS, the candidates shall have to exercise the option out of the following:</p><p style="text-align: justify; ">i. Consent for Government service</p><p style="text-align: justify; ">ii. Not opting for Government service and declare to pay the amount qua the Service Incentive Bond in lump sum</p><p style="text-align: justify; ">iii. Not opting for Government service and declare to pay the amount qua the Service Incentive Bond in monthly instalments</p><p style="text-align: justify; ">(3) The candidates shall execute a tripartite bond, which will be signed between the candidate, bank and Government through the Institution concerned in which the candidate gets admission.</p><p style="text-align: justify; ">(4) The loan towards Service Incentive Bond will be at a rate of interest linked with REPO Linked Lending Rate (RLLR), which may vary from time to time.</p><p style="text-align: justify; ">(5) The total duration of the Service Incentive Bond shall be five years, starting from completion of the MBBS course.</p><p style="text-align: justify; ">(6) The government will repay the entire bond amount with interest to the bank in lieu of the service rendered by the candidate in Government.</p><p style="text-align: justify; ">(7) The said Service Incentive Bond shall be implemented after completion of the MBBS course. One-year moratorium period shall be provided. Candidate is not required to repay any amount of the Bond during the period of study, including the period of Postgraduation.</p><p style="text-align: justify; ">(8) State Government shall offer a ‘Contractual service’ in Public health institutions / Government/Government aided Medical Colleges to the candidate within 01 year of completion of MBBS course upon which repayment towards loan by State Government shall begin immediately</p><p style="text-align: justify; ">(9) Candidate will be at liberty to appear for any Central /State Government service including Judicial Services /Armed forces etc. In case the candidate obtains employment with Central / any State Government / Armed forces/Judicial Services/, then the Government of Haryana shall repay the loan (both principal and interest) till the time he/she continues to serve in the said job, up to completion of bond period or total repayment; whichever is earlier.</p><p style="text-align: justify; ">(10) The State Government shall repay the monthly installments of the loan (both principal and interest) till the time he/she is serving in the Public Health Institutions / Government/ Government aided Medical Collegesof Government of Haryana in ‘Permanent’ or ‘Contractual service’.</p><p style="text-align: justify; ">(11) No deductions shall be made by the Government from the salary of candidates who choose to work with Government for the purpose of repayment towards the Service Incentive Bond.</p><p style="text-align: justify; ">(12) Should there arise a situation that despite best efforts the candidate is not able to secure a regular/contractual employment with the Government even after one year, the loan repayment qua such candidates shall also be made by the Government of Haryana</p><p style="text-align: justify; ">(13) The candidates shall be liable to repay the amount qua the Service Incentive Bond, only when the candidate chooses NOT to join any Government Service, either permanent/contractual when offered the service</p><p style="text-align: justify; ">(14) Upon selection for Post-Graduation in Haryana or any other State in India, the period of Post Graduation shall be deducted from the total bond period of five years.</p><p style="text-align: justify; ">Specifying regarding this, the policy mentions-</p><p style="text-align: justify; ">i. The candidates shall be awarded provisional degree upon completion of MBBS Course. Original Degree shall be awarded upon completion of period envisaged under the Service Incentive Bond.</p><p style="text-align: justify; ">ii. An MBBS candidate, shall be at liberty to pursue any Post Graduate Degree /diploma course (in any Institute across the Country), before/during the service. The period of Post-graduation shall be deducted from the total period of Service under the Service Incentive Bond. The candidate shall complete the remaining period of Service after completion of such Post Graduate Degree /Diploma course by serving in the State of Haryana not later than 03 months from the date of completion of the PG course.</p><p style="text-align: justify; ">iii. Candidates who pursue PG courses outside the State of Haryana will be required to undertake to complete the remaining period of Government service after the completion of his/her PG course.</p><p style="text-align: justify; ">(15) If a candidate is not able to secure a contractual service within 01 year of completion of his/her course, the candidate can take up any employment, and the repayment of loan against such candidate shall be made by the Government of Haryana. Such candidate shall still be liable to serve in the Government sector, if offered a job by the Government, within the period of service as envisaged under the Service Incentive Bond i.e. within 05 years after completion of course.</p></div><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">The course of repayment of loan (both principal and interest amount) in this scenario shall be as under –</p><div class="pasted-from-word-wrapper"><table border="1" cellspacing="0" style="text-align: justify; "><tbody><tr><td width="205" valign="top"><p class="15">Privately/Self employed Candidate earning less than the initial salary of Medical officer with Government of Haryana</p></td><td width="88" valign="top"><p class="15">Entire Repayment Haryana</p></td><td width="18" valign="top"><p class="15">by</p></td><td width="21" valign="top"><p class="15">the</p></td><td width="59" valign="top"><p class="15">Government</p></td><td width="18" valign="top"><p class="15">of</p></td></tr><tr><td width="205" valign="top"><p class="15">Privately/Self employed Candidate earning more than the initial salary of Medical officer with Government of Haryana but less than 1.5 times of such salary</p></td><td width="205" valign="top" colspan="5"><p class="15">Repayment of loan amount against the equivalent component of salary shall be made by the Government of Haryana.</p><p class="15">The candidate shall be required to repay installment towards the remainder amount Illustration: Presuming the salary of a Govt. medical officer is Rs 100/-, and the candidate is serving outside the Government sector and earning more than Rs 100/- but less than Rs 150/-; then the candidate is liable only to repay the installment against amount above Rs 100/- as installment, i.e. against Rs. 50/-. The proportionate repayment against Rs. 100/- shall be made by the Government</p></td></tr><tr><td width="205" valign="top"><p class="15">Privately/Self employed Candidate earning more than 1.5 times of initial salary of Medical Officer with Government of Haryana</p></td><td width="205" valign="top" colspan="5"><p class="15">Entire Repayment by the Candidate</p></td></tr></tbody></table></div></div><p style="text-align: justify; ">B. The policy further mentions that the candidate can also choose to pay the entire bond amount him /her without recourse to the loan on lump sum basis or in equal installments annually during the course of study. In this case, the candidate shall not be required to serve with Government.</p><div class="pasted-from-word-wrapper"><p style="text-align: justify; ">C. Leaving Government Service:</p><p style="text-align: justify; ">As per the policy, the candidate is at liberty to leave the Government service (Regular/Contractual) at any time before the bond period expires subject to repayment of remaining loan amount with interest. The amount shall be calculated on a pro-rata basis(for both period of service as well as the bond amount).</p><p style="text-align: justify; ">The candidate will have the following options -</p><p style="text-align: justify; "> The remaining amount qua the Service Incentive Bond can be paid in a lump-sum basis.</p><p style="text-align: justify; "> The candidate can choose to pay the installments at his/her own level thereafter.</p><p style="text-align: justify; "><i>"The candidate shall have the option to shift between Options (A)/(B)/(C) at any time, during the duration of study/period of service and serve the Government and pay the bond amount accordingly as specified at point No. 5(A),"</i> mentions the policy.</p><p style="text-align: justify; ">It further mentioned that the Department of Medical Education &amp; Research shall devise an online portal for effective ground implementation of the policy. It added that the Policy shall not be applicable in the unfortunate event of death/insanity/permanent disability of the candidate. Policy shall not be applicable in the unfortunate event of death/insanity/permanent disability of the candidate, the notification further mentioned.</p></div><p style="text-align: justify; "><b><i>To view the bond policy, click on the link below:</i></b></p><p style="text-align: justify; "><a href="https://medicaldialogues.in/pdf_upload/dmer-haryana-bond-283402.pdf"><b><i>https://medicaldialogues.in/pdf_upload/dmer-haryana-bond-283402.pdf</i></b></a></p><p style="text-align: justify; "><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/haryana/haryana-bond-policy-mou-confusion-between-state-and-bank-115775" style="background-color: rgb(255, 255, 255);"><b><i>Also Read: Haryana Bond Policy: MoU Confusion between State and Bank</i></b></a></p>

411. USFDA issues EIR for Lupin Nagpur Injectable facility

     Thu, 17 Apr 2025 09:30:34 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/03/24/279928-lupin-50-4.webp' /><p style="text-align: justify; "><span style="background-color: rgb(255, 255, 255);"><b>Mumbai</b>: Global pharma major <a href="https://medicaldialogues.in/topics/lupin">Lupin </a>Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA), for drug-medical device combination products at its injectable facility in Nagpur, India.</span></p><div class="pasted-from-word-wrapper" style="text-align: justify; "> The EIR was issued following an inspection of the facility conducted from June 10 to June 13, 2024.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "> Nilesh Gupta, Managing Director, Lupin said, “We are very pleased to have received the EIR from the US FDA for drug-device combination products at our Nagpur injectable facility. We remain committed to producing complex generic and essential products that address unmet needs."</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/md-brand-connect/lupin-launches-ajaduo-m-forte-a-triple-fixed-dose-combination-of-empagliflozin-linagliptin-and-metformin-extended-release-er-145769" style="background-color: rgb(255, 255, 255);">Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER)</a></i></b></div><div class="pasted-from-word-wrapper" style="text-align: justify; "> Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The company has a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally.</div><div class="pasted-from-word-wrapper" style="text-align: justify; "><b><i>Read also:&nbsp;<a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/lupin-uk-arm-acquires-renascience-pharma-for-over-rs-138-crore-145988">Lupin UK arm acquires Renascience Pharma for over Rs 138 crore</a></i></b></div>

412. Medical Bulletin 17/ April/ 2025

     Thu, 17 Apr 2025 09:30:00 -0000

     <img src='https://medicaldialogues.in/h-upload/2025/04/17/283378-top-medical-2025-04-17t121109568.webp' /><p style="text-align: justify; "><b>Here are the top medical news for the day:</b></p><div class="pasted-from-word-wrapper"><div style="text-align: justify;"><b>Type 5 Diabetes Officially Recognised at World Congress 2025</b></div><div style="text-align: justify;">A newly recognised form of diabetes—Type 5 diabetes—was officially announced this week at the World Congress of Diabetes 2025 in Bangkok by Prof Peter Schwarz, President of the International Diabetes Federation. Distinct from Type 1 and Type 2, Type 5 diabetes primarily affects underweight individuals who have no family history of diabetes and display atypical symptoms. </div><div style="text-align: justify;">Unlike Type 2 diabetes, which involves insulin resistance, those with Type 5 are insulin deficient but not insulin resistant, indicating a fundamentally different physiological profile. The condition was first observed in the 1960s in Jamaica and referred to as J-type diabetes. It was recognised by the World Health Organization in 1985 but removed from classification in 1998 due to insufficient evidence. </div><div style="text-align: justify;">However, new research published in 2022 by Dr Nihal Thomas and Dr Riddhi Dasgupta of Christian Medical College, Vellore, in collaboration with Prof Meredith Hawkins of Albert Einstein College of Medicine, has confirmed its distinct nature. Their study, published in Diabetes Care, laid the scientific foundation for its reclassification. In response, a global task force will be established to further investigate the condition, aiming to improve diagnosis and treatment, particularly in low-BMI populations where the condition may be more prevalent.</div><div style="text-align: justify;">Reference: https://idf2025.org/</div><div></div><div></div><div style="text-align: justify;"><b>Want Lower Blood Pressure? Reach for a Banana: Study</b></div><div style="text-align: justify;">New research from the University of Waterloo suggests increasing the ratio of dietary potassium to sodium intake may be more effective for lowering blood pressure than simply reducing sodium intake.</div><div style="text-align: justify;">High blood pressure affects over 30 per cent of adults globally. It's the leading cause of coronary heart disease and stroke and may also lead to other afflictions like chronic kidney disease, heart failure, irregular heartbeats, and dementia.</div><div style="text-align: justify;">Potassium and sodium are both electrolytes -- substances that help the body send electrical signals to contract muscles, affect the amount of water in your body and perform other essential functions.</div><div style="text-align: justify;">The researchers developed a mathematical model that successfully identifies how the ratio of potassium to sodium impacts the body. The model also identifies how sex differences affect the relationship between potassium and blood pressure.</div><div style="text-align: justify;">The study found that men develop high blood pressure more easily than pre-menopausal women, but men are also more likely to respond positively to an increased ratio of potassium to sodium.</div><div></div><div></div><div style="text-align: justify;">"Early humans ate lots of fruits and vegetables, and as a result, our body's regulatory systems may have evolved to work best with a high potassium, low sodium diet," said Melissa Stadt, a PhD candidate in Waterloo's Department of Applied Mathematics and the lead author of the study.</div><div style="text-align: justify;">"Today, western diets tend to be much higher in sodium and lower in potassium. That may explain why high blood pressure is found mainly in industrialized societies, not in isolated societies."</div><div style="text-align: justify;">The researchers emphasize that mathematical models like the one used in this study allow these kinds of experiments to identify how different factors impact the body quickly, cheaply, and ethically.</div><div style="text-align: justify;">Reference: https://uwaterloo.ca/news/media/high-blood-pressure-eat-more-bananas</div><div></div><div style="text-align: justify;"><b>Managing Weight Before Pregnancy May Lower Heart Disease Risk: Study Finds</b></div><div style="text-align: justify;">Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature’s stress test and may uncover an individual’s risk for heart disease later in life, according to new research published in the journal of the American College of Cardiology. The study also highlights how weight management before pregnancy may not only improve maternal health but also reduce future cardiovascular disease risk.</div><div style="text-align: justify;">For the study, researchers tracked 4,269 pregnant women across nine countries, following up on outcomes over 10 to 14 years. They looked at measurements for blood pressure, triglycerides, fasting glucose, and hemoglobin A1c, comparing participants with overweight or obesity with those who had normal BMI. Secondary outcomes included incidence of hypertension or diabetes at the midlife follow-up.</div><div style="text-align: justify;">They found that adverse pregnancy outcomes contributed significantly to the link between pre-pregnancy overweight or obesity and cardiovascular risk factors in midlife. In addition, different types of complications affect different health risks. Specifically, gestational diabetes enhanced risk for higher glucose and hemoglobin A1c, while hypertensive disorders contributed to risk for high blood pressure in midlife.</div><div style="text-align: justify;">Jaclyn Borrowman, PhD, a researcher at Northwestern University and lead author of the study noted that, even though these pregnancy complications helped explain the link between pre-pregnancy weight and heart disease risk, they didn’t account for most of the connection—other factors are also involved.</div><div style="text-align: justify;">“The study highlights the significance of adverse pregnancy outcomes as a risk-enhancing factor for cardiovascular disease,” Borrowman said. “Our results also suggest that prioritizing weight management among those considering pregnancy may promote both maternal and future cardiovascular health.”</div><div style="text-align: justify; ">Reference: Pre-Pregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife was published in 2025, in JACC.</div></div>

413. Drag a Puff, BAMS doctor makes 5-year-old child smoke cigarette to cure cold

     Thu, 17 Apr 2025 08:52:42 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/10/03/255193-transferred.webp' /><p style="text-align: justify; "><b>Jalaun: </b>In a&nbsp;disturbing and shocking incident from Uttar Pradesh, a&nbsp;<a href="https://medicaldialogues.in/topics/bams-doctor" target="_blank">BAMS doctor </a>posted at the Central Health Centre in Kuthaund was caught on camera encouraging and forcing a 5-year-old boy to smoke cigarettes, claiming it would cure his cold and cough. The video quickly went viral on social media, following which the doctor was transferred to the district headquarters as part of his disciplinary action.</p><p style="text-align: justify; ">The 5-year-old child was brought to the CHC by his parents for treatment of a cold. Shockingly, in their presence, the doctor made the boy smoke a cigarette and even asked his parents to let him smoke as it would clear the cough buildup in his chest. &nbsp;</p><p style="text-align: justify; ">The parents, without even questioning the doctor's unconventional and dangerous technique, told the doctor that they live in a remote area where cigarettes are not available, and therefore, they took one cigarette for their child from the doctor at Rs 100.</p><p style="text-align: justify; "><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/kerala-doctors-use-of-repeat-all-on-prescriptions-triggers-controversy-146464" target="_blank">Kerala Doctors' use of 'Repeat All' on prescriptions triggers controversy</a></b></p><p style="text-align: justify; ">Instead of prescribing medication or administering injections, the doctor placed a cigarette in the boy’s mouth and even demonstrated how to smoke it, forcing the child to inhale nicotine.&nbsp;</p><p style="text-align: justify; ">In the viral video, the doctor identified as Suresh Chandra was captured allegedly asking the boy to put a cigarette to his mouth. The doctor then lights the cigarette up and asks the boy several times to take a pull on it, report PTI.&nbsp;</p><p style="text-align: justify; ">The doctor is heard telling the child, ‘’Ham jala rahe hain....aur kheencho....andar kheenchon yaar’’ (I am lighting the cigarette....drag a puff....drag deeper buddy). Aaj ki training itni hi hai....baki kal sikhayenge’ (today’s training is now over...will teach you the rest tomorrow)."</p><p style="text-align: justify; ">Shockingly, the doctor even showed him how to puff a cigarette the right way. He inhaled the smoke and asked the body to do the same exactly. The incident has sparked outrage among the medical community and the public, who raised concerns about such doctors practising in the country. It also attracted widespread denunciation in comments.&nbsp;</p><p style="text-align: justify; ">According to media reports, the incident happened last month, but it came to light on Wednesday after the video surfaced on social media.</p><p style="text-align: justify; ">Taking action against the serious act of gross negligence, the state government transferred the doctor to the district headquarters and ordered a probe against him. Additional CMO Dr SD Chaudhary will head the investigation. A detailed report in this connection will be submitted soon to the state government.</p><p style="text-align: justify; ">Speaking to <a href="https://timesofindia.indiatimes.com/india/caught-on-cam-up-doctor-makes-child-smoke-cigarette-as-treatment-probe-on/articleshow/120346793.cms" rel="nofollow">TOI</a>, Chief Medical Officer of the hospital, Dr Narendra Dev Sharma said, "This kind of incident will not be tolerated in the district. We have issued strict instructions to prevent such occurrences in the future," said Dr Sharma.&nbsp;</p><p style="text-align: justify; ">Meanwhile, this is not the first time that the doctor has come under scrutiny. Previously, the doctor was removed from the Kuthaund centre following complaints of misconduct, said CMO Sharma.&nbsp;</p><p style="text-align: justify; ">He told <a href="https://www.hindustantimes.com/cities/lucknow-news/jalaun-doc-makes-child-smoke-cigarette-to-treat-cold-probe-on-101744818849919.html" rel="nofollow">HT</a>, “Chandra had already been removed from his post due to a complaint of physical assault. The cigarette video has now also been taken into account. An inquiry has been handed over to the ACMO, and a letter is being sent to the state government recommending strict action against the doctor."</p><p style="text-align: justify; "><b>Reaction from netizens</b></p><p style="text-align: justify; ">The video shared by a user on the popular social media platform 'X' gained widespread attention and hate from the netizens who called out the doctor for slow poisoning the child to death.&nbsp;</p><p style="text-align: justify; ">An X user who commented on the post said, "If a doctor is treating a child's cough with cigarettes, then he is not treating it, but giving a slow poison. Such doctors are not only hurting the dignity of their profession, but also playing with innocent lives. Cigarettes are the root cause of the disease, not its cure."</p><p>"Why isn't this person in jail? Also, enlighten us about what kind of doctor he is, also the cameraman too is asking the child to take a drag, he too should be punished," said another user.&nbsp;</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/on-duty-doctor-assaulted-by-mob-at-district-hospital-gurdaspur-146580" target="_blank">On-Duty Doctor Assaulted By Mob at District Hopsital Gurdaspur</a></b></p>

414. Zydus Lifesciences announces execution of undertakings to tender over 22 lakh Amplitude Surgical shares

     Thu, 17 Apr 2025 08:30:14 -0000

     <img src='https://medicaldialogues.in/h-upload/2024/02/09/231917-zydus-lifesciences-50.webp' /><p style="text-align: justify; "><b>Ahmedabad:&nbsp;</b><span style="background-color: rgb(255, 255, 255); text-align: justify;"><a href="https://medicaldialogues.in/topics/zydus-lifesciences">Zydus Lifesciences</a> Limited has announced the execution of undertakings from 7 shareholders to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company’s capital and voting rights by them.</span></p><div class="pasted-from-word-wrapper" style="text-align: justify; "> </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">This follows<span style="background-color: rgb(249, 249, 249);">&nbsp;the announcement of the envisaged tender offer on March 11, 2025.</span></div><div class="pasted-from-word-wrapper" style="text-align: justify; ">Considering the 85.6% of the capital that will be acquired by Zydus Lifesciences Limited from PAI Partners, the management of Amplitude Surgical and two minority shareholders, Zydus Lifesciences Limited will be in a position with these undertakings to acquire more than 90% of the capital and voting rights of Amplitude Surgical at the end of the tender offer. </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">These undertakings to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company’s capital and voting rights, may be revoked in the event of a competing tender offer being filed by a third party, declared compliant and opened by the Autorité des marchés financiers. </div><div class="pasted-from-word-wrapper" style="text-align: justify; ">The acquisition of the 85.6% block is expected to be completed by June 2025 and the draft tender offer will be filed with the Autorité des marchés financiers upon receipt of regulatory approvals. The opening of the tender offer will then be subject to the clearance decision of the Autorité des marchés financiers.</div><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-lifesciences-venture-capital-arm-invests-in-feldan-therapeutics-146782">Zydus Lifesciences venture capital arm invests in Feldan Therapeutics</a></i></b></p><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p style="text-align: justify; ">Medical Dialogues team had earlier reported that the Company had entered into exclusive negotiations to purchase from PAI Partners and Amplitude Surgical's management, as well as two minority shareholders, 85.6% of the share capital of Amplitude Surgical, at a price of €6.25 per Amplitude Surgical share (the “Block Acquisition”).</p><p style="text-align: justify; "><b><i>Read also: <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-lifesciences-to-acquire-amplitude-surgical-for-rs-2447-crore-144747">Zydus Lifesciences to acquire Amplitude Surgical for Rs 2,447 crore</a></i></b></p><p style="text-align: justify; ">Zydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive &amp; targeted drugs.</p></div>

415. New Lungs Give Young Girl Her Laugh Back

     Wed, 16 Apr 2025 15:00:00 -0000

     

     Her pulmonary hypertensive crisis was so severe because it was accompanied by flash pulmonary edema, a sudden and severe accumulation of fluid in the lungs.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Sadie smiling" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <figure class="wp-block-image size-large"><img decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-900x506.jpg" alt="Sadie smiling" class="wp-image-27206" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-1200x675-1.jpg 1200w" sizes="(max-width: 900px) 100vw, 900px" /></figure> <p>If you meet 7-year-old Sadie Jackson, the first thing you’ll hear is her laugh. Her mom, Carrie, calls her a “giggler.” It’s full of life and bright, and will bring anyone who hears it joy. But a sudden onset of symptoms and a rare, progressive lung disease took away that giggle.</p> <p>“It got to the point where even laughter would make her sick,” Carrie remembers. “It broke my heart when she would laugh and then start feeling unwell. That was so awful.”</p> <p>In September 2022, when they were living in Southern California, the family was with friends at the zoo, and Sadie’s stomach started to hurt. She was panting and coughing and couldn’t walk the rest of the way to the car.</p> <p>“What we came to learn was that was a pulmonary hypertensive crisis,” Carrie says. “From that point on, she had a crisis every couple of days. She would progressively get worse, so she would thrash about, couldn’t breathe, and turn pale, sweaty, and clammy. Once everything relaxed, she would be back to normal.”</p> <p>After many doctors’ visits, 911 calls, and emergency room trips, it was still unclear exactly what she had until she was admitted to a local children’s hospital. The very next morning, Sadie had another crisis.</p> <p>“I’m a nurse,” Carrie says. “That was the first time I’d seen it on the monitor, so I knew it was bad. I just thought there had to have been angels around us while we were at home.”</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img decoding="async" width="450" height="600" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-and-her-mom-carrie-450x600-1.jpg" alt="Sadie in hospital bed with mother Carrie by her side" class="wp-image-27219" style="width:369px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-and-her-mom-carrie-450x600-1.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-and-her-mom-carrie-450x600-1-338x450.jpg 338w" sizes="(max-width: 450px) 100vw, 450px" /><center><figcaption class="wp-element-caption">Carrie and Sadie Jackson</figcaption></center></figure></div> <p>Her pulmonary hypertensive crisis was so severe this time because it was accompanied by flash pulmonary edema, a sudden and severe accumulation of fluid in the lungs, causing severe respiratory distress. This is seen in patients with pulmonary veno-occlusive disease, or PVOD. PVOD is an extremely rare and often fatal form of <a href="https://www.stanfordchildrens.org/en/services/pulmonary-vascular-disease.html">pulmonary hypertension</a> (PH) where the small veins in the lungs become blocked, causing increased pressure in the pulmonary arteries and eventually affecting heart function. There is no cure. </p> <p>“[The doctor] told us that if she had PVOD, it is a ruthless and incredibly aggressive disease. The only treatment is lung transplant, and they would be referring Sadie to the lung transplant program at Stanford Medicine Children’s Health,” Carrie recalls.</p> <p>Stanford Children’s is the only pediatric program in the Western United States that performs lung or combined heart-lung transplants from infancy through early adulthood, offering more than 35 years of experience—more than any other pediatric hospital in the region. Often, those on the waiting list are like Sadie, with significant pulmonary disease from PH and very young.</p> <p>Through a lot of coordination, in January 2023 Sadie was airlifted to Stanford Children’s, where she was evaluated and then listed for a double-lung transplant.</p> <p>“Literature shows us that survival after diagnosis of PVOD, which is after their first presentation, is usually no more than a year,” says <a href="https://www.stanfordchildrens.org/en/provider/laura-green.html">Laura Green, RN</a>, Pediatric Lung and Heart-Lung Transplant program manager. “It’s urgent to assess them for transplant candidacy, given that once approved to be placed on the transplant waiting list, the wait time for matching organs is unpredictable.”<em></em></p> <h2 class="wp-block-heading">Staying positive during a long wait</h2> <p></p> <p>The smaller a patient is, the longer they often wait for a matching donor, due to smaller numbers of infant and pediatric organ donors. Finding the best way to bridge that gap until transplant was crucial.</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="450" height="600" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-with-dr-450x600-3.jpg" alt="" class="wp-image-27232" style="width:360px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-with-dr-450x600-3.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-with-dr-450x600-3-338x450.jpg 338w" sizes="auto, (max-width: 450px) 100vw, 450px" /><center><figcaption class="wp-element-caption">Sadie with Dr. Si and Laura Green</figcaption></center></figure></div> <p>“We started her on diuretic therapies to help remove some of the fluid from her lungs, and started her on steroids,” says <a href="https://www.stanfordchildrens.org/en/doctor/xin-si.html">Cissy (Xin) Si, MD</a>, medical director of the <a href="https://www.stanfordchildrens.org/en/services/lung-transplant.html">Pediatric Lung and Heart-Lung Transplant</a> program. “Not every patient responds, but Sadie was very responsive. That helped her get to a more stable spot.”</p> <p>Sadie also presented a unique challenge because she was sensitized, meaning she had a high level of Human leukocyte antigen (HLA) antibodies that made it harder to find a compatible donor<em>. </em>The lung transplant program was able to successfully desensitize Sadie while she awaited transplant, improving her chances of finding a suitable match.<em></em></p> <p>Despite the challenges, the Jackson family found ways to remain positive, leaning on their faith. Whether it was the transplant psychologist, their social worker, or music therapists, they knew Sadie was in the best hands possible as they prepared her for a rare treatment for her rare disease.</p> <p>“Some people might say, ‘We can’t do lung transplant. The patient is too small,’” says <a href="https://www.stanfordchildrens.org/en/doctor/e/elisabeth-martin.html">Elisabeth Martin, MD</a>, surgical director of Pediatric Lung and Heart-Lung Transplant. “But it’s a treatment. It’s an option we should use for sick patients. Here at Stanford Children’s, all of the teams from <a href="https://www.stanfordchildrens.org/en/services/rehabilitation-services.html">rehabilitation</a> to the <a href="https://www.stanfordchildrens.org/en/services/cardiovascular-intensive-care.html">Cardiovascular Intensive Care Unit</a> to <a href="https://www.stanfordchildrens.org/en/services/pulmonary-medicine-cystic-fibrosis.html">pulmonology</a> align in their roles in taking on a case like this. They have to be at the top of their game, so everything goes smoothly.”</p> <h3 class="wp-block-heading">Back to laughing and playing</h3> <p>In December 2023, 10 months after she was placed on the transplant waiting list for new lungs, Sadie got the call that there was a set of lungs for her. The family was ready. On the day of her surgery, her care team put up a sign on her door reading, “Happy Lung Day!” with personalized notes.</p> <div class="wp-block-image"> <figure class="aligncenter size-full"><img loading="lazy" decoding="async" width="600" height="450" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-happy-lung-day-600x450-1.jpg" alt="The Jackson family on Lung Day" class="wp-image-27217" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-happy-lung-day-600x450-1.jpg 600w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/sadie-happy-lung-day-600x450-1-450x338.jpg 450w" sizes="auto, (max-width: 600px) 100vw, 600px" /><center><figcaption class="wp-element-caption">The Jackson family</figcaption></center></figure></div> <p>“They all genuinely care about Sadie. There’s an emotional investment. It feels like she’s not just a patient. They are her biggest advocate and truly want to see the best outcomes possible for her,” Carrie says.</p> <p>The surgery went smoothly. Today, Sadie is back to playing the violin and piano, singing, and dancing.</p> <p>“It means everything to me. She’ll just run around the house and say, ‘Look how fast I can go!’ She’s just back to herself. I’m so grateful she can give her sister a run for her money and that they can play together,” Carrie says.</p> <p>Carrie is working on a letter to the donor family to express her gratitude and that the donor’s life continues to live on, helping Sadie thrive.</p> <p>“Transplant is life-changing. We are so grateful to the donor, to the Lord Jesus, and to the team at Stanford Children’s who walked with us through this whole thing. I would encourage anyone to learn more about becoming an organ donor. You could make a world of difference in somebody’s life.”</p> <hr class="wp-block-separator has-alpha-channel-opacity is-style-dots"/> <p>Lucile Packard Children’s Hospital Stanford is nationally ranked No. 10 in pulmonology by U.S. News &amp; World Report and has performed 57 bilateral double lung transplants and 42 combined heart-lung transplants since 1986. <a href="https://www.stanfordchildrens.org/en/services/lung-transplant.html">Learn more about our Lung and Heart-Lung Transplant services ></a></p>

416. At Stanford Children’s, a Young Patient Battles Heart Failure—and Rediscovers Joy in Movement

     Tue, 15 Apr 2025 22:04:33 -0000

     

     After arriving at Stanford Children’s in heart failure, 4-year-old Puuwai was fitted with a VAD, which temporarily impacted his mobility. Now, Puuwai is regaining his strength, one step at a time.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-900x506.jpg" alt="After arriving at Stanford Children’s in heart failure, 4-year-old Puuwai was fitted with a VAD, a device to help support his heart while awaiting a transplant. Although the VAD was crucial for his recovery, it temporarily impacted his mobility. Now, Puuwai is regaining his strength and walking again, one determined step at a time." class="wp-image-27241" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Untitled-design-2.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p>Puuwai was just 4 years old when he arrived at <a href="http://www.stanfordchildrens.org/">Stanford Medicine Children&#8217;s Health</a> in November 2024. His heart was failing. The medical team in the <a href="https://www.stanfordchildrens.org/en/services/heart-center/services.html">Betty Irene Moore Children’s Heart Center</a> acted quickly, implanting a <a href="https://www.stanfordchildrens.org/en/services/heart-transplant/vad.html">ventricular assist device</a> (VAD), a mechanical pump designed to keep his heart working while he awaited a possible heart transplant.</p> <p>The months that followed were marked by a series of challenges for Puuwai—or “Puu,” as his caregivers affectionately call him. Prolonged sedation, limited mobility and numerous medical procedures left him weak, unable to perform even the simplest movements. But in the midst of a complex medical recovery, Puu began another journey: one of rediscovering how to move, play, and to smile again.</p> <p>Guiding him along that path have been occupational therapist Jen Rivera and physical therapist Leslie Lam, who make up the core of Puu’s <a href="https://www.stanfordchildrens.org/en/services/rehabilitation-services.html">Pediatric Rehabilitation Services</a> team. Their sessions have become a daily ritual of music, movement and small but significant victories.</p> <p>“Witnessing Puu’s bravery as he accepts every challenge we throw his way during our therapy sessions has been an inspiration,” say his therapists. “Our rehab team is honored to be part of his journey.”</p> <p>Puu’s hospital stay has included many procedures with long periods of sedation. The months of inactivity left Puu weakened. But with a regimen carefully tailored to his needs, his care team has helped him regain basic abilities: moving in bed, sitting up, standing, and now, walking with support.</p> <figure class="wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex"> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="675" height="900" data-id="27253" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-675x900.jpg" alt="" class="wp-image-27253" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-675x900.jpg 675w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-338x450.jpg 338w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-768x1024.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-1152x1536.jpg 1152w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-1536x2048.jpg 1536w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/PT.11-scaled.jpg 1920w" sizes="auto, (max-width: 675px) 100vw, 675px" /></figure> </figure> <p>Their sessions have become a celebration of joy and milestones. The Addams Family theme songs—complete with snapping and dancing—opens many of their sessions. There are high-fives, balloon games to celebrate his stuffed animals’ birthdays, and hugs to encourage standing and strengthening. In one breakthrough, Puu sat upright on a tilt table for the first time and exclaimed, “Happy!”</p> <p>What makes Puu’s journey particularly unique is the role his VAD plays. The device is used as a bridge to heart transplant, and his medical team specifically selected it to give him time and the strength to undergo intensive rehabilitation.</p> <p>Now, months into his hospital stay, Puu is no longer just sitting up or standing—<a href="https://www.instagram.com/p/DIfAyonzllT/">he’s cruising the hallways</a> on scooter boards, embarking on scavenger hunts, and flashing his bright smile.  </p> <p>There’s still a long road ahead. But for his family and his care team at Stanford Children&#8217;s, Puu’s courage and progress serve as a powerful reminder of what’s possible.</p>

417. Honoring the Memory of Pat Rice and Claire Fitzgerald

     Thu, 10 Apr 2025 19:29:03 -0000

     

     Their legacy lives on through a book cart, featuring a poem Pat wrote.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Reading cart" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-900x506.jpg" alt="Reading cart" class="wp-image-27192" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p><strong>Pat Rice and Claire Fitzgerald</strong>, beloved husband-and-wife volunteers, spent more than 20 years cuddling NICU babies at Lucile Packard Children&#8217;s Hospital Stanford. Claire offered a gentle, grandmotherly touch, while Pat was known for his soothing Irish tunes. </p> <p>Their legacy lives on through a <strong>book cart created in their honor</strong>, featuring a poem Pat wrote—reminding us all of the power of love and presence in the healing process. </p> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-with-books-1200-900x506.jpg" alt="Cart with books" class="wp-image-27190" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-with-books-1200-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-with-books-1200-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-with-books-1200-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/cart-with-books-1200.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p>“<em>You are so new&#8230; But I know you are strong&#8230; You will create a story even fuller and longer.” – Pat Rice</em></p> <figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="646" height="391" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2013/12/cuddlers.jpg" alt="" class="wp-image-2859" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2013/12/cuddlers.jpg 646w, https://healthier.stanfordchildrens.org/wp-content/uploads/2013/12/cuddlers-300x181.jpg 300w" sizes="auto, (max-width: 646px) 100vw, 646px" /></figure>

418. The Heart of a Healer: Jacqueline Arroliga’s Extraordinary Journey From Volunteer to Nurse Leader

     Thu, 10 Apr 2025 18:50:05 -0000

     

     What started as a volunteer role at Lucile Packard Children’s Hospital Stanford became a lifelong calling for Jacqueline Arroliga, now a charge nurse in the Maternity Unit.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Jacqueline Arroliga, Charge Nurse in the Maternity Unit at Lucile Packard Children&#039;s Hospital Stanford" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-900x506.jpg" alt="Jacqueline Arroliga, Charge Nurse in the Maternity Unit at Lucile Packard Children's Hospital Stanford" class="wp-image-27180" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/jacqueline-1200.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p>What started as a volunteer role at <a href="https://www.stanfordchildrens.org/en/lucile-packard-childrens-hospital.html">Lucile Packard Children’s Hospital Stanford</a> became a lifelong calling for Jacqueline Arroliga, now a charge nurse in the <a href="https://www.stanfordchildrens.org/en/services/pregnancy-newborn/maternity-care.html">Maternity Unit</a>. Her story of compassion, perseverance, and dedication proves that even the smallest acts of kindness can shape a career and change lives. When Jacqueline Arroliga first stepped through the doors of Lucile Packard Children’s Hospital in 2009, she didn’t know she was walking into her future. A UC Berkeley graduate with a degree in Molecular Environmental Biology, she was searching for clarity, uncertain whether her path would lead to medical school or nursing.</p> <p>In 2009, she began <a href="https://www.stanfordchildrens.org/en/volunteer.html">volunteering</a> in the Newborn Hearing Program in the Maternity Unit, hoping to get firsthand insight into patient care. The following year, she got her first job at the Information Desk in 2010—but she didn’t stop volunteering. In fact, it was during this time that she transitioned into the Buddy Program, continuing to spend her evenings with pediatric patients after her day shifts at the Info Desk.</p> <p>Her experiences as a Buddy opened her eyes to a side of healthcare she hadn’t expected: many children spent long hours—sometimes days—in the hospital without family at their bedside, not out of neglect but due to life’s circumstances. Parents had other children to care for, jobs to keep, and long distances to travel.</p> <p>One child changed everything for her—a five-year-old boy from the oncology unit. Jacqueline met him through the Buddy Program but also saw him frequently during her Info Desk shifts when he would arrive with his mother. He spoke only Spanish, but the connection they formed was instant. They bonded over card games and simple conversations. One day, he looked up at her and said, “Young lady, go on and paint your nails.” She laughed and promised she would. The next time she saw him, her nails were painted, and he lit up with joy.</p> <p>Later, his mother returned to the hospital alone. She found Jacqueline at the Info Desk, her eyes filled with tears, and thanked her for the time she had spent with her son—because he had passed away. That moment stayed with Jacqueline.</p> <p>“That moment changed me,” she says. “It confirmed everything—I wanted to be the person who<br>brought comfort and care, even in the hardest times.”</p> <p>Determined to follow her heart, Jacqueline enrolled in nursing school at the University of San Francisco. At the same time, she transitioned into a relief position as an Office Assistant in Volunteer Services, helping place and onboard new volunteers while supporting herself through school. She also transitioned her own volunteering to the Cuddler Program, giving comfort to infants when their parents could not be present.</p> <p>“Going to school full-time while working was hard,” she admits, “but I wouldn’t have been able to do it without the help of my amazing manager, Maryellen Brady, who gave me the flexibility I needed.”<br>In 2014, Jacqueline was accepted into the New Grad Program at LPCH and began her professional<br>nursing career in the Maternity Unit—a place she has called home ever since. The early days were<br>challenging. Learning the pace, pressure, and precision of bedside care took everything she had. But she pushed through, leaned on her mentors, and kept showing up with heart and humility.</p> <p>Today, Jacqueline is a clinical nurse IV, one of the charge nurses, co-lead of the Maternity Quality<br>Improvement Committee, and local practice coordinator lead of the Maternity Shared Governance. She is not only a nurse—she is a mentor, an advocate, and a leader deeply committed to her team and her patients.</p> <p>“I’ve seen every level of nursing in my unit, and it’s given me a unique perspective. I want to lead in a<br>way that strengthens my team—where we make decisions together and uplift one another, even on the busiest days.”</p> <p>Looking back, Jacqueline credits every step—every volunteer shift, every office role, every late-night<br>study session—with preparing her for this work.</p> <p>“You never know what someone is going through,” she reflects. “That’s the most valuable lesson I’ve<br>learned. Always lead with kindness.”</p> <p>To those considering volunteering or exploring a career in health care, her advice is clear:<br>“Put yourself in the environment. Experience it firsthand. A shared laugh, a comforting presence, a<br>painted nail—it all matters. It might just change your life, like it did mine.”</p> <p>This <strong>Volunteer Appreciation Week (April 20-27)</strong> and <strong>Nurses Week (May 6-12)</strong>, we honor Jacqueline<br>Arroliga and the countless individuals who dedicate their time, skill, and heart to the care of others.<br>From volunteers who bring warmth into hospital rooms to nurses who walk alongside families in their<br>most vulnerable moments, you are the heartbeat of <a href="https://www.stanfordchildrens.org">Stanford Medicine Children’s Health</a>.</p> <p>Thank you for all that you do.</p> <p><a href="https://www.stanfordchildrens.org/en/volunteer.html"><strong>Learn more about Volunteer Services at Stanford Medicine Children&#8217;s Health &gt;</strong></a></p> <p></p>

419. Pinwheels of Hope: Celebrating National Donate Life Month at Lucile Packard Children’s Hospital Stanford

     Thu, 10 Apr 2025 15:45:00 -0000

     

     Gerri James, RN, Kidney Transplant Program Manager at Stanford Children's Health with Everett planting pinwheels - representing a life-saving transplant.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Pinwheels at Lucile Packard Children&#039;s Hospital Stanford in Palo Alto, CA for Donate Life Month 2025" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <p><em>Raising Awareness and Inspiring Action for Organ Donation</em></p> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-900x506.jpg" alt="Pinwheels at Lucile Packard Children's Hospital Stanford in Palo Alto, CA for Donate Life Month 2025" class="wp-image-27197" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/pinwheels-1200.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /><figcaption class="wp-element-caption">Gerri James, RN, and Everett planting pinwheels &#8211; representing a life-saving transplant.</figcaption></figure> <p>In April, <a href="http://www.stanfordchildrens.org/">Stanford Medicine Children’s Health</a> commemorates National Donate Life Month, a time dedicated to raising awareness about the crucial need for organ and tissue donations. These lifesaving gifts offer a second chance to those battling severe illnesses. At <a href="https://www.stanfordchildrens.org/en/lucile-packard-childrens-hospital">Lucile Packard Children’s Hospital Stanford</a>, 30 young patients are currently waiting for their second chance.</p> <p>To symbolize the hope and urgency for these children, the <a href="https://www.stanfordchildrens.org/en/services/transplant.html">Pediatric Transplant Center</a> care team came together to plant 30 colorful pinwheels in the Dawes Garden, each representing one young patient in need of an organ transplant.</p> <p>Maria Marquez understands the heartache of having a child on the transplant list. Her son is waiting for a lung, and she hopes the pinwheels will remind people of the many children and young adults awaiting donors. “Organs don’t go to heaven. There are people like my son Armando who need them.”</p> <p>According to the United Network for Organ Sharing, there are over 100,000 people in the United States waiting for organ transplants. Of these, approximately 1,900 are children.</p> <p>“The gift of an organ for transplant is a true lifesaver,” said <a href="https://www.stanfordchildrens.org/en/doctor/paul-c-grimm.html">Paul Grimm, MD</a>, pediatric nephrologist and director of the Stanford Medicine Children’s Health <a href="https://www.stanfordchildrens.org/en/services/kidney-transplant.html">Pediatric Kidney Transplant Program.</a> “At Stanford Children’s, we care for many children whose kidneys, livers, hearts, or intestines have failed. When someone donates an organ, whether as a living donor or after passing, they give an incredible gift. This act has the power to profoundly change the life of a child or teen.”</p> <div class="wp-block-image"> <figure class="aligncenter size-large"><img loading="lazy" decoding="async" width="600" height="900" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06773-1-600x900.jpg" alt="" class="wp-image-27166" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06773-1-600x900.jpg 600w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06773-1-300x450.jpg 300w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06773-1-768x1151.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06773-1-1025x1536.jpg 1025w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure></div> <p>Based on 2024 data from the Organ Procurement and Transplantation Network, the Stanford Children’s <a href="https://www.stanfordchildrens.org/en/services/kidney-transplant.html">Pediatric Kidney Transplant Program</a> ranks number one in the country for volume and demonstrates outstanding outcomes for its patients. “People come from all over the United States to us because of our outcomes,” Dr. Grimm explained. “Our world-class team, combined with exceptional posttransplant care and comprehensive patient-family education, exemplifies the global excellence we strive for.”</p> <p>For Dr. Grimm, each pinwheel is more than just a symbol; it’s a call to action. “Some patients wait a long time, and many never get an organ,” Dr. Grimm noted. “They pass away without it. We need more research, more understanding, and more education about the importance of donation.”</p> <figure class="wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-2 is-layout-flex wp-block-gallery-is-layout-flex"> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="900" data-id="27162" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-600x900.jpg" alt="" class="wp-image-27162" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-600x900.jpg 600w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-300x450.jpg 300w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-768x1151.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-1024x1536.jpg 1024w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-1366x2048.jpg 1366w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06697-scaled.jpg 1707w" sizes="auto, (max-width: 600px) 100vw, 600px" /><figcaption class="wp-element-caption">Isabella holding a pinwheel in honor of her brother waiting for a lung transplant. </figcaption></figure> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="600" data-id="27160" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-900x600.jpg" alt="" class="wp-image-27160" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-900x600.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-450x300.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-768x512.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-1536x1025.jpg 1536w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/DSC06740-2048x1366.jpg 2048w" sizes="auto, (max-width: 900px) 100vw, 900px" /><figcaption class="wp-element-caption">Armando is one of 30 young patients currently waiting for an organ transplant.</figcaption></figure> </figure> <p>The Dawes Garden pinwheel event serves as a poignant reminder and an engaging centerpiece to educate the public about the critical need for organ donation.</p> <p>Throughout National Donate Life Month, Stanford Medicine Children’s Health encourages everyone to consider <a href="https://register.donatelifecalifornia.org/lpch4life">registering as an organ donor</a>, potentially offering young patients like those at Lucile Packard Children’s Hospital Stanford a second chance at life.</p>

420. New Heart Leads to Dreams of Becoming a Doctor

     Wed, 09 Apr 2025 15:00:00 -0000

     

     Dedicated care team and timing give a 6-year-old a second chance at life. Mikayla and her family are now raising awareness of the importance of donation in their own community.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Mikayla celebrating her graduation" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <p><em>Dedicated care team and timing give a 6-year-old a second chance at life</em></p> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-900x506.jpg" alt="Mikayla celebrating her graduation." class="wp-image-27144" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-congrats-1200x675-1.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p>Mikayla Huynh, 6, loves to draw, bike, scooter, and play piano, working hard to learn new songs. Her favorite thing to do is sing at the top of her lungs, something that was not possible a couple of years ago.</p> <p>“Mikayla was 4 when she started having symptoms,” says Stephanie Yuan, Mikayla’s mother. “She was short of breath, but we had no idea that was because her heart was sick.”</p> <p>Stephanie took Mikayla to her pediatrician for a PCR test after a COVID-19 exposure in preschool. During that appointment, the doctor happened to detect a heart murmur. He wasn’t overly concerned, but referred them to <a href="https://www.stanfordchildrens.org/en/doctor/n/nikola-h-tede.html">Nikola Tede, MD</a>, at Stanford Medicine Children’s Health in San Francisco, just in case.</p> <p>“My husband and Mikayla went to the doctor’s appointment,” Stephanie says. “That’s when I got a FaceTime call. The cardiologist was next to my husband, Mike, and she said, ‘I have some very difficult news to deliver. Your daughter has <a href="https://www.stanfordchildrens.org/en/services/cardiomyopathy.html">restrictive cardiomyopathy</a>, and eventually she&#8217;ll need a heart transplant to survive.’ My mind just went blank.”</p> <h2 class="wp-block-heading"><strong>A race against the clock</strong></h2> <p></p> <p>Restrictive cardiomyopathy is a condition where the heart muscle becomes stiff, preventing the heart from pumping enough blood to the body. It is the rarest form of cardiomyopathy seen in children, accounting for up to 5% of pediatric cardiomyopathy cases. The only chance for patients is a <a href="https://www.stanfordchildrens.org/en/services/heart-transplant.html">heart transplant</a>.</p> <p>Mikayla was immediately referred to Lucile Packard Children’s Hospital Stanford, where she met <a href="https://www.stanfordchildrens.org/en/doctor/chiu-yu-chen.html">Chiu-Yu Chen, MD</a>, pediatric cardiologist with the <a href="https://www.stanfordchildrens.org/en/services/heart-transplant.html">Pediatric Advanced Cardiac Therapies (PACT) program</a>. As part of the program, children in need of heart transplant receive seamless care from the time of heart failure diagnosis through the waiting for a suitable donor and after heart transplantation.</p> <p>“The thing that was very concerning to me was how rapidly her symptoms seemed to be progressing,” Dr. Chen says. “It was clear she needed expedited evaluation and management, so we admitted her to the <a href="https://www.stanfordchildrens.org/en/services/cardiovascular-intensive-care.html">Cardiovascular Intensive Care Unit</a> that day.”</p> <p>If left untreated, restrictive cardiomyopathy can lead to arrhythmias causing sudden death or high blood pressure in the lungs.</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="400" height="600" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/milkayla-hold-hand-400x600-1.jpg" alt="" class="wp-image-27146" style="width:344px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/milkayla-hold-hand-400x600-1.jpg 400w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/milkayla-hold-hand-400x600-1-300x450.jpg 300w" sizes="auto, (max-width: 400px) 100vw, 400px" /></figure></div> <p>“It becomes a race against the clock because by the time you develop high blood pressures in the lungs, you may not be a heart transplant candidate because the new heart can’t cope with those high pressures and may even be irreversible at that point,” Dr. Chen says.</p> <p>Because there was no way to know how long Mikayla would need to wait for a transplant, the team performed a surgery to connect her to a Berlin Heart, which is a ventricular assist device that helps circulate blood throughout the patient’s body. The Berlin is a machine on wheels and follows the patient wherever they go. Mikayla called it “Mr. Berlin,” and despite her being limited in where she could go, the family found ways to cope.</p> <p>“We started to have some fun in the hospital with her child life therapist and started to make friends with other heart families on the floor. Her nurses, her care team, they all have just been so amazing to her. We are so grateful to Stanford Children’s,” Stephanie says.</p> <p>On June 9, 2023, three months after they were admitted, Stephanie got a call from her husband, who was at the hospital with Mikayla.</p> <p>“He goes, ‘There’s a heart available for her.’ Immediately, I was in tears. He told her Mr. Berlin was coming out, and Mikayla was crying she was so happy,” Stephanie recalls.</p> <p>Two days later, Mikayla came out of surgery with a new heart beating strongly in her chest.</p> <h3 class="wp-block-heading"><strong>‘I want to be a doctor’</strong></h3> <p>Every milestone means so much more to the family.</p> <p>“Whether it’s a big or small achievement, I’m always emotional. There are no words to explain how proud we are of her, and she’s our inspiration,” Stephanie says. “Even seeing her be able to scooter or bike, I’m just in awe and super-grateful that she’s still here.”</p> <p>The pediatric heart transplant waiting list mortality is around <a href="https://med.stanford.edu/news/all-news/2024/08/heart-transplant-pediatrics.html">13%</a> in the United States. The waiting period varies from days to months to years and can be longer, the smaller the child is.</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="400" height="600" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-and-dr-michael-ma-400x600-1.jpg" alt="" class="wp-image-27148" style="width:348px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-and-dr-michael-ma-400x600-1.jpg 400w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/mikayla-and-dr-michael-ma-400x600-1-300x450.jpg 300w" sizes="auto, (max-width: 400px) 100vw, 400px" /><center><figcaption class="wp-element-caption">Mikayla and Michael Ma, MD</figcaption></center></figure></div> <p>“I would say three months is on the shorter side for what we see for a child of Mikayla’s size,” says <a href="https://www.stanfordchildrens.org/en/doctor/m/michael-raosen-ma.html">Michael Ma, MD</a>, division chief of <a href="https://www.stanfordchildrens.org/en/services/cardiothoracic-surgery.html">Pediatric Cardiac Surgery</a> and surgical director of the PACT program. “There is a huge need here for awareness from all communities to encourage organ donation because it’s a scarce resource. And it’s lifesaving for kids like Mikayla.”</p> <p>After recovering from surgery, Mikayla went back to school, and then last summer, the family went on a trip to Hawaii. It was her first time on a plane.</p> <p>“The gift of transplant allows our patients the opportunity to do things they otherwise may not have been able to enjoy,” says <a href="https://www.stanfordchildrens.org/en/provider/donna-w-lee.html">Donna Lee, CPNP</a>, pediatric nurse practitioner. “I see it as a partnership. We provide medical guidance, but in the end, it’s the family learning to live a new normal. So, seeing her thriving is such a reward.”</p> <p>Mikayla and her family are now raising awareness of the importance of donation in their own community.</p> <p>“I did a poll on our Instagram page, and my takeaway was that most people who are following our journey don’t realize what organ donation truly means,” Stephanie says. “So, we try really hard to tell people, ‘What if you knew you could save up to eight people’s lives with donation?’”</p> <p>The impact of donation can be seen clearly in Mikayla. At her preschool graduation last year, every child in her class was asked, “What do you want to be when you grow up?” Without hesitation, Mikayla said, “I want to be a doctor.”</p> <p>The team at Stanford Children’s has been performing heart transplants for more than 50 years, now performing more than 20 transplants each year. <a href="https://www.stanfordchildrens.org/en/services/heart-transplant.html">Learn more about our Heart Transplant services ></a></p>

421. Boy Transformed by Combined Intestinal-Liver Transplant

     Thu, 03 Apr 2025 15:00:00 -0000

     

     Born without working intestines, Zeke Atchison got a new chance at a full life, thanks to our Pediatric Intestinal Transplant Program, the only multi-abdominal organ transplant center on the West Coast.

     <div><img width="768" height="432" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1.jpg" class="attachment-768x768 size-768x768 wp-post-image" alt="Zeke laying in hospital bed" style="margin-bottom: 15px;" decoding="async" loading="lazy" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1.jpg 1200w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-768x432.jpg 768w" sizes="auto, (max-width: 768px) 100vw, 768px" /></div> <p><em>Stanford Medicine Children’s Health’s multivisceral transplant program is the only one on the West Coast</em></p> <figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="900" height="506" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-900x506.jpg" alt="Zeke laying in hospital bed" class="wp-image-27111" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-900x506.jpg 900w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1-768x432.jpg 768w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke4-1200x675-1.jpg 1200w" sizes="auto, (max-width: 900px) 100vw, 900px" /></figure> <p>Ezekiel (Zeke) Atchison loves doing puzzles, stacking blocks, and playing with toys with moving parts. “He definitely has an engineering mind,” says Rayma, his grandmother and custodial parent.</p> <p>While Zeke sounds like an average 5-year-old, the truth is he is fortunate to be alive and just now is beginning to really thrive.</p> <p>When he was a baby in the womb, his intestines didn’t form properly—a condition called intestinal malrotation. They were twisted and in the wrong place. Unfortunately, the twists cut off blood flow, and much of his intestines died.</p> <p>After birth, Zeke was quickly flown by helicopter to a nearby children’s hospital in Phoenix. He had immediate surgery to save as much of the intestines that they could.</p> <p>“They removed about 90 percent of Zeke’s intestines,” Rayma says. “He was left with about 1% of his small intestine and less than half of his large.”</p> <p>Without working intestines, Zeke required <a href="https://www.stanfordchildrens.org/en/services/intestinal-rehabilitation/services.html">total parenteral nutrition (TPN)</a>, an intravenous (IV) nutrition feeding method via a central line. TPN meant he was hooked up to a machine for several hours every day.</p> <p>Zeke went home and received support from his extended family—Rayma; his grandfather, Wayne; his aunt, Tanya; and his great-grandmother, Maggie—where they live near Phoenix, Arizona.&nbsp;</p> <h2 class="wp-block-heading">Coming to Stanford Children’s for an intestinal-liver transplant evaluation</h2> <p>One day near Zeke’s first birthday, he became unresponsive. Rayma rushed him to the hospital, where his doctors discovered that the TPN had damaged his liver. He was in late-stage liver disease.</p> <p>“That incident led us to a referral to Stanford Medicine Children’s Health for a transplant evaluation,” Rayma says.</p> <p>His family met with the <a href="https://www.stanfordchildrens.org/en/services/intestinal-transplant.html">Pediatric Intestinal Transplant</a> team—the only multivisceral (multiple abdominal organ) transplant program on the West Coast. The program has performed more than 50 pediatric intestinal transplants since its inception and achieved a 100% three-year success rate in the last decade, according to <a href="https://www.srtr.org/" target="_blank" rel="noreferrer noopener">Scientific Registry of Transplant Recipients (SRTR)</a> data.</p> <p>“When we evaluated Zeke, it was clear that he needed an intestinal and liver transplant,” says <a href="https://www.stanfordchildrens.org/en/doctor/ke-you-zhang.html">Ke-You (Yoyo) Zhang, MD</a>, pediatric gastroenterologist and director of the Pediatric Intestinal Transplant Program.</p> <h3 class="wp-block-heading">Waiting for donor organs</h3> <p>Little Zeke faced a big hurdle: enduring a long wait for donated organs. “Zeke came to us very small for his age, and he only had so much space in his abdomen. We needed to wait for the perfect match for his size and age,” Dr. Zhang says.</p> <p>Zeke was very sick and fragile, and he required 24-hour attention. To go home and await transplant, Rayma received intensive training from the <a href="https://www.stanfordchildrens.org/en/services/intestinal-transplant/careteam.html">multivisceral transplant care team</a> on managing Zeke’s intestinal and liver needs, including his central line, TPN medications and pump, gastrostomy tube, and monitoring his health for signs of change. They were always available for questions and guidance. “The team at Stanford cares enough to make sure caregivers know what they are doing,” Rayma says.</p> <p>Rayma’s skills and commitment paid off. During the multiyear wait, Zeke never had a single central line infection and had few inpatient visits.</p> <p>“We met with the Stanford team virtually, who often exclaimed that Zeke was the ‘healthiest sick child they had ever seen.’ That felt good to hear,” Rayma says.</p> <p>“Rayma is an incredible caregiver for Zeke. His health while awaiting transplant is a testament to her diligence and hypervigilance in caring for him,” Dr. Zhang says. “She became a part of the care team, and we trusted her.”&nbsp; &nbsp;&nbsp;</p> <p>In the middle of the night, nearly three years after Zeke was listed for transplant, Rayma got the call her family had been waiting so desperately for: The Stanford team had a liver-intestine for Zeke. “When I saw the Palo Alto area code come up on my phone, I thought, ‘This is it!’ My heart went in my throat.”</p> <h3 class="wp-block-heading">A successful multivisceral transplant for Zeke</h3> <p>Zeke’s combined liver-intestinal transplant went perfectly, with just one complication that was easily managed and zero organ rejection. Stanford Children’s prides itself in handling the toughest cases and achieving exceptional outcomes for very sick babies and children.</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="400" height="560" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke6-400x560-1.jpg" alt="Zeke dressed up for Halloween" class="wp-image-27113" style="width:265px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke6-400x560-1.jpg 400w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke6-400x560-1-321x450.jpg 321w" sizes="auto, (max-width: 400px) 100vw, 400px" /></figure></div> <p>Dr. Zhang reveled in replacing Zeke’s old liver, which was brown, thick, and leathery, with a new healthy one. “His donor intestines and liver came together as one unit, called en bloc, and were transplanted together. They were both nice and pink,” she says.</p> <p>Zeke recovered remarkably well. He needed to stay in the hospital just 43 days after transplant, one of the shortest stays ever for an out-of-state patient in the program. A major victory was getting Zeke home for Halloween so he could trick-or-treat as his favorite Paw Patrol character.&nbsp;</p> <p>“Zeke’s care was amazing. Stanford has a different standard of care. You are with them so much that you feel like you are part of their family and they are part of yours. We knew every nurse on the third floor, and we love them and they love us,” Rayma says.</p> <p>When Zeke first came to Stanford Children’s, he would shake from fear due to medical anxiety. Dr. Zhang gave him a special stuffed animal, named Belly Dog. Belly Dog is weighted, and his pressure on Zeke’s chest calms him. The staff also catered to his unique needs as an autistic child, ensuring that he felt comfortable. &nbsp;&nbsp;</p> <p>“He still sleeps with Belly Dog every night,” Rayma says.</p> <div class="wp-block-image"> <figure class="aligncenter size-full is-resized"><img loading="lazy" decoding="async" width="800" height="450" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke12-800x450-1.jpg" alt="Zeke holding Belly Dog while sleeping" class="wp-image-27115" style="width:588px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke12-800x450-1.jpg 800w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke12-800x450-1-450x253.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke12-800x450-1-768x432.jpg 768w" sizes="auto, (max-width: 800px) 100vw, 800px" /></figure></div> <h3 class="wp-block-heading">Home and growing by leaps and bounds</h3> <p>Now that Zeke is home with a working liver and intestine, he is making up for lost time. Rayma quickly got him on formula and off TPN, which frees Zeke from cords and pumps and carrying a machine around in a backpack. He still receives nutrition and medicines through a gastrostomy tube (a tube inserted into the stomach), but he is learning to eat by mouth, a task that can be difficult for kids who never had a chance to practice as babies. Zeke is receiving feeding therapy locally, and Rayma hopes for a day when he can eat all his meals by mouth.</p> <div class="wp-block-image"> <figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="450" height="450" src="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1.jpg" alt="Zeke and Rayma" class="wp-image-27117" style="width:315px;height:auto" srcset="https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1.jpg 450w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-300x300.jpg 300w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-125x125.jpg 125w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-24x24.jpg 24w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-48x48.jpg 48w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-96x96.jpg 96w, https://healthier.stanfordchildrens.org/wp-content/uploads/2025/04/Zeke5-450x450-1-150x150.jpg 150w" sizes="auto, (max-width: 450px) 100vw, 450px" /></figure></div> <p>“Zeke is more vibrant since the transplant. He has progressed so much. I feel like he is growing up fast,” Rayma says.</p> <p>Zeke is nonverbal and has developmental delays, but he communicates through actions, sounds, hugs, and smiles. Since the transplant, he is starting to babble. He has even said a word here and there.</p> <p>“Now that he can absorb nutrition, his brain is waking up and connecting the dots. I think he will be talking soon,” Rayma says. She looks forward to the day when he can go to kindergarten.</p> <p>Dr. Zhang is endlessly amazed by the resiliency of her young patients. And Zeke holds a special place in her heart. “I went through this whole journey with him, and I have about 5,000 pictures of him on my phone. He is the sweetest boy and incredibly strong. I love how he looks at me with those big, beautiful brown eyes,” she says. “I absolutely love him.”</p> <p><a href="https://www.stanfordchildrens.org/en/services/intestinal-transplant.html">Learn more about our Pediatric Intestinal Transplant services &gt;</a></p>